"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,B1,US 6396583 B1,152-200-365-146-634,2002-05-28,2002,US 49526300 A,2000-01-31,US 49526300 A,2000-01-31,Optical fluid sensor,"
    A fluid sensor for determining the presence of fluid in a light-transmissive conduit includes a light emitter and a light detector positioned proximate to the conduit. The light detector is juxtaposed relative to the light emitter to receive light emitted by the light emitter. The light received by the light detector is dependent upon the presence of fluid in the conduit. The light received by the light detector varies due to the different optical properties between a conduit that is empty and one that has fluid in it. The light detector may be a phototransistor whose output is amplified to increase the signal attributable to the presence or absence of fluid in the conduit. The light emitter may be an 
",ETHICON INC,CLARE CHRISTOPHER R,ETHICON INC (2000-07-05),https://lens.org/152-200-365-146-634,Granted Patent,yes,8,114,1,1,0,A61M3/0258;;A61M5/14232;;A61M2205/123;;A61M2205/3355;;A61M2205/3379;;A61M2205/7536;;A61M2206/14;;A61M3/022;;A61M3/0208;;A61M3/0212;;A61M1/742;;A61M1/777;;A61M1/74;;A61M3/0202;;A61M1/77;;A61M3/0201;;A61M1/72;;A61M3/0258;;A61M2206/14;;A61M3/0212;;A61M3/022;;A61M2205/3379;;A61M2205/7536;;A61M5/14232;;A61M2205/123;;A61M2205/3355;;A61M3/0208;;A61M1/74;;A61M1/742;;A61M1/777;;A61M1/77;;A61M3/0202,A61M1/00;;A61M3/02,356/436;;356/440;;604/31;;604/67;;250/576,0,0,,,,EXPIRED
2,AU,A,AU 2002/027584 A,093-915-680-592-504,2002-10-03,2002,AU 2002/027584 A,2002-03-22,US 82338301 A,2001-03-30,Filter for fluid scale,,ETHICON INC,CLARE CHRISTOPHER R,,https://lens.org/093-915-680-592-504,Patent Application,no,0,0,6,6,0,G01G17/04;;G01G19/14;;G01G23/3728;;Y10S128/13;;G01G13/00;;G01G23/3728;;G01G17/04;;G01G19/14;;Y10S128/13,G01G23/37;;A61B19/00;;G01G13/00;;G01G17/04;;G01G19/14,,0,0,,,,EXPIRED
3,AU,B2,AU 779229 B2,089-576-605-185-409,2005-01-13,2005,AU 2002/027584 A,2002-03-22,US 82338301 A,2001-03-30,Filter for fluid scale,,ETHICON INC,CLARE CHRISTOPHER R,,https://lens.org/089-576-605-185-409,Granted Patent,no,1,0,6,6,0,G01G17/04;;G01G19/14;;G01G23/3728;;Y10S128/13;;G01G13/00;;G01G23/3728;;G01G17/04;;G01G19/14;;Y10S128/13,G01G23/37;;A61B19/00;;G01G13/00;;G01G17/04;;G01G19/14,,0,0,,,,EXPIRED
4,US,S,US D0730377 S,005-399-024-870-65X,2015-05-26,2015,US 201329459446 F,2013-06-28,US 201329459446 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,CLARE CHRISTOPHER JAMES,MICROSOFT CORPORATION (2013-08-19),https://lens.org/005-399-024-870-65X,Design Right,no,0,10,1,1,0,,,1404;;D14/486;;D14/488,0,0,,,,ACTIVE
5,KR,A,KR 20020077228 A,077-045-243-448-831,2002-10-11,2002,KR 20020017249 A,2002-03-29,US 82338301 A,2001-03-30,Filter for fluid scale,"PURPOSE: A filter for a fluid scale is provided to stabilize the reading of the scale monitoring the changeable volume of fluid in a fluid receptacle. CONSTITUTION: A scale system for measuring the weight of fluid is composed of a scale(12) hanging a fluid receptacle(16), a supporting body holding objects, a transducer combined to the supporting body to convert force applied to the objects into electric signals, and a digital filter receiving the electric signal from the transducer and suppressing noise in the signals with selected frequency. In additional, the digital filter suppresses oscillations in a weight reading due to the pendulous motion of the fluid receptacle to have rejection notches at the frequencies of weight oscillation.",ETHICON INC,CLARE CHRISTOPHER R,,https://lens.org/077-045-243-448-831,Patent Application,no,0,0,6,6,0,G01G17/04;;G01G19/14;;G01G23/3728;;Y10S128/13;;G01G13/00;;G01G23/3728;;G01G17/04;;G01G19/14;;Y10S128/13,G01G23/37;;A61B19/00;;G01G13/00;;G01G17/04;;G01G19/14,,0,0,,,,DISCONTINUED
6,US,A1,US 2002/0170753 A1,022-051-769-992-490,2002-11-21,2002,US 82338301 A,2001-03-30,US 82338301 A,2001-03-30,Filter for fluid scale,"
   A device for weighing fluid includes a scale from which a fluid receptacle is suspended. Oscillations in the weight reading due to the pendulous motion of the receptacle are suppressed by a digital filter selected to have rejection notches at the frequencies of weight oscillation. 
",ETHICON INC,CLARE CHRISTOPHER R,ETHICON INC (2001-03-23),https://lens.org/022-051-769-992-490,Patent Application,yes,0,17,6,6,0,G01G17/04;;G01G19/14;;G01G23/3728;;Y10S128/13;;G01G13/00;;G01G23/3728;;G01G17/04;;G01G19/14;;Y10S128/13,G01G23/37;;A61B19/00;;G01G13/00;;G01G17/04;;G01G19/14,177/45;;177/185;;177/25.13,0,0,,,,EXPIRED
7,US,B2,US 6590167 B2,186-132-702-894-10X,2003-07-08,2003,US 82338301 A,2001-03-30,US 82338301 A,2001-03-30,Digital filter for fluid scale,"
    A device for weighing fluid includes a scale from which a fluid receptacle is suspended. Oscillations in the weight reading due to the pendulous motion of the receptacle are suppressed by a digital filter selected to have rejection notches at the frequencies of weight oscillation. 
",ETHICON INC,CLARE CHRISTOPHER R,ETHICON INC (2001-03-23),https://lens.org/186-132-702-894-10X,Granted Patent,yes,9,45,6,6,0,G01G17/04;;G01G19/14;;G01G23/3728;;Y10S128/13;;G01G13/00;;G01G23/3728;;G01G17/04;;G01G19/14;;Y10S128/13,G01G23/37;;A61B19/00;;G01G13/00;;G01G17/04;;G01G19/14,177/25.13;;177/185;;177/245;;177/45;;604/500;;604/65;;604/318;;600/584;;X128DIG  13;;702/101,3,0,,,"""The Electrical Engineering Handbook"", Richard Dorf, Ed.; CRC Press, Inc., copyright 1993, pp. 238-240, 242-244, & 250.*;;""Digital Control System Analysis and Design"", Phillips et al., Prentice-Hall, Inc., copyright 1984, pp. 355-368 & 379.*;;An Article entitled ""Digital Filter Designer's Handbook"" by C. Britton Rorabaugh, McGraw Hill, Inc., NY 1993, pp. 271 and 272.",EXPIRED
8,JP,A,JP 2002340663 A,160-545-838-801-39X,2002-11-27,2002,JP 2002096580 A,2002-03-29,US 82338301 A,2001-03-30,FILTER FOR FLUID SCALE,PROBLEM TO BE SOLVED: To provide an equipment for weighing fluids provided with a scale for hanging a fluid container. SOLUTION: Oscillations in weight readout by a pendulum-like motion of the container is restrained by a digital filter selected to have a rejection notch portion in each frequency in the oscillations of the weight value.,ETHICON INC,CLARE CHRISTOPHER R,,https://lens.org/160-545-838-801-39X,Patent Application,no,0,0,6,6,0,G01G17/04;;G01G19/14;;G01G23/3728;;Y10S128/13;;G01G13/00;;G01G23/3728;;G01G17/04;;G01G19/14;;Y10S128/13,G01G23/37;;A61B19/00;;G01G13/00;;G01G17/04;;G01G19/14,,0,0,,,,PENDING
9,EP,A2,EP 1129732 A2,097-782-261-598-222,2001-09-05,2001,EP 01300800 A,2001-01-30,US 49722100 A,2000-01-31,Surgical fluid management system with a dampening chamber,"An apparatus for controlling the volume of surgical fluid present in a cavity(12) of the body during surgery includes a fluid pump (32) for pumping surgical fluid to the cavity via a conduit. A dampener (34) is disposed between the pump and the cavity, with the dampener receiving the fluid output of the pump and having a pressure sensitive volumetric capacity therefor such that variations in output volume of the pump are diminished by the dampener, the output of which is directed to the cavity. The dampener may be in the form of a hollow chamber into which surgical fluid flows trapping a selected quantity of gas thereabove with the gas quantity being determined by a vent valve. A hydrophobic filter or a float valve may be employed as the vent valve.",ETHICON INC,GRIFFITHS STEVE;;CLARE CHRISTOPHER R,,https://lens.org/097-782-261-598-222,Patent Application,yes,0,2,3,3,0,A61M3/0258;;A61M2205/123;;A61M2205/3355;;A61M2205/3379;;A61M2205/7536;;A61M2206/14;;Y10T137/3115;;A61M2205/3341;;A61M3/0208;;A61M3/0212;;A61M3/0216;;A61M3/022;;A61M2205/50;;A61M1/734;;A61M1/732;;A61M1/742;;A61M1/777;;A61M1/74;;A61M1/77;;A61M3/0202;;A61M3/0201;;A61M1/72;;Y10T137/3115;;A61M3/022;;A61M3/0208;;A61M2205/3379;;A61M2205/3341;;A61M2206/14;;A61M2205/3355;;A61M2205/7536;;A61M2205/123;;A61M3/0216;;A61M3/0258;;A61M2205/50;;A61M3/0212;;A61M1/74;;A61M1/742;;A61M1/777;;A61M1/732;;A61M1/734;;A61M1/77;;A61M3/0202,A61M1/00;;A61M3/02,,0,0,,,,DISCONTINUED
10,US,S,US D0725141 S,108-753-993-289-366,2015-03-24,2015,US 201329459435 F,2013-06-28,US 201329459435 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,IZOTOV DMYTRO;;CLARE CHRISTOPHER JAMES,MICROSOFT CORPORATION (2013-08-19),https://lens.org/108-753-993-289-366,Design Right,no,0,4,1,1,0,,,1404;;D14/486,0,0,,,,ACTIVE
11,EP,A3,EP 1129733 A3,113-098-573-105-084,2003-10-15,2003,EP 01300801 A,2001-01-30,US 49500500 A,2000-01-31,Surgical fluid management system with suction control,"Apparatus for controlling the volume of surgical fluid present in a cavity (12) in the body of a patient during surgery includes a conduit to the cavity for conducting the surgical fluid therefrom to at least one receptacle (24), (26) for receiving the fluid from said cavity. A source of vacuum (18) assists in withdrawing fluid from the cavity and a vacuum controller (46) interposed between the vacuum source and the receptacle controls the duration of time the receptacle is exposed to vacuum from the vacuum source. The apparatus preferably has a vacuum sensor (48) for sensing vacuum levels in the receptacle when disconnected from the source of vacuum and shares the source of vacuum with another application, giving priority to maintaining a proper vacuum level in the receptacle.",ETHICON INC,CLARE CHRISTOPHER R;;GRIFFITHS STEVE,,https://lens.org/113-098-573-105-084,Search Report,yes,5,0,3,3,0,A61M3/0258;;A61M2205/123;;A61M2205/3355;;A61M2205/3379;;A61M2205/7536;;A61M2206/14;;Y10T137/86871;;Y10T137/2544;;A61M3/022;;A61M3/0216;;A61M3/0208;;A61M3/0212;;A61M1/742;;A61M1/74;;A61M1/77;;A61M3/0202;;A61M3/0201;;A61M1/72;;Y10T137/86871;;Y10T137/2544;;A61M3/0258;;A61M3/0216;;A61M3/0212;;A61M3/0208;;A61M3/022;;A61M2205/3355;;A61M2205/7536;;A61M2206/14;;A61M2205/123;;A61M2205/3379;;A61M1/74;;A61M1/742;;A61M1/77;;A61M3/0202,A61M1/00;;A61M3/02,,0,0,,,,DISCONTINUED
12,EP,A2,EP 1129733 A2,170-695-429-786-324,2001-09-05,2001,EP 01300801 A,2001-01-30,US 49500500 A,2000-01-31,Surgical fluid management system with suction control,"Apparatus for controlling the volume of surgical fluid present in a cavity (12) in the body of a patient during surgery includes a conduit to the cavity for conducting the surgical fluid therefrom to at least one receptacle (24), (26) for receiving the fluid from said cavity. A source of vacuum (18) assists in withdrawing fluid from the cavity and a vacuum controller (46) interposed between the vacuum source and the receptacle controls the duration of time the receptacle is exposed to vacuum from the vacuum source. The apparatus preferably has a vacuum sensor (48) for sensing vacuum levels in the receptacle when disconnected from the source of vacuum and shares the source of vacuum with another application, giving priority to maintaining a proper vacuum level in the receptacle.",ETHICON INC,CLARE CHRISTOPHER R;;GRIFFITHS STEVE,,https://lens.org/170-695-429-786-324,Patent Application,yes,0,4,3,3,0,A61M3/0258;;A61M2205/123;;A61M2205/3355;;A61M2205/3379;;A61M2205/7536;;A61M2206/14;;Y10T137/86871;;Y10T137/2544;;A61M3/022;;A61M3/0216;;A61M3/0208;;A61M3/0212;;A61M1/742;;A61M1/74;;A61M1/77;;A61M3/0202;;A61M3/0201;;A61M1/72;;Y10T137/86871;;Y10T137/2544;;A61M3/0258;;A61M3/0216;;A61M3/0212;;A61M3/0208;;A61M3/022;;A61M2205/3355;;A61M2205/7536;;A61M2206/14;;A61M2205/123;;A61M2205/3379;;A61M1/74;;A61M1/742;;A61M1/77;;A61M3/0202,A61M1/00;;A61M3/02,,0,0,,,,DISCONTINUED
13,US,B1,US 7204821 B1,046-744-022-411-785,2007-04-17,2007,US 49500500 A,2000-01-31,US 49500500 A,2000-01-31,Surgical fluid management system with suction control,"Apparatus for controlling the volume of surgical fluid present in a cavity in the body of a patient during surgery includes a conduit to the cavity for conducting the surgical fluid therefrom to at least one receptacle for receiving the fluid from said cavity. A source of vacuum assists in withdrawing fluid from the cavity and a vacuum controller interposed between the vacuum source and the receptacle controls the duration of time the receptacle is exposed to vacuum from the vacuum source. The apparatus preferably has a vacuum sensor for sensing vacuum levels in the receptacle when disconnected from the source of vacuum and shares the source of vacuum with another application, giving priority to maintaining a proper vacuum level in the receptacle.",ETHICON INC,CLARE CHRISTOPHER R;;GRIFFITHS STEVE,ETHICON INC (2000-05-22),https://lens.org/046-744-022-411-785,Granted Patent,yes,22,58,3,3,0,A61M3/0258;;A61M2205/123;;A61M2205/3355;;A61M2205/3379;;A61M2205/7536;;A61M2206/14;;Y10T137/86871;;Y10T137/2544;;A61M3/022;;A61M3/0216;;A61M3/0208;;A61M3/0212;;A61M1/742;;A61M1/74;;A61M1/77;;A61M3/0202;;A61M3/0201;;A61M1/72;;Y10T137/86871;;Y10T137/2544;;A61M3/0258;;A61M3/0216;;A61M3/0212;;A61M3/0208;;A61M3/022;;A61M2205/3355;;A61M2205/7536;;A61M2206/14;;A61M2205/123;;A61M2205/3379;;A61M1/74;;A61M1/742;;A61M1/77;;A61M3/0202,A61M1/00;;A61M3/02;;A61M31/00,604/30;;604/67;;137/102;;137/625.47,0,0,,,,EXPIRED
14,US,B1,US 6595957 B1,094-582-715-863-890,2003-07-22,2003,US 49722100 A,2000-01-31,US 49722100 A,2000-01-31,Surgical fluid management system with a dampening chamber,"
    An apparatus for controlling the volume of surgical fluid present in a cavity of the body during surgery includes a fluid pump for pumping surgical fluid to the cavity via a conduit. A dampener is disposed between the pump and the cavity, with the dampener receiving the fluid output of the pump and having a pressure sensitive volumetric capacity, therefor such that variations in output volume of the pump are diminished by the dampener, the output of which is directed to the cavity. The dampener may be in the form of a hollow chamber into which surgical fluid flows trapping a selected quantity of gas thereabove with the gas quantity being determined by a vent valve. A hydrophobic filter or a float valve may be employed as the vent valve. 
",ETHICON INC,GRIFFITHS STEVE;;CLARE CHRISTOPHER R,ETHICON INC (2000-05-22),https://lens.org/094-582-715-863-890,Granted Patent,yes,17,60,3,3,0,A61M3/0258;;A61M2205/123;;A61M2205/3355;;A61M2205/3379;;A61M2205/7536;;A61M2206/14;;Y10T137/3115;;A61M2205/3341;;A61M3/0208;;A61M3/0212;;A61M3/0216;;A61M3/022;;A61M2205/50;;A61M1/734;;A61M1/732;;A61M1/742;;A61M1/777;;A61M1/74;;A61M1/77;;A61M3/0202;;A61M3/0201;;A61M1/72;;Y10T137/3115;;A61M3/022;;A61M3/0208;;A61M2205/3379;;A61M2205/3341;;A61M2206/14;;A61M2205/3355;;A61M2205/7536;;A61M2205/123;;A61M3/0216;;A61M3/0258;;A61M2205/50;;A61M3/0212;;A61M1/74;;A61M1/742;;A61M1/777;;A61M1/732;;A61M1/734;;A61M1/77;;A61M3/0202,A61M1/00;;A61M3/02,604/156;;604/20;;604/131;;604/27;;137/206;;138/30,0,0,,,,EXPIRED
15,EP,A3,EP 1129732 A3,013-139-616-486-204,2003-07-16,2003,EP 01300800 A,2001-01-30,US 49722100 A,2000-01-31,Surgical fluid management system with a dampening chamber,"An apparatus for controlling the volume of surgical fluid present in a cavity(12) of the body during surgery includes a fluid pump (32) for pumping surgical fluid to the cavity via a conduit. A dampener (34) is disposed between the pump and the cavity, with the dampener receiving the fluid output of the pump and having a pressure sensitive volumetric capacity therefor such that variations in output volume of the pump are diminished by the dampener, the output of which is directed to the cavity. The dampener may be in the form of a hollow chamber into which surgical fluid flows trapping a selected quantity of gas thereabove with the gas quantity being determined by a vent valve. A hydrophobic filter or a float valve may be employed as the vent valve.",ETHICON INC,GRIFFITHS STEVE;;CLARE CHRISTOPHER R,,https://lens.org/013-139-616-486-204,Search Report,yes,5,0,3,3,0,A61M3/0258;;A61M2205/123;;A61M2205/3355;;A61M2205/3379;;A61M2205/7536;;A61M2206/14;;Y10T137/3115;;A61M2205/3341;;A61M3/0208;;A61M3/0212;;A61M3/0216;;A61M3/022;;A61M2205/50;;A61M1/734;;A61M1/732;;A61M1/742;;A61M1/777;;A61M1/74;;A61M1/77;;A61M3/0202;;A61M3/0201;;A61M1/72;;Y10T137/3115;;A61M3/022;;A61M3/0208;;A61M2205/3379;;A61M2205/3341;;A61M2206/14;;A61M2205/3355;;A61M2205/7536;;A61M2205/123;;A61M3/0216;;A61M3/0258;;A61M2205/50;;A61M3/0212;;A61M1/74;;A61M1/742;;A61M1/777;;A61M1/732;;A61M1/734;;A61M1/77;;A61M3/0202,A61M1/00;;A61M3/02,,0,0,,,,DISCONTINUED
16,CN,A,CN 113260294 A,170-061-731-343-204,2021-08-13,2021,CN 201980087543 A,2019-11-07,US 201862756760 P;;US 2019/0060233 W,2018-11-07,DEBRIS COMPACTOR FOR A VACUUM CLEANER AND VACUUM CLEANER HAVING THE SAME,"A debris compactor may include an inlet configured to receive debris, an auger chamber having an auger extending therein, and a dust cup disposed at a distal end of the auger chamber. The auger may be configured to urge the debris into the dust cup.",SHARKNINJA OPERATING LLC,CLARE DAVID S;;PINCHES CHRISTOPHER P,,https://lens.org/170-061-731-343-204,Patent Application,no,8,0,6,6,0,A47L9/1608;;A47L9/1683;;A47L9/108;;A47L9/1691;;A47L9/16;;A47L9/1666;;A47L9/122;;A47L9/108;;A47L9/122;;A47L9/16;;A47L9/1608;;A47L9/1666;;A47L9/1683;;A47L9/1691;;A47L9/1683;;A47L9/1608,A47L9/10;;A47L9/00;;A47L9/16;;B01D46/02;;B01D46/10;;B01D46/24;;B01D46/26,,0,0,,,,DISCONTINUED
17,US,A,US 5718719 A,073-078-146-215-660,1998-02-17,1998,US 68602196 A,1996-07-25,US 68602196 A;;US 24322994 A,1994-05-16,Switch apparatus and method for switching between multiple electrodes for diagnostic and therapeutic procedures,"A switch apparatus for performing diagnostic and/or therapeutic procedures on a patient by the use of first and second electrodes which are placed on a patient. A defibrillator unit and another medical device utilizing radio frequency energy from a radio frequency generator unit comprises a multi-function adapter unit. The adapter unit is coupled to the first and second electrodes, to the defibrillator unit and to the electrosurgery unit for switching between the defibrillation unit and another medical device to permit performing diagnostic and therapeutic procedures on the patient.",PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;IMRAN MIR A,,https://lens.org/073-078-146-215-660,Granted Patent,yes,2,40,4,4,0,A61B18/1206;;A61B18/1206;;A61B18/12;;A61B18/12;;A61B18/14;;A61B18/14;;A61B18/16;;A61B18/16;;A61B2018/00178;;A61B2018/00178;;A61B2018/0066;;A61B2018/0066;;A61N1/40;;A61N1/40,A61B18/12;;A61B18/14;;A61B18/16;;A61N1/00;;A61N1/39;;A61N1/40,607/5,0,0,,,,EXPIRED
18,US,A,US 5540722 A,099-923-706-065-824,1996-07-30,1996,US 24322994 A,1994-05-16,US 24322994 A,1994-05-16,Switch apparatus and method for switching between multiple electrodes for diagnostic and therapeutic procedures,A switch apparatus for performing diagnostic and/or therapeutic procedures on a patient by the use of first and second electrodes adapted to be placed on the patient and by the use of a defibrillator unit and another medical device utilizing radiofrequency energy from a radiofrequency generator unit comprising a multi-function adapter unit adapted to be coupled to the first and second electrodes and adapted to be coupled to the defibrillator unit and to the electrosurgery unit for switching between the defibrillation unit and another medical device to permit performing the diagnostic and therapeutic procedures on the patient utilizing the same first and second electrodes.,PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;IMRAN MIR A,PHYSIOMETRIX INC (1994-05-13);;PHYSIOMETRIX INC. A DELAWARE CORPORATION (1996-04-24),https://lens.org/099-923-706-065-824,Granted Patent,yes,2,45,4,4,0,A61B18/1206;;A61B18/1206;;A61B18/12;;A61B18/12;;A61B18/14;;A61B18/14;;A61B18/16;;A61B18/16;;A61B2018/00178;;A61B2018/00178;;A61B2018/0066;;A61B2018/0066;;A61N1/40;;A61N1/40,A61B18/12;;A61B18/14;;A61B18/16;;A61N1/00;;A61N1/39;;A61N1/40,607/5;;128/709,0,0,,,,EXPIRED
19,WO,A1,WO 1995/031248 A1,128-426-094-093-527,1995-11-23,1995,US 9505491 W,1995-05-03,US 24322994 A,1994-05-16,METHOD AND APPARATUS FOR SWITCHING BETWEEN MEDICAL DEVICES,"A switch apparatus (12) for performing diagnostic and/or therapeutic procedures (26, 31) on a patient by the use of first (16) and second (17) electrodes adapted to be placed on the patient and by the use of a defibrillator unit (26) and another medical device (31) utilizing radiofrequency energy from a radiofrequency generator unit comprising a multifunction adapter unit (12) adapted to be coupled to the defibrillator unit and to the electrosurgery unit for switching between the defibrillator unit and another medical device to permit performing the diagnostic and therapeutic procedures on the patient utilizing the same first (16) and second (17) electrodes.",PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;IMRAN MIR A,,https://lens.org/128-426-094-093-527,Patent Application,yes,2,1,4,4,0,A61B18/1206;;A61B18/1206;;A61B18/12;;A61B18/12;;A61B18/14;;A61B18/14;;A61B18/16;;A61B18/16;;A61B2018/00178;;A61B2018/00178;;A61B2018/0066;;A61B2018/0066;;A61N1/40;;A61N1/40,A61B18/12;;A61B18/14;;A61B18/16;;A61N1/00;;A61N1/39;;A61N1/40,,0,0,,,,PENDING
20,AU,A,AU 1995/023734 A,164-551-635-841-291,1995-12-05,1995,AU 1995/023734 A,1995-05-03,US 24322994 A;;US 9505491 W,1994-05-16,Method and apparatus for switching between medical devices,,PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;IMRAN MIR A,,https://lens.org/164-551-635-841-291,Patent Application,no,0,0,4,4,0,A61B18/1206;;A61B18/1206;;A61B18/12;;A61B18/12;;A61B18/14;;A61B18/14;;A61B18/16;;A61B18/16;;A61B2018/00178;;A61B2018/00178;;A61B2018/0066;;A61B2018/0066;;A61N1/40;;A61N1/40,A61B18/12;;A61B18/14;;A61B18/16;;A61N1/00;;A61N1/39;;A61N1/40,,0,0,,,,PENDING
21,GB,B,GB 2593320 B,168-758-269-711-318,2022-11-30,2022,GB 202106460 A,2019-11-07,US 201862756760 P;;US 2019/0060233 W,2018-11-07,Debris compactor for a vacuum cleaner and vacuum cleaner having the same,,SHARKNINJA OPERATING LLC,DAVID S CLARE;;CHRISTOPHER P PINCHES,,https://lens.org/168-758-269-711-318,Granted Patent,no,3,0,6,6,0,A47L9/1608;;A47L9/1683;;A47L9/108;;A47L9/1691;;A47L9/16;;A47L9/1666;;A47L9/122;;A47L9/108;;A47L9/122;;A47L9/16;;A47L9/1608;;A47L9/1666;;A47L9/1683;;A47L9/1691;;A47L9/1683;;A47L9/1608,A47L9/10;;A47L9/00;;A47L9/16;;B01D46/02;;B01D46/10;;B01D46/24;;B01D46/26,,0,0,,,,ACTIVE
22,US,A1,US 2015/0339049 A1,017-824-304-193-286,2015-11-26,2015,US 201414490397 A,2014-09-18,US 201414490397 A;;US 201462002725 P,2014-05-23,INSTANTANEOUS SPEAKING OF CONTENT ON TOUCH DEVICES,"Systems and processes are disclosed for initiating and controlling content speaking on touch-sensitive devices. A gesture can be detected on a touchscreen for causing text to be spoken. Displayed content can be analyzed, and a determination can be made based on size, position, and other attributes as to which portion of displayed text should be spoken. In response to detecting the gesture, the identified portion of text can be spoken using a text-to-speech process. A menu of controls can be displayed for controlling the speaking. The menu can automatically be hidden and a persistent virtual button can be displayed that can remain available on the touchscreen despite the user navigating to another view. Selecting the persistent virtual button can restore the full menu of controls, thereby allowing the user to continue to control the speaking even after navigating away from the content being spoken.",APPLE INC,KASEMSET CLARE T;;FLEIZACH CHRISTOPHER B,APPLE INC (2014-09-10),https://lens.org/017-824-304-193-286,Patent Application,yes,7,234,2,2,0,G10L13/00;;G06F3/04883;;G06F3/167;;G06F3/04886;;G06F3/04883;;G06F3/167;;G06F3/04886;;G06F3/0482;;G10L13/02;;G10L13/00,G06F3/0482;;G06F3/0488;;G06F3/0484;;G06F3/16;;G10L13/02,,0,0,,,,ACTIVE
23,WO,A1,WO 2020/097308 A1,118-594-376-630-159,2020-05-14,2020,US 2019/0060233 W,2019-11-07,US 201862756760 P,2018-11-07,DEBRIS COMPACTOR FOR A VACUUM CLEANER AND VACUUM CLEANER HAVING THE SAME,"A debris compactor may include an inlet configured to receive debris, an auger chamber having an auger extending therein, and a dust cup disposed at a distal end of the auger chamber. The auger may be configured to urge the debris into the dust cup.",SHARKNINJA OPERATING LLC,CLARE DAVID S;;PINCHES CHRISTOPHER P,,https://lens.org/118-594-376-630-159,Patent Application,yes,3,0,6,6,0,A47L9/1608;;A47L9/1683;;A47L9/108;;A47L9/1691;;A47L9/16;;A47L9/1666;;A47L9/122;;A47L9/108;;A47L9/122;;A47L9/16;;A47L9/1608;;A47L9/1666;;A47L9/1683;;A47L9/1691;;A47L9/1683;;A47L9/1608,A47L9/10;;A47L9/00;;A47L9/16;;B01D46/02;;B01D46/10;;B01D46/24;;B01D46/26,,0,0,,,,PENDING
24,GB,A,GB 2593320 A,097-750-677-287-982,2021-09-22,2021,GB 202106460 A,2019-11-07,US 201862756760 P;;US 2019/0060233 W,2018-11-07,Debris compactor for a vacuum cleaner and vacuum cleaner having the same,"A debris compactor may include an inlet configured to receive debris, an auger chamber having an auger extending therein, and a dust cup disposed at a distal end of the auger chamber. The auger may be configured to urge the debris into the dust cup.",SHARKNINJA OPERATING LLC,DAVID S CLARE;;CHRISTOPHER P PINCHES,,https://lens.org/097-750-677-287-982,Patent Application,no,3,0,6,6,0,A47L9/1608;;A47L9/1683;;A47L9/108;;A47L9/1691;;A47L9/16;;A47L9/1666;;A47L9/122;;A47L9/108;;A47L9/122;;A47L9/16;;A47L9/1608;;A47L9/1666;;A47L9/1683;;A47L9/1691;;A47L9/1683;;A47L9/1608,A47L9/10;;A47L9/00;;A47L9/16;;B01D46/02;;B01D46/10;;B01D46/24;;B01D46/26,,0,0,,,,ACTIVE
25,US,A1,US 2020/0138258 A1,126-074-786-176-412,2020-05-07,2020,US 201916676827 A,2019-11-07,US 201916676827 A;;US 201862756760 P,2018-11-07,DEBRIS COMPACTOR FOR A VACUUM CLEANER AND VACUUM CLEANER HAVING THE SAME,"A debris compactor may include an inlet configured to receive debris, an auger chamber having an auger extending therein, and a dust cup disposed at a distal end of the auger chamber. The auger may be configured to urge the debris into the dust cup.",SHARKNINJA OPERATING LLC,CLARE DAVID S;;PINCHES CHRISTOPHER P,SHARKNINJA OPERATING LLC (2019-04-16),https://lens.org/126-074-786-176-412,Patent Application,yes,0,0,6,6,0,A47L9/1608;;A47L9/1683;;A47L9/108;;A47L9/1691;;A47L9/16;;A47L9/1666;;A47L9/122;;A47L9/108;;A47L9/122;;A47L9/16;;A47L9/1608;;A47L9/1666;;A47L9/1683;;A47L9/1691;;A47L9/1683;;A47L9/1608,A47L9/16,,0,0,,,,DISCONTINUED
26,US,B2,US 10592095 B2,095-042-170-633-76X,2020-03-17,2020,US 201414490397 A,2014-09-18,US 201414490397 A;;US 201462002725 P,2014-05-23,Instantaneous speaking of content on touch devices,"Systems and processes are disclosed for initiating and controlling content speaking on touch-sensitive devices. A gesture can be detected on a touchscreen for causing text to be spoken. Displayed content can be analyzed, and a determination can be made based on size, position, and other attributes as to which portion of displayed text should be spoken. In response to detecting the gesture, the identified portion of text can be spoken using a text-to-speech process. A menu of controls can be displayed for controlling the speaking. The menu can automatically be hidden and a persistent virtual button can be displayed that can remain available on the touchscreen despite the user navigating to another view. Selecting the persistent virtual button can restore the full menu of controls, thereby allowing the user to continue to control the speaking even after navigating away from the content being spoken.",APPLE INC,KASEMSET CLARE T;;FLEIZACH CHRISTOPHER B,APPLE INC (2014-09-10),https://lens.org/095-042-170-633-76X,Granted Patent,yes,3071,7,2,2,0,G10L13/00;;G06F3/04883;;G06F3/167;;G06F3/04886;;G06F3/04883;;G06F3/167;;G06F3/04886;;G06F3/0482;;G10L13/02;;G10L13/00,G06F17/00;;G06F3/0482;;G06F3/0488;;G06F3/16;;G10L13/00;;G10L13/02,,917,299,046-797-362-932-711;;052-977-165-653-882;;009-439-131-211-43X;;012-667-080-171-708;;023-633-825-930-611;;060-049-621-750-669;;168-222-257-960-776;;093-749-323-098-937;;001-271-568-835-221;;027-671-321-246-878;;018-048-153-658-513;;168-242-517-034-663;;033-541-178-196-83X;;073-707-130-156-984;;112-259-026-653-362;;070-896-814-559-406;;028-590-986-979-170;;039-139-011-417-47X;;181-772-292-797-828;;034-786-773-887-75X;;059-197-369-579-95X;;088-776-821-353-518;;030-810-498-116-775;;119-642-531-997-998;;115-544-559-568-103;;095-660-235-979-71X;;117-322-792-577-857;;120-366-118-924-653;;010-155-563-031-062;;045-354-925-885-105;;063-440-071-760-555;;023-594-680-814-476;;041-164-046-131-400;;046-244-678-942-799;;023-966-937-073-568;;037-104-823-974-957;;003-359-051-006-083;;022-314-791-223-921;;031-676-088-170-877;;095-263-032-116-149;;064-861-848-506-049;;091-131-661-115-720;;091-525-946-717-081;;057-782-864-180-449;;110-007-247-051-636;;085-290-407-430-267;;031-897-833-293-017;;050-768-644-354-392;;100-018-923-031-771;;196-995-949-147-436;;127-393-340-581-530;;074-495-916-390-988;;031-979-769-088-930;;021-293-454-138-025;;066-974-261-387-435;;045-758-499-542-302;;094-388-759-183-468;;090-335-106-202-305;;099-519-034-044-128;;047-533-149-229-792;;094-697-687-743-014;;099-179-774-731-312;;101-743-038-023-400;;000-370-968-573-205;;077-572-813-468-16X;;007-324-534-359-524;;019-046-683-963-029;;013-751-073-982-981;;167-377-823-610-990;;092-673-674-096-023;;106-552-164-768-630;;110-596-441-495-941;;053-877-450-638-006;;095-925-341-127-159;;158-960-361-051-857;;046-909-167-794-679;;066-434-377-645-523;;000-185-319-333-442;;152-785-292-693-536;;037-718-378-709-720;;145-555-792-553-639;;167-724-453-415-20X;;072-168-397-668-595;;099-816-389-514-96X;;098-303-631-738-428;;058-606-137-831-413;;005-840-178-604-017;;143-519-606-739-763;;014-463-306-251-216;;023-123-773-463-475;;060-132-985-085-855;;016-374-298-211-481;;078-777-190-795-011;;070-782-332-572-696;;149-042-582-765-520;;000-575-398-819-232;;129-748-875-143-038;;028-800-506-989-488;;093-329-059-411-873;;012-695-290-817-093;;047-646-769-122-479;;098-934-052-061-839;;018-079-855-914-149;;071-750-059-850-893;;087-812-765-095-508;;032-805-584-031-862;;080-807-283-385-907;;096-760-534-039-781;;108-795-669-681-679;;057-402-416-770-448;;104-553-773-721-063;;081-024-395-618-600;;011-317-180-495-025;;169-380-977-375-129;;095-226-613-750-452;;108-420-487-862-769;;024-307-545-554-861;;116-061-306-982-584;;118-555-997-256-700;;156-046-912-101-519;;188-964-659-273-176;;013-649-243-040-196;;112-388-702-961-59X;;139-522-667-955-374;;040-798-731-531-902;;095-668-440-499-498;;096-806-551-591-392;;068-078-298-402-755;;090-958-539-770-00X;;044-065-791-071-503;;158-355-644-218-260;;153-341-959-147-146;;101-309-997-772-413;;030-601-863-436-160;;066-238-943-154-350;;034-580-742-762-31X;;046-919-408-855-081;;149-993-485-517-190;;012-588-697-118-83X;;034-399-016-135-024;;083-698-847-485-110;;090-978-960-985-571;;012-217-754-598-882;;002-049-204-526-689;;030-504-198-203-767;;109-076-342-262-507;;086-194-487-964-205;;022-672-016-859-777;;051-187-880-939-115;;017-436-641-817-737;;097-101-155-701-779;;144-837-804-461-424;;004-106-913-247-27X;;035-080-699-079-077;;168-547-477-859-130;;059-111-079-263-674;;119-609-365-875-818;;160-679-542-291-558;;066-009-416-680-35X;;082-860-946-419-254;;057-355-656-121-157;;138-764-299-415-707;;127-533-198-911-501;;001-284-994-386-628;;112-840-706-761-075;;020-940-482-167-968;;080-922-697-001-938;;144-317-880-379-941;;011-669-441-793-864;;039-654-729-232-702;;011-126-156-683-550;;010-727-513-007-823;;024-305-156-382-593;;043-739-408-556-156;;061-704-937-953-889;;033-710-588-123-865;;046-137-609-386-22X;;051-196-256-625-096;;019-306-530-980-029;;138-011-474-979-635;;179-866-072-244-362;;004-684-779-820-331;;056-686-904-235-277;;012-360-025-678-884;;027-287-069-751-840;;000-160-268-358-752;;018-550-930-076-002;;119-874-400-427-728;;138-500-058-438-79X;;011-347-859-684-292;;027-506-196-530-159;;055-857-090-386-574;;001-834-483-769-786;;057-945-182-861-021;;143-826-435-341-290;;068-612-596-123-970;;033-902-001-851-430;;158-741-893-836-196;;032-313-885-866-360;;172-883-501-425-904;;019-077-900-988-495;;016-565-161-559-462;;112-108-268-692-817;;035-184-497-306-290;;012-263-710-852-890;;037-593-432-754-623;;006-960-094-835-988;;112-579-680-800-008;;008-367-460-701-476;;084-647-623-865-559;;057-219-838-610-676;;134-394-924-338-989;;160-329-654-620-491;;095-330-621-931-069;;036-398-228-710-578;;033-037-389-034-301;;151-690-424-857-494;;093-832-440-101-717;;111-506-968-022-66X;;008-708-960-845-751;;025-295-405-104-341;;000-460-975-308-193;;020-577-966-998-22X;;021-364-379-150-889;;017-302-972-695-902;;001-546-863-098-359;;102-248-896-630-547;;162-155-344-435-202;;008-695-767-504-779;;060-399-771-941-030;;000-051-552-113-08X;;087-806-560-571-709;;128-085-707-015-917;;009-924-305-787-99X;;090-893-063-153-254;;031-608-203-140-83X;;052-573-652-484-739;;018-638-996-532-417;;018-638-996-532-417;;081-521-382-267-386;;189-641-992-701-787;;071-403-659-489-839;;012-153-363-623-18X;;113-589-387-894-565;;069-716-449-946-451;;116-059-787-934-088;;018-947-563-548-164;;183-497-020-488-633;;048-560-221-159-46X;;022-589-786-138-645;;116-553-776-811-457;;166-401-515-526-827;;006-139-341-259-489;;084-017-837-470-53X;;094-899-616-189-568;;063-491-355-882-036;;054-476-321-401-749;;088-494-075-679-19X;;074-582-692-197-34X;;000-869-607-418-608;;052-425-092-501-486;;017-690-438-717-38X;;002-276-303-800-831;;059-876-839-611-657;;017-881-554-270-409;;024-330-832-103-09X;;154-925-903-130-500;;155-956-185-710-479;;096-997-572-618-712;;092-372-463-922-234;;134-531-628-661-026;;130-383-607-309-325;;026-861-498-521-063;;030-316-005-196-401;;059-125-873-177-527;;059-123-960-291-919;;095-922-592-428-737;;063-940-035-347-203;;098-088-077-371-921;;095-850-762-176-772;;030-883-457-240-769;;101-762-621-250-540;;033-558-191-033-454;;077-685-545-021-003;;111-823-925-195-607;;096-498-525-771-179;;081-282-094-792-367;;154-156-911-105-90X;;045-575-034-098-254;;000-708-069-186-231;;021-447-546-168-503;;045-124-329-614-014;;189-139-631-322-809;;070-378-883-791-401;;011-787-870-829-260;;040-214-362-914-577;;030-136-936-524-671;;101-906-672-384-59X;;181-072-396-769-365,10.1109/nnsp.1991.239508;;10.3115/1072133.1072149;;10.1145/1989734.1989744;;10.1016/j.specom.2004.09.009;;10.1109/infcom.1990.91356;;10.1109/tassp.1980.1163445;;10.1109/icassp.1996.541117;;10.3115/976815.976834;;10.1007/bf01408590;;10.1109/mc.1987.1663693;;10.1109/assp.1989.28064;;10.1109/icassp.1990.115971;;10.1109/icassp.1991.150483;;10.1109/icassp.1987.1169742;;10.3115/981623.981627;;10.1109/icassp.1995.479676;;10.1145/2402536.2402585;;10.1109/97.661561;;10.21236/ada460973;;10.1109/icassp.1983.1172248;;10.1109/tpami.1983.4767370;;21869099;;10.1109/29.32278;;10.1109/icassp.1988.196628;;10.1109/89.232617;;10.1109/icassp.1988.196504;;10.3115/981967.981975;;10.1109/tpami.1984.4767483;;21869173;;10.1109/89.709671;;10.1109/icassp.1996.540318;;10.1145/279044.279168;;10.1109/89.817455;;10.3115/1072017.1072039;;10.1109/icassp.1998.675355;;10.1145/215585.215978;;10.1109/38.595268;;10.1109/vl.1997.626556;;10.1109/icassp.1986.1169257;;10.1145/800023.808329;;10.1145/99332.99365;;10.1109/tcom.1985.1096372;;10.1145/5401.5403;;10.1145/142750.142982;;10.1109/icassp.1986.1169055;;10.1145/166266.166276;;10.1145/1386352.1386366;;10.1109/acssc.1991.186466;;10.1145/2207676.2208660;;10.1145/319120.319127;;10.1145/223904.223934;;10.1145/22627.22342;;10.1147/sj.203.0321;;10.1016/s0165-1684(00)00028-1;;10.1145/358274.358284;;10.1109/tit.1981.1056410;;10.1145/257089.257285;;10.1109/tassp.1984.1164317;;10.1147/sj.183.0432;;10.1109/icassp.1985.1168103;;10.13182/nse91-a15728;;pmc310826;;10.1101/gr.9.11.1106;;10568750;;10.1145/24919.24928;;10.1145/192426.192501;;10.1109/icassp.1996.541110;;10.1145/223904.223932;;10.1145/238386.238582;;10.1109/assp.1989.28065;;10.1109/infvis.1996.559214;;10.1109/tassp.1982.1163907;;10.1145/223904.223919;;10.1145/192495.192497;;10.1109/icassp.1987.1169530;;10.1109/ijcnn.1992.227109;;10.1109/iscas.1994.409593;;10.1145/237170.237260;;10.1109/icassp.1995.479659;;10.1145/192426.192430;;10.1145/637069.637106;;10.1145/97243.97301;;10.1145/91478.91551;;10.1177/154193129003400429;;10.1145/180171.180173;;10.1109/35.256873;;10.1109/iv.1997.626499;;10.1145/192426.192434;;10.1145/259963.260406;;10.1109/acssc.1991.186554;;10.1006/ijhc.1994.1081;;10.1145/108844.108870;;10.1145/191666.191775;;10.1145/948449.948464;;10.1109/ipcc.1995.554859;;10.1145/192426.192435;;10.1016/b978-0-444-70304-0.50095-9;;10.1177/154193128903300518;;10.1177/154193129003400430;;10.3115/1557856.1557859;;10.1145/166117.166126;;10.1109/icassp.2004.1326656;;10.1147/sj.193.0382;;10.1109/icassp.2010.5495026;;10.1109/86.331560;;10.1109/icassp.1989.266532;;10.1109/icassp.1997.599610;;10.1109/icassp.1992.226015;;10.1109/tencon.1989.176891;;10.1145/91478.91549;;10.1109/ijcnn.1991.170701;;10.1109/2.993771;;10.3115/1075527.1075622;;10.1145/77276.77282;;10.1016/s0020-7373(86)80060-8;;10.1145/319463.319652;;10.1177/154193129203600407;;10.1145/142750.143079;;10.1080/10447318909525956;;10.1145/57167.57171;;10.1145/223355.223745;;10.1145/191666.191776;;10.1109/proc.1976.10158;;10.1109/icassp.1985.1168061;;10.1007/978-0-387-35349-4_2;;10.1145/355324.355328;;10.1007/978-0-387-35175-9_14;;10.1109/icsmc.1991.169837;;10.1145/255950.153577;;10.1145/168642.168652;;10.1109/icassp.1983.1172241;;10.1109/icassp.1985.1168381;;10.1109/tassp.1984.1164346;;10.1006/csla.1994.1005;;10.1145/198366.198384;;10.1145/142750.142763;;10.1145/168642.168650;;10.1109/proc.1975.9799;;10.1145/230562.230577;;10.1145/22949.24053;;10.1109/icassp.2001.940785;;10.1109/tce.1984.354042;;10.1145/65734.65736;;10.1109/iwmc.1992.666170;;10.1007/bf01210503;;10.3115/976973.976994;;10.3115/981574.981608;;10.1109/icassp.1985.1168283;;10.1109/icassp.1984.1172751;;10.1177/107118139704100180;;10.1016/0020-7373(91)90037-8;;10.1080/01449299308924362;;10.1109/icslp.1996.607776;;10.1109/29.90372;;10.1145/238218.238281;;10.1109/vl.1996.545307;;10.1109/52.73754;;10.1109/29.90373;;10.1109/caapwd.1992.217416;;10.1109/icassp.2000.862076;;10.1109/percomw.2004.1276933;;10.1016/0306-4573(90)90006-n;;10.21236/ada177198;;10.1109/ozchi.1996.559981;;10.1109/icassp.1986.1168703;;10.1145/259963.260389;;10.1109/icassp.1992.226506;;10.1145/317426.317435;;10.1109/tassp.1985.1164584;;10.1177/0145482x9909301006;;10.1177/0145482x9909300206;;10.1142/s0218001494000115;;10.1145/223355.223749;;10.1145/99332.99338;;10.1145/358080.358101;;10.1109/tassp.1982.1163960;;10.1109/icassp.1983.1172244;;10.1016/s0167-6393(00)00075-3;;10.1109/18.119739;;10.1109/29.1620;;10.1109/icassp.1991.150392;;10.1109/iwisa.2010.5473702;;10.1147/sj.183.0374;;10.1109/iswc.2002.1167235;;10.1145/1029632.1029674;;10.1109/89.294352;;10.1016/0167-6393(94)90083-3;;10.1109/icassp.1990.115540;;10.3115/1118853.1118859;;10.3115/1117601.1117615;;10.1109/53.54527;;10.1002/j.1538-7305.1983.tb03196.x;;10.3115/974499.974501;;10.1145/317426.317440;;10.1145/238386.238442;;10.1109/icassp.1989.266349;;10.1109/icassp.1979.1170638;;10.1006/csla.1996.0011;;10.1109/tassp.1978.1163055;;10.1016/s0140-3664(97)00027-3;;10.1109/icassp.2000.859190;;10.1007/bfb0027515;;10.1016/s0020-7373(85)80016-x;;10.1109/2.56871;;10.1109/superc.1992.236684;;10.1109/icslp.1996.607449;;10.1007/978-3-540-45218-8_4;;10.1109/icassp.1986.1168676;;10.1007/3-540-59498-1_248;;10.1109/icassp.1999.758143;;10.1145/274946.274954;;10.3115/1034678.1034713;;10.1109/64.546581;;10.1145/309844.309895;;10.1109/tsmc.1980.4308414;;10.1109/tasl.2009.2038810;;10.1016/0167-6393(92)90027-5;;10.1109/wss.2002.1224414;;10.1016/s0959-440x(96)80054-6;;8804820;;10.1145/359545.359550;;10.1109/icassp.1996.541121;;10.3115/1075812.1075857;;10.3115/116580.116621;;10.1145/365153.365168;;10.1109/aiaws.1991.236580;;10.1109/icslp.1996.607739;;10.1145/92755.92769;;10.1007/978-3-642-82815-7_6;;10.1016/b978-0-08-051584-7.50045-0;;10.1109/sipnn.1994.344808;;10.1023/a:1024189224508;;10.1109/icsmc.1990.142109;;10.1109/tassp.1987.1165125;;10.3115/991635.991700;;10.3115/1117755.1117764;;10.1109/2.86837;;10.1109/89.890070;;956516;;10.1121/1.380986;;10.1109/icassp.1990.115557;;10.1016/0004-3702(87)90050-6;;10.1145/122344.122365;;10.1109/icassp.1990.115538;;10.1109/icassp.1990.115538;;10.1145/1017494.1017496;;10.1145/1040830.1040880;;10.1147/sj.393.0617;;10.1109/icassp.1993.319276;;10.1109/tcom.1980.1094577;;10.1109/icassp.1992.225923;;10.1080/088395199117504;;10.1017/s1351324997001344;;10.1007/3-540-46439-5_6;;10.1145/238218.238290;;10.3115/982023.982028;;10.1109/69.54722;;10.1109/mis.1999.757623;;10.1109/lsp.2005.860538;;10.1109/icassp.1990.115777;;10.3115/112405.112418;;10.1109/icassp.1996.540316;;10.1109/89.861370;;10.1145/267658.267731;;10.1109/hicss.1997.661696;;10.1016/j.websem.2007.11.011;;10.4018/jswis.2007010101;;10.1007/11926078_84;;10.1016/s0020-7373(82)80042-4;;10.1109/wi-iatw.2006.27;;10.1145/320251.320253;;2341679;;10.1121/1.399423;;10.1109/icassp.1993.319236;;18276460;;10.1109/72.143374;;10.1109/icassp.1991.150482;;10.1006/csla.1993.1007;;10.21236/ada273556;;10.1007/3-540-48157-5_27;;10.1109/icassp.1994.389339;;10.1109/4.280697;;10.1145/1067627.806607;;10.1109/eit.2007.4374447;;10.1145/358150.358156;;10.1145/5666.5671;;10.1145/143457.371592;;10.1145/1125021.1125103;;10.1109/vl.1993.269620;;10.1109/icassp.1989.266425;;10.1109/msp.2005.1511825;;10.1109/29.61531;;10.1109/89.222873;;10.1109/tce.2011.5955216;;10.1145/1459352.1459355;;10.1145/279044.279172;;10.1145/302979.302981;;10.3115/981574.981582;;10.3115/981732.981748;;10.1145/48511.48518;;10.1109/massp.1984.1162229;;10.1145/1056663.1056723;;10.3115/974194.974201;;10.1016/0004-3702(87)90011-7;;10.1006/knac.1993.1008;;10.1007/bf00130716;;10.1006/ijhc.1995.1081,"“Top 10 Best Practices for Voice User Interface Design” available at <http://www.developer.com/voice/article.php/1567051/Top-10-Best-Practices-for-Voice-UserInterface-Design.htm>, Nov. 1, 2002, 4 pages.;;Combined Search Report and Examination Report under Sections 17 and 18(3) received for GB Patent Application No. 1009318.5, dated Oct. 8, 2010, 5 pages.;;Combined Search Report and Examination Report under Sections 17 and 18(3) received for GB Patent Application No. 1217449.6, dated Jan. 17, 2013, 6 pages.;;Aikawa et al., “Speech Recognition Using Time-Warping Neural Networks”, Proceedings of the 1991, IEEE Workshops on Neural Networks for Signal Processing, 1991, 10 pages.;;Bellegarda et al., “Performance of the IBM Large Vocabulary Continuous Speech Recognition System on the ARPA Wall Street Journal Task”, Signal Processing VII: Theories and Applications, European Association for Signal Processing, 1994, 4 pages.;;Bellegarda et al., “The Metamorphic Algorithm: A Speaker Mapping Approach to Data Augmentation”, IEEE Transactions on Speech and Audio Processing, vol. 2, No. 3, Jul. 1994, 8 pages.;;Belvin et al., “Development of the HRL Route Navigation Dialogue System”, Proceedings of the First International Conference on Human Language Technology Research, Paper, 2001, 5 pages.;;Berry et al., “PTIME: Personalized Assistance for Calendaring”, ACM Transactions on Intelligent Systems and Technology, vol. 2, No. 4, Article 40, Jul. 2011, pp. 1-22.;;Berry et al., “Task Management under Change and Uncertainty Constraint Solving Experience with the CALO Project”, Proceedings of CP'05 Workshop on Constraint Solving under Change, 2005, 5 pages.;;Black et al., “Automatically Clustering Similar Units for Unit Selection in Speech Synthesis”, Proceedings of Eurospeech, vol. 2, 1997, 4 pages.;;Blair et al., “An Evaluation of Retrieval Effectiveness for a Full-Text Document-Retrieval System”, Communications of the ACM, vol. 28, No. 3, Mar. 1985, 11 pages.;;Bobrow et al., “Knowledge Representation for Syntactic/Semantic Processing”, From: AAA-80 Proceedings, Copyright 1980, AAAI, 1980, 8 pages.;;Bouchou et al., “Using Transducers in Natural Language Database Query”, Proceedings of 4th International Conference on Applications of Natural Language to Information Systems, Austria, Jun. 1999, 17 pages.;;Bratt et al., “The SRI Telephone-Based ATIS System”, Proceedings of ARPA Workshop on Spoken Language Technology, 1995, 3 pages.;;Briner, L. L., “Identifying Keywords in Text Data Processing”, In Zelkowitz, Marvin V., Ed, Directions and Challenges, 15th Annual Technical Symposium, Gaithersbury, Maryland, Jun. 17, 1976, 7 pages.;;Bulyko et al., “Error-Correction Detection and Response Generation in a Spoken Dialogue System”, Speech Communication, vol. 45, 2005, pp. 271-288.;;Bulyko et al., “Joint Prosody Prediction and Unit Selection for Concatenative Speech Synthesis”, Electrical Engineering Department, University of Washington, Seattle, 2001, 4 pages.;;Burke et al., “Question Answering from Frequently Asked Question Files”, AI Magazine, vol. 18, No. 2, 1997, 10 pages.;;Burns et al., “Development of a Web-Based Intelligent Agent for the Fashion Selection and Purchasing Process via Electronic Commerce”, Proceedings of the Americas Conference on Information System (AMCIS), Dec. 31, 1998, 4 pages.;;Bussey, et al., “Service Architecture, Prototype Description and Network Implications of a Personalized Information Grazing Service”, INFOCOM'90, Ninth Annual Joint Conference of the IEEE Computer and Communication Societies, Available online at <http://slrohall.com/oublications/>, Jun. 1990, 8 pages.;;Bussler et al., “Web Service Execution Environment (WSMX)”, retrieved from Internet on Sep. 17, 2012, available at <http://www.w3.org/Submission/WSMX>, Jun. 3, 2005, 29 pages.;;Butcher, Mike, “EVI Arrives in Town to go Toe-to-Toe with Siri”, TechCrunch, Jan. 23, 2012, 2 pages.;;Buzo et al., “Speech Coding Based Upon Vector Quantization”, IEEE Transactions on Acoustics, Speech and Signal Processing, vol. Assp-28, No. 5, Oct. 1980, 13 pages.;;Caminero-Gil et al., “Data-Driven Discourse Modeling for Semantic Interpretation”, Proceedings of the IEEE International Conference on Acoustics, Speech and Signal Processing, May 1996, 6 pages.;;Car Working Group, “Hands-Free Profile 1.5 HFP1.5_SPEC”, Bluetooth Doc, available at <www.bluetooth.org>, Nov. 25, 2005, 93 pages.;;Carter, D., “Lexical Acquisition in the Core Language Engine”, Proceedings of the Fourth Conference of the European Chapter of the Association for Computational Linguistics, 1989, 8 pages.;;Carter et al., “The Speech-Language Interface in the Spoken Language Translator”, SRI International, Nov. 23, 1994, 9 pages.;;Cawley, Gavin C. “The Application of Neural Networks to Phonetic Modelling”, PhD. Thesis, University of Essex, Mar. 1996, 13 pages.;;Chai et al., “Comparative Evaluation of a Natural Language Dialog Based System and a Menu Driven System for Information Access: A Case Study”, Proceedings of the International Conference on Multimedia Information Retrieval (RIAO), Paris, Apr. 2000, 11 pages.;;Chang et al., “A Segment-Based Speech Recognition System for Isolated Mandarin Syllables”, Proceedings TENCON '93, IEEE Region 10 Conference on Computer, Communication, Control and Power Engineering, vol. 3, Oct. 1993, 6 pages.;;Chen, Yi, “Multimedia Siri Finds and Plays Whatever You Ask for”, PSFK Report, Feb. 9, 2012, 9 pages.;;Cheyer, Adam, “A Perspective on AI & Agent Technologies for SCM”, VerticalNet Presentation, 2001, 22 pages.;;Cheyer, Adam, “About Adam Cheyer”, available at <http://www.adam.cheyer.com/about.html>, retrieved on Sep. 17, 2012, 2 pages.;;Cheyer et al., “Multimodal Maps: An Agent-Based Approach”, International Conference on Co-operative Multimodal Communication, 1995, 15 pages.;;Cheyer et al., “Spoken Language and Multimodal Applications for Electronic Realties”, Virtual Reality, vol. 3, 1999, pp. 1-15.;;Cheyer et al., “The Open Agent Architecture”, Autonomous Agents and Multi-Agent Systems, vol. 4, Mar. 1, 2001, 6 pages.;;Cheyer et al., “The Open Agent Architecture: Building Communities of Distributed Software Agents”, Artificial Intelligence Center, SRI International, Power Point Presentation, Available online at <http://www.ai.sri.com/-oaa/>, retrieved on Feb. 21, 1998, 25 pages.;;Codd, E. F., “Databases: Improving Usability and Responsiveness—How About Recently”, Copyright 1978, Academic Press, Inc., 1978, 28 pages.;;Cohen et al., “An Open Agent Architecture”, available at <http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.30.480>, 1994, 8 pages.;;Cohen et al., “Voice User Interface Design,”, Excerpts from Chapter 1 and Chapter 10, 2004, 36 pages.;;Coles et al., “Chemistry Question-Answering”, SRI International, Jun. 1969, 15 pages.;;Coles et al., “Techniques for Information Retrieval Using an Inferential Question-Answering System with Natural-Language Input”, SRI International, Nov. 1972, 198 pages.;;Coles et al., “The Application of Theorem Proving to Information Retrieval”, SRI International, Jan. 1971, 21 pages.;;Conklin, Jeff, “Hypertext: An Introduction and Survey”, Computer Magazine, Sep. 1987, 25 pages.;;Connolly et al., “Fast Algorithms for Complex Matrix Multiplication Using Surrogates”, IEEE Transactions on Acoustics, Speech and Signal Processing, vol. 37, No. 6, Jun. 1989, 13 pages.;;Constantinides et al., “A Schema Based Approach to Dialog Control”, Proceedings of the International Conference on Spoken Language Processing, 1998, 4 pages.;;Cox et al., “Speech and Language Processing for Next-Millennium Communications Services”, Proceedings of the IEEE, vol. 88, No. 8, Aug. 2000, 24 pages.;;Craig et al., “Deacon: Direct English Access and Control”, AFIPS Conference Proceedings, vol. 19, San Francisco, Nov. 1966, 18 pages.;;Cutkosky et al., “PACT: An Experiment in Integrating Concurrent Engineering Systems”, Journal & Magazines, Computer, vol. 26, No. 1, Jan. 1993, 14 pages.;;Dar et al., “DTL's DataSpot: Database Exploration Using Plain Language”, Proceedings of the 24th VLDB Conference, New York, 1998, 5 pages.;;Davis et al., “A Personal Handheld Multi-Modal Shopping Assistant”, International Conference on Networking and Services, IEEE, 2006, 9 pages.;;SRI, “SRI Speech: Products: Software Development Kits: EduSpeak”, available at <http://web.archive.org/web/20090828084033/http://www.speechatsri.com/products/eduspeak>shtml, retrieved on Jun. 20, 2013, 2 pages.;;“Mel Scale”, Wikipedia the Free Encyclopedia, Last modified on Oct. 13, 2009 and retrieved on Jul. 28, 2010, available at <http://en.wikipedia.org/wiki/Mel_scale>, 2 pages.;;“Minimum Phase”, Wikipedia the free Encyclopedia, Last modified on Jan. 12, 2010 and retrieved on Jul. 28, 2010, available at <http://en.wikipedia.org/wiki/Minimum_phase>, 8 pages.;;Acero et al., “Environmental Robustness in Automatic Speech Recognition”, International Conference on Acoustics, Speech and Signal Processing (ICASSP'90), Apr. 1990, 4 pages.;;Acero et al., “Robust Speech Recognition by Normalization of the Acoustic Space”, International Conference on Acoustics, Speech and Signal Processing, 1991, 4 pages.;;Agnas et al., “Spoken Language Translator: First-Year Report”, SICS (ISSN 0283-3638), SRI and Telia Research AB, Jan. 1994, 161 pages.;;Ahlbom et al., Modeling Spectral Speech Transitions Using Temporal Decomposition Techniques, IEEE International Conference of Acoustics, Speech and Signal Processing (ICASSP'87), vol. 12, Apr. 1987, 4 pages.;;Alfred App, “Alfred”, available at <http://www.alfredapp.com/>, retrieved on Feb. 8, 2012, 5 pages.;;Allen, J., “Natural Language Understanding”, 2nd Edition, The Benjamin/Cummings Publishing Company, Inc., 1995, 671 pages.;;Alshawi et al., “CLARE: A Contextual Reasoning and Co-operative Response Framework for the Core Language Engine”, SRI International, Cambridge Computer Science Research Centre, Cambridge, Dec. 1992, 273 pages.;;Alshawi et al., “Declarative Derivation of Database Queries from Meaning Representations”, Proceedings of the BANKAI Workshop on Intelligent Information Access, Oct. 1991, 12 pages.;;Alshawi et al., “Logical Forms in the Core Language Engine”, Proceedings of the 27th Annual Meeting of the Association for Computational Linguistics, 1989, pp. 25-32.;;Alshawi et al., “Overview of the Core Language Engine”, Proceedings of Future Generation Computing Systems, Tokyo, 13 pages.;;Alshawi, H., “Translation and Monotonic Interpretation/Generation”, SRI International, Cambridge Computer Science Research Centre, Cambridge, available at <http://www.cam.sri.com/tr/crc024/paper.ps.Z1992>, Jul. 1992, 18 pages.;;Ambite et al., “Design and Implementation of the CALO Query Manager”, American Association for Artificial Intelligence, 2006, 8 pages.;;Ambite et al., “Integration of Heterogeneous Knowledge Sources in the CALO Query Manager”, The 4th International Conference on Ontologies, Databases and Applications of Semantics (ODBASE), 2005, 18 pages.;;Anastasakos et al., “Duration Modeling in Large Vocabulary Speech Recognition”, International Conference on Acoustics, Speech and Signal Processing (ICASSP'95), May 1995, pp. 628-631.;;Anderson et al., “Syntax-Directed Recognition of Hand-Printed Two-Dimensional Mathematics”, Proceedings of Symposium on Interactive Systems for Experimental Applied Mathematics: Proceedings of the Association for Computing Machinery Inc. Symposium, 1967, 12 pages.;;Ansari et al., “Pitch Modification of Speech using a Low-Sensitivity Inverse Filter Approach”, IEEE Signal Processing Letters, vol. 5, No. 3, Mar. 1998, pp. 60-62.;;Anthony et al., “Supervised Adaption for Signature Verification System”, IBM Technical Disclosure, Jun. 1, 1978, 3 pages.;;Appelt et al., “Fastus: A Finite-State Processor for Information Extraction from Real-world Text”, Proceedings of IJCAI, 1993, 8 pages.;;Appelt et al., “SRI International Fastus System MUC-6 Test Results and Analysis”, SRI International, Menlo Park, California, 1995, 12 pages.;;Apple Computer, “Guide Maker User's Guide”, Apple Computer, Inc., Apr. 27, 1994, 8 pages.;;Apple Computer, “Introduction to Apple Guide”, Apple Computer, Inc., Apr. 28, 1994, 20 pages.;;Archbold et al., “A Team Users Guide”, SRI International, Dec. 21, 1981, 70 pages.;;Asanovic et al., “Experimental Determination of Precision Requirements for Back-Propagation Training of Artificial Neural Networks”, Proceedings of the 2nd International Conference of Microelectronics for Neural Networks, 1991, www.ICSI.Berkelev.EDU, 1991, 7 pages.;;Atal et al., “Efficient Coding of LPC Parameters by Temporal Decomposition”, IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP'83), Apr. 1983, 4 pages.;;Bahl et al., “A Maximum Likelihood Approach to Continuous Speech Recognition”, IEEE Transaction on Pattern Analysis and Machine Intelligence, vol. PAMI-5, No. 2, Mar. 1983, 13 pages.;;Bahl et al., “A Tree-Based Statistical Language Model for Natural Language Speech Recognition”, IEEE Transactions on Acoustics, Speech and Signal Processing, vol. 37, No. 7, Jul. 1989, 8 pages.;;Bahl et al., “Acoustic Markov Models Used in the Tangora Speech Recognition System”, Proceeding of International Conference on Acoustics, Speech and Signal Processing (ICASSP'88), vol. 1, Apr. 1988, 4 pages.;;Bahl et al., “Large Vocabulary Natural Language Continuous Speech Recognition”, Proceedings of 1989 International Conference on Acoustics, Speech and Signal Processing, vol. 1, May 1989, 6 pages.;;Bahl et al., “Multonic Markov Word Models for Large Vocabulary Continuous Speech Recognition”, IEEE Transactions on Speech and Audio Processing, vol. 1, No. 3, Jul. 1993, 11 pages.;;Bahl et al., “Speech Recognition with Continuous-Parameter Hidden Markov Models”, Proceeding of International Conference on Acoustics, Speech and Signal Processing (ICASSP'88), vol. 1, Apr. 1988, 8 pages.;;Banbrook, M., “Nonlinear Analysis of Speech from a Synthesis Perspective”, A Thesis Submitted for the Degree of Doctor of Philosophy, The University of Edinburgh, Oct. 15, 1996, 35 pages.;;Bear et al., “A System for Labeling Self-Repairs in Speech”, SRI International, Feb. 22, 1993, 9 pages.;;Bear et al., “Detection and Correction of Repairs in Human-Computer Dialog”, SRI International, May 1992, 11 pages.;;Bear et al., “Integrating Multiple Knowledge Sources for Detection and Correction of Repairs in Human-Computer Dialog”, Proceedings of the 30th Annual Meeting on Association for Computational Linguistics (ACL), 1992, 8 pages.;;Bear et al., “Using Information Extraction to Improve Document Retrieval”, SRI International, Menlo Park, California, 1998, 11 pages.;;Belaid et al., “A Syntactic Approach for Handwritten Mathematical Formula Recognition”, IEEE Transactions on Pattern Analysis and Machine Intelligence, vol. PAMI-6, No. 1, Jan. 1984, 7 pages.;;Bellegarda et al., “A Latent Semantic Analysis Framework for Large-Span Language Modeling”, 5th European Conference on Speech, Communication and Technology (EUROSPEECH'97), Sep. 1997, 4 pages.;;Bellegarda et al., “A Multispan Language Modeling Framework for Large Vocabulary Speech Recognition”, IEEE Transactions on Speech and Audio Processing, vol. 6, No. 5, Sep. 1998, 12 pages.;;Bellegarda et al., “A Novel Word Clustering Algorithm Based on Latent Semantic Analysis”, Proceedings of the IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP'96), vol. 1, 1996, 4 pages.;;Bellegarda et al., “Experiments Using Data Augmentation for Speaker Adaptation”, International Conference on Acoustics, Speech and Signal Processing (ICASSP'95), May 1995, 4 pages.;;Bellegarda, Jerome R., “Exploiting Latent Semantic Information in Statistical Language Modeling”, Proceedings of the IEEE, vol. 88, No. 8, Aug. 2000, 18 pages.;;Bellegarda, Jerome R., “Interaction-Driven Speech Input—A Data-Driven Approach to the Capture of both Local and Global Language Constraints”, available at <http://old.sig.chi.ora/bulletin/1998.2/bellegarda.html>, 1992, 7 pages.;;Bellegarda, Jerome R., “Large Vocabulary Speech Recognition with Multispan Statistical Language Models”, IEEE Transactions on Speech and Audio Processing, vol. 8, No. 1, Jan. 2000, 9 pages.;;Bellegarda et al., “On-Line Handwriting Recognition using Statistical Mixtures”, Advances in Handwriting and Drawings: A Multidisciplinary Approach, Europia, 6th International IGS Conference on Handwriting and Drawing, Paris, France, Jul. 1993, 11 pages.;;Appelt et al., “SRI: Description of the JV-FASTUS System used for MUC-5”, SRI International, Artificial Intelligence Center, 1993, 19 pages.;;Bellegarda, Jerome R., “Exploiting both Local and Global Constraints for Multi-Span Statistical Language Modeling”, Proceeding of the 1998 IEEE International Conference on Acoustics, Speech and Signal Processing (1CASSP'98), vol. 2, May 1998, 5 pages.;;Carpendale et al., “3-Dimensional Pliable Surfaces: For the Effective Presentation of Visual Information”, UIST '95 Proceedings of the 8th Annual ACM Symposium on User Interface and Software Technology, Nov. 14-17, 1995, pp. 217-226.;;Carpendale et al., “Extending Distortion Viewing from 2D to 3D”, IEEE Computer Graphics and Applications, Jul./Aug. 1997, pp. 42-51.;;Carpendale et al., “Making Distortions Comprehensible”, IEEE Proceedings of Symposium on Visual Languages, 1997, 10 pages.;;Casner et al., “N-Way Conferencing with Packet Video”, The Third International Workshop on Packet Video, Mar. 22-23, 1990, pp. 1-6.;;Chakarova et al., “Digital Still Cameras—Downloading Images to a Computer”, Multimedia Reporting and Convergence, available at <http://journalism.berkeley.edu/multimedia/tutorials/stillcams/downloading.html>, retrieved on May 9, 2005, 2 pages.;;Chartier, David, “Using Multi-Network Meebo Chat Service on Your iPhone”, available at <http://www.tuaw.com/2007/07/04/using-multi-network-meebo-chat-service-on-your-iphone/>, Jul. 4, 2007, 5 pages.;;Extended European Search Report (includes European Search Report and European Search Opinion) received for European Patent Application No. 06256215.2, dated Feb. 20, 2007, 6 pages.;;Extended European Search Report (includes Supplementary European Search Report and Search Opinion) received for European Patent Application No. 07863218.9, dated Dec. 9, 2010, 7 pages.;;Extended European Search Report (includes European Search Report and European Search Opinion) received for European Patent Application No. 12186113.2, dated Apr. 28, 2014, 14 pages.;;Extended European Search Report (includes European Search Report and European Search Opinion) received for European Patent Application No. 13155688.8, dated Aug. 22, 2013, 11 pages.;;Abcom Pty. Ltd. “12.1” 925 Candela Mobile PC, LCDHardware.com, available at <http://www.lcdhardware.com/panel/12_1_panel/default.asp.>, retrieved on Dec. 19, 2002, 2 pages.;;Cisco Systems, Inc., “Cisco Unity Unified Messaging User Guide”, Release 4.0(5), Apr. 14, 2005, 152 pages.;;Cisco Systems, Inc., “Installation Guide for Cisco Unity Unified Messaging with Microsoft Exchange 2003/2000 (With Failover Configured)”, Release 4.0(5), Apr. 14, 2005, 152 pages.;;Cisco Systems, Inc., “Operations Manager Tutorial, Cisco's IPC Management Solution”, 2006, 256 pages.;;Coleman, David W., “Meridian Mail Voice Mail System Integrates Voice Processing and Personal Computing”, Speech Technology, vol. 4, No. 2, Mar./Apr. 1988, pp. 84-87.;;COMPAQ, “Personal Jukebox”, available at <http://research.compaq.com/SRC/pjb/>, 2001, 3 pages.;;COMPAQ Inspiration Technology, “Personal Jukebox (PJB)—Systems Research Center and PAAD”, Oct. 13, 2000, 25 pages.;;Conkie et al., “Preselection of Candidate Units in a Unit Selection-Based Text-to-Speech Synthesis System”, ISCA, 2000, 4 pages.;;Conklin, Jeffrey, “A Survey of Hypertext”, MCC Software Technology Program, Dec. 1987, 40 pages.;;Copperi et al., “CELP Coding for High Quality Speech at 8 kbits/s”, Proceedings of IEEE International Acoustics, Speech and Signal Processing Conference, Apr. 1986), as reprinted in Vector Quantization (IEEE Press), 1990, pp. 324-327.;;Corr, Paul, “Macintosh Utilities for Special Needs Users”, available at <http://homepage.mac.com/corrp/macsupt/columns/specneeds.html>, Feb. 1994 (content updated Sep. 19, 1999), 4 pages.;;Creative, “Creative NOMAD MuVo”, available at <http://web.archive.org/web/20041024075901/www.creative.com/products/product.asp?category=213&subcategory=216&product=4983>, retrieved on Jun. 7, 2006, 1 page.;;Creative, “Creative NOMAD MuVo TX”, available at <http://web.archive.org/web/20041024175952/www.creative.com/products/pfriendly.asp?product=9672>, retrieved on Jun. 6, 2006, 1 page.;;Creative, “Digital MP3 Player”, available at <http://web.archive.org/web/20041024074823/www.creative. com/products/product.asp?category=213&subcategory=216&product=4983, 2004, 1 page.;;Creative Technology Ltd., “Creative NOMAD®: Digital Audio Player: User Guide (On-Line Version)”, available at <http://ec1.images-amazon.com/media/i3d/01/A/man-migrate/MANUAL000010757.pdf>, Jun. 1999, 40 pages.;;Creative Technology Ltd., “Creative NOMAD® II: Getting Started—User Guide (On Line Version)”, available at <http://ec1.images-amazon.com/media/i3d/01/A/man-migrate/MANUAL000026434.pdf>, Apr. 2000, 46 pages.;;Creative Technology Ltd., “Nomad Jukebox”, User Guide, Version 1.0, Aug. 2000, 52 pages.;;Croft et al., “Task Support in an Office System”, Proceedings of the Second ACM-SIGOA Conference on Office Information Systems, 1984, pp. 22-24.;;Crowley et al., “MMConf: An Infrastructure for Building Shared Multimedia Applications”, CSCW 90 Proceedings, Oct. 1990, pp. 329-342.;;Cuperman et al., “Vector Predictive Coding of Speech at 16 kbit s/s”, (IEEE Transactions on Communications, Jul. 1985), as reprinted in Vector Quantization (IEEE Press, 1990), 1990, pp. 300-311.;;ABF Software, “Lens—Magnifying Glass 1.5”, available at <http://download.com/3000-2437-10262078.html?tag=1st-0-1>, retrieved on Feb. 11, 2004, 1 page.;;Davis et al., “Stone Soup Translation”, Department of Linguistics, Ohio State University, 2001, 11 pages.;;De Herrera, Chris, “Microsoft ActiveSync 3.1”, Version 1.02, available at <http://www.cewindows.net/wce/activesync3.1.htm>, Oct. 13, 2000, 8 pages.;;Degani et al., “‘Soft’ Controls for Hard Displays: Still a Challenge”, Proceedings of the 36th Annual Meeting of the Human Factors Society, 1992, pp. 52-56.;;Del Strother, Jonathan, “Coverflow”, available at <http://www.steelskies.com/coverflow>, retrieved on Jun. 15, 2006, 14 pages.;;Diamond Multimedia Systems, Inc., “Rio PMP300: User's Guide”, available at <http://ec1.images-amazon.com/media/i3d/01/A/man-migrate/MANUAL000022854.pdf>, 1998, 28 pages.;;Dickinson et al., “Palmtips: Tiny Containers for All Your Data”, PC Magazine, vol. 9, Mar. 1990, p. 218(3).;;Digital Equipment Corporation, “OpenVMS RTL DECtalk (DTK$) Manual”, May 1993, 56 pages.;;Donahue et al., “Whiteboards: A Graphical Database Tool”, ACM Transactions on Office Information Systems, vol. 4, No. 1, Jan. 1986, pp. 24-41.;;Dourish et al., “Portholes: Supporting Awareness in a Distributed Work Group”, CHI 1992;, May 1992, pp. 541-547.;;Abut et al., “Low-Rate Speech Encoding Using Vector Quantization and Subband Coding”, (Proceedings of the IEEE International Acoustics, Speech and Signal Processing Conference, Apr. 1986), as reprinted in Vector Quantization IEEE Press, 1990, pp. 312-315.;;dyslexic.com, “AlphaSmart 3000 with CoWriter SmartApplet: Don Johnston Special Needs”, available at <http://www.dyslexic.com/procuts.php?catid-2&pid=465&PHPSESSID=2511b800000f7da>, retrieved on Dec. 6, 2005, 13 pages.;;Edwards, John R., “Q&A: Integrated Software with Macros and an Intelligent Assistant”, Byte Magazine, vol. 11, No. 1, Jan. 1986, pp. 120-122.;;Egido, Carmen, “Video Conferencing as a Technology to Support Group Work: A Review of its Failures”, Bell Communications Research, 1988, pp. 13-24.;;Elliot, Chip, “High-Quality Multimedia Conferencing Through a Long-Haul Packet Network”, BBN Systems and Technologies, 1993, pp. 91-98.;;Elliott et al., “Annotation Suggestion and Search for Personal Multimedia Objects on the Web”, CIVR, Jul. 7-9, 2008, pp. 75-84.;;Elofson et al., “Delegation Technologies: Environmental Scanning with Intelligent Agents”, Jour. of Management Info. Systems, Summer 1991, vol. 8, No. 1, 1991, pp. 37-62.;;Eluminx, “Illuminated Keyboard”, available at <http://www.elumix.com/>, retrieved on Dec. 19, 2002, 1 page.;;Engst, Adam C., SoundJam Keeps on Jammin, available at <http://db.tidbits.com/getbits.acgi?tbart=05988>, Jun. 19, 2000, 3 pages.;;Ericsson Inc., “Cellular Phone with Integrated MP3 Player”, Research Disclosure Journal No. 41815, Feb. 1999, 2 pages.;;Eslambolchilar et al., “Making Sense of Fisheye Views”, Second Dynamics and Interaction Workshop at University of Glasgow, Aug. 2005, 6 pages.;;Eslambolchilar et al., “Multimodal Feedback for Tilt Controlled Speed Dependent Automatic Zooming”, UIST'04, Oct. 24-27, 2004, 2 pages.;;Fanty et al., “A Comparison of DFT, PLP and Cochleagram for Alphabet Recognition”, IEEE, Nov. 1991.;;Findlater et al., “Beyond QWERTY: Augmenting Touch-Screen Keyboards with Multi-Touch Gestures for Non-Alphanumeric Input”, CHI '12, Austin, Texas, USA, May 5-10, 2012, 4 pages.;;Fisher et al., “Virtual Environment Display System”, Interactive 3D Graphics, Oct. 23-24, 1986, pp. 77-87.;;Forsdick, Harry, “Explorations into Real-Time Multimedia Conferencing”, Proceedings of the Ifip Tc 6 International Symposium on Computer Message Systems, 1986, 331 pages.;;Furnas et al., “Space-Scale Diagrams: Understanding Multiscale Interfaces”, CHI '95 Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, 1995, pp. 234-241.;;Furnas, George W., “Effective View Navigation”, Proceedings of the ACM SIGCHI Conference on Human Factors in Computing Systems, Mar. 1997, pp. 367-374.;;Furnas, George W., “Generalized Fisheye Views”, CHI '86 Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, vol. 17, No. 4, Apr. 1986, pp. 16-23.;;Furnas, George W., “The Fisheye Calendar System”, Bellcore Technical Memorandum, Nov. 19, 1991.;;Gardner, Jr., P. C., “A System for the Automated Office Environment”, IBM Systems Journal, vol. 20, No. 3, 1981, pp. 321-345.;;Garretson, R., “IBM Adds ‘Drawing Assistant’ Design Tool to Graphic Series”, PC Week, vol. 2, No. 32, Aug. 13, 1985, 1 page.;;Gaver et al., “One Is Not Enough: Multiple Views in a Media Space”, INTERCHI, Apr. 24-29, 1993, pp. 335-341.;;Gaver et al., “Realizing a Video Environment: EuroPARC's RAVE System”, Rank Xerox Cambridge EuroPARC, 1992, pp. 27-35.;;Giachin et al., “Word Juncture Modeling Using Inter-Word Context-Dependent Phone-Like Units”, Cselt Technical Reports, vol. 20, No. 1, Mar. 1992, pp. 43-47.;;Gillespie, Kelly, “Adventures in Integration”, Data Based Advisor, vol. 9, No. 9, Sep. 1991, pp. 90-92.;;Gillespie, Kelly, “Internationalize Your Applications with Unicode”, Data Based Advisor, vol. 10, No. 10, Oct. 1992, pp. 136-137.;;Gilloire et al., “Innovative Speech Processing for Mobile Terminals: An Annotated Bibliography”, Signal Processing, vol. 80, No. 7, Jul. 2000, pp. 1149-1166.;;Glinert-Stevens, Susan, “Microsoft Publisher: Desktop Wizardry”, PC Sources, vol. 3, No. 2, Feb. 1992, 1 page.;;Gmail, “About Group Chat”, available at <http://mail.google.com/support/bin/answer.py?answer=81090>, Nov. 26, 2007, 2 pages.;;Goldberg, Cheryl, “IBM Drawing Assistant: Graphics for the EGA”, PC Magazine, vol. 4, No. 26, Dec. 24, 1985, 1 page.;;Good et al., “Building a User-Derived Interface”, Communications of the ACM; (Oct. 1984) vol. 27, No. 10, Oct. 1984, pp. 1032-1043.;;Gray et al., “Rate Distortion Speech Coding with a Minimum Discrimination Information Distortion Measure”, (IEEE Transactions on Information Theory, Nov. 1981), as reprinted in Vector Quantization (IEEE Press), 1990, pp. 208-221.;;Greenberg, Saul, “A Fisheye Text Editor for Relaxed-WYSIWIS Groupware”, CHI '96 Companion, Vancouver, Canada, Apr. 13-18, 1996, 2 pages.;;Griffin et al., “Signal Estimation From Modified Short-Time Fourier Transform”, IEEE Transactions on Acoustics, Speech and Signal Processing, vol. ASSP-32, No. 2, Apr. 1984, pp. 236-243.;;Gruhn et al., “A Research Perspective on Computer-Assisted Office Work”, IBM Systems Journal, vol. 18, No. 3, 1979, pp. 432-456.;;Hain et al., “The Papageno TTS System”, Siemens AG, Corporate Technology, Munich, Germany TC-STAR Workshop, 2006, 6 pages.;;Halbert, D. C., “Programming by Example”, Dept. Electrical Engineering and Comp. Sciences, University of California, Berkley, Nov. 1984, pp. 1-76.;;Hall, William S., “Adapt Your Program for Worldwide Use with Windows.TM. Internationalization Support”, Microsoft Systems Journal, vol. 6, No. 6, Nov./Dec. 1991, pp. 29-58.;;Haoui et al., “Embedded Coding of Speech: A Vector Quantization Approach”, (Proceedings of the IEEE International Acoustics, Speech and Signal Processing Conference, Mar. 1985), as reprinted in Vector Quantization (IEEE Press, 1990), 1990, pp. 297-299.;;Hartson et al., “Advances in Human-Computer Interaction”, Chapters 1, 5, and 6, vol. 3, 1992, 121 pages.;;Heger et al., “KNOWBOT: An Adaptive Data Base Interface”, Nuclear Science and Engineering, V. 107, No. 2, Feb. 1991, pp. 142-157.;;Hendrix et al., “The Intelligent Assistant: Technical Considerations Involved in Designing Q&A's Natural-Language Interface”, Byte Magazine, Issue 14, Dec. 1987, 1 page.;;Heyer et al., “Exploring Expression Data: Identification and Analysis of Coexpressed Genes”, Genome Research, vol. 9, 1999, pp. 1106-1115.;;Hill, R. D., “Some Important Features and Issues in User Interface Management System”, Dynamic Graphics Project, University of Toronto, CSRI, vol. 21, No. 2, Apr. 1987, pp. 116-120.;;Hinckley et al., “A Survey of Design Issues in Spatial Input”, UIST '94 Proceedings of the 7th Annual ACM Symposium on User Interface Software and Technology, 1994, pp. 213-222.;;Hiroshi, “TeamWork Station: Towards a Seamless Shared Workspace”, NTT Human Interface Laboratories, CSCW 90 Proceedings, Oct. 1990, pp. 13-26.;;Holmes, “Speech System and Research”, 1955, pp. 129-135, 152-153.;;Hon et al., “Towards Large Vocabulary Mandarin Chinese Speech Recognition”, Conference on Acoustics, Speech, and Signal Processing, ICASSP-94, IEEE International, vol. 1, Apr. 1994, pp. 545-548.;;Hopper, Andy, “Pandora—An Experimental System for Multimedia Applications”, Olivetti Research Laboratory, Apr. 1990, pp. 19-34.;;Howard, John H., “(Abstract) An Overview of the Andrew File System”, Information Technology Center, Carnegie Mellon University; (CMU-ITC-88-062) to Appear in a future issue of the ACM Transactions on Computer Systems, 1988, pp. 1-6.;;Huang et al., “Real-Time Software-Based Video Coder for Multimedia Communication Systems”, Department of Computer Science and Information Engineering, 1993, 10 pages.;;Hukin, R. W., “Testing an Auditory Model by Resynthesis”, European Conference on Speech Communication and Technology, Sep. 26-29, 1989, pp. 243-246.;;Hunt, “Unit Selection in a Concatenative Speech Synthesis System Using a Large Speech Database”, Copyright 1996 IEEE. “To appear in Proc. ICASSP-96, May 7-10, Atlanta, GA” ATR Interpreting Telecommunications Research Labs, Kyoto Japan, 1996, pp. 373-376.;;IBM, “Why Buy: ThinkPad”, available at <http://www.pc.ibm.com/us/thinkpad/easeofuse.html>, retrieved on Dec. 19, 2002, 2 pages.;;IBM Corporation, “Simon Says Here's How”, Users Manual, 1994, 3 pages.;;ICHAT AV, “Video Conferencing for the Rest of Us”, Apple—Mac OS X—iChat AV, available at <http://www.apple.com/macosx/features/ichat/>, retrieved on Apr. 13, 2006, 3 pages.;;IPhone Hacks, “Native iPhone MMS Application Released”, available at <http://www.iphonehacks.com/2007/12/iphone-mms-app.html>, retrieved on Dec. 25, 2007, 5 pages. et al.",ACTIVE
27,CN,U,CN 212368881 U,015-275-472-878-813,2021-01-19,2021,CN 201921909601 U,2019-11-07,US 201862756760 P,2018-11-07,"Scrap compactor, collecting system for collecting scraps and vacuum cleaner","The invention relates to a scrap compactor, a collecting system for collecting scraps and a vacuum cleaner. The debris compactor may include an inlet configured to receive debris, a twist drill chamber having a twist drill extending in the twist drill chamber, and a dust collection cup disposed at a distal end of the twist drill chamber. The auger may be configured to push debris into the dust collection cup.",SHARKNINJA OPERATING LLC,CLARE DAVID S;;CHRISTOPHER P PINCHES,,https://lens.org/015-275-472-878-813,Limited Patent,no,0,2,6,6,0,A47L9/1608;;A47L9/1683;;A47L9/108;;A47L9/1691;;A47L9/16;;A47L9/1666;;A47L9/122;;A47L9/108;;A47L9/122;;A47L9/16;;A47L9/1608;;A47L9/1666;;A47L9/1683;;A47L9/1691;;A47L9/1683;;A47L9/1608,A47L9/16,,0,0,,,,ACTIVE
28,AT,T1,AT E433988 T1,004-436-342-234-273,2009-07-15,2009,AT 05701927 T,2005-01-18,GB 0401088 A;;GB 2005000161 W,2004-01-19,PHOSPHORAMIDATDERIVATE,"The present invention provides a phosphoramidate compound having the structure (I) wherein X comprises a monosaccharide group comprising the structure (II) or (III) or a pharmaceutically acceptable salt, ester or salt of such ester. The present invention also provides processes for the production of (I) and uses thereof.",UNIV CARDIFF,MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE;;CURTIS CLARE LOUISE,,https://lens.org/004-436-342-234-273,Granted Patent,no,0,0,12,12,0,C07H11/04;;Y02P20/55;;A61P19/02;;A61P21/00;;A61P25/00;;A61P25/28;;A61P29/00;;A61P35/00;;A61P43/00;;A61P3/10;;C07H11/04;;Y02P20/55,C07H11/04,,0,0,,,,INACTIVE
29,US,A1,US 2017/0357389 A1,091-990-400-939-700,2017-12-14,2017,US 201715609777 A,2017-05-31,US 201715609777 A;;US 201662348885 P,2016-06-11,"Device, Method, and Graphical User Interface for Media Playback in an Accessibility Mode","In accordance with some embodiments, a method is performed at a device, coupled to a display, with one or more processors and non-transitory memory. The method includes displaying, on the display, a plurality of user interface objects. The method includes detecting a selection input while a first user interface object of the plurality of user interface objects has accessibility focus. In response to detecting the selection user input, the method includes displaying, on the display, an accessibility menu for the first user interface object including one or more selectable options for interacting with the first user interface object and a selectable option for displaying a virtual remote. The method includes detecting a virtual remote activation input while the selectable option for displaying the virtual remote has accessibility focus. In response to detecting the virtual remote activation input, the method includes displaying, on the display, a virtual remote including a plurality of virtual remote user interface objects.",APPLE INC,FLEIZACH CHRISTOPHER BRIAN;;KASEMSET CLARE T;;MINIFIE DARREN CHRISTOPHER,APPLE INC (2017-06-12),https://lens.org/091-990-400-939-700,Patent Application,yes,0,12,2,2,0,G06F3/0482;;G06F3/0482;;G06F3/0485;;G06F3/0485;;G06F3/0488;;G06F3/0488;;H04N21/42204;;H04N21/42204,G06F3/0482;;G06F3/0485;;G06F3/0488,,0,0,,,,ACTIVE
30,US,B2,US 10353550 B2,014-757-231-435-03X,2019-07-16,2019,US 201715609777 A,2017-05-31,US 201715609777 A;;US 201662348885 P,2016-06-11,"Device, method, and graphical user interface for media playback in an accessibility mode","In accordance with some embodiments, a method is performed at a device, coupled to a display, with one or more processors and non-transitory memory. The method includes displaying, on the display, a plurality of user interface objects. The method includes detecting a selection input while a first user interface object of the plurality of user interface objects has accessibility focus. In response to detecting the selection user input, the method includes displaying, on the display, an accessibility menu for the first user interface object including one or more selectable options for interacting with the first user interface object and a selectable option for displaying a virtual remote. The method includes detecting a virtual remote activation input while the selectable option for displaying the virtual remote has accessibility focus. In response to detecting the virtual remote activation input, the method includes displaying, on the display, a virtual remote including a plurality of virtual remote user interface objects.",APPLE INC,FLEIZACH CHRISTOPHER BRIAN;;KASEMSET CLARE T;;MINIFIE DARREN CHRISTOPHER,APPLE INC (2017-06-12),https://lens.org/014-757-231-435-03X,Granted Patent,yes,18,1,2,2,0,G06F3/0482;;G06F3/0482;;G06F3/0485;;G06F3/0485;;G06F3/0488;;G06F3/0488;;H04N21/42204;;H04N21/42204,G06F3/0482;;G06F3/0485;;G06F3/0488;;H04N5/44;;H04N21/422,,0,0,,,,ACTIVE
31,DK,T3,DK 1709056 T3,151-396-999-535-819,2009-08-10,2009,DK 05701927 T,2005-01-18,GB 0401088 A;;GB 2005000161 W,2004-01-19,Phosphoramidatderivater,"The present invention provides a phosphoramidate compound having the structure (I) wherein X comprises a monosaccharide group comprising the structure (II) or (III) or a pharmaceutically acceptable salt, ester or salt of such ester. The present invention also provides processes for the production of (I) and uses thereof.",UNIV CARDIFF,MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE ELIZABETH;;CURTIS CLARE LOUISE,,https://lens.org/151-396-999-535-819,Granted Patent,no,0,0,12,12,0,C07H11/04;;Y02P20/55;;A61P19/02;;A61P21/00;;A61P25/00;;A61P25/28;;A61P29/00;;A61P35/00;;A61P43/00;;A61P3/10;;C07H11/04;;Y02P20/55,C07H11/04;;A61K31/7024;;A61P29/00,,0,0,,,,ACTIVE
32,US,A1,US 2007/0275910 A1,162-885-430-505-312,2007-11-29,2007,US 58610105 A,2005-01-18,GB 0401088 A;;GB 2005000161 W,2004-01-19,Phosphoramidate Derivatives,"The present invention provides a phosphoramidate compound comprising the structure (I) Formula (I) wherein: X comprises a monosaccharide group comprising the structure (II) or (III), 8 Formula (II), (III) B and B are independently selected from the group consisting of —O—, —CH 2 — and a bond, preferably —O—; R 1 is selected from the group consisting of —H, protecting groups and monovalent hydrocarbon radicals; R 2 and R 3 are independently selected from the group consisting of —H and monovalent hydrocarbon radicals, or R 2 and R 3 together form an alkylene or heteroalkylene chain so as to provide, together with the C atom to which they are attached, a cyclic system; R 4 is selected from the group consisting of —H and monovalent hydrocarbon radicals; R 5 -R 12 are independently selected from the group consisting of —H, —OH, N 3 , halogen, —SH, —OR 13 , —SR 13′ , NHR 14 , —NR 14 2 and group Formula (I) wherein B″ is selected from the group consisting of —O—, —CH 2 — and a bond, preferably —O—; R 1 -R 4 are independently selected and are as defined above, wherein R 13 and R 13′ are independently selected from the group consisting of —H, monovalent hydrocarbon radicals, protecting groups and —C(O)R 15 , and wherein R 14 is selected from the group consisting of —H, monovalent hydrocarbon radicals, protecting groups and —C(O)R 15 , wherein R 15 is selected from the group consisting of —H and monovalent hydrocarbon radicals; or a pharmaceutically acceptable derivative or metabolite of a compound of formula (I). The present invention also provides processes for the production of (I) and uses thereof.",MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE E;;CURTIS CLARE L,MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE E;;CURTIS CLARE L,UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (2006-10-18),https://lens.org/162-885-430-505-312,Patent Application,yes,1,2,12,12,0,C07H11/04;;Y02P20/55;;A61P19/02;;A61P21/00;;A61P25/00;;A61P25/28;;A61P29/00;;A61P35/00;;A61P43/00;;A61P3/10;;C07H11/04;;Y02P20/55,A61K31/70;;A61P3/10;;A61P19/02;;A61P25/28;;A61P35/00;;A61P43/00;;C07H1/06;;C07H11/04,514/25;;536/127;;536/17.1,0,0,,,,INACTIVE
33,EP,A1,EP 1709056 A1,107-026-851-353-097,2006-10-11,2006,EP 05701927 A,2005-01-18,GB 2005000161 W;;GB 0401088 A,2004-01-19,PHOSPHORAMIDATE DERIVATIVES,"The present invention provides a phosphoramidate compound having the structure (I) wherein X comprises a monosaccharide group comprising the structure (II) or (III) or a pharmaceutically acceptable salt, ester or salt of such ester. The present invention also provides processes for the production of (I) and uses thereof.",UNIV CARDIFF,MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE ELIZABETH;;CURTIS CLARE LOUISE,UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (2009-06-03),https://lens.org/107-026-851-353-097,Patent Application,yes,0,1,12,12,0,C07H11/04;;Y02P20/55;;A61P19/02;;A61P21/00;;A61P25/00;;A61P25/28;;A61P29/00;;A61P35/00;;A61P43/00;;A61P3/10;;C07H11/04;;Y02P20/55,C07H11/04;;A61K31/7024;;A61P29/00,,0,0,,,,ACTIVE
34,EP,B1,EP 1709056 B1,170-961-528-789-036,2009-06-17,2009,EP 05701927 A,2005-01-18,GB 2005000161 W;;GB 0401088 A,2004-01-19,PHOSPHORAMIDATE DERIVATIVES,"The present invention provides a phosphoramidate compound having the structure (I) wherein X comprises a monosaccharide group comprising the structure (II) or (III) or a pharmaceutically acceptable salt, ester or salt of such ester. The present invention also provides processes for the production of (I) and uses thereof.",UNIV CARDIFF,MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE ELIZABETH;;CURTIS CLARE LOUISE,UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (2009-06-03),https://lens.org/170-961-528-789-036,Granted Patent,yes,2,0,12,12,0,C07H11/04;;Y02P20/55;;A61P19/02;;A61P21/00;;A61P25/00;;A61P25/28;;A61P29/00;;A61P35/00;;A61P43/00;;A61P3/10;;C07H11/04;;Y02P20/55,C07H11/04;;A61K31/7024;;A61P29/00,,0,0,,,,ACTIVE
35,US,B2,US 8119779 B2,030-646-587-900-789,2012-02-21,2012,US 58610105 A,2005-01-18,GB 0401088 A;;GB 2005000161 W,2004-01-19,Phosphoramidate derivatives,"The present invention provides a phosphoramidate compound having the structure (I) wherein X comprises a monosaccharide group comprising the structure (II) or (III) or a pharmaceutically acceptable salt, ester or salt of such ester. The present invention also provides processes for the production of (I) and uses thereof.",MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE ELIZABETH;;CURTIS CLARE LOUISE;;UNIV CARDIFF,MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE ELIZABETH;;CURTIS CLARE LOUISE,UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (2006-10-18),https://lens.org/030-646-587-900-789,Granted Patent,yes,10,30,12,12,0,C07H11/04;;Y02P20/55;;A61P19/02;;A61P21/00;;A61P25/00;;A61P25/28;;A61P29/00;;A61P35/00;;A61P43/00;;A61P3/10;;C07H11/04;;Y02P20/55,C07H5/04;;C07H1/00;;C07H3/00;;C07H5/06;;C07H11/04;;C08B37/00,536/18.7;;536/124,5,1,040-895-383-437-294,10.1021/jm800594c;;18714981,"McGuigan et al., ""Phosphate Prodrugs Derived from N-Acetylglucosamine Have Enhanced Chrondroprotective Activity in Explant Cultures and Represent a New Lead in Antisteoarthritis Drug Discovery,"" J. Medicinal Chemistry, 51(18), 5807-5812 (2008): WEB publ. Aug. 21, 2008.;;International Search Report: PCT/GB2005/000161 filed Jan. 18, 2005, mailed Jun. 6, 2005.;;International Preliminary Report on Patentability: PCT/GB2005/000161 filed Jan. 18, 2005, issued Jul. 24, 2005.;;Written Opinion of the International Searching Authority: PCT/GB2005/000161 filed Jan. 18,2005.;;Search Report for corresponding GB patent application No. 0401088.0, dated May 14, 2004.",INACTIVE
36,DE,D1,DE 602005014936 D1,054-012-783-660-459,2009-07-30,2009,DE 602005014936 T,2005-01-18,GB 0401088 A;;GB 2005000161 W,2004-01-19,PHOSPHORAMIDATDERIVATE,"The present invention provides a phosphoramidate compound having the structure (I) wherein X comprises a monosaccharide group comprising the structure (II) or (III) or a pharmaceutically acceptable salt, ester or salt of such ester. The present invention also provides processes for the production of (I) and uses thereof.",UNIV CARDIFF,MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE ELIZABETH;;CURTIS CLARE LOUISE,,https://lens.org/054-012-783-660-459,Granted Patent,no,0,0,12,12,0,C07H11/04;;Y02P20/55;;A61P19/02;;A61P21/00;;A61P25/00;;A61P25/28;;A61P29/00;;A61P35/00;;A61P43/00;;A61P3/10;;C07H11/04;;Y02P20/55,C07H11/04;;A61K31/7024;;A61P29/00,,0,0,,,,ACTIVE
37,WO,A1,WO 2005/070944 A1,089-953-790-902-65X,2005-08-04,2005,GB 2005000161 W,2005-01-18,GB 0401088 A,2004-01-19,PHOSPHORAMIDATE DERIVATIVES,"The present invention provides a phosphoramidate compound comprising the structure (I) Formula (I)wherein: X comprises a monosaccharide group comprising the structure (II) or (III),8Formula (II) , (III) B and B are independently selected from the group consisting of -O-, -CH2- and a bond, preferably -O-; R1 is selected from the group consisting of -H, protecting groups and monovalent hydrocarbon radicals; R2 and R3 are independently selected from the group consisting of -H and monovalent hydrocarbon radicals, or R2 and R3 together form an alkylene or heteroalkylene chain so as to provide, together with the C atom to which they are attached, a cyclic system; R4 is selected from the group consisting of -H and monovalent hydrocarbon radicals; R5-R12 are independently selected from the group consisting of -H, -OH, N3, halogen, -SH,-OR13, -SR13&apos;, -NHR14, -NR142 and group Formula (1) wherein B' is selected from the group consisting of -O-, -CH2- and a bond, preferably -O-; R1-R4 are independently selected and are as defined above, wherein R13 and R13&rsquo; are independently selected from the group consisting of -H, monovalent hydrocarbon radicals, protecting groups and -C(O)R15, and wherein R14 is selected from the group consisting of -H, monovalent hydrocarbon radicals, protecting groups and -C(O)R15, wherein R15 is selected from the group consisting of -H and monovalent hydrocarbon radicals; or a pharmaceutically acceptable derivative or metabolite of a compound of formula (I). The present invention also provides processes for the production of (I) and uses thereof.",UNIV CARDIFF;;MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE ELIZABETH;;CURTIS CLARE LOUISE,MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE ELIZABETH;;CURTIS CLARE LOUISE,,https://lens.org/089-953-790-902-65X,Patent Application,yes,2,6,12,12,0,C07H11/04;;Y02P20/55;;A61P19/02;;A61P21/00;;A61P25/00;;A61P25/28;;A61P29/00;;A61P35/00;;A61P43/00;;A61P3/10;;C07H11/04;;Y02P20/55,C07H11/04,,0,0,,,,PENDING
38,JP,A,JP 2009171584 A,062-030-302-033-788,2009-07-30,2009,JP 2009007339 A,2009-01-16,GB 0801019 A,2008-01-18,FEMTOCELL DEVICE,"<P>PROBLEM TO BE SOLVED: To provide a femtocell device which allows providing simultaneous access to both of open subscriber groups and closed subscriber groups. <P>SOLUTION: There is provided a femtocell device for communicating with one or more user devices in a communication network. The network has a plurality of subchannels available for communication, in which the femtocell device is adapted to use a first subset of the plurality of subchannels to communicate with the user devices that are in a closed subscriber group of the femtocell device and present within a first area, and to use a second subset of the plurality of subchannels to communicate with other user devices. <P>COPYRIGHT: (C)2009,JPO&INPIT",PICOCHIP DESIGNS LTD,SMART CHRISTOPHER BRIAN;;SOMERVILLE FIONA CLARE ANGHARA,,https://lens.org/062-030-302-033-788,Patent Application,no,4,3,11,11,0,H04W4/06;;H04W16/12;;H04W16/24;;H04W84/045;;H04L12/56;;H04W16/12;;H04W16/24;;H04W4/06;;H04W84/045,H04W16/16;;H04W16/32,,3,0,,,"JPN6013003651; ＮＴＴ ＤｏＣｏＭｏ， Ｔ-Ｍｏｂｉｌｅ: 'Ｃｌａｒｉｆｉｃａｔｉｏｎ ｏｆ Ｈｏｍｅ ｅＮＢ ｓｃｅｎａｒｉｏｓ ａｎｄ ｉｓｓｕｅｓ ｆｏｒ ＲＡＮ２／３／４' ３ＧＰＰ ＴＳＧ ＲＡＮ ＷＧ２ ＃６０ Ｔｄｏｃ-Ｒ２-０７５１５１ , 20071109, ３ＧＰＰ;;JPN6013003652; 小西聡他１名: 'Ｂ-５-５９ ＯＦＤＭＡ系セルラシステム用Ｆｒａｃｔｉｏｎａｌ Ｆｒｅｑｕｅｎｃｙ Ｒｅｕｓｅに関す' 電子情報通信学会２００７年通信ソサイエティ大会講演論文集１ , 20070829, 第３８１頁, 社団法人電子情報通信学会;;CSNJ200810003381; 小西聡他１名: 'Ｂ-５-５９ ＯＦＤＭＡ系セルラシステム用Ｆｒａｃｔｉｏｎａｌ Ｆｒｅｑｕｅｎｃｙ Ｒｅｕｓｅに関す' 電子情報通信学会２００７年通信ソサイエティ大会講演論文集１ , 20070829, 第３８１頁, 社団法人電子情報通信学会",INACTIVE
39,GB,B,GB 2456572 B,088-275-965-878-852,2012-03-14,2012,GB 0801019 A,2008-01-18,GB 0801019 A,2008-01-18,Femtocell device,,PICOCHIP DESIGNS LTD,SMART CHRISTOPHER BRIAN;;SOMERVILLE FIONA CLARE ANGHARAD,,https://lens.org/088-275-965-878-852,Granted Patent,no,1,0,11,11,0,H04W4/06;;H04W16/12;;H04W16/24;;H04W84/045;;H04L12/56;;H04W16/12;;H04W16/24;;H04W4/06;;H04W84/045,H04L12/56,,0,0,,,,INACTIVE
40,US,S,US D0725140 S,161-601-170-128-448,2015-03-24,2015,US 201329459425 F,2013-06-28,US 201329459425 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,IZOTOV DMYTRO;;CLARE CHRISTOPHER JAMES;;REHBERG TORSTEN,MICROSOFT CORPORATION (2013-08-19),https://lens.org/161-601-170-128-448,Design Right,no,0,18,1,1,0,,,1404;;D14/486,0,0,,,,ACTIVE
41,US,S,US D0734358 S,010-657-737-310-708,2015-07-14,2015,US 201329459433 F,2013-06-28,US 201329459433 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,REHBERG TORSTEN;;IZOTOV DMYTRO;;CLARE CHRISTOPHER JAMES,MICROSOFT CORPORATION (2013-08-19),https://lens.org/010-657-737-310-708,Design Right,no,0,87,1,1,0,,,1404;;D14/488;;D14/487;;D14/492,0,0,,,,ACTIVE
42,ES,T3,ES 2328495 T3,109-894-215-979-913,2009-11-13,2009,ES 05701927 T,2005-01-18,GB 0401088 A,2004-01-19,DERIBADOS DE FOSFORAMIDATO.,"The present invention provides a phosphoramidate compound having the structure (I) wherein X comprises a monosaccharide group comprising the structure (II) or (III) or a pharmaceutically acceptable salt, ester or salt of such ester. The present invention also provides processes for the production of (I) and uses thereof.",UNIV CARDIFF,MCGUIGAN CHRISTOPHER;;CARANGIO ANTONELLA;;CATERSON BRUCE;;HUGHES CLARE ELIZABETH;;CURTIS CLARE LOUISE,,https://lens.org/109-894-215-979-913,Granted Patent,no,0,0,12,12,0,C07H11/04;;Y02P20/55;;A61P19/02;;A61P21/00;;A61P25/00;;A61P25/28;;A61P29/00;;A61P35/00;;A61P43/00;;A61P3/10;;C07H11/04;;Y02P20/55,C07H11/04;;A61K31/7024;;A61P29/00,,0,0,,,,ACTIVE
43,GB,A,GB 2456572 A,190-730-539-063-799,2009-07-22,2009,GB 0801019 A,2008-01-18,GB 0801019 A,2008-01-18,Femtocell device,"A femtocell device for communicating with one or more user devices in a communication network, the network having a plurality of subchannels available for transmissions, wherein the femtocell device is adapted to use a first subset of the plurality of subchannels for communicating with user devices that are in a closed subscriber group of the femtocell device and within a first area, and a second subset of the plurality of subchannels for communicating with other user devices.",PICOCHIP DESIGNS LTD,SMART CHRISTOPHER BRIAN;;SOMERVILLE FIONA CLARE ANGHARA,,https://lens.org/190-730-539-063-799,Patent Application,no,1,2,11,11,0,H04W4/06;;H04W16/12;;H04W16/24;;H04W84/045;;H04L12/56;;H04W16/12;;H04W16/24;;H04W4/06;;H04W84/045,H04L12/56,,0,0,,,,INACTIVE
44,US,B2,US 8160011 B2,098-976-318-974-447,2012-04-17,2012,US 35500209 A,2009-01-16,GB 0801019 A,2008-01-18,Femtocell device,"There is provided a femtocell device for communicating with one or more user devices in a communication network, the network having a plurality of subchannels available for transmissions, wherein the femtocell device is adapted to use a first subset of the plurality of subchannels for communicating with user devices that are in a closed subscriber group of the femtocell device and within a first area, and a second subset of the plurality of subchannels for communicating with other user devices.",SMART CHRISTOPHER BRIAN;;SOMERVILLE FIONA CLARE ANGHARAD;;PICOCHIP LTD,SMART CHRISTOPHER BRIAN;;SOMERVILLE FIONA CLARE ANGHARAD,MINDSPEED TECHNOLOGIES U.K. LIMITED (2012-03-08);;INTEL CORPORATION (2014-02-04),https://lens.org/098-976-318-974-447,Granted Patent,yes,7,0,11,11,0,H04W4/06;;H04W16/12;;H04W16/24;;H04W84/045;;H04L12/56;;H04W16/12;;H04W16/24;;H04W4/06;;H04W84/045,H04B14/08,370/329;;370/338,3,1,017-870-602-051-777,10.1109/pimrc.2007.4394515,"European Extended Search Report for Application No. 09150654.3-2412/2081408, dated Mar. 23, 2011.;;Holger Claussen, Bell Laboratories, Alcatel-Lucent; ""Performance of Macro and Co-Channel Femtocells in a Hierarchical Cell Structure""; The 18th Annual IEEE International Symposium on Personal, Indoor and Mobile Radio Communications (PIMRC'07); Sep. 1, 2007; pp. 1-5, XP031168593, ISBN: 978-1-4244-1143-6; Swindon, United Kingdom.;;UK Search Report for Application No. GB0801019.1, dated Apr. 28, 2008.",ACTIVE
45,US,S,US D0729832 S,009-939-690-161-847,2015-05-19,2015,US 201329459438 F,2013-06-28,US 201329459438 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,IZOTOV DMYTRO;;CLARE CHRISTOPHER JAMES;;REHBERG TORSTEN,MICROSOFT CORPORATION (2013-08-19),https://lens.org/009-939-690-161-847,Design Right,no,0,1,1,1,0,,,1404;;D14/486,0,0,,,,ACTIVE
46,US,S,US D0725139 S,034-693-783-730-921,2015-03-24,2015,US 201329459421 F,2013-06-28,US 201329459421 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,IZOTOV DMYTRO;;REHBERG TORSTEN;;CLARE CHRISTOPHER JAMES,MICROSOFT CORPORATION (2013-08-19),https://lens.org/034-693-783-730-921,Design Right,no,0,8,1,1,0,,,1404;;D14/486,0,0,,,,ACTIVE
47,US,A1,US 2009/0187690 A1,152-289-000-472-035,2009-07-23,2009,US 35500209 A,2009-01-16,GB 0801019 A,2008-01-18,FEMTOCELL DEVICE,"There is provided a femtocell device for communicating with one or more user devices in a communication network, the network having a plurality of subchannels available for transmissions, wherein the femtocell device is adapted to use a first subset of the plurality of subchannels for communicating with user devices that are in a closed subscriber group of the femtocell device and within a first area, and a second subset of the plurality of subchannels for communicating with other user devices.",SMART CHRISTOPHER BRIAN;;SOMERVILLE FIONA CLARE ANGHARA,SMART CHRISTOPHER BRIAN;;SOMERVILLE FIONA CLARE ANGHARA,MINDSPEED TECHNOLOGIES U.K. LIMITED (2012-03-08);;INTEL CORPORATION (2014-02-04),https://lens.org/152-289-000-472-035,Patent Application,yes,5,11,11,11,0,H04W4/06;;H04W16/12;;H04W16/24;;H04W84/045;;H04L12/56;;H04W16/12;;H04W16/24;;H04W4/06;;H04W84/045,G06F13/00,710/105,0,0,,,,ACTIVE
48,WO,A2,WO 2006/067520 A2,008-069-705-992-537,2006-06-29,2006,GB 2005050219 W,2005-11-30,GB 0428191 A,2004-12-23,DIGITAL SIGNAL PROCESSING METHODS AND APPARATUS,"This invention relates to a method of digitally processing data in a data array defining a target matrix (X) using non-negative matrix factorisation to determine a pair of matrices (F, G), a first matrix of said pair determining a set of features for representing said data, a second matrix of said pair determining weights of said features, such that a product of said first and second matrices approximates said target matrix, the method comprising: inputting said target matrix data (X); selecting a row of said one of said first and second matrices and a column of the other of said first and second matrices; determining a target contribution (R) of said selected row and column to said target matrix; determining, subject to a non- negativity constraint, updated values for said selected row and column from said target contribution; and repeating said selecting and determining for the other rows and columns of said first and second matrices until all said rows and columns have been updated. The invention is applicable to multi-line addressing (MLA) techniques for displays such as passive-matrix OLED displays.",CAMBRIDGE DISPLAY TECH LTD;;SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,,https://lens.org/008-069-705-992-537,Patent Application,yes,0,13,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32,,0,0,,,,PENDING
49,EP,A1,EP 1545754 A1,043-482-673-191-150,2005-06-29,2005,EP 03750468 A,2003-08-29,EP 03750468 A;;EP 0309665 W;;EP 02256859 A,2002-10-02,METHOD FOR CONTROLLING DROPLET SIZE OF AN EMULSION WHEN MIXING TWO IMMISCIBLE FLUIDS,,UNILEVER NV;;UNILEVER PLC,CLARE HUGH;;PEARSON CHRISTOPHER ANTHONY;;SHANKS IAN ALEXANDER,UNILEVER PLC (2006-02-22);;UNILEVER N.V. (2006-02-22),https://lens.org/043-482-673-191-150,Patent Application,yes,0,0,6,6,0,B01F23/4111;;B01F25/31421;;B01F31/83;;B01F31/85;;B01F25/31421;;B01F23/4111;;B01F31/83;;B01F31/85,B01J19/10;;C09K23/00,,0,0,,,,DISCONTINUED
50,EP,A4,EP 2713864 A4,042-412-448-651-974,2014-12-03,2014,EP 12794026 A,2012-06-01,US 201161492136 P;;US 2012/0040581 W,2011-06-01,SYSTEM AND METHOD FOR POWER-EFFICIENT TRANSMISSION OF EMG DATA,,TECH TEAM LLC,CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN,,https://lens.org/042-412-448-651-974,Search Report,no,3,0,7,7,0,A61B5/6833;;A61B5/7405;;A61B5/742;;A61B5/0022;;A61B2562/0215;;G16H40/67;;A61B5/224;;A61B5/296;;G16Z99/00;;A61B5/742;;A61B5/6833;;A61B5/0022;;A61B5/7405;;A61B2562/0215;;G16H40/67;;A61B5/296;;G16Z99/00;;A61B5/224;;A61B5/1107,A61B5/296;;A61B5/00;;A61B5/22;;G16Z99/00,,1,0,,,See also references of WO 2012167177A1,DISCONTINUED
51,GB,B,GB 2421604 B,180-785-837-467-236,2007-03-07,2007,GB 0524337 A,2005-11-30,GB 0428191 A,2004-12-23,Digital Image Display Methods and Apparatus,,CAMBRIDGE DISPLAY TECH LTD,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,,https://lens.org/180-785-837-467-236,Granted Patent,no,3,0,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32;;G09G3/36,G4A ACX           CX;;G5C CHBH          CHBH,3,0,,,"Nature, Vol. 401, 21 October 1991, pages 788-791.;;Advances in Neural Information Processing Systems, Vol. 13, 2001, pages 556-562.;;S. Shahnaz et al., ""Document Clustering using Nonnegative Matrix Factorization"" [online], 13 August 2004. Available from http://www.math.wfu.edu/publications/plemmons/documentclustering.pdf [Accessed 16 Mar 2006].",INACTIVE
52,CN,B,CN 101278282 B,002-431-656-460-577,2012-09-05,2012,CN 200580048603 A,2005-11-30,GB 2005050219 W;;GB 0428191 A,2004-12-23,Digital signal processing methods and apparatus,"This invention generally relates to methods, apparatus and computer program for processing digital data using non-negative matrix factorisation. A method of digitally processing data in a data array defining a target matrix (X) using non-negative matrix factorisation to determine a pair of matrices (F, G), a first matrix of said pair determining a set of features for representing said data, a second matrix of said pair determining weights of said features, such that a product of said first and second matrices approximates said target matrix, the method comprising: inputting said target matrixdata (X); selecting a row of said one of said first and second matrices and a column of the other of said first and second matrices; determining a target contribution (R) of said selected row and column to said target matrix; determining, subject to a non- negativity constraint, updated values for said selected row and column from said target contribution; and repeating said selecting and determining for the other rows and columns of said first and second matrices until all said rows and columns have been updated.",CAMBRIDGE DISPLAY TECH LTD,CLARE FODEN;;RICHARD ROUTLEY PAUL;;CHRISTOPHER SMITH EUAN,,https://lens.org/002-431-656-460-577,Granted Patent,no,0,1,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32,,0,0,,,,INACTIVE
53,KR,A,KR 20060073489 A,036-923-313-853-357,2006-06-28,2006,KR 20050128058 A,2005-12-22,GB 0428191 A,2004-12-23,DIGITAL SIGNAL PROCESSING METHODS AND APPARATUS,,CAMBRIDGE DISPLAY TECH LTD,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,,https://lens.org/036-923-313-853-357,Patent Application,no,0,0,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G09G3/20;;G06F17/16;;G09G3/30;;G09G3/32;;H04N5/272,,0,0,,,,INACTIVE
54,WO,A1,WO 2012/167177 A1,107-174-847-140-747,2012-12-06,2012,US 2012/0040581 W,2012-06-01,US 201161492136 P,2011-06-01,SYSTEM AND METHOD FOR POWER-EFFICIENT TRANSMISSION OF EMG DATA,"The system for displaying muscle force data includes a wearable patch and a remote visual display. The wearable patch carries electrodes suitable for sensing electromyographic signals on the skin of the patient. The patch carries circuitry which converts the detected electromyographic signal to a digital output which can be transmitted to the remote visual display. The circuitry relies on filtering to produce a usable digital signal at very low power consumption. The transmitted signal can be used to drive a variety of visual displays, including a conventional hand-held personal communicators and entertainment devices which had been programmed to suitably process the visual display.",TECH TEAM LLC;;CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN,CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN,,https://lens.org/107-174-847-140-747,Patent Application,yes,29,3,7,7,0,A61B5/6833;;A61B5/7405;;A61B5/742;;A61B5/0022;;A61B2562/0215;;G16H40/67;;A61B5/224;;A61B5/296;;G16Z99/00;;A61B5/742;;A61B5/6833;;A61B5/0022;;A61B5/7405;;A61B2562/0215;;G16H40/67;;A61B5/296;;G16Z99/00;;A61B5/224;;A61B5/1107,A61B5/296;;G16Z99/00,,1,0,,,See also references of EP 2713864A4,PENDING
55,CN,A,CN 1688381 A,191-158-595-090-881,2005-10-26,2005,CN 03823618 A,2003-08-29,EP 02256859 A,2002-10-02,Method for controlling droplet size of an emulsion when mixing two immiscible fluids,,UNILEVER NV,HUGH CLARE;;ANTHONY PEARSON CHRISTOPHER;;ALEXANDER SHANKS IAN,,https://lens.org/191-158-595-090-881,Patent Application,no,0,1,6,6,0,B01F23/4111;;B01F25/31421;;B01F31/83;;B01F31/85;;B01F25/31421;;B01F23/4111;;B01F31/83;;B01F31/85,C09K23/00;;B01J19/10,,0,0,,,,DISCONTINUED
56,WO,A3,WO 2006/067520 A3,071-294-155-909-238,2008-04-10,2008,GB 2005050219 W,2005-11-30,GB 0428191 A,2004-12-23,DIGITAL SIGNAL PROCESSING METHODS AND APPARATUS,"This invention relates to a method of digitally processing data in a data array defining a target matrix (X) using non-negative matrix factorisation to determine a pair of matrices (F, G), a first matrix of said pair determining a set of features for representing said data, a second matrix of said pair determining weights of said features, such that a product of said first and second matrices approximates said target matrix, the method comprising: inputting said target matrix data (X); selecting a row of said one of said first and second matrices and a column of the other of said first and second matrices; determining a target contribution (R) of said selected row and column to said target matrix; determining, subject to a non- negativity constraint, updated values for said selected row and column from said target contribution; and repeating said selecting and determining for the other rows and columns of said first and second matrices until all said rows and columns have been updated. The invention is applicable to multi-line addressing (MLA) techniques for displays such as passive-matrix OLED displays.",CAMBRIDGE DISPLAY TECH LTD;;SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,,https://lens.org/071-294-155-909-238,Search Report,yes,4,0,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32,,7,3,175-669-239-103-281;;080-006-460-871-501;;000-741-954-960-28X,10.1016/j.csda.2006.11.006;;10.1889/1.2785234;;10.1007/978-3-540-72845-0_26,"LIU W ET AL: ""Existing and new algorithms for non-negative matrix factorization"", FINAL REPORT CS 383C PROJECT, DEPARTEMENT OF COMPUTER SCIENCE, UNIVERSITY OF TEXAS, AUSTION, USA, 26 August 2004 (2004-08-26), XP002468343, Retrieved from the Internet <URL:http://web.archive.org/web/20040826233249/www.cs.utexas.edu/users/liuwg/383CProject/final_report.pdf> [retrieved on 20080206];;CHU M ET AL: ""Optimality, computation, and interpretation of nonnegative matrix factorizations (Version: October 18, 2004)"", 18 October 2004 (2004-10-18), pages 1 - 18, XP002468344, Retrieved from the Internet <URL:http://www.wfu.edu/~plemmons/papers/chu_ple.pdf> [retrieved on 20080206];;TROPP J A: ""Literature Survey: Non-negative matrix factorization"", PREPRINT, UNIVERSITY OF TEXAS AT AUSTIN, 2003, XP002468345, Retrieved from the Internet <URL:http://www.acm.caltech.edu/~jtropp/notes/Tro03-Literature-Survey.pdf> [retrieved on 20080207];;LEE D D ET AL: ""Algorithms for non-negative matrix factorization"", PROCEEDINGS OF THE 2000 CONFERENCE ON ADVANCES IN NEURAL INFORMATION PROCESSING SYSTEMS, 2000, XP002468346, Retrieved from the Internet <URL:http://books.nips.cc/papers/files/nips13/LeeSeung.pdf> [retrieved on 20080208];;BERRY ET AL: ""Algorithms and applications for approximate nonnegative matrix factorization"", COMPUTATIONAL STATISTICS AND DATA ANALYSIS, vol. 52, no. 1, 30 August 2007 (2007-08-30), pages 155 - 173, XP022222910, ISSN: 0167-9473;;SMITH E C: ""Total Matrix Addressing"", SID 2007 INTERNATIONAL SYMPOSIUM DIGEST OF TECHNICAL PAPERS, 2007, pages 93 - 96, XP008088356;;EISENBRAND F ET AL: ""Algorithms for longer OLED lifetime"", 6TH WORKSHOP ON EXPERIMENTAL ALGORITHMS WEA 2007, LECTURE NOTES IN COMPUTER SCIENCE, vol. 4525, 2007, pages 338 - 351, XP019060471, ISBN: 978-3-540-72844-3",PENDING
57,TW,A,TW 200634595 A,073-194-429-807-752,2006-10-01,2006,TW 94143130 A,2005-12-07,GB 0428191 A,2004-12-23,Digital signal processing methods and apparatus,"This invention generally relates to methods, apparatus and computer program code processing digital data using non-negative matrix factorisation. A method of digitally processing data in a data array defining a target matrix (X) using non-negative matrix factorisation to determine a pair of matrices (F, G), a first matrix of said pair determining a set of features for representing said data, a second matrix of said pair determining weights of said features, such that a product of said first and second matrices approximates said target matrix, the method comprising: inputting said target matrix data (X); selecting a row of said one of said first and second matrices and a column of the other of said first and second matrices; determining a target contribution (R) of said selected row and column to said target matrix; determining, subject to a non-negativity constraint. updated values for said selected row and column from said target contribution; and repeating said selecting and determining for the other rows and columns of said first and second matrices until alf said rows and columns have been updated.",CAMBRIDGE DISPLAY TECH LTD,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,,https://lens.org/073-194-429-807-752,Patent of Addition,no,0,2,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32,,0,0,,,,INACTIVE
58,US,B2,US 8768428 B2,152-565-163-599-514,2014-07-01,2014,US 201213486257 A,2012-06-01,US 201213486257 A;;US 201161492136 P,2011-06-01,System and method for power-efficient transmission of EMG data,"The system for displaying muscle force data includes a wearable patch and a remote visual display. The wearable patch carries electrodes suitable for sensing electromyographic signals on the skin of the patient. The patch carries circuitry which converts the detected electromyographic signal to a digital output which can be transmitted to the remote visual display. The circuitry relies on filtering to produce a usable digital signal at very low power consumption. The transmitted signal can be used to drive a variety of visual displays, including a conventional hand-held personal communicators and entertainment devices which had been programmed to suitably process the visual display.",CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN;;TECH TEAM LLC,CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN,TECH TEAM LLC (2012-06-06),https://lens.org/152-565-163-599-514,Granted Patent,yes,36,9,7,7,0,A61B5/6833;;A61B5/7405;;A61B5/742;;A61B5/0022;;A61B2562/0215;;G16H40/67;;A61B5/224;;A61B5/296;;G16Z99/00;;A61B5/742;;A61B5/6833;;A61B5/0022;;A61B5/7405;;A61B2562/0215;;G16H40/67;;A61B5/296;;G16Z99/00;;A61B5/224;;A61B5/1107,A61B5/296;;G16Z99/00,600/384;;600/382;;600/393;;607/115,2,1,055-865-692-278-589,10.1016/s1050-6411(14)00006-6,"""Standards for Reporting EMG Data"" Dr. Roberto Merletti. Journal of Electromyography and Kinesiology. 1999.;;International search report and written opinion dated Sep. 7, 2012 for PCT Application No. US2012/40581.",ACTIVE
59,US,A1,US 2015/0051471 A1,138-952-923-289-731,2015-02-19,2015,US 201414285363 A,2014-05-22,US 201414285363 A;;US 201213486257 A;;US 201161492136 P,2011-06-01,SYSTEM AND METHOD FOR POWER-EFFICIENT TRANSMISSION OF EMG DATA,"The system for displaying muscle force data includes a wearable patch and a remote visual display. The wearable patch carries electrodes suitable for sensing electromyographic signals on the skin of the patient. The patch carries circuitry which converts the detected electromyographic signal to a digital output which can be transmitted to the remote visual display. The circuitry relies on filtering to produce a usable digital signal at very low power consumption. The transmitted signal can be used to drive a variety of visual displays, including a conventional hand-held personal communicators and entertainment devices which had been programmed to suitably process the visual display.",TECH TEAM LLC,CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN,TECH TEAM LLC (2012-06-06),https://lens.org/138-952-923-289-731,Patent Application,yes,0,2,7,7,0,A61B5/6833;;A61B5/7405;;A61B5/742;;A61B5/0022;;A61B2562/0215;;G16H40/67;;A61B5/224;;A61B5/296;;G16Z99/00;;A61B5/742;;A61B5/6833;;A61B5/0022;;A61B5/7405;;A61B2562/0215;;G16H40/67;;A61B5/296;;G16Z99/00;;A61B5/224;;A61B5/1107,A61B5/22;;A61B5/296;;A61B5/00;;A61B5/11;;G16Z99/00,600/391;;600/546;;600/393,0,0,,,,ACTIVE
60,EP,A1,EP 2713864 A1,084-065-830-431-366,2014-04-09,2014,EP 12794026 A,2012-06-01,US 201161492136 P;;US 2012/0040581 W,2011-06-01,SYSTEM AND METHOD FOR POWER-EFFICIENT TRANSMISSION OF EMG DATA,,TECH TEAM LLC,CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN,,https://lens.org/084-065-830-431-366,Patent Application,yes,0,0,7,7,0,A61B5/6833;;A61B5/7405;;A61B5/742;;A61B5/0022;;A61B2562/0215;;G16H40/67;;A61B5/224;;A61B5/296;;G16Z99/00;;A61B5/742;;A61B5/6833;;A61B5/0022;;A61B5/7405;;A61B2562/0215;;G16H40/67;;A61B5/296;;G16Z99/00;;A61B5/224;;A61B5/1107,A61B5/296;;A61B5/00;;A61B5/22;;G16Z99/00,,0,0,,,,DISCONTINUED
61,EP,A2,EP 1834254 A2,041-346-702-566-822,2007-09-19,2007,EP 05813467 A,2005-11-30,GB 2005050219 W;;GB 0428191 A,2004-12-23,DIGITAL SIGNAL PROCESSING METHODS AND APPARATUS,,CAMBRIDGE DISPLAY TECH LTD,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (2015-03-18),https://lens.org/041-346-702-566-822,Patent Application,yes,0,2,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32,,1,0,,,See references of WO 2006067520A3,DISCONTINUED
62,US,S,US D0725668 S,190-986-428-353-792,2015-03-31,2015,US 201329459408 F,2013-06-28,US 201329459408 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,CLARE CHRISTOPHER JAMES;;LOXHA LYRA XHARRA;;IZOTOV DMYTRO,MICROSOFT CORPORATION (2013-08-19),https://lens.org/190-986-428-353-792,Design Right,no,0,38,1,1,0,,,1404;;D14/486,0,0,,,,ACTIVE
63,TW,B,TW I385552 B,028-795-752-563-577,2013-02-11,2013,TW 94143130 A,2005-12-07,GB 0428191 A,2004-12-23,Digital signal processing methods and apparatus,,CAMBRIDGE DISPLAY TECH LTD,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,,https://lens.org/028-795-752-563-577,Granted Patent,no,4,1,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32,,0,0,,,,INACTIVE
64,US,B2,US 9042956 B2,174-948-597-883-092,2015-05-26,2015,US 201414285363 A,2014-05-22,US 201414285363 A;;US 201213486257 A;;US 201161492136 P,2011-06-01,System and method for power-efficient transmission of EMG data,"The system for displaying muscle force data includes a wearable patch and a remote visual display. The wearable patch carries electrodes suitable for sensing electromyographic signals on the skin of the patient. The patch carries circuitry which converts the detected electromyographic signal to a digital output which can be transmitted to the remote visual display. The circuitry relies on filtering to produce a usable digital signal at very low power consumption. The transmitted signal can be used to drive a variety of visual displays, including a conventional hand-held personal communicators and entertainment devices which had been programmed to suitably process the visual display.",TECH TEAM LLC,CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN,TECH TEAM LLC (2012-06-06),https://lens.org/174-948-597-883-092,Granted Patent,yes,40,1,7,7,0,A61B5/6833;;A61B5/7405;;A61B5/742;;A61B5/0022;;A61B2562/0215;;G16H40/67;;A61B5/224;;A61B5/296;;G16Z99/00;;A61B5/742;;A61B5/6833;;A61B5/0022;;A61B5/7405;;A61B2562/0215;;G16H40/67;;A61B5/296;;G16Z99/00;;A61B5/224;;A61B5/1107,A61B5/296;;A61B5/00;;A61B5/11;;A61B5/22;;A61N1/00;;G16Z99/00,600/384;;600/382;;600/393;;607/115,6,1,055-865-692-278-589,10.1016/s1050-6411(14)00006-6,"European search report and written opinion dated Nov. 5, 2014 for EP Application No. 12794026.;;International search report and written opinion dated Sep. 7, 2012 for PCT Application No. US2012/40581.;;Notice of allowance dated Feb. 21, 2014 for U.S. Appl. No. 13/486,257.;;Office action dated Mar. 29, 2013 for U.S. Appl. No. 13/486,257.;;Office action dated Dec. 5, 2012 for U.S. Appl. No. 13/486,257.;;Standards for Reporting EMG Data. Dr. Roberto Merletti. Journal of Electromyography and Kinesiology. 1999.",ACTIVE
65,US,A1,US 2018/0213126 A1,167-698-141-541-198,2018-07-26,2018,US 201815924769 A,2018-03-19,US 201815924769 A;;US 201514863195 A;;US 201562172123 P,2015-06-07,TOUCH ACCOMMODATION OPTIONS,"The present disclosure generally relates to methods and devices for providing touch accommodations to users with tremors or other fine motor impairments to improve the accuracy of such users' touch inputs on touch-sensitive surfaces. Such methods and devices include various approaches for compensating for brief, inadvertent touch inputs; touch inputs with inadvertent motion across the touch-sensitive surface; and/or touch inputs with inadvertent recoil contacts. In some embodiments, the touch accommodations are implemented in a software layer separate from the application layer, such as the operating system.",APPLE INC,FLEIZACH CHRISTOPHER;;KASEMSET CLARE;;SUNDARA RAMAN NANDINI KANNAMANGALAM,,https://lens.org/167-698-141-541-198,Patent Application,yes,1,6,7,7,0,G06F3/0486;;G06F3/04883;;H04N3/155;;G06F3/0486;;G06F3/04883,H04N3/14;;G06F3/0486;;G06F3/0488,,0,0,,,,DISCONTINUED
66,GB,A,GB 2421604 A,169-527-455-109-468,2006-06-28,2006,GB 0524337 A,2005-11-30,GB 0428191 A,2004-12-23,Processing digital data using non-negative matrix factorization,"The invention concerns processing digital data using non-negative matrix factorization (NMF). Data defining a target matrix X is processed using NMF to determine a pair a matrices F, G. A first matrix of the pair determines a set of features for representing said data and a second matrix of the pair determines weights of said features. A product of F, G approximates target matrix X. A method involves determining a target contribution R of a row selected from one of either F, G and a column selected from the other of F, G and determining, subject to a non-negativity constraint, updated values for the selected row and column from said target contribution. The method is applicable to multi-line addressing (MLA) techniques for driving displays such as OLED (organic light emitting diode) displays. The invention may also be applied to image data, network security, data mining, sensor data, biological data, machine learning, and pattern recognition.",CAMBRIDGE DISPLAY TECH LTD,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,,https://lens.org/169-527-455-109-468,Patent Application,no,3,3,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32;;G09G3/36,G4A ACX           CX;;G5C CHBH          CHBH,3,0,,,"Nature, Vol. 401, 21 October 1991, pages 788-791.;;Advances in Neural Information Processing Systems, Vol. 13, 2001, pages 556-562.;;S. Shahnaz et al., ""Document Clustering using Nonnegative Matrix Factorization"" [online], 13 August 2004. Available from http://www.math.wfu.edu/publications/plemmons/documentclustering.pdf [Accessed 16 Mar 2006].",INACTIVE
67,CN,A,CN 101278282 A,181-854-890-203-187,2008-10-01,2008,CN 200580048603 A,2005-11-30,GB 2005050219 W;;GB 0428191 A,2004-12-23,Digital signal processing methods and apparatus,"This invention generally relates to methods, apparatus and computer program for processing digital data using non-negative matrix factorisation. A method of digitally processing data in a data array defining a target matrix (X) using non-negative matrix factorisation to determine a pair of matrices (F, G), a first matrix of said pair determining a set of features for representing said data, a second matrix of said pair determining weights of said features, such that a product of said first and second matrices approximates said target matrix, the method comprising: inputting said target matrix data (X); selecting a row of said one of said first and second matrices and a column of the other of said first and second matrices; determining a target contribution (R) of said selected row and column to said target matrix; determining, subject to a non- negativity constraint, updated values for said selected row and column from said target contribution; and repeating said selecting and determining for the other rows and columns of said first and second matrices until all said rows and columns have been updated.",CAMBRIDGE DISPLAY TECH LTD,CHRISTOPHER SMITH EUAN;;RICHARD ROUTLEY PAUL;;CLARE FODEN,,https://lens.org/181-854-890-203-187,Patent Application,no,0,8,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32,,0,0,,,,INACTIVE
68,WO,A1,WO 2004/030799 A1,013-488-034-474-823,2004-04-15,2004,EP 0309665 W,2003-08-29,EP 02256859 A,2002-10-02,METHOD FOR CONTROLLING DROPLET SIZE OF AN EMULSION WHEN MIXING TWO IMMISCIBLE FLUIDS,The invention relates to a method for preparing an emulsion by membrane emulsification enabling control of the dispersed phase size and size distribution by interrupting extrusion of the dispersed phase.,UNILEVER NV;;UNILEVER PLC;;LEVER HINDUSTAN LTD;;CLARE HUGH;;PEARSON CHRISTOPHER ANTHONY;;SHANKS IAN ALEXANDER,CLARE HUGH;;PEARSON CHRISTOPHER ANTHONY;;SHANKS IAN ALEXANDER,,https://lens.org/013-488-034-474-823,Patent Application,yes,5,13,6,6,0,B01F23/4111;;B01F25/31421;;B01F31/83;;B01F31/85;;B01F25/31421;;B01F23/4111;;B01F31/83;;B01F31/85,B01J19/10;;C09K23/00,,1,0,,,"DATABASE WPI Week 200112, Derwent World Patents Index; AN 2001-107914, XP002233398",PENDING
69,US,B2,US 11470225 B2,031-887-520-731-451,2022-10-11,2022,US 202117224997 A,2021-04-07,US 202117224997 A;;US 201916534291 A;;US 201815924769 A;;US 201514863195 A;;US 201562172123 P,2015-06-07,Touch accommodation options,"The present disclosure generally relates to methods and devices for providing touch accommodations to users with tremors or other fine motor impairments to improve the accuracy of such users' touch inputs on touch-sensitive surfaces. Such methods and devices include various approaches for compensating for brief, inadvertent touch inputs; touch inputs with inadvertent motion across the touch-sensitive surface; and/or touch inputs with inadvertent recoil contacts. In some embodiments, the touch accommodations are implemented in a software layer separate from the application layer, such as the operating system.",APPLE INC,FLEIZACH CHRISTOPHER;;KASEMSET CLARE;;SUNDARA RAMAN NANDINI KANNAMANGALAM,,https://lens.org/031-887-520-731-451,Granted Patent,yes,193,0,7,7,0,G06F3/0486;;G06F3/04883;;H04N3/155;;G06F3/0486;;G06F3/04883,G06F3/01;;G06F3/0486;;G06F3/04883;;H04N3/14,,99,0,,,"Applicant Initiated Interview Summary received for U.S. Appl. No. 16/939,922, dated Nov. 23, 2021, 3 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 17/074,396, dated Dec. 17, 2021, 2 pages.;;Office Action received for Australian Patent Application No. 2020230308, dated Sep. 8, 2021, 3 pages.;;Office Action received for Chinese Patent Application No. 201810008374.6, dated Jun. 25, 2021, 26 pages (4 pages of English Translation and 22 pages of Official Copy).;;Notice of Allowance received for Japanese Patent Application No. 2020-131850, dated Mar. 1, 2021, 4 pages (1 page of English Translation and 3 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201810008374.6, dated Mar. 24, 2021, 35 pages (8 pages of English Translation and 27 pages of Official Copy).;;Non-Final Office Action received for U.S. Appl. No. 16/939,922, dated Aug. 31, 2021, 21 pages.;;Notice of Acceptance received for Australian Patent Application No. 2020230308, dated Jan. 4, 2022, 3 pages.;;Advisory Action received for U.S. Appl. No. 14/833,439, dated Jan. 11, 2019, 3 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 14/833,439, dated May 27, 2020, 3 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 14/833,439, dated Oct. 21, 2019, 3 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 16/179,545, dated Feb. 4, 2020, 4 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 16/534,291, dated Oct. 14, 2020, 5 pages.;;Brief Communication regarding Oral Proceedings received for European Patent Application No. 11704865.2, mailed on Jan. 10, 2020, 12 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 15/061,651, dated Aug. 27, 2018, 2 pages.;;Decision to Grant received for European Patent Application No. 12727533.7, dated Jul. 30, 2020, 2 pages.;;Decision to Refuse received for European Patent Application No. 11704865.2, dated Feb. 12, 2020, 13 pages.;;Final Office Action received for U.S. Appl. No. 13/217,654, dated Mar. 27, 2014, 21 pages.;;Final Office Action received for U.S. Appl. No. 14/833,439, dated Feb. 21, 2020, 14 pages.;;Final Office Action received for U.S. Appl. No. 14/833,439, dated Oct. 2, 2018, 10 pages.;;Final Office Action received for U.S. Appl. No. 15/924,769, dated Apr. 24, 2019, 4 pages.;;Intention to Grant received for European Patent Application No. 12727533.7, dated Mar. 18, 2020, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2011/21010, dated Jul. 26, 2012, 18 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2012/040920, dated Dec. 27, 2013, 22 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2011/21010, dated Aug. 19, 2011, 20 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2012/040920, dated Feb. 12, 2013, 27 pages.;;Minutes of the Oral Proceedings received for European Patent Application No. 11704865.2, mailed on Feb. 11, 2020, 3 pages.;;Non-Final Office Action received for U.S. Appl. No. 12/688,558, dated Jun. 8, 2012, 20 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/217,654 dated Sep. 25, 2015, 31 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/217,654, dated Jan. 16, 2015, 21 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/217,654, dated Sep. 9, 2013, 46 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/436,340, dated Nov. 6, 2014, 16 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/833,439, dated Aug. 8, 2019, 10 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/833,439, dated Jan. 25, 2019, 9 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/833,439, dated Mar. 8, 2018, 8 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/863,195, dated May 4, 2017, 9 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/061,651, dated Feb. 9, 2018, 12 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/924,769, dated Jan. 24, 2019, 6 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/179,545, dated Nov. 18, 2019, 12 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/534,291, dated May 15, 2020, 9 pages.;;Notice of Acceptance received for Australian Patent Application No. 2012268384, dated Feb. 8, 2016, 2 pages.;;Notice of Acceptance received for Australian Patent Application No. 2013257534, dated Jan. 5, 2016, 2 pages.;;Notice of Acceptance received for Australian Patent Application No. 2016203253, dated May 2, 2018, 3 pages.;;Notice of Acceptance received for Australian Patent Application No. 2018217331, dated Jun. 2, 2020, 3 pages.;;Notice of Allowance Action received for U.S. Appl. No. 14/863,195, dated Jan. 2, 2018, 7 pages.;;Notice of Allowance received for Chinese Patent Application No. 201280027757.9, dated Oct. 25, 2017, 2 pages.;;Notice of Allowance received for Chinese Patent Application No. 201710576007.1, dated Apr. 13, 2020, 2 pages.;;Notice of Allowance received for Japanese Patent Application No. 2014-513803, dated Jan. 5, 2016, 3 pages.;;Notice of Allowance received for Japanese Patent Application No. 2016-020183, dated Jul. 7, 2017, 3 pages.;;Notice of Allowance received for Japanese Patent Application No. 2017-152690, dated Oct. 26, 2020, 4 pages.;;Notice of Allowance received for Korean Patent Application No. 10-2012-7021301, dated Jul. 28, 2014, 2 pages.;;Notice of Allowance received for Korean Patent Application No. 10-2013-7034793, dated Nov. 30, 2015, 3 pages.;;Notice of Allowance received for Korean Patent Application No. 10-2015-7016587, dated May 18, 2018, 3 pages.;;Notice of Allowance received for Korean Patent Application No. 10-2016-7027346, dated Dec. 22, 2017, 3 pages.;;Notice of Allowance received for U.S. Appl. No. 12/688,558, dated Dec. 28, 2012, 5 pages.;;Notice of Allowance received for U.S. Appl. No. 13/217,654, dated Aug. 12, 2016, 5 pages.;;Notice of Allowance received for U.S. Appl. No. 13/436,340, dated Apr. 20, 2015, 5 pages.;;Notice of Allowance received for U.S. Appl. No. 14/833,439, dated Jun. 24, 2020, 5 pages.;;Notice of Allowance received for U.S. Appl. No. 15/061,651, dated Jul. 2, 2018, 6 pages.;;Notice of Allowance received for U.S. Appl. No. 16/179,545, dated May 4, 2020, 7 pages.;;Notice of Allowance received for U.S. Appl. No. 16/534,291, dated Dec. 9, 2020, 7 pages.;;Office Action received for Australian Patent Application No. 2012238305, dated Aug. 13, 2013, 5 pages.;;Office Action received for Australian Patent Application No. 2012268384, dated Feb. 5, 2015, 3 pages.;;Office Action received for Australian Patent Application No. 2013257534, dated Jan. 6, 2015, 2 pages.;;Office Action received for Australian Patent Application No. 2016202360, dated Feb. 23, 2018, 4 pages.;;Office Action received for Australian Patent Application No. 2016202360, dated Mar. 20, 2017, 3 pages.;;Office Action received for Australian Patent Application No. 2016203253, dated Jul. 21, 2017, 3 pages.;;Office Action received for Australian Patent Application No. 2018217331, dated Nov. 21, 2019, 4 pages.;;Office Action received for Chinese Patent Application No. 201280027757.9, dated Apr. 12, 2017, 6 pages.;;Office Action received for Chinese Patent Application No. 201280027757.9, dated Aug. 5, 2016, 6 pages.;;Office Action Received for Chinese Patent Application No. 201280027757.9, dated Nov. 18, 2015, 14 pages.;;Office Action received for Chinese Patent Application No. 201710576007.1, dated Oct. 23, 2019, 12 pages.;;Office Action received for Chinese Patent Application No. 201810008374.6, dated Sep. 29, 2020, 17 pages.;;Office Action received for European Patent Application No. 11704865.2, dated May 24, 2018, 7 pages.;;Office Action Received for European Patent Application No. 11704865.2, dated Oct. 22, 2015, 8 pages.;;Office Action received for European Patent Application No. 12727533.7 dated Dec. 15, 2015, 4 pages.;;Office Action received for European Patent Application No. 12727533.7, dated Jul. 5, 2017, 6 pages.;;Office Action received for European Patent Application No. 12727533.7, dated Jun. 4, 2018, 5 pages.;;Office Action Received for Japanese Patent Application No. 2014-513803, dated Jan. 9, 2015, 7 pages.;;Office Action received for Japanese Patent Application No. 2016020183, dated Dec. 22, 2016, 6 pages.;;Office Action received for Japanese Patent Application No. 2017-152690, dated Apr. 3, 2020, 6 pages.;;Office Action received for Japanese Patent Application No. 2017-152690, dated Apr. 8, 2019, 8 pages.;;Office Action received for Japanese Patent Application No. 2017-152690, dated Jun. 8, 2018, 9 pages.;;Office Action received for Japanese Patent Application No. 2020-131850, dated Oct. 12, 2020, 6 pages.;;Office Action received for Korean Patent Application No. 10-2013-7034793, dated Jan. 21, 2015, 4 pages.;;Office Action received for Korean Patent Application No. 10-2015-7016587, dated Jan. 31, 2018, 6 pages.;;Office Action received for Korean Patent Application No. 10-2015-7016587, dated Mar. 31, 2016, 5 pages.;;Office Action received for Korean Patent Application No. 10-2015-7016587, dated Mar. 31, 2017, 7 pages.;;Office Action received for Korean Patent Application No. 1020167027346, dated Jun. 21, 2017, 7 pages.;;Pocketables, “No pinch to zoom on my new Streak”, Pocketables Forum, http://www.pocketables.com/forum/showthread.php?t=6939, Aug. 18, 2010, 2 pages.;;Savov, “iPhone and Magic Mouse linked up by BT stack”, (video) Jan. 4, 2010, http://www.engadget.com/2010/01/04/iphone-and-magic-mouse-linked-up-by-btstack-video/, 5 pages.;;Summons to attend oral proceedings received for European Patent Application No. 11704865.2, mailed on Aug. 26, 2019, 6 pages.;;Swartzfager B, “Google's new virtual room service (Lively) may have potential”, Thought Delimited, http://www.thoughtdelimited.org/thoughts/post.cfm/google-s-new-virtual-room-service-lively-may-have-potential, Jul. 10, 2008, 2 pages.;;Totalcontrol, “TotalControl-Iphone-Itouch-Ipad Vidcam Edition OS4 Update”, Intelligent Designs Group, LLC, http://totalcontrolapp.com/index.php?option=com_myblog&show=Iphone-Itouch-Ipad-Vidcam-Edition-OS4-Update.html&ItemId=87, Jul. 12, 2010, 2 pages.;;Non-Final Office Action received for U.S. Appl. No. 17/074,396, dated Oct. 6, 2021, 15 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 16/939,922, dated Feb. 23, 2022, 2 pages.;;Notice of Allowance received for U.S. Appl. No. 16/939,922, dated Feb. 7, 2022, 13 pages.;;Non-Final Office Action received for U.S. Appl. No. 17/074,396, dated Mar. 7, 2022, 15 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 17/074,396, dated May 5, 2022, 3 pages.",ACTIVE
70,MY,A,MY 141448 A,062-747-081-355-465,2010-04-30,2010,MY PI20056155 A,2005-12-22,GB 0428191 A,2004-12-23,DIGITAL IMAGE DISPLAY METHODS AND APPARATUS,"THIS INVENTION GENERALLY RELATES TO METHODS, APPARATUS AND COMPUTER PROGRAM CODE PROCESSING DIGITAL DATA USING NON-NEGATIVE MATRIX FACTORISATION. A METHOD OF DIGITALLY PROCESSING DATA IN A DATA ARRAY DEFINING A TARGET MATRIX (X) USING NON-NEGATIVE MATRIX FACTORISATION TO DETERMINE A PAIR OF MATRICES (F, G), A FIRST MATRIX OF SAID PAIR DETERMINING A SET OF FEATURES FOR REPRESENTING SAID DATA, A SECOND MATRIX OF SAID PAIR DETERMINING WEIGHTS OF SAID FEATURES, SUCH THAT A PRODUCT OF SAID FIRST AND SECOND MATRICES APPROXIMATES SAID TARGET MATRIX, THE METHOD COMPRISING: INPUTTING SAID TARGET MATRIX DATA (X); SELECTING A ROW OF SAID ONE OF SAID FIRST AND SECOND MATRICES AND A COLUMN OF THE OTHER OF SAID FIRST AND SECOND MATRICES; DETERMINING A TARGET CONTRIBUTION (R) OF SAID SELECTED ROW AND COLUMN TO SAID TARGET MATRIX; DETERMINING, SUBJECT TO A NON-NEGATIVITY CONSTRAINT, UPDATED VALUES FOR SAID SELECTED ROW AND COLUMN FROM SAID TARGET CONTRIBUTION; AND REPEATING SAID SELECTING AND DETERMINING FOR THE OTHER ROWS AND COLUMNS OF SAID FIRST AND SECOND MATRICES UNTIL ALL SAID ROWS AND COLUMNS HAVE BEEN UPDATED.",CAMBRIDGE DISPLAY TECH LTD,CHRISTOPHER SMITH EUAN;;RICHARD ROUTLEY PAUL;;CLARE FODEN,,https://lens.org/062-747-081-355-465,Granted Patent,no,0,0,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32,,0,0,,,,ACTIVE
71,US,A1,US 2012/0310069 A1,090-888-104-173-90X,2012-12-06,2012,US 201213486257 A,2012-06-01,US 201213486257 A;;US 201161492136 P,2011-06-01,SYSTEM AND METHOD FOR POWER-EFFICIENT TRANSMISSION OF EMG DATA,"The system for displaying muscle force data includes a wearable patch and a remote visual display. The wearable patch carries electrodes suitable for sensing electromyographic signals on the skin of the patient. The patch carries circuitry which converts the detected electromyographic signal to a digital output which can be transmitted to the remote visual display. The circuitry relies on filtering to produce a usable digital signal at very low power consumption. The transmitted signal can be used to drive a variety of visual displays, including a conventional hand-held personal communicators and entertainment devices which had been programmed to suitably process the visual display.",CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN;;TECH TEAM LLC,CLARE CHRISTOPHER R;;GOTTFRIED DENISE F;;GOTTFRIED JONATHAN,TECH TEAM LLC (2012-06-06),https://lens.org/090-888-104-173-90X,Patent Application,yes,9,7,7,7,0,A61B5/6833;;A61B5/7405;;A61B5/742;;A61B5/0022;;A61B2562/0215;;G16H40/67;;A61B5/224;;A61B5/296;;G16Z99/00;;A61B5/742;;A61B5/6833;;A61B5/0022;;A61B5/7405;;A61B2562/0215;;G16H40/67;;A61B5/296;;G16Z99/00;;A61B5/224;;A61B5/1107,A61B5/296;;G16Z99/00,600/391;;600/386,1,1,055-865-692-278-589,10.1016/s1050-6411(14)00006-6,"""Standards for Reporting EMG Data"" Dr. Roberto Merletti. Journal of Electromyography and Kinesiology. 1999",ACTIVE
72,US,B2,US 9961239 B2,135-225-259-920-23X,2018-05-01,2018,US 201514863195 A,2015-09-23,US 201514863195 A;;US 201562172123 P,2015-06-07,Touch accommodation options,"The present disclosure generally relates to methods and devices for providing touch accommodations to users with tremors or other fine motor impairments to improve the accuracy of such users' touch inputs on touch-sensitive surfaces. Such methods and devices include various approaches for compensating for brief, inadvertent touch inputs; touch inputs with inadvertent motion across the touch-sensitive surface; and/or touch inputs with inadvertent recoil contacts. In some embodiments, the touch accommodations are implemented in a software layer separate from the application layer, such as the operating system.",APPLE INC,FLEIZACH CHRISTOPHER;;KASEMSET CLARE;;KANNAMANGALAM SUNDARA RAMAN NANDINI,APPLE INC (2015-11-12),https://lens.org/135-225-259-920-23X,Granted Patent,yes,2,5,7,7,0,G06F3/0486;;G06F3/04883;;H04N3/155;;G06F3/0486;;G06F3/04883,G06F3/041;;G06F3/0486;;G06F3/0488;;H04N3/14,,0,0,,,,ACTIVE
73,AU,A1,AU 2003/270129 A1,158-101-608-315-872,2004-04-23,2004,AU 2003/270129 A,2003-08-29,EP 02256859 A;;EP 0309665 W,2002-10-02,METHOD FOR CONTROLLING DROPLET SIZE OF AN EMULSION WHEN MIXING TWO IMMISCIBLE FLUIDS,,UNILEVER PLC,CLARE HUGH;;PEARSON CHRISTOPHER ANTHONY;;SHANKS IAN ALEXANDER,,https://lens.org/158-101-608-315-872,Patent Application,no,0,1,6,6,0,B01F23/4111;;B01F25/31421;;B01F31/83;;B01F31/85;;B01F25/31421;;B01F23/4111;;B01F31/83;;B01F31/85,C09K23/00;;B01J19/10,,0,0,,,,DISCONTINUED
74,ZA,B,ZA 892587 B,002-004-801-292-754,1990-03-28,1990,ZA 892587 A,1989-04-10,GB 8808433 A,1988-04-11,SPIROCYCLIC COMPOUNDS INCORPORATING FIVE-MEMBERED RINGS WITH TWO HETERO-ATOMS,,MERCK SHARP & DOHME,KNEEN CLARE O;;SAUNDER JOHN;;JOHN SAUNDER;;SWAIN CHRISTOPHER;;CHRISTOPHER SWAIN;;BAKER RAYMOND;;RAYMOND BAKER;;CLARE O KNEEN,,https://lens.org/002-004-801-292-754,Granted Patent,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,A61K31/40;;C07D487/10;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
75,US,B2,US 10986252 B2,114-918-207-908-44X,2021-04-20,2021,US 201916534291 A,2019-08-07,US 201916534291 A;;US 201815924769 A;;US 201514863195 A;;US 201562172123 P,2015-06-07,Touch accommodation options,"The present disclosure generally relates to methods and devices for providing touch accommodations to users with tremors or other fine motor impairments to improve the accuracy of such users' touch inputs on touch-sensitive surfaces. Such methods and devices include various approaches for compensating for brief, inadvertent touch inputs; touch inputs with inadvertent motion across the touch-sensitive surface; and/or touch inputs with inadvertent recoil contacts. In some embodiments, the touch accommodations are implemented in a software layer separate from the application layer, such as the operating system.",APPLE INC,FLEIZACH CHRISTOPHER;;KASEMSET CLARE;;SUNDARA RAMAN NANDINI KANNAMANGALAM,,https://lens.org/114-918-207-908-44X,Granted Patent,yes,177,0,7,7,0,G06F3/0486;;G06F3/04883;;H04N3/155;;G06F3/0486;;G06F3/04883,G06F3/041;;G06F3/0486;;G06F3/0488;;H04N3/14,,83,0,,,"Summons to attend oral proceedings received for European Patent Application No. 11704865.2, mailed on Aug. 26, 2019, 6 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 16/179,545, dated Feb. 4, 2020, 4 pages.;;Brief Communication regarding Oral Proceedings received for European Patent Application No. 11704865.2, mailed on Jan. 10, 2020, 12 pages.;;Pocketables, “No pinch to zoom on my new Streak”, Pocketable Forum, Online available at: http://www.pocketables.com/forum/showthread.php?t=6939, Aug. 18, 2010, 2 pages.;;Swartzfager, B., “Google's new virtual room service (Lively) may have potential”, Thought Delimited, Online available at: http://www.thoughtdelimited.org/thoughts/post.cfm/google-s-new-virtual-room-service-lively-may-have-potential, Jul. 10, 2008, 2 pages.;;Totalcontrol, “TotalControl—Iphone-Itouch-Ipad Vidcam Edition OS4 Update”, Intelligent Designs Group, LLC, Online available at: http://totalcontrolapp.com/index.php?option=com_myblog&show=Iphone-Itouch-Ipad-Vidcam-Edition-OS4-Update.html&ItemId=87, Jul. 12, 2010, 2 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/179,545, dated Nov. 18, 2019, 12 pages.;;Office Action received for Australian Patent Application No. 2018217331, dated Nov. 21, 2019, 4 pages.;;Office Action received for Chinese Patent Application No. 201710576007.1, dated Oct. 23, 2019, 12 pages (7 pages of English Translation and 5 pages of Official Copy).;;Advisory Action received for U.S. Appl. No. 14/833,439, dated Jan. 11, 2019, 3 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 15/061,651, dated Aug. 27, 2018, 2 pages.;;Final Office Action received for U.S. Appl. No. 14/833,439, dated Oct. 2, 2018, 10 pages.;;Final Office Action received for U.S. Appl. No. 15/924,769, dated Apr. 24, 2019, 4 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/833,439, dated Jan. 25, 2019, 9 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/833,439, dated Mar. 8, 2018, 8 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/863,195, dated May 4, 2017, 9 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/061,651, dated Feb. 9, 2018, 12 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/924,769, dated Jan. 24, 2019, 6 pages.;;Notice of Acceptance received for Australian Patent Application No. 2016203253, dated May 2, 2018, 3 pages.;;Notice of Allowance Action received for U.S. Appl. No. 14/863,195, dated Jan. 2, 2018, 7 pages.;;Notice of Allowance received for Chinese Patent Application No. 201280027757.9, dated Oct. 25, 2017, 2 pages.;;Notice of Allowance received for Japanese Patent Application No. 2016-020183, dated Jul. 7, 2017, 3 pages.;;Notice of Allowance received for Korean Patent Application No. 10-2015-7016587, dated May 18, 2018, 3 pages.;;Notice of Allowance received for Korean Patent Application No. 10-2016-7027346, dated Dec. 22, 2017, 3 pages.;;Notice of Allowance received for U.S. Appl. No. 13/217,654, dated Aug. 12, 2016, 5 pages.;;Notice of Allowance received for U.S. Appl. No. 15/061,651, dated Jul. 2, 2018, 6 pages.;;Office Action received for Australian Patent Application No. 2016202360, dated Feb. 23, 2018, 4 pages.;;Office Action received for Australian Patent Application No. 2016202360, dated Mar. 20, 2017, 3 pages.;;Office Action received for Australian Patent Application No. 2016203253, dated Jul. 21, 2017, 3 pages.;;Office Action received for Chinese Patent Application No. 201280027757.9, dated Apr. 12, 2017, 6 pages.;;Office Action received for Chinese Patent Application No. 201280027757.9, dated Aug. 5, 2016, 6 pages.;;Office Action received for European Patent Application No. 11704865.2, dated May 24, 2018, 7 pages.;;Office Action received for European Patent Application No. 12727533.7, dated Jul. 5, 2017, 6 pages.;;Office Action received for European Patent Application No. 12727533.7, dated Jun. 4, 2018, 5 pages.;;Office Action received for Japanese Patent Application No. 2016020183, dated Dec. 22, 2016, 6 pages.;;Office Action received for Japanese Patent Application No. 2017-152690, dated Jun. 8, 2018, 9 pages.;;Office Action received for Korean Patent Application No. 10-2015-7016587, dated Jan. 31, 2018, 6 pages.;;Office Action received for Korean Patent Application No. 10-2015-7016587, dated Mar. 31, 2017, 7 pages.;;Office Action received for Korean Patent Application No. 1020167027346, dated Jun. 21, 2017, 7 pages.;;Notice of Allowance received for Korean Patent Application No. 10-2012-7021301, dated Jul. 28, 2014, 2 pages.;;Notice of Allowance received for Korean Patent Application No. 10-2013-7034793, dated Nov. 30, 2015, 3 pages.;;Office Action received for Korean Patent Application No. 10-2013-7034793, dated Jan. 21, 2015, 4 pages.;;Office Action received for Korean Patent Application No. 10-2015-7016587, dated Mar. 31, 2016, 5 pages.;;Office Action Received for European Patent Application No. 11704865.2, dated Oct. 22, 2015, 8 pages.;;Non-Final Office Action received for U.S. Appl. No. 12/688,558, dated Jun. 8, 2012, 20 pages.;;Notice of Allowance received for U.S. Appl. No. 12/688,558, dated Dec. 28, 2012, 5 pages.;;Office Action received for European Patent Application No. 12727533.7 dated Dec. 15, 2015, 4 pages.;;Final Office Action received for U.S. Appl. No. 13/217,654, dated Mar. 27, 2014, 21 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/217,654 dated Sep. 25, 2015, 31 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/217,654, dated Jan. 16, 2015, 21 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/217,654, dated Sep. 9, 2013, 46 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/436,340, dated Nov. 6, 2014, 16 pages.;;Notice of Allowance received for U.S. Appl. No. 13/436,340, dated Apr. 20, 2015, 5 pages.;;Office Action received for Australian Patent Application No. 2012238305, dated Aug. 13, 2013, 5 pages.;;Notice of Acceptance received for Australian Patent Application No. 2012268384, dated Feb. 8, 2016, 2 pages.;;Office Action received for Australian Patent Application No. 2012268384, dated Feb. 5, 2015, 3 pages.;;Office Action Received for Chinese Patent Application No. 201280027757.9, dated Nov. 18, 2015, 14 pages.;;Notice of Acceptance received for Australian Patent Application No. 2013257534, dated Jan. 5, 2016, 2 pages.;;Office Action received for Australian Patent Application No. 2013257534, dated Jan. 6, 2015, 2 pages.;;Notice of Allowance received for Japanese Patent Application No. 2014-513803, dated Jan. 5, 2016, 3 pages.;;Office Action Received for Japanese Patent Application No. 2014-513803, dated Jan. 9, 2015, 7 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2011/21010, dated Jul. 26, 2012, 18 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2011/21010, dated Aug. 19, 2011, 20 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2012/040920, dated Dec. 27, 2013, 22 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2012/040920, dated Feb. 12, 2013, 27 pages.;;Savov, “iPhone and Magic Mouse linked up by BT stack”, http://www.engadget.com/2010/01/04/iphone-and-magic-mouse-linked-up-by-btstack-video/, Jan. 4, 2010, 5 pages.;;Decision to Refuse received for European Patent Application No. 11704865.2, dated Feb. 12, 2020, 13 pages.;;Final Office Action received for U.S. Appl. No. 14/833,439, dated Feb. 21, 2020, 14 pages.;;Minutes of the Oral Proceedings received for European Patent Application No. 11704865.2, mailed on Feb. 11, 2020, 3 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/833,439, dated Aug. 8, 2019, 10 pages.;;Office Action received for Japanese Patent Application No. 2017-152690, dated Apr. 8, 2019, 8 pages (4 pages of English Translation and 4 pages of Official Copy).;;Intention to Grant received for European Patent Application No. 12727533.7, dated Mar. 18, 2020, 8 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 14/833,439, dated Oct. 21, 2019, 3 pages.;;Decision to Grant received for European Patent Application No. 12727533.7, dated Jul. 30, 2020, 2 pages.;;Notice of Allowance received for Japanese Patent Application No. 2017-152690, dated Oct. 26, 2020, 4 pages (1 page of English Translation and 3 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201810008374.6, dated Sep. 29, 2020, 17 pages (5 pages of English Translation and 12 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2020-131850, dated Oct. 12, 2020, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Notice of Allowance received for Chinese Patent Application No. 201710576007.1, dated Apr. 13, 2020, 2 pages (1 pages of English Translation and 1 pages of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 16/179,545, dated May 4, 2020, 7 pages.;;Office Action received for Japanese Patent Application No. 2017-152690, dated Apr. 3, 2020, 6 pages (3 pages English Translation and 3 pages Official copy).;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 14/833,439, dated May 27, 2020, 3 pages.;;Notice of Acceptance received for Australian Patent Application No. 2018217331, dated Jun. 2, 2020, 3 pages.;;Notice of Allowance received for U.S. Appl. No. 14/833,439, dated Jun. 24, 2020, 5 pages.",ACTIVE
76,BR,A,BR PI0516422 A,143-489-999-473-93X,2008-09-02,2008,BR PI0516422 A,2005-11-30,GB 0428191 A;;GB 2005050219 W,2004-12-23,método e aparelho de processamento de sinal digital,"MéTODO E APARELHO DE PROCESSAMENTO DE SINAL DIGITAL. Esta invenção geralmente se relaciona com métodos, aparelho e código de programa de computador processando dados digitais utilizando a fatoração de matriz não negativa. Um método para de forma digital processar dados em um arranjo de dados definindo uma matriz alvo (X) utilizando fatoração de matriz não negativa para determinar um par de matrizes (F,G), uma primeira matriz do dito par determinando um conjunto de aspectos para representar os ditos dados, uma segunda matriz do dito par determinando pesos dos ditos aspectos, de modo que um produto das ditas primeira e segunda matrizes se aproxime da dita matriz alvo, o método compreendendo: informar os ditos dados da matriz alvo (X); selecionar uma fileira da dita uma das ditas primeira e segunda matrizes e uma coluna da outra das ditas primeira e segunda matrizes; determinar uma contribuição alvo (R) das ditas fileira e coluna selecionadas para a dita matriz alvo; determinar, sujeitos à uma restrição de não negatividade, valores atualizados para as ditas fileira e coluna selecionadas a partir da dita contribuição alvo; e repetir as ditas seleção e determinação para as outras fileiras e colunas das ditas primeira e segunda matrizes até que todas as ditas fileiras e colunas tenham sido atualizadas.",CAMBRIDGE DISPLAY TECH LTD,SMITH EUAM CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE,,https://lens.org/143-489-999-473-93X,Patent Application,no,0,0,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F17/16;;G09G3/32,,0,0,,,,DISCONTINUED
77,US,A1,US 2016/0357281 A1,141-267-692-351-763,2016-12-08,2016,US 201514863195 A,2015-09-23,US 201514863195 A;;US 201562172123 P,2015-06-07,TOUCH ACCOMMODATION OPTIONS,"The present disclosure generally relates to methods and devices for providing touch accommodations to users with tremors or other fine motor impairments to improve the accuracy of such users' touch inputs on touch-sensitive surfaces. Such methods and devices include various approaches for compensating for brief, inadvertent touch inputs; touch inputs with inadvertent motion across the touch-sensitive surface; and/or touch inputs with inadvertent recoil contacts. In some embodiments, the touch accommodations are implemented in a software layer separate from the application layer, such as the operating system.",APPLE INC,FLEIZACH CHRISTOPHER;;KASEMSET CLARE;;KANNAMANGALAM SUNDARA RAMAN NANDINI,APPLE INC (2015-11-12),https://lens.org/141-267-692-351-763,Patent Application,yes,2,34,7,7,0,G06F3/0486;;G06F3/04883;;H04N3/155;;G06F3/0486;;G06F3/04883,G06F3/044;;G06F3/01;;G06F3/041;;G06F3/0488;;H04N3/14,,0,0,,,,ACTIVE
78,US,A1,US 2021/0227099 A1,156-379-100-635-924,2021-07-22,2021,US 202117224997 A,2021-04-07,US 202117224997 A;;US 201916534291 A;;US 201815924769 A;;US 201514863195 A;;US 201562172123 P,2015-06-07,TOUCH ACCOMMODATION OPTIONS,"The present disclosure generally relates to methods and devices for providing touch accommodations to users with tremors or other fine motor impairments to improve the accuracy of such users' touch inputs on touch-sensitive surfaces. Such methods and devices include various approaches for compensating for brief, inadvertent touch inputs; touch inputs with inadvertent motion across the touch-sensitive surface; and/or touch inputs with inadvertent recoil contacts. In some embodiments, the touch accommodations are implemented in a software layer separate from the application layer, such as the operating system.",APPLE INC,FLEIZACH CHRISTOPHER;;KASEMSET CLARE;;SUNDARA RAMAN NANDINI KANNAMANGALAM,,https://lens.org/156-379-100-635-924,Patent Application,yes,0,2,7,7,0,G06F3/0486;;G06F3/04883;;H04N3/155;;G06F3/0486;;G06F3/04883,H04N3/14;;G06F3/0486;;G06F3/0488,,0,0,,,,ACTIVE
79,US,A1,US 2019/0364173 A1,188-739-855-872-124,2019-11-28,2019,US 201916534291 A,2019-08-07,US 201916534291 A;;US 201815924769 A;;US 201514863195 A;;US 201562172123 P,2015-06-07,TOUCH ACCOMMODATION OPTIONS,"The present disclosure generally relates to methods and devices for providing touch accommodations to users with tremors or other fine motor impairments to improve the accuracy of such users' touch inputs on touch-sensitive surfaces. Such methods and devices include various approaches for compensating for brief, inadvertent touch inputs; touch inputs with inadvertent motion across the touch-sensitive surface; and/or touch inputs with inadvertent recoil contacts. In some embodiments, the touch accommodations are implemented in a software layer separate from the application layer, such as the operating system.",APPLE INC,FLEIZACH CHRISTOPHER;;KASEMSET CLARE;;SUNDARA RAMAN NANDINI KANNAMANGALAM,,https://lens.org/188-739-855-872-124,Patent Application,yes,2,7,7,7,0,G06F3/0486;;G06F3/04883;;H04N3/155;;G06F3/0486;;G06F3/04883,H04N3/14;;G06F3/0486;;G06F3/0488,,0,0,,,,ACTIVE
80,AU,B2,AU 617785 B2,032-372-117-737-291,1991-12-05,1991,AU 1989/032632 A,1989-04-10,GB 8808433 A,1988-04-11,SPIROCYCLIC COMPOUNDS INCORPORATING FIVE-MEMBERED RINGS WITH TWO HETEROATOMS,,MERCK SHARP & DOHME,BAKER RAYMOND;;SAUNDERS JOHN;;KNEEN CLARE O;;SWAIN CHRISTOPHER,,https://lens.org/032-372-117-737-291,Granted Patent,no,3,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
81,WO,A1,WO 2008/133790 A1,056-572-223-166-071,2008-11-06,2008,US 2008/0003822 W,2008-03-24,US 92673507 P,2007-04-27,SYSTEM AND METHOD FOR ANALYSIS AND DISPLAY OF GEO-REFERENCED IMAGERY,"An improved system and method for analysis and display of geo-referenced imagery overlaid with information such as vegetation health, land cover type and impervious surface coverage. In one aspect, an image analysis system creates a map of a selected area of land by overlaying information extracted from an image or images onto a base map or image. In another, a spatially-indexed image database is maintained having a plurality of images corresponding to a plurality of geographic locations; a user-specified geographic location is accepted through an interactive graphical user interface; a user-specified extraction analysis is accepted for application upon one ormore images; a user-specified extraction analysis is automatically executed to extract overlay information from such images corresponding to user-specified geographic location(s); and extracted overlay information is overlaid on a geo-referenced image, and displayed though a graphical user interface.",LPA SYSTEMS INC;;CLARE JOHN J;;RUSSELL DAVID P;;WOLFE CHRISTOPHER W,CLARE JOHN J;;RUSSELL DAVID P;;WOLFE CHRISTOPHER W,,https://lens.org/056-572-223-166-071,Patent Application,yes,3,2,2,2,0,G09B29/007;;G09B29/007,G01C21/32,,0,0,,,,PENDING
82,BR,A,BR 0314967 A,055-970-711-501-155,2005-08-02,2005,BR 0314967 A,2003-08-29,EP 02256859 A;;EP 0309665 W,2002-10-02,"Método para preparar uma dispersão de um fluido em outro fluido, e, uso do mesmo","""MéTODO PARA PREPARAR UMA DISPERSãO DE UM FLUIDO EM OUTRO FLUIDO, E, USO DO MESMO"". A invenção é relativa a um método para preparar uma emulsão por meio de emulsificação com membrana que possibilita controle do tamanho da fase dispersada e distribuição de tamanho interrompendo extrusão da fase dispersada.",UNILEVER NV,CLARE HUGH JOHN;;PEARSON CHRISTOPHER ANTHONY;;SHANKS IAN ALEXANDER,,https://lens.org/055-970-711-501-155,Patent Application,no,0,0,6,6,0,B01F23/4111;;B01F25/31421;;B01F31/83;;B01F31/85;;B01F25/31421;;B01F23/4111;;B01F31/83;;B01F31/85,C09K23/00;;B01J19/10,,0,0,,,,DISCONTINUED
83,WO,A1,WO 1995/031145 A1,086-912-632-409-739,1995-11-23,1995,US 9504840 W,1995-05-03,US 24322694 A,1994-05-16,MEDICAL ELECTRODE AND METHOD,A low impedance medical electrode (11) for providing a more uniform current distribution comprising a flexible carrier layer (12) formed of an insulating material. A layer of conductive material (27) is carried by the carrier layer (12). The layer of conductive material (27) being separated into at least two segments (27a-27c) with a space therebetween so that the two segments are electrically isolated. A continuous layer of hydrogel material (33) containing an electrolyte overlies the segments and is disposed in said space. The hydrogel material (33) has a bulk resistivity of less than 250 ohm centimeters. A connector (52) is adapted to be connected to a power supply (62) whereby substantially equal current flow can be achieved from each segment without sharp transitions in current flow between the segments and the space between the segments. The connector (52) includes at least one resistor for controlling the flow of current in one segment with respect to the other segment.,PHYSIOMETRIX INC,SUBRAMANIAM RAJ;;CLARE CHRISTOPHER R;;BARNETT DONALD E JR,,https://lens.org/086-912-632-409-739,Patent Application,yes,2,6,3,3,0,A61N1/0492;;A61N1/0492;;A61B2562/125;;A61B2562/125;;A61N1/048;;A61N1/048,A61N1/04,,0,0,,,,PENDING
84,AT,T1,AT E102205 T1,132-206-896-321-288,1994-03-15,1994,AT 89200862 T,1989-04-06,EP 89200862 A;;GB 8808433 A,1988-04-11,SPIROCYCLISCHE VERBINDUNGEN MIT ZWEI HETEROATOME ENTHALTENDEN FUENFGLIEDRIGEN RINGEN.,,MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/132-206-896-321-288,Granted Patent,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,DISCONTINUED
85,DK,D0,DK 170489 D0,111-555-864-841-784,1989-04-10,1989,DK 170489 A,1989-04-10,GB 8808433 A,1988-04-11,"SPIROCYCLISK FORBINDELSE MED FEM RINGE OG TO HETEROATOMER, FREMGANGSMAADE TIL FREMSTILLING DERAF OG FARMACEUTISK PRAEPARAT OG INDEHOLDENDE EN SAADAN FORBINDELSE",,MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/111-555-864-841-784,Patent Application,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
86,AU,A,AU 1995/023588 A,150-545-869-833-658,1995-12-05,1995,AU 1995/023588 A,1995-05-03,US 24322694 A;;US 9504840 W,1994-05-16,Medical electrode and method,,PHYSIOMETRIX INC,SUBRAMANIAM RAJ;;CLARE CHRISTOPHER R;;BARNETT DONALD E JR,,https://lens.org/150-545-869-833-658,Patent Application,no,0,0,3,3,0,A61N1/0492;;A61N1/0492;;A61B2562/125;;A61B2562/125;;A61N1/048;;A61N1/048,A61N1/04,,0,0,,,,PENDING
87,AU,A,AU 1987/077193 A,143-954-885-049-904,1988-03-17,1988,AU 1987/077193 A,1987-08-19,GB 8621790 A,1986-09-10,SUBSTITUTED CYCLOALKYL AMINES,,ICI PLC,ANTHONY VIVIENNE MARGARET;;URCH CHRISTOPHER JOHN;;ELLIOTT ALISON CLARE,,https://lens.org/143-954-885-049-904,Patent Application,no,0,0,16,16,0,A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/033;;C07F7/0812;;C07D295/02,A01N33/04;;A01N33/08;;A01N33/10;;A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;A01N55/10;;C07C67/00;;C07C209/00;;C07C209/24;;C07C211/40;;C07C213/00;;C07C217/74;;C07C291/02;;C07C291/04;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/02;;C07D295/033;;C07D295/04;;C07F7/08,,0,0,,,,DISCONTINUED
88,US,B2,US 8512657 B2,062-292-991-176-29X,2013-08-20,2013,US 201113222929 A,2011-08-31,US 201113222929 A;;GB 0903262 A;;GB 0922612 A;;US 71268110 A;;US 201313203631 A;;GB 2010050347 W,2009-02-26,Method and system using a filter for treating exhaust gas having particulate matter,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine or a compression ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH;;JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2011-12-16),https://lens.org/062-292-991-176-29X,Granted Patent,yes,69,15,8,8,0,B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y10S55/30;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01J35/657;;B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y02T10/12;;B01J35/40;;B01J35/56;;B01J35/60;;B01J35/657;;B01D53/9431;;Y10S55/30;;B01D53/9409,B01D46/10;;B01D53/94;;F01N3/10;;F01N3/28,423/213.2;;423/213.5;;423/213.7;;423/215.5;;60/299;;60/301;;X 55DIG 30;;95/273;;95/285,11,4,181-846-970-824-83X;;136-018-336-535-98X;;041-473-714-569-707;;056-364-975-278-598,10.4271/2009-01-0292;;10.4271/1999-01-3530;;10.4271/980525;;10.4271/810114,"Preliminary Discussion Paper-Amendments to California's Low-Emission Vehicle Regulations for Criteria Pollutants-LEV III, State of California Air Resources Board (Release Date: Feb. 8, 2010).;;Furuta et al., ""Study on Next Generation Diesel Particulate Filter,"" SAE Technical Paper Series, Paper No. 2009-01-0292, Copyright © 2009 SAE International.;;Wei et al., ""Single-Stage Diluation Tunnel Performance,"" SAE Technical Paper Series, Paper No. 2001-01-0201, Copyright © 2001 Society of Automotive Engineers, Inc.;;Hall et al., ""Measurement of the Number and Size Distribution of Particles Emitted from a Gasoline Direct Injection Vehicle,"" SAE Technical Paper Series, Paper No. 1999-01-3530, Copyright © 1999 Society of Automotive Engineers, Inc.;;Abdul-Khalek et al., ""Diesel Exhaust Particle Size: Measurement Issues and Trends,"" SAE Technical Paper Series, Paper No. 980525, Copyright © 1998 Society of Automotive Engineers, Inc.;;Howitt et al., ""Cellular Ceramic Diesel Particulate Filter,"" SAE Technical Paper Series, Paper No. 810114, Copyright © 1981 Society of Automotive Engineers, Inc.;;International Search Report dated Jun. 4, 2010, from PCT International Application No. PCT/GB2010/050347.;;British Search Report dated Jun. 9, 2010, from British Patent Application No. 1003244.9.;;British Search Report dated May 6, 2009, from British Patent Application No. 0903262.4.;;International Search Report for corresponding PCT Patent Application No. PCT/GB2012/052136 dated Nov. 7, 2012.;;GB Search Report for corresponding Great Britain Patent Application No. GB1204258.6 dated Jun. 1, 2012.",ACTIVE
89,US,A,US 4940703 A,067-562-809-717-336,1990-07-10,1990,US 33307689 A,1989-04-04,GB 8808433 A,1988-04-11,"Spirocyclic compounds incorporating five-membered rings with two heteroatoms for treating psychotic disorders, etc.","The present invention provides a compound of formula I or a salt or prodrug thereof: ##STR1## wherein the dotted line represents an optional chemical bond in one of the two possible positions; A represents a group of formula II: ##STR2## in which R.sup.1 represents hydrogen, hydroxy, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkoxy, benzyloxy, hydroxy (C.sub.1-6)alkyl, halogen, amino, cyano, nitro, --CONR.sup.6 R.sup.7 or --SO.sub.2 NR.sup.6 R.sup.7, in which R.sup.6 and R.sup.7 independently represent hydrogen, halogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl or C.sub.2-6 alkynyl; R.sup.2 represents hydrogen, halogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy or C.sub.1-6 alkylcarbonyl; V represents nitrogen, --CH or --C--; and W represents oxygen, sulphur or --NR.sup.8, in which R.sup.8 represents hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl or C.sub.2-6 alkynyl; two of X, Y and Z are the same or different and each represents oxygen, sulphur or nitrogen; and the remaining group X, Y or Z is carbon, or Y is carbonyl (C=O); and Q is the residue of an azacyclic or azabicyclic ring system; which compounds are useful in the treatment of psychotic disorders (e.g. schizophrenia and mania); anxiety; alcohol or drug withdrawal or dependence; pain; gastric stasis; gastric dysfunction (such as occurs with dyspepsia, peptic ulcer, reflux oesophagitis and flatulence); migraine, nausea and vomiting; movement disorders; and presenile and senile dementia.",MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,MERCK SHARP & DOHME LIMITED A BRITISH COMPANY (1989-02-21),https://lens.org/067-562-809-717-336,Granted Patent,yes,8,8,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;C07D487/10;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,514/210;;514/212;;514/214;;514/278;;514/365;;514/374;;514/378;;514/409;;540/543;;546/18;;546/19;;548/147;;548/216;;548/240;;548/409;;548/410;;548/411;;548/950;;548/952;;548/953,0,0,,,,EXPIRED
90,US,A1,US 2015/0093300 A1,126-264-289-973-16X,2015-04-02,2015,US 201414564999 A,2014-12-09,US 201414564999 A;;GB 0903262 A;;GB 0922612 A;;US 201313970109 A;;US 201113222929 A;;US 71268110 A;;US 201213203631 A;;GB 2010050347 W,2009-02-26,METHOD AND SYSTEM USING A FILTER FOR TREATING EXHAUST GAS HAVING PARTICULATE MATTER,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine or a compression ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2011-12-16),https://lens.org/126-264-289-973-16X,Patent Application,yes,0,2,8,8,0,B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y10S55/30;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01J35/657;;B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y02T10/12;;B01J35/40;;B01J35/56;;B01J35/60;;B01J35/657;;B01D53/9431;;Y10S55/30;;B01D53/9409,B01D53/94,422/180,0,0,,,,ACTIVE
91,ES,T3,ES 2061933 T3,030-571-316-059-816,1994-12-16,1994,ES 89200862 T,1989-04-06,GB 8808433 A,1988-04-11,COMPUESTOS ESPIROCICLICOS QUE INCORPORAN ANILLOS DE CINCO MIEMBROS CON DOS HETEROATOMOS.,"LA PRESENTE INVENCION PROPORCIONA UN COMPUESTO DE FORMULA I O UNA SAL O PROFARMACO SUYO, EN EL QUE LA LINEA DISCONTINUA REPRESENTA UN ENLACE QUIMICO OPCIONAL EN UNA DE LAS DOS POSICIONES POSIBLES; A REPRESENTA UN GRUPO DE FORMULA II (EN EL QUE R EXP1 REPRESENTA H, OH, ALQUILO, ALQUENILO, ALQUINILO, ALCOXI, E HIDROXI - ALQUILO DE HASTA 6C, BENCILOXI, HALOGENO, AMINO, CIANO, NITRO, - CONR EXP6 R EXP7 (EN EL QUE R EXP6 Y R EXP7 SON INDEPENDIENTEMENTE H, ALQUILO, ALQUENILO O ALQUINILO DE HASTA 6C); R (AL CUADRADO) REPRESENTA H, HALOGENO, ALQUILO, ALCOXI O ALQUILCARBONILO DE HASTA 6C; V REPRESENTA N, - CH O - C -; Y W REPRESENTA O, S O - NR EXP8, SIENDO R EXP8 UN ATOMO DE H, O ALQUILO, ALQUENILO O ALQUINILO DE HASTA 6C); DE X, Y Y Z DOS SON IGUALES O DIFERENTES Y REPRESENTAN O, S, O N Y EL RESTANTE ES C, O Y ES CARBONILO (C = O); Y Q ES EL RESTO DE UN SISTEMA AZACICLICO O AZALICICLICO. LOS CITADOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ALTERACIONES PSICOTICAS (POR EJEMPLO ESQUIZOFRENIA YMANIA), ANSIEDAD, ABSTINENCIA O DEPENDENCIA DE DROGAS O ALCOHOL, DOLOR, ESTASIS GASTRICO, DISFUNCION GASTRICA, MIGRAÑA, NAUSEAS, VOMITOS, ALTERACIONES DEL MOVIMIENTO Y DEMENCIA SENIL Y PRESENIL.",MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/030-571-316-059-816,Granted Patent,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
92,EP,B1,EP 0337547 B1,036-118-201-165-806,1994-03-02,1994,EP 89200862 A,1989-04-06,GB 8808433 A,1988-04-11,Spirocyclic compounds incorporating five-membered rings with two heteroatoms.,,MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/036-118-201-165-806,Granted Patent,yes,9,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
93,AU,B2,AU 676875 B2,018-277-585-243-329,1997-03-27,1997,AU 1994/057312 A,1993-11-30,US 98382492 A;;US 15979893 A;;US 9311553 W,1992-12-01,Electrode construction,,PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;HIGHE ALBERT J;;IMRAN MIR A,,https://lens.org/018-277-585-243-329,Granted Patent,no,2,0,8,8,0,A61B5/0017;;A61B5/6814;;A61B2562/0217;;Y10S439/909;;A61B5/291;;A61B5/0017;;A61B5/6814;;A61B5/291,A61B5/00;;A61B5/0478,,0,0,,,,EXPIRED
94,EP,A1,EP 1109486 A1,136-855-880-943-299,2001-06-27,2001,EP 99943654 A,1999-08-05,US 9917782 W;;US 14679898 A,1998-09-03,SYSTEM AND METHOD FOR CONTROLLED INFUSION AND PRESSURE MONITORING,,ETHICON INC,HSEI PAUL K;;CLARE CHRISTOPHER R;;ALDEN DONALD L,,https://lens.org/136-855-880-943-299,Patent Application,yes,0,5,8,8,0,A61B17/32002;;A61B18/1482;;A61M3/0258;;A61M3/0283;;A61M3/0287;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202;;A61M3/0258;;A61B18/1482;;A61M3/0287;;A61M3/0283;;A61B17/32002;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202,A61B5/00;;A61B17/00;;A61B17/32;;A61B18/14;;A61M1/00;;A61M3/02;;A61M5/00;;G05D16/20,,0,0,,,,DISCONTINUED
95,US,B2,US 9415344 B2,025-999-711-678-795,2016-08-16,2016,US 201414564999 A,2014-12-09,US 201414564999 A;;GB 0903262 A;;GB 0922612 A;;US 201313970109 A;;US 201113222929 A;;US 71268110 A;;US 201213203631 A;;GB 2010050347 W,2009-02-26,Method and system using a filter for treating exhaust gas having particulate matter,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine or a compression ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2011-12-16),https://lens.org/025-999-711-678-795,Granted Patent,yes,6,4,8,8,0,B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y10S55/30;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01J35/657;;B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y02T10/12;;B01J35/40;;B01J35/56;;B01J35/60;;B01J35/657;;B01D53/9431;;Y10S55/30;;B01D53/9409,F01N3/021;;B01D53/94;;B01J23/46;;B01J29/06;;B01J29/08;;B01J29/12;;B01J29/14;;B01J29/16;;B01J29/40;;B01J29/44;;B01J29/46;;B01J29/50;;B01J29/54;;B01J29/56;;B01J29/70;;B01J29/72;;B01J29/74;;B01J29/76;;B01J29/78;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/00;;B01J37/02;;F01N3/022;;F01N3/035;;F01N3/08;;F01N3/20,,0,0,,,,ACTIVE
96,BR,A,BR 8704696 A,133-806-436-864-244,1988-04-26,1988,BR 8704696 A,1987-09-09,GB 8621790 A,1986-09-10,"COMPOSTO FUNGICIDA,PROCESSO PARA SUA PREPARACAO,COMPOSICAO FUNGICIDA E PROCESSO PARA COMBATER FUNGOS",,ICI PLC,ANTHONY VIVIENNE MARGARET;;URCH CHRISTOPHER JOHN;;ELLIOTT ALISON CLARE,,https://lens.org/133-806-436-864-244,Patent Application,no,0,0,16,16,0,A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/033;;C07F7/0812;;C07D295/02,A01N33/08;;A01N33/10;;A01N33/04;;A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;A01N55/10;;C07C67/00;;C07C209/00;;C07C209/24;;C07C211/40;;C07C213/00;;C07C217/74;;C07C291/02;;C07C291/04;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/02;;C07D295/033;;C07D295/04;;C07F7/08,,0,0,,,,DISCONTINUED
97,AU,B2,AU 752269 B2,169-343-013-955-150,2002-09-12,2002,AU 1999/056707 A,1999-08-05,US 14679898 A;;US 9917782 W,1998-09-03,System and method for controlled infusion and pressure monitoring,,ETHICON INC,HSEI PAUL K;;CLARE CHRISTOPHER R;;ALDEN DONALD L,,https://lens.org/169-343-013-955-150,Granted Patent,no,3,0,8,8,0,A61B17/32002;;A61B18/1482;;A61M3/0258;;A61M3/0283;;A61M3/0287;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202;;A61M3/0258;;A61B18/1482;;A61M3/0287;;A61M3/0283;;A61B17/32002;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202,A61B5/00;;A61B17/00;;A61B17/32;;A61B18/14;;A61M1/00;;A61M3/02;;A61M5/00;;G05D16/20,,0,0,,,,EXPIRED
98,CA,A1,CA 2150813 A1,181-938-346-151-975,1994-06-09,1994,CA 2150813 A,1993-11-30,US 98382492 A;;US 15979893 A,1992-12-01,"ELECTRODE CONSTRUCTION, ASSEMBLY THEREOF, PACKAGE THEREFOR AND METHOD","An electrode construction a support structure (32), a conductive electrode material (46) carried by the support structure and having a length and a width and having proximal and distal extremities said support structure including a campliant sleeve (41) having an open end and surrounding the distal extremity ofthe conductive electrode material to protrude through the open end, and conductive contact means making contact with the proximal extremity of the conductive electrode material.",PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;HIGHE ALBERT J;;IMRAN MIR A,,https://lens.org/181-938-346-151-975,Patent Application,no,0,0,8,8,0,A61B5/0017;;A61B5/6814;;A61B2562/0217;;Y10S439/909;;A61B5/291;;A61B5/0017;;A61B5/6814;;A61B5/291,A61B5/00;;A61B5/0478,,0,0,,,,DISCONTINUED
99,AU,A,AU 1997/026843 A,199-684-124-592-560,1997-09-25,1997,AU 1997/026843 A,1997-06-25,US 98382492 A;;US 15979893 A,1992-12-01,Electrode construction assembly,,PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;HIGHE ALBERT J;;IMRAN MIR A,,https://lens.org/199-684-124-592-560,Patent Application,no,0,0,8,8,0,A61B5/0017;;A61B5/6814;;A61B2562/0217;;Y10S439/909;;A61B5/291;;A61B5/0017;;A61B5/6814;;A61B5/291,A61B5/00;;A61B5/0478,,0,0,,,,PENDING
100,US,B2,US 8919110 B2,199-258-993-289-369,2014-12-30,2014,US 201313970109 A,2013-08-19,US 201313970109 A;;GB 0903262 A;;GB 0922612 A;;US 201113222929 A;;US 71268110 A;;US 201213203631 A;;US 201113203631 A,2009-02-26,Method and system using a filter for treating exhaust gas having particulate matter,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine or a compression ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2011-12-16),https://lens.org/199-258-993-289-369,Granted Patent,yes,25,12,8,8,0,B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y10S55/30;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01J35/657;;B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y02T10/12;;B01J35/40;;B01J35/56;;B01J35/60;;B01J35/657;;B01D53/9431;;Y10S55/30;;B01D53/9409,B01D53/94;;B01J23/46;;B01J29/06;;B01J29/08;;B01J29/12;;B01J29/14;;B01J29/16;;B01J29/40;;B01J29/44;;B01J29/46;;B01J29/50;;B01J29/54;;B01J29/56;;B01J29/70;;B01J29/72;;B01J29/74;;B01J29/76;;B01J29/78;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/00;;B01J37/02;;F01N3/035;;F01N3/08;;F01N3/20;;F01N3/28,60/299;;60/301;;423/213.2;;423/213.5;;423/213.7;;423/215.5;;X 55DIG 30;;95/273;;95/285,0,0,,,,ACTIVE
101,DK,A,DK 170489 A,037-735-250-542-356,1989-10-12,1989,DK 170489 A,1989-04-10,GB 8808433 A,1988-04-11,SPIROCYCLISK FORBINDELSE MED MINDST EN RING MED FEM LED OG TO HETEROATOMER,,MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/037-735-250-542-356,Patent Application,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
102,US,A1,US 2015/0351393 A1,092-107-018-945-940,2015-12-10,2015,US 201414762927 A,2014-01-29,EP 13153600 A;;EP 2014051731 W,2013-02-01,COMPOSITION,Antimicrobial composition comprising a lactam and a hydrotrope. Antimicrobial additive composition containing a lactam and a hydrotrope.,CONOPCO INC DBA UNILEVER;;CONOPCO INC DBA UNILEVER,PARRY NEIL JAMES;;O'KEEFFE JOANNE CLARE;;SMITH CHRISTOPHER FRANCIS,CONOPCO INC. D/B/A UNILEVER (2014-02-24),https://lens.org/092-107-018-945-940,Patent Application,yes,1,12,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N43/36;;A01N25/00;;A61K8/34;;A61K8/49;;A61K8/69;;A61K8/92;;A61Q5/02;;A61Q5/12;;A61Q15/00;;A61Q17/00;;A61Q19/10,,0,0,,,,ACTIVE
103,EP,A3,EP 0259977 A3,097-837-181-489-814,1990-03-07,1990,EP 87307080 A,1987-08-10,GB 8621790 A,1986-09-10,TERTIARY AMINE COMPOUNDS,"Compounds having plantfungicidal properties are offor- mula:
  and stereoisomers thereof, wherein R 1 , R 2 , R 3  and R 4  each represents a hydrogen atom, a halogen atom, or an alkyl group containing from 1 to 4 carbon atoms but R 4  is not halogen, R 5  and R 6  each represents an alkyl group containing from 1 to 4 carbon atoms or R 5  and R 6  together with the adjacent nitrogen atom form a heterocyclic ring which may optionally contain an additional heteroatom, X and Y each represent a hydrogen atom, a halogen atom, or an alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, aryl, aralkyl, alkoxy or aryloxy group, or a
  group wherein R 19 , R 20  and R 21  can be an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl group, n has the value 0 or 1 and Q and Z are bridging groups as defined; and acid addition salts and N-oxides thereof.",IMPERIAL CHEMICAL INDUSTRIES PLC,"ANTHONY, VIVIENNE MARGARET;;URCH, CHRISTOPHER JOHN;;ELLIOTT, ALISON CLARE",,https://lens.org/097-837-181-489-814,Search Report,yes,6,0,16,16,0,A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/033;;C07F7/0812;;C07D295/02,A01N33/08;;A01N33/10;;A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;A01N33/04;;A01N55/10;;C07C67/00;;C07C209/00;;C07C209/24;;C07C211/40;;C07C213/00;;C07C217/74;;C07C291/02;;C07C291/04;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/02;;C07D295/033;;C07D295/04;;C07F7/08,,2,1,091-700-580-889-182,4635966;;10.1021/jm00282a009,"JOURNAL OF MEDICINAL CHEMISTRY, vol. 15, no. 12, December 1972, pages 1239-1243; D. LEDNICER et al.: ""Partly reduced biphenyls as central nervous system agents. 2. cis- and trans-4-arylcyclohexylamines"";;CHEMICAL ABSTRACTS, vol. 73, no. 1, 6th July 1970, pages 203,204, abstract no. 2397r, Columbus, Ohio, US; G. CANTARELLI et al.: ""[Phenylcyclohexyl)amines]. III. ÄN-substituted and N,N-disubstituted (3- and 4-phenylcyclohexyl)aminesÜ. Their local anesthetic and pressor activity"", & FARMACO, ED. SCI. 1970, 25(4), 248-94",DISCONTINUED
104,EP,B1,EP 2950645 B1,113-781-234-761-809,2020-10-21,2020,EP 14701586 A,2014-01-29,EP 13153600 A;;EP 2014051731 W;;EP 14701586 A,2013-02-01,ANTIMICROBIAL COMPOSITION COMPRISING A LACTAM AND A HYDROTROPE,,UNILEVER PLC;;UNILEVER NV,PARRY NEIL JAMES;;O'KEEFFE JOANNE CLARE;;SMITH CHRISTOPHER FRANCIS,"UNILEVER GLOBAL IP LIMITED, WIRRAL, GB (2021-08-24)",https://lens.org/113-781-234-761-809,Granted Patent,yes,9,0,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N25/02;;A01N25/30;;A01N43/36;;A01P1/00;;A61K8/69;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61Q15/00;;A61Q19/10,,0,0,,,,ACTIVE
105,DE,D1,DE 68913327 D1,144-641-237-941-362,1994-04-07,1994,DE 68913327 T,1989-04-06,GB 8808433 A,1988-04-11,Spirocyclische Verbindungen mit zwei Heteroatome enthaltenden fünfgliedrigen Ringen.,,MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/144-641-237-941-362,Granted Patent,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
106,EP,A4,EP 1109486 A4,003-864-433-410-994,2004-10-27,2004,EP 99943654 A,1999-08-05,US 9917782 W;;US 14679898 A,1998-09-03,SYSTEM AND METHOD FOR CONTROLLED INFUSION AND PRESSURE MONITORING,,ETHICON INC,HSEI PAUL K;;CLARE CHRISTOPHER R;;ALDEN DONALD L,,https://lens.org/003-864-433-410-994,Search Report,no,2,0,8,8,0,A61B17/32002;;A61B18/1482;;A61M3/0258;;A61M3/0283;;A61M3/0287;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202;;A61M3/0258;;A61B18/1482;;A61M3/0287;;A61M3/0283;;A61B17/32002;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202,A61B5/00;;A61B17/00;;A61B17/32;;A61B18/14;;A61M1/00;;A61M3/02;;A61M5/00;;G05D16/20,,1,0,,,See also references of WO 0028890A1,DISCONTINUED
107,DK,A,DK 455287 A,165-132-228-354-963,1988-03-11,1988,DK 455287 A,1987-08-31,GB 8621790 A,1986-09-10,TERTIAERE AMINFORBINDELSER,,ICI PLC,ANTHONY VIVIENNE MAGARET;;URCH CHRISTOPHER JOHN;;ELLIOTT ALISON CLARE,,https://lens.org/165-132-228-354-963,Patent Application,no,0,0,16,16,0,A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/033;;C07F7/0812;;C07D295/02,A01N33/08;;A01N33/10;;A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;A01N55/10;;C07C67/00;;A01N33/04;;C07C209/00;;C07C209/24;;C07C211/40;;C07C213/00;;C07C217/74;;C07C291/02;;C07C291/04;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/02;;C07D295/033;;C07D295/04;;C07F7/08,,0,0,,,,DISCONTINUED
108,AU,A1,AU 2014/211458 A1,001-257-441-466-296,2015-08-13,2015,AU 2014/211458 A,2014-01-29,EP 13153600 A;;EP 2014051731 W,2013-02-01,Antimicrobial composition comprising a lactam and a hydrotrope,Antimicrobial composition comprising a lactam and a hydrotrope.Antimicrobial additive composition containing a lactam and a hydrotrope.,UNILEVER PLC,PARRY NEIL JAMES;;O'KEEFFE JOANNE CLARE;;SMITH CHRISTOPHER FRANCIS,UNILEVER GLOBAL IP LIMITED (2021-10-14),https://lens.org/001-257-441-466-296,Patent Application,no,0,0,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N25/02;;A01N25/30;;A01N43/36;;A01P1/00;;A61K8/00,,0,0,,,,ACTIVE
109,US,A1,US 2012/0107203 A1,099-826-957-146-237,2012-05-03,2012,US 201113222929 A,2011-08-31,US 201113222929 A;;GB 0903262 A;;GB 0922612 A;;US 71268110 A;;US 201313203631 A;;GB 2010050347 W,2009-02-26,METHOD AND SYSTEM USING A FILTER FOR TREATING EXHAUST GAS HAVING PARTICULATE MATTER,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine or a compression ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH;;JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2011-12-16),https://lens.org/099-826-957-146-237,Patent Application,yes,6,26,8,8,0,B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y10S55/30;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01J35/657;;B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y02T10/12;;B01J35/40;;B01J35/56;;B01J35/60;;B01J35/657;;B01D53/9431;;Y10S55/30;;B01D53/9409,B01D53/94,423/213.5;;422/171;;423/213.2,0,0,,,,ACTIVE
110,BR,B1,BR 112015017911 B1,107-834-292-968-188,2021-03-02,2021,BR 112015017911 A,2014-01-29,EP 2014051731 W;;EP 13153600 A,2013-02-01,"composição antimicrobiana, método para produzir uma composição antimicrobiana e uso de uma composição antimicrobiana","composição antimicrobiana, método para produzir uma composição antimicrobiana e uso de uma composição antimicrobiana. composição antimicrobiana compreendendo uma lactama e um hidrótopo. composição aditiva antimicrobiana contendo uma lactama e um hidrótopo.",UNILEVER IP HOLDINGS B V;;UNILEVER NV,CHRISTOPHER FRANCIS SMITH;;JOANNE CLARE O'KEEFFE;;NEIL JAMES PARRY,UNILEVER IP HOLDINGS B.V. (PB) (2021-02-09),https://lens.org/107-834-292-968-188,Granted Patent,no,0,0,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N25/02;;A01N25/30;;A01N43/36;;A01P1/00;;A61K8/00,,0,0,,,,ACTIVE
111,DK,D0,DK 455287 D0,117-240-496-967-851,1987-08-31,1987,DK 455287 A,1987-08-31,GB 8621790 A,1986-09-10,TERTIAERE AMINFORBINDELSER,,ICI PLC,ANTHONY VIVIENNE MAGARET;;URCH CHRISTOPHER JOHN;;ELLIOTT ALISON CLARE,,https://lens.org/117-240-496-967-851,Patent Application,no,0,0,16,16,0,A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/033;;C07F7/0812;;C07D295/02,A01N33/08;;A01N33/10;;A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;A01N55/10;;C07C67/00;;A01N33/04;;C07C209/00;;C07C209/24;;C07C211/40;;C07C213/00;;C07C217/74;;C07C291/02;;C07C291/04;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/02;;C07D295/033;;C07D295/04;;C07F7/08,,0,0,,,,DISCONTINUED
112,WO,A1,WO 1994/012099 A1,150-644-497-967-658,1994-06-09,1994,US 9311553 W,1993-11-30,US 15979893 A;;US 98382492 A,1992-12-01,"ELECTRODE CONSTRUCTION, ASSEMBLY THEREOF, PACKAGE THEREFOR AND METHOD","An electrode construction comprising a support structure (32), a conductive electrode material (46) carried by the support structure and having a length and a width and having proximal and distal extremities, said support structure including a compliant sleeve (41) having an open end and surrounding the distal extremity of the conductive electrode material to protrude through the open end, and conductive contact means making contact with the proximal extremity of the conductive electrode material.",PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;HIGHE ALBERT J;;IMRAN MIR A,,https://lens.org/150-644-497-967-658,Patent Application,yes,3,9,8,8,0,A61B5/0017;;A61B5/6814;;A61B2562/0217;;Y10S439/909;;A61B5/291;;A61B5/0017;;A61B5/6814;;A61B5/291,A61B5/00;;A61B5/0478,,1,0,,,See also references of EP 0675696A4,PENDING
113,US,A,US 6159160 A,178-077-922-910-774,2000-12-12,2000,US 14679898 A,1998-09-03,US 14679898 A;;US 7951598 P,1998-03-26,System and method for controlled infusion and pressure monitoring,"Improved systems and methods are used for controlled infusion of fluid into a body cavity. In particular, the improved system allows a user to accurately control pressure created in a body cavity over a broad range of fluid flow rates required in various medical procedures. In one embodiment, the system comprises a pump having a conduit which defines a fluid flow path from the pump. Typically, a surgical instrument such as a resectoscope is coupled to the conduit to direct the fluid into the body cavity. The system controls pressure in the body cavity by using a first sensor to measure pump output and a second sensor to measure body cavity pressure. Preferably, the second sensor measures the actual pressure in the body cavity to correct for any pressure losses that may occur during fluid delivery from the pump.",ETHICON INC,HSEI PAUL K;;CLARE CHRISTOPHER R;;ALDEN DONALD L,,https://lens.org/178-077-922-910-774,Granted Patent,yes,8,489,8,8,0,A61B17/32002;;A61B18/1482;;A61M3/0258;;A61M3/0283;;A61M3/0287;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202;;A61M3/0258;;A61B18/1482;;A61M3/0287;;A61M3/0283;;A61B17/32002;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202,A61B5/00;;A61B17/00;;A61B17/32;;A61B18/14;;A61M1/00;;A61M3/02;;A61M5/00;;G05D16/20,600/560,3,3,010-722-117-313-439;;058-092-199-153-720;;148-980-127-116-662,10.1016/s0140-6736(94)92030-3;;7908082;;9050492;;10.1016/s1074-3804(05)81015-1;;9384163,"Willem M. Ankum, Jan Vonk, The spring balance: a simple monitoring system for fluid overload during hysteroscopic surgery, The Lancet, vol. 343, Apr. 2, 1994, pp 836 837.;;G.J. Shirk, R.J. Gimpelson, Control of Intrauterine Fluid Pressure During Operative Hysteroscopy, J. of Am. Assn. of Byn. Lap., vol. I, May 1994, pp 229 233.;;Paulette Stafford, New Technology Helps Prevent Fluid Intravasation During Operative Hysteroscopy, Minimally Invasive Surgical Nursing, vol. 11, No. 2, 1997, pp. 63 66.",EXPIRED
114,WO,A1,WO 2000/028890 A1,194-903-087-096-810,2000-05-25,2000,US 9917782 W,1999-08-05,US 14679898 A,1998-09-03,SYSTEM AND METHOD FOR CONTROLLED INFUSION AND PRESSURE MONITORING,"Improved systems and methods are used for controlled infusion of fluid into a body cavity. In particular, the improved system allows a user to accurately control pressure created in a body cavity over a broad range of fluid flow rates required in various medical procedures. In one embodiment, the system comprises a pump (40) having a conduit (30) which defines a fluid flow path from the pump (40). Typically, a surgical instrument such as a rectoscope (50) is coupled to the conduit to direct the fluid into the body cavity. The system controls pressure in the body cavity by using a first sensor (110) to measure pump output, and a second sensor (120) to measure body cavity pressure. Preferably, the second sensor (120) measures the actual pressure in the body cavity to correct for any pressure losses that may occur during fluid delivery from the pump (40).",ETHICON INC;;HSEI PAUL K;;CLARE CHRISTOPHER R;;ALDEN DONALD L,HSEI PAUL K;;CLARE CHRISTOPHER R;;ALDEN DONALD L,,https://lens.org/194-903-087-096-810,Patent Application,yes,4,56,8,8,0,A61B17/32002;;A61B18/1482;;A61M3/0258;;A61M3/0283;;A61M3/0287;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202;;A61M3/0258;;A61B18/1482;;A61M3/0287;;A61M3/0283;;A61B17/32002;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202,A61B5/00;;A61B17/00;;A61B17/32;;A61B18/14;;A61M1/00;;A61M3/02;;A61M5/00;;G05D16/20,,1,0,,,See also references of EP 1109486A4,PATENTED
115,GB,A,GB 2610835 A,012-306-516-553-173,2023-03-22,2023,GB 202113257 A,2021-09-16,GB 202113257 A,2021-09-16,Stochastic structures,"A method of forming a stochastic structure comprises the steps of selecting a parent structure which defines an array of unit cells. Each unit has a size, a geometry, a relative density and at least one node. An implicit function of an object or part of an object is placed at each node. The object has position (xcn, ycn, zcn), and extent (rxn, ryn, rzn) parameters or a shape defined by an equation having at least the parameters x, y and z. One or more of the parameters are randomised by applying a statistical distribution having a standard deviation σ, which controls at least one of the three dimensions (Fig. 6) where random values of each parameter are created. A Monte-Carlo array of unit cells representative of the stochastic structure is created. The randomised unit cells may form three-dimensional volume data comprising iso-surfaces which may be rendered or printed with an additive manufacturing process. The implicit function may be any one or a combination of an ellipsoid, sphere, polygon, minimal surface or triply periodic minimal surface. A gas turbine engine including said randomised structure is also disclosed.",SIEMENS ENERGY GLOBAL GMBH & CO KG,ADAM CLARE;;JAN-HENDRIK GROTH;;MIRCO MAGNINI;;CHRISTOPHER TUCK,,https://lens.org/012-306-516-553-173,Patent Application,no,2,0,1,2,0,F05D2220/32;;F01D5/147;;F05D2240/127;;F01D5/187;;F05D2250/231;;F05D2240/15;;F01D5/288;;F05D2260/2212;;F05D2260/2214;;F05D2250/63;;F05D2250/18;;F05D2250/28;;F05D2200/25;;F02C7/045;;F01D5/16;;F01D25/04;;F02C7/185;;F01D25/145;;F23R3/002;;F05D2200/23;;F05D2200/20;;B22F5/04;;B33Y10/00;;B22F5/009;;F05D2230/22;;F05D2230/30;;F05D2230/234;;B33Y80/00;;F15D1/003;;F23R3/005;;F23R3/46;;F23R2900/00014;;B22F10/28;;B22F10/85;;B33Y50/00;;B29C64/386;;F28F2210/02;;F28F13/08;;F28D2021/0021;;F28D7/10;;G06T17/00;;B33Y50/00;;A61L27/00;;B29C64/00;;F01D5/00;;F01N3/00;;F28D7/00;;G06T15/00;;G06T17/10;;G06T17/20;;G06T17/30,B33Y50/00;;A61L27/00;;B29C64/00;;F01D5/00;;F01N3/00;;F28D7/00;;G06T15/00;;G06T17/10;;G06T17/20;;G06T17/30,,1,0,,,"B. Sjodin, How to Generate Randomized Inhomogeneous Material Data, Comsol blog, 20 June 2017, available at https://www.comsol.com/blogs/how-to-generate-randomized-inhomogeneous-material-data/ [retrieved 7 March 2022]",PENDING
116,PT,A,PT 90223 A,073-626-118-168-718,1989-11-10,1989,PT 9022389 A,1989-04-07,GB 8808433 A,1988-04-11,PROCESSO PARA A PREPARACAO DE COMPOSTOS ESPIROCICLICOS QUE INCORPORAM ANEIS DE CINCO ELEMENTOS COM DOIS HETEROATOMOS,,MERCK SHARP & DOHME,BAKER RAYMOND;;SAUNDERS JOHN;;KNEEN CLARE O;;SWAIN CHRISTOPHER,,https://lens.org/073-626-118-168-718,Patent Application,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
117,US,B2,US 9930888 B2,066-360-703-166-722,2018-04-03,2018,US 201414762927 A,2014-01-29,EP 13153600 A;;EP 2014051731 W,2013-02-01,Composition,Antimicrobial composition comprising a lactam and a hydrotrope. Antimicrobial additive composition containing a lactam and a hydrotrope.,CONOPCO INC,PARRY NEIL JAMES;;O'KEEFFE JOANNE CLARE;;SMITH CHRISTOPHER FRANCIS,CONOPCO INC. D/B/A UNILEVER (2014-02-24),https://lens.org/066-360-703-166-722,Granted Patent,yes,15,9,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N43/36;;A01N25/00;;A61K8/34;;A61K8/49;;A61K8/69;;A61K8/92;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61Q15/00;;A61Q17/00;;A61Q19/10,,9,4,001-978-317-058-033;;043-912-087-533-303;;021-760-248-635-119;;072-419-755-833-006,9603842;;pmc106306;;10.1128/aem.64.6.2240-2246.1998;;pmc271866;;3905855;;10.1128/jcm.22.6.996-1006.1985;;10.1073/pnas.96.4.1639;;9990077;;pmc15544;;9618536;;10.1073/pnas.95.12.7046;;pmc22733,"Andersen et al., New Unstable Variants of Green Fluorescent Protein for Studies of Transient Gene Expression in Bacteria, Applied and Envrionmental Microbiology,, 1998, p. 2240-2246, 64 No. 6, US.;;Christensen, Simpson, Younger, Baddour, Barrett, Melton, Beachey, Adherence of Coagulase-Negative Staphylococci to Plastic Tissue Culture Plates, Journal of Clinical Microbiology 1985 vol. 22 No. 6 p. 996-1006, 1985, pp. 996-1006, 22 No. 6, US.;;Surette et al., Quorum sensing in Escherichia coli, Slamonella typhimurium, and Vibrio harveyi: A new family of genes responsible for autoinducer production, Proc. Natl. Acad. Sci USA 1999, 1999, pp. 1639-1644, 96.;;Surette MG BL Bassler, Quorum sensin in Escherichia coli and Salmonella typhimurium, Proc Natl Acad Sci USA, 1998, pp. 7046-7050, 95, US.;;Mar. 4, 2014, Search Report in PCTEP2014051731 (NPL 1, pp. 1-5).;;Mar. 4, 2014, Written Opinion in PCTEP2014051731 (NPL 1, pp. 6-10).;;Search Report in EP13153600, dated Mar 18, 2013 (NPL 1, pp. 11-13).;;Written Opinion in EP13153600, dated Mar 18, 2013 (NPL 1, pp. 14-16).;;Rosen et al., “Surfactants and Interfacial Phenomena”; pp. 212-215, 2012.",ACTIVE
118,BR,A2,BR 112015017911 A2,073-004-034-382-286,2017-07-11,2017,BR 112015017911 A,2014-01-29,EP 2014051731 W;;EP 13153600 A,2013-02-01,"composição aditiva antimicrobiana, composição antimicrobiana, composição antimicrobiana ou composição aditiva, método para produzir uma composição aditiva antimicrobiana, método para produzir uma composição antimicrobiana, uso de uma composição aditiva ou composição antimicrobiana",ÿþr,UNILEVER NV,CHRISTOPHER FRANCIS SMITH;;JOANNE CLARE O'KEEFFE;;NEIL JAMES PARRY,UNILEVER IP HOLDINGS B.V. (PB) (2021-02-09),https://lens.org/073-004-034-382-286,Patent Application,no,0,0,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N25/02;;A01N25/30;;A01N43/36;;A01P1/00;;A61K8/00,,0,0,,,,ACTIVE
119,CN,A,CN 105050393 A,105-999-299-432-311,2015-11-11,2015,CN 201480006257 A,2014-01-29,EP 2014051731 W;;EP 13153600 A,2013-02-01,Antimicrobial composition comprising a lactam and a hydrotrope,Antimicrobial composition comprising a lactam and a hydrotrope.Antimicrobial additive composition containing a lactam and a hydrotrope.,UNILEVER NV,PARRY NEIL JAMES;;O'KEEFFE JOANNE CLARE;;SMITH CHRISTOPHER FRANCIS,,https://lens.org/105-999-299-432-311,Patent Application,no,3,4,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N25/02;;A01N25/30;;A01N43/36;;A01P1/00;;A61K8/00,,0,0,,,,ACTIVE
120,DE,A1,DE 19645849 A1,117-782-691-590-46X,1997-05-15,1997,DE 19645849 A,1996-11-07,US 55537495 A,1995-11-09,Einrichtung und Verfahren zur Herstellung einer offenen MR-Magnetgradientspule,,GEN ELECTRIC,REPINSKI GREGORY A;;KINSEY KEVIN A;;MYERS CHRISTOPHER CLARE,,https://lens.org/117-782-691-590-46X,Patent Application,no,0,0,3,3,0,G01R33/3806;;G01R33/385;;H01F41/071;;Y10T29/49799;;Y10T29/4902;;Y10T29/49799;;Y10T29/4902;;G01R33/385;;G01R33/3806;;H01F41/071,A61B5/055;;G01R33/38;;G01R33/385;;H01F41/06,,0,0,,,,DISCONTINUED
121,WO,A1,WO 2013/030584 A1,186-760-194-636-071,2013-03-07,2013,GB 2012052136 W,2012-08-31,US 201113222929 A,2011-08-31,METHOD AND SYSTEM USING A FILTER FOR TREATING EXHAUST GAS HAVING PARTICULATE MATTER,"A system for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine or a compression ignition engine, said system comprising a filter having inlet surfaces, outlet surfaces, and a porous structure between the inlet surfaces and the outlet surfaces; a selective catalytic reduction (SCR) washcoat com¬ prising a small pore zeolite promoted with at least one metal select¬ ed from the group consisting of Cr, Co, Cu, Fe, Hf, La, Ce, In, V, Mn, Ni, Zn, Ga, Ag, Au, Pt, Pd and Rh, wherein the washcoat provides a wash- coated filter for filtering the particulate matter; and a NOx absorber disposed upstream of the washcoat.",JOHNSON MATTHEY PLC;;ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/186-760-194-636-071,Patent Application,yes,23,4,8,8,0,B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y10S55/30;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01J35/657;;B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y02T10/12;;B01J35/40;;B01J35/56;;B01J35/60;;B01J35/657;;B01D53/9431;;Y10S55/30;;B01D53/9409,B01D53/94;;B01J29/76;;B01J37/02;;F01N3/035;;F01N3/08;;F01N3/20,,0,0,,,,PENDING
122,WO,A1,WO 2012/017222 A1,196-773-996-074-993,2012-02-09,2012,GB 2011051319 W,2011-07-14,GB 201013188 A,2010-08-05,STORAGE AND TRANSPORTATION DEVICE,"The present invention relates to storage and transportation devices, especially such devices used in relation to picnics. The present disclosure provides a storage and transportation device suitable for use in picnics comprising at least two receptacles (10), each receptacle (10) having at least one internal compartment, an access aperture for accessing said internal compartment, an attachment device (18) for enabling attachment to the other receptacle (10) thereby forming a conjoined receptacle (10), wherein access to each internal compartment is not restricted by the formation of the conjoined container. The present disclosure also provides storage and transportation device of this type mounted upon a wheeled and manually propelled vehicle. Such a vehicle may be a golf cart.",LOWER CLARE;;MARSHALL-REES STEPHEN;;KEEGAN CHRISTOPHER JOHN CAMERON,LOWER CLARE;;MARSHALL-REES STEPHEN;;KEEGAN CHRISTOPHER JOHN CAMERON,,https://lens.org/196-773-996-074-993,Patent Application,yes,11,6,4,4,0,A45C7/005;;A45C11/20;;A45F3/46;;A45C7/0045;;A63B55/60;;A45C11/20;;A45F3/46;;A63B55/60;;A63B55/60;;B65D21/02;;B65D21/0228;;B65D25/005;;B65D25/54,A45C7/00;;A45C11/20;;A45F3/46;;A63B55/00;;B65D21/02;;B65D25/00;;B65D25/54,,0,0,,,,PENDING
123,PT,B,PT 90223 B,073-440-122-910-721,1994-07-29,1994,PT 9022389 A,1989-04-07,GB 8808433 A,1988-04-11,PROCESSO PARA A PREPARACAO DE COMPOSTOS ESPIROCICLICOS QUE INCORPORAM ANEIS DE CINCO ELEMENTOS COM DOIS HETEROATOMOS,,MERCK SHARP & DOHME,BAKER RAYMOND;;SAUNDERS JOHN;;KNEEN CLARE O;;SWAIN CHRISTOPHER,,https://lens.org/073-440-122-910-721,Granted Patent,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
124,US,A1,US 2008/0291122 A1,169-020-064-274-295,2008-11-27,2008,US 57865906 A,2006-05-09,GB 0428191 A;;GB 2005050219 W,2004-12-23,Digital Signal Processing Methods and Apparatus,"This invention generally relates to methods, apparatus and computer program code processing digital data using non-negative matrix factorisation. A method of digitally processing data in a data array defining a target matrix (X) using non-negative matrix factorisation to determine a pair of matrices (F, G), a first matrix of said pair determining a set of features for representing said data, a second matrix of said pair determining weights of said features, such that a product of said first and second matrices approximates said target matrix, the method comprising: inputting said target matrix data (X); selecting a row of said one of said first and second matrices and a column of the other of said first and second matrices; determining a target contribution (R) of said selected row and column to said target matrix; determining, subject to a non-negativity constraint, updated values for said selected row and column from said target contribution; and repeating said selecting and determining for the other rows and columns of said first and second matrices until all said rows and columns have been updated.",SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE LOUISE,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE LOUISE,CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (2006-03-15),https://lens.org/169-020-064-274-295,Patent Application,yes,73,37,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G09G3/20;;G06F17/16;;G09G3/32,345/55,0,0,,,,INACTIVE
125,WO,A1,WO 2023/041402 A1,000-659-145-341-291,2023-03-23,2023,EP 2022074912 W,2022-09-07,GB 202113257 A;;GB 202113258 A,2021-09-16,STOCHASTIC STRUCTURES,"A method of forming a stochastic structure, the method comprising the steps: selecting a parent structure, the parent structure defining an array of unit cells, initially the array of unit cells is uniform, defining each unit cell of the array of unit cells a size, a geometry, a relative density and at least one node, placing an implicit function of an object or part of an object at each node, wherein the object having parameters to define its position xc n , yc n , zc n , and extent rx n , ry n , and rz n or a shape defined by an equation having at least the parameters x, y and z, randomising any one or more of the parameters by applying a statistical distribution, the statistical distribution having a standard deviation σ, the standard deviation σ controls at least one of the three dimensions where random values of each parameter are created and selecting a value greater than zero of the standard deviation σ to define the degree of randomisation for any one or more of the parameters, thereby creating a randomised array of unit cells representative of the stochastic structure wherein the randomised array of unit cells forms three-dimensional volume data comprising iso-surfaces, the method comprising rendering the iso-surfaces with polygons having faces and vertices to form a solid model of the stochastic structure and optionally printing the stochastic structure in an additive manufacturing process.",SIEMENS ENERGY GLOBAL GMBH & CO KG,CLARE ADAM;;GROTH JAN-HENDRIK;;MAGNINI MIRCO;;TUCK CHRISTOPHER,,https://lens.org/000-659-145-341-291,Patent Application,yes,0,0,1,2,0,G06F30/20;;G06F2113/10;;B33Y50/00;;G06T17/205,G06F30/20;;G06F113/10;;G06T17/10,,5,5,014-321-998-149-808;;097-144-100-162-78X;;049-701-789-979-914;;159-408-859-476-921;;069-750-683-573-816,10.1016/j.msec.2015.06.039;;26249613;;10.1063/1.4989441;;10.1016/j.addma.2021.102488;;10.1016/j.ijimpeng.2018.05.002;;10.1007/s00170-019-04116-z,"YANG NAN ET AL: ""Simple method to generate and fabricate stochastic porous scaffolds"", MATERIALS SCIENCE AND ENGINEERING C, vol. 56, 27 June 2015 (2015-06-27), pages 444 - 450, XP029252678, ISSN: 0928-4931, DOI: 10.1016/J.MSEC.2015.06.039;;MIRZAALI M J ET AL: ""Rational design of soft mechanical metamaterials: Independent tailoring of elastic properties with randomness"", APPLIED PHYSICS LETTERS, AMERICAN INSTITUTE OF PHYSICS, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747, vol. 111, no. 5, 4 August 2017 (2017-08-04), XP012220553, ISSN: 0003-6951, [retrieved on 20170804], DOI: 10.1063/1.4989441;;GROTH JAN-HENDRIK ET AL: ""Five simple tools for stochastic lattice creation"", ADDITIVE MANUFACTURING, vol. 49, 1 January 2022 (2022-01-01), NL, pages 102488, XP093022105, ISSN: 2214-8604, Retrieved from the Internet <URL:https://www.sciencedirect.com/science/article/pii/S2214860421006369/pdfft?md5=3c716051a979a6481abfb571e5e7d0bf&pid=1-s2.0-S2214860421006369-main.pdf> DOI: 10.1016/j.addma.2021.102488;;VOILLAT R. ET AL: ""Hypervelocity impact testing on stochastic and structured open porosity cast Al-Si cellular structures for space applications"", INTERNATIONAL JOURNAL OF IMPACT ENGINEERING., vol. 120, 1 October 2018 (2018-10-01), GB, pages 126 - 137, XP093022110, ISSN: 0734-743X, Retrieved from the Internet <URL:https://www.sciencedirect.com/science/article/pii/S0734743X17311119/pdfft?md5=d629014f431b7a9129d8c7e55a073c92&pid=1-s2.0-S0734743X17311119-main.pdf> DOI: 10.1016/j.ijimpeng.2018.05.002;;GUDDATI SUBHASH ET AL: ""Recent advancements in additive manufacturing technologies for porous material applications"", THE INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY, SPRINGER, LONDON, vol. 105, no. 1-4, 5 August 2019 (2019-08-05), pages 193 - 215, XP036930776, ISSN: 0268-3768, [retrieved on 20190805], DOI: 10.1007/S00170-019-04116-Z",PENDING
126,EP,A4,EP 0675696 A4,140-041-027-649-908,1998-09-16,1998,EP 94903332 A,1993-11-30,US 9311553 W;;US 98382492 A;;US 15979893 A,1992-12-01,"ELECTRODE CONSTRUCTION, ASSEMBLY THEREOF, PACKAGE THEREFOR AND METHOD.",,PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;HIGHE ALBERT J;;IMRAN MIR A,,https://lens.org/140-041-027-649-908,Search Report,no,3,0,8,8,0,A61B5/0017;;A61B5/6814;;A61B2562/0217;;Y10S439/909;;A61B5/291;;A61B5/0017;;A61B5/6814;;A61B5/291,A61B5/00;;A61B5/0478,,1,0,,,See also references of WO 9412099A1,DISCONTINUED
127,DE,T2,DE 68913327 T2,151-043-884-358-441,1994-07-28,1994,DE 68913327 T,1989-04-06,GB 8808433 A,1988-04-11,Spirocyclische Verbindungen mit zwei Heteroatome enthaltenden fünfgliedrigen Ringen.,,MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/151-043-884-358-441,Granted Patent,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
128,US,A1,US 2013/0330259 A1,151-663-329-763-728,2013-12-12,2013,US 201313970109 A,2013-08-19,US 201313970109 A;;GB 0903262 A;;GB 0922612 A;;US 201113222929 A;;US 71268110 A;;US 201213203631 A;;US 201113203631 A,2009-02-26,METHOD AND SYSTEM USING A FILTER FOR TREATING EXHAUST GAS HAVING PARTICULATE MATTER,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine or a compression ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2011-12-16),https://lens.org/151-663-329-763-728,Patent Application,yes,0,1,8,8,0,B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y10S55/30;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01J35/657;;B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y02T10/12;;B01J35/40;;B01J35/56;;B01J35/60;;B01J35/657;;B01D53/9431;;Y10S55/30;;B01D53/9409,B01D53/94,423/213.5;;422/170;;423/213.2,0,0,,,,ACTIVE
129,ZA,B,ZA 876160 B,004-001-113-310-516,1988-03-10,1988,ZA 876160 A,1987-08-19,GB 8621790 A,1986-09-10,TERTIARY AMINE COMPOUNDS,,IMPERIAL CHEMICAL INDUSTRIES PLC.,VIVIENNE MARGARET ANTHONY;;CHRISTOPHER JOHN URCH;;ALISON CLARE ELLIOTT,,https://lens.org/004-001-113-310-516,Granted Patent,no,0,0,16,16,0,A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/033;;C07F7/0812;;C07D295/02,A01N33/08;;A01N33/10;;A01N43/36;;A01N43/40;;A01N33/04;;A01N43/84;;A01N55/00;;A01N55/10;;C07C67/00;;C07C209/00;;C07C209/24;;C07C211/40;;C07C213/00;;C07C217/74;;C07C291/02;;C07C291/04;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/02;;C07D295/033;;C07D295/04;;C07F7/08,,0,0,,,,EXPIRED
130,ZA,B,ZA 201505403 B,025-750-477-199-222,2019-01-30,2019,ZA 201505403 A,2015-07-27,EP 13153600 A;;EP 2014051731 W,2013-02-01,ANTIMICROBIAL COMPOSITION COMPRISING A LACTAM AND A HYDROTROPE,,UNILEVER PLC,NEIL JAMES PARRY;;JOANNE CLARE O'KEEFFE;;CHRISTOPHER FRANCIS SMITH,,https://lens.org/025-750-477-199-222,Granted Patent,no,0,0,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,,,0,0,,,,ACTIVE
131,FI,A0,FI 891584 A0,084-455-854-740-351,1989-04-03,1989,FI 891584 A,1989-04-03,GB 8808433 A,1988-04-11,SPIROCYKLISKA FOERENINGAR MED FEMLEDADE RINGAR VILKA INNEHAOLLER TVAO HETEROATOMER.,,MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/084-455-854-740-351,Patent Application,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,DISCONTINUED
132,EP,A2,EP 0259977 A2,196-068-850-359-159,1988-03-16,1988,EP 87307080 A,1987-08-10,GB 8621790 A,1986-09-10,Tertiary amine compounds.,"Compounds having plantfungicidal properties are offor- mula:
  and stereoisomers thereof, wherein R 1 , R 2 , R 3  and R 4  each represents a hydrogen atom, a halogen atom, or an alkyl group containing from 1 to 4 carbon atoms but R 4  is not halogen, R 5  and R 6  each represents an alkyl group containing from 1 to 4 carbon atoms or R 5  and R 6  together with the adjacent nitrogen atom form a heterocyclic ring which may optionally contain an additional heteroatom, X and Y each represent a hydrogen atom, a halogen atom, or an alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, aryl, aralkyl, alkoxy or aryloxy group, or a
  group wherein R 19 , R 20  and R 21  can be an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl group, n has the value 0 or 1 and Q and Z are bridging groups as defined; and acid addition salts and N-oxides thereof.",ICI PLC,ANTHONY VIVIENNE MARGARET;;URCH CHRISTOPHER JOHN;;ELLIOTT ALISON CLARE,,https://lens.org/196-068-850-359-159,Patent Application,yes,0,13,16,16,0,A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/033;;C07F7/0812;;C07D295/02,A01N33/08;;A01N33/10;;A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;A01N33/04;;A01N55/10;;C07C67/00;;C07C209/00;;C07C209/24;;C07C211/40;;C07C213/00;;C07C217/74;;C07C291/02;;C07C291/04;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/02;;C07D295/033;;C07D295/04;;C07F7/08,,0,0,,,,DISCONTINUED
133,CA,A1,CA 2342635 A1,012-457-316-553-919,2000-05-25,2000,CA 2342635 A,1999-08-05,US 14679898 A;;US 9917782 W,1998-09-03,SYSTEM AND METHOD FOR CONTROLLED INFUSION AND PRESSURE MONITORING,"Improved systems and methods are used for controlled infusion of fluid into a body cavity. In particular, the improved system allows a user to accurately control pressure created in a body cavity over a broad range of fluid flow rates required in various medical procedures. In one embodiment, the system comprises a pump (40) having a conduit (30) which defines a fluid flow path from the pump (40). Typically, a surgical instrument such as a rectoscope (5 0) is coupled to the conduit to direct the fluid into the body cavity. The syst em controls pressure in the body cavity by using a first sensor (110) to measur e pump output, and a second sensor (120) to measure body cavity pressure. Preferably, the second sensor (120) measures the actual pressure in the body cavity to correct for any pressure losses that may occur during fluid delive ry from the pump (40).",ETHICON INC,HSEI PAUL K;;CLARE CHRISTOPHER R;;ALDEN DONALD L,,https://lens.org/012-457-316-553-919,Patent Application,no,0,0,8,8,0,A61B17/32002;;A61B18/1482;;A61M3/0258;;A61M3/0283;;A61M3/0287;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202;;A61M3/0258;;A61B18/1482;;A61M3/0287;;A61M3/0283;;A61B17/32002;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202,A61B5/00;;A61B17/00;;A61B17/32;;A61B18/14;;A61M1/00;;A61M3/02;;A61M5/00;;G05D16/20,,0,0,,,,DISCONTINUED
134,US,A,US 5520683 A,032-430-307-530-868,1996-05-28,1996,US 24322694 A,1994-05-16,US 24322694 A,1994-05-16,Medical electrode and method,A medical electrode for use with a power supply for providing a more uniform current distribution for contacting an exposed surface of skin of a living body comprising a flexible carrier layer formed of an insulating material. A layer of conductive material is carried by the carrier layer. The layer of conductive material is separated into at least two segments with a space therebetween so that the two segments are electrically isolated from each other. A continuous layer of hydrogel material overlies the segments and is disposed in said space. The hydrogel material has a resistivity greater than the resistivity of the skin of the patient. A connector is adapted to be connected to the source of power whereby substantially equal current flow can be achieved from each segment through the skin of the patient without sharp transitions in current flow between the segments and the space between the segments.,PHYSIOMETRIX INC,SUBRAMANIAM RAJ;;CLARE CHRISTOPHER R;;BARNETT JR DONALD E,PHYSIOMETRIX INC (1994-05-13);;PHYSIOMETRIX INC. A DELAWARE CORPORATION (1996-04-24),https://lens.org/032-430-307-530-868,Granted Patent,yes,5,94,3,3,0,A61N1/0492;;A61N1/0492;;A61B2562/125;;A61B2562/125;;A61N1/048;;A61N1/048,A61N1/04,606/32;;607/142;;607/149;;607/152,0,0,,,,EXPIRED
135,FI,A,FI 891584 A,100-229-096-245-425,1989-10-12,1989,FI 891584 A,1989-04-03,GB 8808433 A,1988-04-11,SPIROCYKLISKA FOERENINGAR MED FEMLEDADE RINGAR VILKA INNEHAOLLER TVAO HETEROATOMER.,,MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/100-229-096-245-425,Patent Application,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,DISCONTINUED
136,EP,A1,EP 0337547 A1,095-780-731-783-149,1989-10-18,1989,EP 89200862 A,1989-04-06,GB 8808433 A,1988-04-11,Spirocyclic compounds incorporating five-membered rings with two heteroatoms.,"The present invention provides a compound of formula I or a salt or prodrug thereof:
  wherein the dotted line represents an optional chemical bond in one of the two possible positions; A represents a group of formula II:
  in which R 1  represents hydrogen, hydroxy, C 1 - 6  alkyl, C 2 - 6  alkenyl, C 2-6  alkynyl, C 1-6  alkoxy, benzyloxy, hydroxy(C 1-6 )alkyl, halogen, amino, cyano, nitro, -CONR 6 R 7  or -S0 2 NR 6 R 7 , in which R 6  and R 7  independently represent hydrogen, C 1-6  alkyl, C 2-6  alkenyl or C 2-6  alkynyl;
 R 2  represents hydrogen, halogen, C 1  - 6  alkyl, C 1  - 6  alkoxy or C 1 - 6  alkylcarbonyl; V represents nitrogen, -CH or -C-; and W represents oxygen, sulphur or -NR 8 , in which R 8  represents hydrogen, C, - 6  alkyl, C 2-6  alkenyl or C 2 - 6  alkynyl; two of X, Y and Z are the same or different and each represents oxygen, sulphur or nitrogen; and the remaining group X, Y or Z is carbon, or Y is carbonyl (C = 0); and Q is the residue of an azacyclic or azabicyclic ring system; which compounds are useful in the treatment of psychotic disorders (e.g. schizophrenia and mania); anxiety; alcohol or drug withdrawal or,dependence; pain; gastric stasis; gastric dysfunction (such as occurs with dyspepsia, peptic ulcer, reflux oesophagitis and flatulence); migraine, nausea and vomiting; moyement disorders; and presenile and senile dementia,",MERCK SHARP & DOHME,BAKER RAYMOND;;KNEEN CLARE O;;SAUNDERS JOHN;;SWAIN CHRISTOPHER,,https://lens.org/095-780-731-783-149,Patent Application,yes,9,27,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
137,EP,A1,EP 2750783 A1,163-293-151-146-49X,2014-07-09,2014,EP 12756814 A,2012-08-31,US 201113222929 A;;GB 2012052136 W,2011-08-31,METHOD AND SYSTEM USING A FILTER FOR TREATING EXHAUST GAS HAVING PARTICULATE MATTER,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/163-293-151-146-49X,Patent Application,yes,0,0,8,8,0,B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y10S55/30;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01J35/657;;B01J37/0246;;B01J23/464;;B01D53/9418;;B01D53/9422;;B01D53/9468;;B01D53/9477;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;F01N3/0842;;F01N3/2066;;F01N3/035;;B01D2255/2065;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2255/9202;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;Y02T10/12;;B01J35/40;;B01J35/56;;B01J35/60;;B01J35/657;;B01D53/9431;;Y10S55/30;;B01D53/9409,B01D53/94;;B01J29/76;;B01J37/02;;F01N3/035;;F01N3/08;;F01N3/20,,0,0,,,,DISCONTINUED
138,EP,A1,EP 0675696 A1,169-832-691-417-594,1995-10-11,1995,EP 94903332 A,1993-11-30,US 9311553 W;;US 98382492 A;;US 15979893 A,1992-12-01,"ELECTRODE CONSTRUCTION, ASSEMBLY THEREOF, PACKAGE THEREFOR AND METHOD.",,PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;HIGHE ALBERT J;;IMRAN MIR A,,https://lens.org/169-832-691-417-594,Patent Application,yes,0,0,8,8,0,A61B5/0017;;A61B5/6814;;A61B2562/0217;;Y10S439/909;;A61B5/291;;A61B5/0017;;A61B5/6814;;A61B5/291,A61B5/00;;A61B5/0478,,0,0,,,,DISCONTINUED
139,PT,A,PT 85664 A,179-933-640-908-92X,1987-10-01,1987,PT 8566487 A,1987-09-09,GB 8621790 A,1986-09-10,TERTIARY AMINE COMPOUNDS,,ICI PLC,ANTHONY VIVIENNE MARGARET;;URCH CHRISTOPHER JOHN;;ELLIOT ALISON CLARE,,https://lens.org/179-933-640-908-92X,Patent Application,no,0,0,16,16,0,A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/033;;C07F7/0812;;C07D295/02,A01N33/08;;A01N33/10;;A01N43/36;;A01N33/04;;A01N43/40;;A01N43/84;;A01N55/00;;A01N55/10;;C07C67/00;;C07C209/00;;C07C209/24;;C07C211/40;;C07C213/00;;C07C217/74;;C07C291/02;;C07C291/04;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/02;;C07D295/033;;C07D295/04;;C07F7/08,,0,0,,,,DISCONTINUED
140,US,B2,US 7953682 B2,066-097-951-003-994,2011-05-31,2011,US 57865906 A,2006-05-09,GB 0428191 A;;GB 2005050219 W,2004-12-23,Method of driving a display using non-negative matrix factorization to determine a pair of matrices for representing features of pixel data in an image data matrix and determining weights of said features such that a product of the matrices approximates the image data matrix,"This invention generally relates to methods, apparatus and computer program code processing digital data using non-negative matrix factorisation. A method of digitally processing data in a data array defining a target matrix (X) using non-negative matrix factorisation to determine a pair of matrices (F, G), a first matrix of said pair determining a set of features for representing said data, a second matrix of said pair determining weights of said features, such that a product of said first and second matrices approximates said target matrix, the method comprising: inputting said target matrix data (X); selecting a row of said one of said first and second matrices and a column of the other of said first and second matrices; determining a target contribution (R) of said selected row and column to said target matrix; determining, subject to a non-negativity constraint, updated values for said selected row and column from said target contribution; and repeating said selecting and determining for the other rows and columns of said first and second matrices until all said rows and columns have been updated.",CAMBRIDGE DISPLAY TECH LTD,SMITH EUAN CHRISTOPHER;;ROUTLEY PAUL RICHARD;;FODEN CLARE LOUISE,CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (2006-03-15),https://lens.org/066-097-951-003-994,Granted Patent,yes,99,27,19,58,0,G06F17/16;;G09G3/3208;;G09G3/3611;;G09G3/20;;G09G3/3216;;G09G3/3216;;G06F17/16;;G06F17/16;;G09G3/30;;G09G2310/0208;;G09G2310/0208;;G09G2320/043;;G09G2320/043;;H04N5/272,G06F15/18;;G06F3/038;;G06F17/16;;G09G3/32;;G09G5/00;;G09G5/39,706/25;;345/643;;345/644;;345/530;;345/204,34,8,083-732-789-210-536;;083-732-789-210-536;;026-592-845-840-243;;132-111-039-931-792;;175-669-239-103-281;;000-741-954-960-28X;;080-006-460-871-501;;095-130-738-813-65X,10548103;;10.1038/44565;;10548103;;10.1038/44565;;10.1109/tencon.2001.949582;;10.1039/b401202j;;15152324;;10.1016/j.csda.2006.11.006;;10.1007/978-3-540-72845-0_26;;10.1889/1.2785234;;10.1007/3-540-36079-4_29,"Lee et al., Learning the parts of objects by non-negative matrix factorization, 1999.;;""United Kingdom Search Report for Application No. GB0524337.3"", 1 Page.;;Lee, Daniel D., et al., ""Algorithms for Non-negative Matrix Factorization"", Advances in Neural Information Processing Systems, vol. 13, (2001), 556-562.;;Lee, Daniel D., et al., ""Learning the parts of objects by non-negative matrix factorization"", Nature, vol. 401, (Oct. 1991), 788-791.;;Lui, Wenguo, et al., ""Existing and new algorithms for non-negative matrix factorization"", http://www.cs.utexas.edu/users/liuwg/383Cproject/CS-383C-Project.htm, (2002).;;Shahnaz, Farial, et al., ""Document clustering using nonnegative matrix factorization"", Information Processing and Management, (2004),14 Pages.;;Tangsrirat, W., et al., ""FTFN with variable current gain"", Proceedings of IEEE Region 10 International Conference on Electrical and Electronic Technology, 2001. TENCON., vol. 1, (2001), 209-212.;;Vogt, Frank, et al., ""Revent advancements in chemometrics for smart sensors"", Analyst, vol. 129, (2004), 492-502.;;PCT Application Serial No. PCT/GB2005/050219, International Search Report mailed Feb. 20, 2008, 3 pgs.;;Berry, M. W., et al., ""Algorithms and Applications for Approximate Nonnegative Matrix Factorization"", Computational Statistics & Data Analysis, 52, (2007), 155-173.;;Chu, M., et al., ""Optimality, Computation, and Interpretation of Nonnegative Matrix Factorizations"", [online]. Version: Oct. 18, 2004. [retrieved Feb. 6, 2008]. Retrieved from the Internet: , (2004), 18 pgs.;;Eisenbrand, F. , et al., ""Algorithms for Longer OLED Lifetime"", Proceedings, 6th Workshop on Experimental Algorithms (WEA 2007), Lecture Notes in Computer Science, vol. 4525, (2007), 338-351.;;Smith, E. C., ""8.3: Total Matrix Addressing (TMA(TM))"", International Symposium Digest of Technical Papers (SID 2007), (2007), 93-96.;;Tropp, J. A., ""Literature Survey: Non-Negative Matrix Factorization"", [online]. Preprint, University of Texas at Austin. [retrieved Feb. 7, 2008]. Retrieved from the Internet: , (2003), 10 pgs.;;PCT Application Serial No. PCT/GB2005/050219, Written Opinion mailed Feb. 20, 2008, 17 pgs.;;""U.S. Appl. No. 10/578,941, Non-Final Office Action mailed Dec. 23, 2008"", 36 pgs.;;""U.S. Appl. No. 10/578,941, Final Office Action mailed Aug. 5, 2009"", 19 pgs.;;""U.S. Appl. No. 10/578,941, Response filed Apr. 21, 2009 to Non Final Office Action mailed Dec. 23, 2008"", 18 pgs.;;""U.S. Appl. No. 10/578,941, Response filed Oct. 27, 2009 to Final Office Action mailed Aug. 5, 2009"", 11 pgs.;;""U.S. Appl. No. 10/578,941, Non-Final Office Action mailed Jan. 21, 2010"", 21 Pgs.;;""U.S. Appl. No. 10/578,786, Final Office Action mailed Oct. 7, 2009"", 29 pgs.;;""U.S. Appl. No. 10/578,786, Non-Final Office Action mailed on Dec. 8, 2008"", 58 pgs.;;""U.S. Appl. No. 10/578,786, Preliminary Amendment filed May 9, 2006"", 11 pgs.;;""U.S. Appl. No. 10/578,786, Response filed Feb. 5, 2010 to Final Office Action mailed Oct. 7, 2009"", 18 pgs.;;""U.S. Appl. No. 10/578,786, Response filed Apr. 7, 2009 to Non Final Office Action mailed Dec. 8, 2008"", 27 pgs.;;""U.S. Appl. No. 10/578,941 Final Office Action mailed Jul. 12, 2010"", 19 pgs.;;""U.S. Appl. No. 10/578,941, Preliminary Amendment filed Mar. 23, 2007"", 3 pgs.;;""U.S. Appl. No. 10/578,941, Response filed Apr. 22, 2010 to Non Final Office Action mailed Jan. 21, 2010"", 11 pgs.;;""Great Britain Application Serial No. GB0421712.1, Search Report dated Dec. 31, 2004"", 1 pg.;;""International Application Serial No. PCT/GB2005/050169, International Search Report and Written Opinion mailed Feb. 7, 2006"", 6 pgs.;;""International Application Serial No. PCT/GB2005/050167, International Search Report mailed Jan. 17, 2007"", 2 pgs.;;""International Application Serial No. PCT/GB2005/050167, Written Opinion mailed Jan. 17, 2007"", 7 pgs.;;Guillamet, D., et al., ""Non-negative Matrix Factorizeration for Face Recognition"", Lecture Notes in Computer Science, vol. 2504/2002-Topics in Artificial Intelligence: 5th Catalonian Conference on AI (CCIA 2002), (2002), 336-344.;;Routley, P. R., et al., ""Display Driver Circuits"", Great Britain Application Serial No. GB20020013989.7, filed Jun. 18, 2002, 56 pgs.",INACTIVE
141,AU,A,AU 1994/057312 A,084-901-399-247-406,1994-06-22,1994,AU 1994/057312 A,1993-11-30,US 98382492 A;;US 15979893 A;;US 9311553 W,1992-12-01,"Electrode construction, assembly thereof, package therefor and method",,PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;HIGHE ALBERT J;;IMRAN MIR A,,https://lens.org/084-901-399-247-406,Patent Application,no,0,0,8,8,0,A61B5/0017;;A61B5/6814;;A61B2562/0217;;Y10S439/909;;A61B5/291;;A61B5/0017;;A61B5/6814;;A61B5/291,A61B5/00;;A61B5/0478,,0,0,,,,EXPIRED
142,AU,B2,AU 2014/211458 B2,096-618-997-328-785,2016-08-11,2016,AU 2014/211458 A,2014-01-29,EP 13153600 A;;EP 2014051731 W,2013-02-01,Antimicrobial composition comprising a lactam and a hydrotrope,Antimicrobial composition comprising a lactam and a hydrotrope.Antimicrobial additive composition containing a lactam and a hydrotrope.,UNILEVER GLOBAL IP LTD,PARRY NEIL JAMES;;O'KEEFFE JOANNE CLARE;;SMITH CHRISTOPHER FRANCIS,UNILEVER GLOBAL IP LIMITED (2021-10-14),https://lens.org/096-618-997-328-785,Granted Patent,no,3,0,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N25/02;;A01N25/30;;A01N43/36;;A01P1/00;;A61K8/00,,0,0,,,,ACTIVE
143,GB,A,GB 2195999 A,142-176-442-590-22X,1988-04-20,1988,GB 8718885 A,1987-08-10,GB 8621790 A,1986-09-10,TERTIARY AMINE COMPOUNDS,"Compounds having plant fungicidal properties are of formula: <IMAGE> wherein R<1>, R<2>, R<3> and R<4> each represents a hydrogen atom, a halogen atom, or an alkyl group containing from 1 to 4 carbon atoms but R<4> is not halogen, R<5> and R<6> each represent an alkyl group containing from 1 to 4 carbon atoms or R<5> and R<6> together with the adjacent nitrogen atom form a heterocyclic ring which may optionally contain an additional heteroatom, X and Y each represent a hydrogen atom, a halogen atom, or an alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, aryl, aralkyl, alkoxy or aryloxy group, or a <IMAGE> group wherein R<19>, R<20> and R<21> can be an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl group, n has the value 0 or 1 and Q and Z are bridging groups as defined; and acid addition salts and N- oxides thereof.",ICI PLC,ANTHONY VIVIENNE MARGARET;;URCH CHRISTOPHER JOHN;;ELLIOTT ALISON CLARE,,https://lens.org/142-176-442-590-22X,Patent Application,no,4,0,16,16,0,A01N43/36;;A01N43/40;;A01N43/84;;A01N55/00;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/033;;C07F7/0812;;C07D295/02,A01N33/08;;A01N33/10;;A01N43/36;;A01N43/40;;A01N33/04;;A01N43/84;;A01N55/00;;A01N55/10;;C07C67/00;;C07C209/00;;C07C209/24;;C07C211/40;;C07C213/00;;C07C217/74;;C07C291/02;;C07C291/04;;C07D211/14;;C07D211/42;;C07D211/46;;C07D211/52;;C07D265/30;;C07D295/02;;C07D295/033;;C07D295/04;;C07F7/08,C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CNK;;C2C CWH;;C2C CYX;;C2C CZM;;C2C C1174;;C2C C1174;;C2C C1174;;C2C C1174;;C2C C1175;;C2C C1175;;C2C C1175;;C2C C1175;;C2C C1204;;C2C C1341;;C2C C1532;;C2C C1532;;C2C C1562;;C2C C1562;;C2C C1562;;C2C C215;;C2C C215;;C2C C215;;C2C C22X;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C221;;C2C C225;;C2C C225;;C2C C225;;C2C C225;;C2C C226;;C2C C226;;C2C C226;;C2C C226;;C2C C227;;C2C C246;;C2C C246;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C250;;C2C C250;;C2C C251;;C2C C251;;C2C C253;;C2C C253;;C2C C253;;C2C C30Y;;C2C C30Y;;C2C C30Y;;C2C C30Y;;C2C C31Y;;C2C C313;;C2C C32Y;;C2C C323;;C2C C334;;C2C C338;;C2C C36Y;;C2C C360;;C2C C362;;C2C C364;;C2C C43X;;C2C C43X;;C2C C45Y;;C2C C456;;C2C C55X;;C2C C619;;C2C C620;;C2C C623;;C2C C624;;C2C C660;;C2C C662;;C2C C672;;C2C C699;;C2C C699;;C2C C699;;C2C C77X;;C2C C77Y;;C2C C776;;C2C C778,5,0,,,CHEMICAL ABSTRACTS VOL 96(9): 68469X;;CHEMICAL ABSTRACTS VOL 81(9): 49702S;;CHEMICAL ABSTRACTS VOL 78(7): 37879E;;CHEMICAL ABSTRACTS VOL 73(1): 2397R;;CHEMICAL ABSTRACTS VOL 71(25): 124149R,DISCONTINUED
144,AU,A,AU 1999/056707 A,192-257-038-666-470,2000-06-05,2000,AU 1999/056707 A,1999-08-05,US 14679898 A;;US 9917782 W,1998-09-03,System and method for controlled infusion and pressure monitoring,,ETHICON INC,HSEI PAUL K;;CLARE CHRISTOPHER R;;ALDEN DONALD L,,https://lens.org/192-257-038-666-470,Patent Application,no,0,0,8,8,0,A61B17/32002;;A61B18/1482;;A61M3/0258;;A61M3/0283;;A61M3/0287;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202;;A61M3/0258;;A61B18/1482;;A61M3/0287;;A61M3/0283;;A61B17/32002;;A61M2205/3344;;A61M2205/3355;;A61M2209/084;;A61M3/0216;;A61B2017/4216;;A61M1/77;;A61M3/0202,A61B5/00;;A61B17/00;;A61B17/32;;A61B18/14;;A61M1/00;;A61M3/02;;A61M5/00;;G05D16/20,,0,0,,,,EXPIRED
145,AU,A,AU 1989/032632 A,019-887-365-317-44X,1989-10-12,1989,AU 1989/032632 A,1989-04-10,GB 8808433 A,1988-04-11,SPIROCYCLIC COMPOUNDS INCORPORATING FIVE-MEMBERED RINGS WITH TWO HETEROATOMS,,MERCK SHARP & DOHME,BAKER RAYMOND;;SAUNDERS JOHN;;KNEEN CLARE O;;SWAIN CHRISTOPHER,,https://lens.org/019-887-365-317-44X,Patent Application,no,0,0,24,24,0,C07D498/10;;C07D498/20;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/02;;C07D498/10;;C07D498/20,C07D487/10;;A61K31/40;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/46;;A61P1/08;;A61P1/14;;A61P25/04;;A61P25/18;;A61P25/28;;A61P25/30;;C07D451/00;;C07D453/00;;C07D453/06;;C07D471/20;;C07D487/20;;C07D491/113;;C07D491/20;;C07D495/10;;C07D495/20;;C07D498/10;;C07D498/20;;C07D513/20,,0,0,,,,EXPIRED
146,US,A1,US 2009/0271719 A1,055-206-457-743-998,2009-10-29,2009,US 44162108 A,2008-03-24,US 44162108 A;;US 92673507 P;;US 2008/0003822 W,2007-04-27,SYSTEM AND METHOD FOR ANALYSIS AND DISPLAY OF GEO-REFERENCED IMAGERY,"An improved system and method for analysis and display of geo-referenced imagery overlaid with information such as vegetation health, land cover type and impervious surface coverage. In one aspect, an image analysis system creates a map of a selected area of land by overlaying information extracted from an image or images onto a base map or image. In another, a spatially-indexed image database is maintained having a plurality of images corresponding to a plurality of geographic locations; a user-specified geographic location is accepted through an interactive graphical user interface; a user-specified extraction analysis is accepted for application upon one or more images; a user-specified extraction analysis is automatically executed to extract overlay information from such images corresponding to user-specified geographic location(s); and extracted overlay information is overlaid on a geo-referenced image, and displayed though a graphical user interface.",LPA SYSTEMS INC,CLARE JOHN J;;RUSSELL DAVID P;;WOLFE CHRISTOPHER W,,https://lens.org/055-206-457-743-998,Patent Application,yes,33,33,2,2,0,G09B29/007;;G09B29/007,G06F3/00,715/762,0,0,,,,DISCONTINUED
147,EP,A1,EP 2950645 A1,058-869-401-338-105,2015-12-09,2015,EP 14701586 A,2014-01-29,EP 13153600 A;;EP 2014051731 W;;EP 14701586 A,2013-02-01,ANTIMICROBIAL COMPOSITION COMPRISING A LACTAM AND A HYDROTROPE,,UNILEVER PLC;;UNILEVER NV,PARRY NEIL JAMES;;O'KEEFFE JOANNE CLARE;;SMITH CHRISTOPHER FRANCIS,"UNILEVER GLOBAL IP LIMITED, WIRRAL, GB (2021-08-24)",https://lens.org/058-869-401-338-105,Patent Application,yes,0,0,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N25/02;;A01N25/30;;A01N43/36;;A01P1/00;;A61K8/00,,0,0,,,,ACTIVE
148,US,A1,US 2006/0128815 A1,093-969-562-809-788,2006-06-15,2006,US 52961805 A,2005-09-12,EP 02256859 A;;EP 0309665 W,2002-10-02,Method for controlling droplet size of an emulsion when mixing two immiscible fluids,The invention relates to a method for preparing an emulsion by membrane emulsification enabling control of the dispersed phase size and size distribution by interrupting extrusion of the dispersed phase.,CLARE HUGH J;;PEARSON CHRISTOPHER A;;SHANKS IAN A,CLARE HUGH J;;PEARSON CHRISTOPHER A;;SHANKS IAN A,,https://lens.org/093-969-562-809-788,Patent Application,yes,2,11,6,6,0,B01F23/4111;;B01F25/31421;;B01F31/83;;B01F31/85;;B01F25/31421;;B01F23/4111;;B01F31/83;;B01F31/85,C09K23/00;;B01J19/10,516/9,0,0,,,,DISCONTINUED
149,US,A,US 5452718 A,129-202-677-901-091,1995-09-26,1995,US 15979893 A,1993-11-26,US 15979893 A;;US 98382492 A;;US 79041291 A,1991-11-08,"Electrode construction, assembly thereof, package therefor and method","An electrode construction comprising a support structure, a conductive electrode material carried by the support structure and having a length and a width and having proximal and distal extremities, said support structure including a compliant sleeve having an open end and surrounding the distal extremity of the conductive electrode material while permitting the conductive electrode material to protrude through the open end, and conductive contact means making contact with the proximal extremity of the conductive electrode material.",CLARE; CHRISTOPHER R.;;HIGHE; ALBERT J.;;IMRAN; MIR A.,CLARE CHRISTOPHER R;;HIGHE ALBERT J;;IMRAN MIR A,PHYSIOMETRIX INC (1993-11-23);;PHYSIOMETRIX INC. A DELAWARE CORPORATION (1996-04-24),https://lens.org/129-202-677-901-091,Granted Patent,yes,1,31,8,8,0,A61B5/0017;;A61B5/6814;;A61B2562/0217;;Y10S439/909;;A61B5/291;;A61B5/0017;;A61B5/6814;;A61B5/291,A61B5/00;;A61B5/0478,128/639;;439/909,0,0,,,,EXPIRED
150,WO,A1,WO 2014/118240 A1,178-470-922-245-031,2014-08-07,2014,EP 2014051731 W,2014-01-29,EP 13153600 A,2013-02-01,ANTIMICROBIAL COMPOSITION COMPRISING A LACTAM AND A HYDROTROPE,Antimicrobial composition comprising a lactam and a hydrotrope.Antimicrobial additive composition containing a lactam and a hydrotrope.,UNILEVER PLC;;UNILEVER NV;;CONOPCO INC DBA UNILEVER,PARRY NEIL JAMES;;O'KEEFFE JOANNE CLARE;;SMITH CHRISTOPHER FRANCIS,,https://lens.org/178-470-922-245-031,Patent Application,yes,11,43,13,13,0,A01N25/02;;A01N25/30;;A01N43/36;;A61K8/00;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36;;A01N25/00;;A61K8/922;;A61K2800/591;;A61K8/345;;A61K8/4913;;A61Q5/02;;A61Q5/12;;A61Q11/00;;A61K8/69;;A61Q15/00;;A61Q17/005;;A61Q19/10;;A01N43/36,A01N25/02;;A01N25/30;;A01N43/36;;A01P1/00;;A61K8/00,,0,0,,,,PENDING
151,GB,A,GB 2474071 A,139-719-644-039-620,2011-04-06,2011,GB 0917370 A,2009-10-05,GB 0917370 A,2009-10-05,THE MAXIMUM PERMITTED TRANSMISSION POWER OF A FEMTOCELL BASE STATION IS DETERMINED BASED ON THE REASON FOR HAND-IN OR RESELECTION.,"There is provided a method of operating a femtocell base station comprising, following a hand-in or reselection of the femtocell base station by a mobile device, determining a reason, preferably a measurement event from an event history, for the hand-in or reselection by the mobile device (103) and adjusting a maximum permitted transmission power of the femtocell base station according to the determined reason (107, 11 1). The reason may be poor signal levels in serving cell, which may result in maintaining or increasing the maximum permitted transmission power, or high interference due to transmissions fro the femtocell base station, which may result in the maximum permitted transmission power being reduced. As appropriate for the measurement event which may comprise A2, A3, A4 and A5 as defined in 3GPP TS 36.331 parameters for the threshold(s), offset and signal power or signal quality may be determined.",PICOCHIP DESIGNS LTD,WHINNETT NICK W;;SOMMERVILLE FIONA CLARE ANGHARAD;;SMART CHRISTOPHER BRIAN,,https://lens.org/139-719-644-039-620,Patent Application,no,0,0,6,6,0,H04W36/04;;H04W52/143;;H04W52/244;;H04W52/367;;H04W84/045;;H04W36/04;;H04W36/04;;H04W52/243;;H04W52/243;;H04W52/244;;H04W52/244;;H04W52/245;;H04W52/245;;H04W52/367;;H04W52/367;;H04W52/40;;H04W52/40;;H04W84/045;;H04W84/045,H04W52/14,,0,0,,,,INACTIVE
152,GB,B,GB 2474071 B,192-859-075-599-105,2013-08-07,2013,GB 0917370 A,2009-10-05,GB 0917370 A,2009-10-05,Femtocell base station,,PICOCHIP DESIGNS LTD,WHINNETT NICK W;;SOMMERVILLE FIONA CLARE ANGHARAD;;SMART CHRISTOPHER BRIAN,,https://lens.org/192-859-075-599-105,Granted Patent,no,0,0,6,6,0,H04W36/04;;H04W52/143;;H04W52/244;;H04W52/367;;H04W84/045;;H04W36/04;;H04W36/04;;H04W52/243;;H04W52/243;;H04W52/244;;H04W52/244;;H04W52/245;;H04W52/245;;H04W52/367;;H04W52/367;;H04W52/40;;H04W52/40;;H04W84/045;;H04W84/045,H04W52/14;;H04W36/04;;H04W52/24;;H04W52/36,,1,0,,,None,INACTIVE
153,US,S,US D0730388 S,125-872-170-815-669,2015-05-26,2015,US 201329459432 F,2013-06-28,US 201329459432 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,REHBERG TORSTEN;;IZOTOV DMYTRO;;CLARE CHRISTOPHER JAMES;;PALMER JAMES EDWARD,MICROSOFT CORPORATION (2013-08-19),https://lens.org/125-872-170-815-669,Design Right,no,0,112,1,1,0,,,1404;;D14/488;;D14/489;;D14/492,0,0,,,,ACTIVE
154,WO,A1,WO 2022/011432 A1,000-070-923-989-691,2022-01-20,2022,AU 2021/050768 W,2021-07-16,AU 2020/902476 A,2020-07-17,WEARABLE VIBRO-TACTILE FEEDBACK DEVICE,"Described herein is a wearable tactile feedback device (100, 300, 500) for attachment to a body part such as a forearm (102) of a user. The device (100, 300, 500) comprises a body (104) adapted to fit to the forearm (102) of the user. The device (100, 300, 500) also includes a plurality of vibration motors (106-121) attached to or embedded within the body (104) at spaced apart locations. A microcontroller (124) is configured to send control signals to the plurality of vibration motors (106-121). The plurality of vibration motors (106-121) are responsive to respective ones of the control signals to vibrate at predetermined intensities, frequencies and durations to provide vibratory tactile feedback to the user in the form of three dimensional direction cues for movement of the forearm (102). (Figure 1)",UNIV SWINBURNE TECHNOLOGY,PRABHU DEEPA;;MCCARTHY CHRISTOPHER;;HASAN MUHAMMAD;;WISE LISA;;MACMAHON CLARE,,https://lens.org/000-070-923-989-691,Patent Application,yes,6,1,1,1,0,G06F3/016;;A61M2205/582;;G08B6/00;;A61B2562/0219;;A61F9/08;;A61H2003/063;;A61H2201/1635;;A61H2201/165;;G06F3/011;;G06F3/014;;G06T19/003;;A41D20/00;;A61B5/6801;;G01C21/16;;G01C21/1656;;A41D27/20;;A41D1/002;;G06F3/016;;G06F3/014;;G06F3/011;;G01C21/1656;;G08B6/00,G06F3/01;;A61B5/00;;A61F9/08;;A61H3/06;;G01C21/16;;G06T19/00;;G08B6/00,,0,0,,,,PENDING
155,US,S,US D0729834 S,036-701-246-409-809,2015-05-19,2015,US 201329459443 F,2013-06-28,US 201329459443 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,REZENDE ANTONIO PEDRO PERNAMBUCO;;CLARE CHRISTOPHER JAMES;;LOXHA LYRA XHARRA,MICROSOFT CORPORATION (2013-08-19),https://lens.org/036-701-246-409-809,Design Right,no,0,55,1,1,0,,,1404;;D14/486;;D14/487,0,0,,,,ACTIVE
156,GB,A,GB 2523086 A,157-546-113-384-222,2015-08-19,2015,GB 201402077 A,2014-02-07,GB 201402077 A,2014-02-07,System and method for instantaneous access to dynamic media production data,"The media management system 124 captures signals from and deliver signals to a user device 101 via a control module 104. The captured data 110 and delivered data 111 exchanged between the user device 101 and the media management system 124 comprises media content, such as video, audio, images, text, et cetera, and/or such as metadata describing the content (timecode, GPS locations, camera settings, etc). The data capture and delivery and the control module 104 are preferably part of an application programming interface (API) 105. The system may be used for complex media productions such as film, television or music productions.",ADVENTURE PICTURES LTD,SHEPPARD CHRISTOPHER;;MANZI MICHAEL;;TASICH MIHAILO;;CALIC JANKO;;HOLDEN CLARE,,https://lens.org/157-546-113-384-222,Patent Application,no,1,0,3,3,0,G06F16/40;;G06F16/489;;G06F16/70;;G06F16/489;;G06F16/487,G06F17/30,,2,0,,,"Vantage Product Brochure, copyright 2012, downloaded from internet at http://dve-x.com/fileadmin/user upload/produkte/Telestream/PDFs/bro-Vanatge Broschure.pdfon 30/06/14;;Dalet's Galaxy, introduced 2012, downloaded from internet at www.dalet.com/galaxy on 30/06/14",DISCONTINUED
157,SK,B6,SK 282665 B6,004-972-360-518-615,2002-11-06,2002,SK 106798 A,1997-01-02,US 1127896 P;;US 9700255 W,1996-02-07,Cyclic amino acid and pharmaceutical preparation based on it,"Disclosed is a cyclic amino acid with general formula (Ia) or (Ib) or its pharmaceutically acceptable salt, wherein X is O, S, S(O), S(O)2 or NR1, wherein R1 is hydrogen, direct or branched alkyl group with 1 to 6 carbon atoms or benzyl group, -C(O)R2 means directly branched alkyl group with C1 to C6, benzyl group or phenyl group, -CO2R3, wherein R3 is direct or branched alkyl group with C1 to C6 or benzyl group, wherein benzyl group can be unsubstituted or is substituted by 1 to 3 substituents selected independently form the complex containing halogen, CF3 and nitro group; and R is hydrogen or alkyl group with C1 to C4. Pharmaceutical preparation containing therapeutically effective amount of such cyclic amino acid and pharmaceutically acceptable carrier.",WARNER LAMBERT CO,HORWELL DAVID C;;BRYANS JUSTIN S;;KNEEN CLARE O;;RATCLIFFE GILES S;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA,,https://lens.org/004-972-360-518-615,Granted Patent,no,0,0,31,32,0,C07D309/04;;C07D335/02;;A61P25/00;;A61P25/04;;A61P25/06;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;C07D335/02;;C07D309/04,A61K31/00;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61P25/06;;A61P25/08;;A61P25/20;;A61P25/22;;A61P25/24;;A61P25/28;;C07D309/04;;C07D335/02,,0,0,,,,EXPIRED
158,TW,B,TW 424100 B,040-685-080-165-994,2001-03-01,2001,TW 86113216 A,1997-09-11,GB 9619081 A;;GB 9714386 A,1996-09-12,Polymerisation catalyst,"A catalyst composition suitable for use in the polymerisation of olefins comprises a discrete metal complex having chelating ligands comprising at least one atom from O, S, N and P bound directly to the metal. The complexes are used in the presence of Lewis acids and may be exemplified by bis(cyclopentadienyl) zirconium complexs. Typical chelating ligands include acetylacetonate and the complexes have the particular advantage of not requiring traditional activators such as MAO.",BP CHEM INT LTD,DORER BIRGIT ANGELIKA;;LITTLE IAN RAYMOND;;SHARP CHRISTOPHER;;STICHBURY JOANNE CLARE,,https://lens.org/040-685-080-165-994,Granted Patent,no,0,0,11,14,0,C08F10/00;;C07F17/00;;C08F4/61908;;C08F4/61912;;C08F110/02,C07F7/00;;C07F7/28;;C07F17/00;;C08F4/60;;C08F4/619;;C08F4/64;;C08F10/00,,0,0,,,,EXPIRED
159,US,A1,US 2010/0098827 A1,136-558-144-574-682,2010-04-22,2010,US 64775909 A,2009-12-28,US 64775909 A;;US 83272907 A,2007-08-02,"MODIFIED PROTEIN-BASED, LOW-CARBOHYDRATE FOOD INGREDIENT AND PROCESS FOR MAKING SAME","A process for producing a protein-carbohydrate complex includes the steps of: providing a modified protein (MP), the MP characterized by being denatured and heated sufficiently to gel; mixing the MP with a carbohydrate to form an MP-carbohydrate mixture; and heating the MP-carbohydrate mixture to a temperature and for a time sufficient to faun MP-carbohydrate complexes. The resulting protein-carbohydrate complex may have properties that include a viscosity of at least 1.0 Pa-s at a shear rate of a 50 s −1 at 25° C. and a creaming index of less than 25 percent.",DAUBERT CHRISTOPHER R;;PICHAN PRABHASANKAR;;CLARE DEBRA A;;LILLARD STEPHEN JONATHAN,DAUBERT CHRISTOPHER R;;PICHAN PRABHASANKAR;;CLARE DEBRA A;;LILLARD STEPHEN JONATHAN,,https://lens.org/136-558-144-574-682,Patent Application,yes,2,1,2,2,0,A23J3/08;;A23V2002/00;;A23L29/273;;A23L29/281;;A23J3/08;;A23V2002/00;;A23L29/281;;A23L29/273,A23L29/281,426/576,0,0,,,,DISCONTINUED
160,NO,D0,NO 991190 D0,127-915-028-534-663,1999-03-11,1999,NO 991190 A,1999-03-11,GB 9619081 A;;GB 9714386 A;;GB 9702419 W,1996-09-12,Polymerisasjonskatalysator,,BP CHEM INT LTD,DORER BIRGIT ANGELIKA;;LITTLE IAN RAYMOND;;SHARP CHRISTOPHER;;STICHBURY JOANNE CLARE,,https://lens.org/127-915-028-534-663,Patent Application,no,0,0,11,14,0,C08F10/00;;C07F17/00;;C08F4/61908;;C08F4/61912;;C08F110/02,C07F7/00;;C07F7/28;;C07F17/00;;C08F4/60;;C08F4/619;;C08F4/64;;C08F10/00,,0,0,,,,DISCONTINUED
161,EP,A1,EP 0925312 A1,043-138-679-709-333,1999-06-30,1999,EP 97939065 A,1997-09-05,GB 9702419 W;;GB 9619081 A;;GB 9714386 A,1996-09-12,POLYMERISATION CATALYST,,BP CHEM INT LTD,DORER BIRGIT ANGELIKA;;LITTLE IAN RAYMOND;;SHARP CHRISTOPHER;;STICHBURY JOANNE CLARE,,https://lens.org/043-138-679-709-333,Patent Application,yes,0,0,11,14,0,C08F10/00;;C07F17/00;;C08F4/61908;;C08F4/61912;;C08F110/02,C07F7/00;;C07F7/28;;C07F17/00;;C08F4/60;;C08F4/619;;C08F4/64;;C08F10/00,,1,0,,,See references of WO 9811144A1,DISCONTINUED
162,US,A1,US 2009/0035445 A1,085-832-198-785-195,2009-02-05,2009,US 83272907 A,2007-08-02,US 83272907 A,2007-08-02,"Modified Protein-Based, Low-Carbohydrate Food Ingredient and Process for Making Same","A process for producing a protein-carbohydrate complex includes the steps of providing a modified protein (MP), the MP characterized by being denatured and heated sufficiently to gel; mixing the MP with a carbohydrate to form an MP-carbohydrate mixture; and heating the MP-carbohydrate mixture to a temperature and for a time sufficient to form MP-carbohydrate complexes. The resulting protein-carbohydrate complex may have properties that include a viscosity of at least 1.0 Pa-s at a shear rate of a 50 s −1 at 25° C. and a creaming index of less than 25 percent.",DAUBERT CHRISTOPHER R;;PICHAN PRABHASANKAR;;CLARE DEBRA A;;LILLARD STEPHEN JONATHAN,DAUBERT CHRISTOPHER R;;PICHAN PRABHASANKAR;;CLARE DEBRA A;;LILLARD STEPHEN JONATHAN,NORTH CAROLINA STATE UNIVERSITY (2008-01-31),https://lens.org/085-832-198-785-195,Patent Application,yes,2,4,2,2,0,A23J3/08;;A23V2002/00;;A23L29/273;;A23L29/281;;A23J3/08;;A23V2002/00;;A23L29/281;;A23L29/273,A23J3/00;;A23L29/281,426/656,0,0,,,,DISCONTINUED
163,GB,B,GB 2468210 B,150-405-923-821-697,2013-09-25,2013,GB 201003244 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Catalysed filter for a positive ignition engine,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER,,https://lens.org/150-405-923-821-697,Granted Patent,no,10,6,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D46/24;;B01D53/94;;B01J23/40;;B01J23/46;;B01J29/06;;B01J29/08;;B01J29/12;;B01J29/14;;B01J29/16;;B01J29/40;;B01J29/44;;B01J29/46;;B01J29/50;;B01J29/54;;B01J29/56;;B01J29/70;;B01J29/72;;B01J29/74;;B01J29/76;;B01J29/78;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/02;;B01J37/03;;F01N3/022;;F01N3/035,,0,0,,,,ACTIVE
164,EP,A1,EP 3369459 A1,131-500-992-866-545,2018-09-05,2018,EP 17020083 A,2017-03-01,EP 17020083 A,2017-03-01,KIT OF COSMETIC SKINCARE COMPOSITIONS,"According to the present invention there is provided a kit of cosmetic compositions, the kit comprising: 
1) a cleansing composition, the cleansing composition comprising: (i) a cosmetically acceptable carrier; (ii) one or more surfactants; (iii) one or more anti-inflammatory agent; (iv) one or more antioxidant agent selected from polyphenolic antioxidant agents and antioxidant vitamins; (v) one or more skin-soothing agent; 
2) a skin balancing composition, the skin balancing composition comprising: (i) a cosmetically acceptable carrier; (ii)  Ophiopogon japonicas  extract; (iii) one or more antioxidant agent selected from polyphenolic antioxidant agents and antioxidant vitamins; (iv) one or more sebum control agent selected from  Rosa canina  extract and sphingosine compounds; 
3) a daytime protective composition, the daytime protective composition comprising: (i) a cosmetically acceptable carrier; (ii) one or more UV-filter; (iii) one or more antioxidant agent selected from polyphenolic antioxidant agents and antioxidant vitamins; (iv) one or more skin-soothing agent; and 
4) an overnight treatment composition, the overnight treatment composition comprising: (i) a cosmetically acceptable carrier; (ii) one or more polyphenolic antioxidant agent; (iii) one or more antioxidant vitamin; (iv) one or more skin-soothing agent.
",BOOTS CO PLC,JAMES LEANNE MARIE;;O'CONNOR CLARE HELENA;;ROWNEY JAMIE;;ELMS CHRISTOPHER JOHN,,https://lens.org/131-500-992-866-545,Patent Application,yes,9,3,10,10,0,A61K8/31;;A61K8/41;;A61Q19/00;;A61K8/31;;A61K8/34;;A61K8/345;;A61K8/345;;A61K8/361;;A61K8/361;;A61K8/368;;A61K8/368;;A61K8/41;;A61K8/41;;A61K8/42;;A61K8/42;;A61K8/44;;A61K8/44;;A61K8/4946;;A61K8/4946;;A61K8/602;;A61K8/602;;A61K8/676;;A61K8/676;;A61K8/676;;A61K8/678;;A61K8/678;;A61K8/678;;A61K8/68;;A61K8/68;;A61K8/68;;A61K8/73;;A61K8/735;;A61K8/735;;A61K8/922;;A61K8/922;;A61K8/97;;A61K8/9711;;A61K8/9711;;A61K8/9722;;A61K8/9722;;A61K8/9767;;A61K8/9767;;A61K8/9783;;A61K8/9789;;A61K8/9789;;A61K8/9794;;A61K8/9794;;A61K8/988;;A61K8/988;;A61K2800/20;;A61K2800/522;;A61K2800/59;;A61K2800/884;;A61K2800/884;;A61K2800/884;;A61Q17/00;;A61Q17/04;;A61Q17/04;;A61Q17/04;;A61Q19/00;;A61Q19/10;;A61Q19/10;;A61Q19/10,A61Q17/04,,4,0,,,"DATABASE GNPD [online] MINTEL; October 2006 (2006-10-01), ANONYMOUS: ""Anti-Acne Papaya Skin Care System"", XP002773099, Database accession no. 609906;;DATABASE GNPD [online] MINTEL; June 2007 (2007-06-01), ANONYMOUS: ""Radiance Cleansing Milk"", XP002773100, Database accession no. 728283;;DATABASE GNPD [online] MINTEL; March 2007 (2007-03-01), ANONYMOUS: ""Anti-Aging Starter Kit"", XP002773101, Database accession no. 675690;;DATABASE GNPD [online] MINTEL; November 2008 (2008-11-01), ANONYMOUS: ""Optimizing Regimen Pre/Post Kit"", XP002773102, Database accession no. 1002154",DISCONTINUED
165,ZA,B,ZA 978060 B,116-125-604-742-941,1999-03-08,1999,ZA 978060 A,1997-09-08,GB 9619081 A,1996-09-12,Polymerisation catalyst,,BP CHEM INT LTD,DORER BIRGIT ANGELIKA;;SHARP CHRISTOPHER;;LITTLE IAN RAYMOND;;STICHBURY JOANNE CLARE,,https://lens.org/116-125-604-742-941,Granted Patent,no,0,0,2,14,0,,B01J/;;C01F/;;C01G/,,0,0,,,,EXPIRED
166,AU,A,AU 1997/041289 A,112-547-171-382-526,1998-04-02,1998,AU 1997/041289 A,1997-09-05,GB 9619081 A;;GB 9714386 A;;GB 9702419 W,1996-09-12,Polymerisation catalyst,,BP CHEM INT LTD,DORER BIRGIT ANGELIKA;;LITTLE IAN RAYMOND;;SHARP CHRISTOPHER;;STICHBURY JOANNE CLARE,,https://lens.org/112-547-171-382-526,Patent Application,no,0,0,11,14,0,C08F10/00;;C07F17/00;;C08F4/61908;;C08F4/61912;;C08F110/02,C07F7/00;;C07F7/28;;C07F17/00;;C08F4/60;;C08F4/619;;C08F4/64;;C08F10/00,,0,0,,,,PENDING
167,GB,A,GB 2468210 A,173-810-366-249-790,2010-09-01,2010,GB 201003244 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filtering particulate matter from exhaust gas,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine comprises a porous substrate 10 having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores 12 of a first mean pore size. The porous structure is coated with a washcoat 14 comprising a plurality of solid particles, wherein the porous structure of the washcoated porous substrate contains pores 16 of a second mean pore size. The second mean pore size is less than the first mean pore size. The washcoat may substantially cover surface pores of the porous structure. Alternatively, the washcoat may sit substantially within the porous structure of the porous substrate. The washcoat can be a catalytic washcoat, which may comprise at least one molecular sieve. The molecular sieve can be metallised. A method of trapping particulate matter is also claimed.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER,,https://lens.org/173-810-366-249-790,Patent Application,no,6,14,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D46/24;;F01N3/022;;F01N3/035,,0,0,,,,ACTIVE
168,WO,A1,WO 1998/011144 A1,184-831-035-807-016,1998-03-19,1998,GB 9702419 W,1997-09-05,GB 9619081 A;;GB 9714386 A,1996-09-12,POLYMERISATION CATALYST,"A catalyst composition suitable for use in the polymerisation of olefins comprises a discrete metal complex having chelating ligands comprising at least one atom from O, S, N and P bound directly to the metal. The complexes are used in the presence of Lewis acids and may be exemplified by bis(cyclopentadienyl) zirconium complexes. Typical chelating ligands include acetylacetonate and the complexes have the particular advantages of not requiring traditional activators such as MAO.",BP CHEM INT LTD;;DORER BIRGIT ANGELIKA;;LITTLE IAN RAYMOND;;SHARP CHRISTOPHER;;STICHBURY JOANNE CLARE,DORER BIRGIT ANGELIKA;;LITTLE IAN RAYMOND;;SHARP CHRISTOPHER;;STICHBURY JOANNE CLARE,,https://lens.org/184-831-035-807-016,Patent Application,yes,6,48,11,14,0,C08F10/00;;C07F17/00;;C08F4/61908;;C08F4/61912;;C08F110/02,C07F7/00;;C07F7/28;;C07F17/00;;C08F4/60;;C08F4/619;;C08F4/64;;C08F10/00,,2,2,010-094-517-158-058;;021-843-290-460-969,10.1016/0022-328x(94)05237-6;;10.1021/ic50052a010,"GOMEZ R ET AL: ""MONO-ETA-CYCLOPENTADIENYL-BENZAMIDINATO CHLORO COMPOUNDS OF TITANIUM, ZIRCONIUM AND HAFNIUM"", JOURNAL OF ORGANOMETALLIC CHEMISTRY, vol. 491, 1995, pages 153 - 158, XP000606087;;DOYLE GERALD: ""Synthesis of beta-diketonate chelates of the bis(cyclopentadienyl)titanium(IV) moiety."", INORGANIC CHEMISTRY, vol. 6, no. 6, 1967, pages 1111 - 1115, XP002048974",PENDING
169,CN,A,CN 101263132 A,026-745-083-824-590,2008-09-10,2008,CN 200680033876 A,2006-08-02,GB 2006002886 W;;GB 0516706 A,2005-08-15,Chemical compounds,"The use of a compound of formula (I) wherein X is (i), (ii) or (iii), formula (i),formula (ii), formula (iii) Y is O, S(O)m, NR<3>, CR<5>R<6>, CR<5>R<6>-CR<7>R<8>, O-CR<7>R<8>, S(O)m-CR<7>R<8>, NR<3>-CR<7>R<8>, CR<5>R<6 >-O, CR<5>R<6>-S(O)m, CR<5>R<6>-NR<3>, SO2-NR<3>, NR<3>-SO2, NR<3>-O or O-NR<3>; m is 0, 1, or 2; the ring (T) formula (T) is a 5- or 6-membered aromatic or heteroaromatic ring; R<1> to R<10> are specified organic groups and n and is 0, 1, 2, 3 or 4; or salts or N-oxides thereof or compositions containing them in controlling insects, acarines, nematodes or molluscs. Novel compounds are also provided.",SYNGENTA PARTICIPATIONS AG,HARRY SCHAETZER JUERGEN;;CHRISTOPHE LUETHY;;CLARE ELLIOTT ALISON;;JOHN MATHEWS CHRISTOPHER,,https://lens.org/026-745-083-824-590,Patent Application,no,0,1,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D283/00;;A01N43/78;;A01P5/00;;A01P7/02;;A01P7/04;;A01P9/00,,0,0,,,,INACTIVE
170,WO,A1,WO 2015/118291 A1,108-212-447-921-924,2015-08-13,2015,GB 2015000048 W,2015-02-06,GB 201402077 A,2014-02-07,SYSTEM AND METHOD FOR INSTANTANEOUS ACCESS TO DYNAMIC MEDIA PRODUCTION DATA,"A system and related methods for instantaneous capture of and access to media production data, where the production data refers to digital media content such as video, audio, image or text data, and digital metadata that describes the content or any part of the media production process. In certain embodiments of the system, categories of metadata and/or content are created dynamically, thus facilitating adaptation to different types and/or scales of media production, distribution, exploitation and archiving. The instantaneous propagation of content and dynamic metadata facilitates active engagement of a wide range of stakeholders in all stages of the media product lifecycle, including producers, financiers, archivists and end-users. In some embodiments, the content and/or metadata are propagated globally over existing global computer networks, such as the Internet, while in other embodiments, the exchange of data happens over a local network of computers and other connected devices. The media production data can be contributed and curated by all users, thus facilitating exploitation of user generated content and social media in services such as media distribution, archiving, education and production management.",ADVENTURE PICTURES LTD,SHEPPARD CHRISTOPHER;;MANZI MICHAEL;;TASICH MIHAILO;;CALIC DR JANKO;;HOLDEN CLARE,,https://lens.org/108-212-447-921-924,Patent Application,yes,5,1,3,3,0,G06F16/40;;G06F16/489;;G06F16/70;;G06F16/489;;G06F16/487,G06F17/30,,0,0,,,,PENDING
171,NO,L,NO 991190 L,063-967-471-325-107,1999-05-12,1999,NO 991190 A,1999-03-11,GB 9619081 A;;GB 9714386 A;;GB 9702419 W,1996-09-12,Polymerisasjonskatalysator,"Katalysatorsammensetning egnet for bruk i polymerisasjonen av olefiner omfattende et definert metallkompleks med chelaterende ligander omfattende minst ett atom fra O, S, N og P bundet direkte til metallet. Kompleksene anvendes i nærvær av Lewis-syrer og kan eksemplifiseres ved bis(cyklopentadienyl)zirkoniumkomplekser. Typiske chelaterende ligander inkluderer acetylacetonat og kompleksene har de spesielle fordeler ved at de ikke krever tradisjonelle aktivatorer slik som MAO.",BP CHEM INT LTD,DORER BIRGIT ANGELIKA;;LITTLE IAN RAYMOND;;SHARP CHRISTOPHER;;STICHBURY JOANNE CLARE,,https://lens.org/063-967-471-325-107,Abstract,no,0,0,11,14,0,C08F10/00;;C07F17/00;;C08F4/61908;;C08F4/61912;;C08F110/02,C07F7/00;;C07F7/28;;C07F17/00;;C08F4/60;;C08F4/619;;C08F4/64;;C08F10/00,,0,0,,,,DISCONTINUED
172,US,S,US D0729833 S,102-200-255-338-674,2015-05-19,2015,US 201329459440 F,2013-06-28,US 201329459440 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,CLARE CHRISTOPHER JAMES;;REZENDE ANTONIO PEDRO PERNAMBUCO;;WATT LYNDSAY;;IZOTOV DMYTRO,MICROSOFT CORPORATION (2013-08-19),https://lens.org/102-200-255-338-674,Design Right,no,0,36,1,1,0,,,1404;;D14/486;;D14/488,0,0,,,,ACTIVE
173,TW,B,TW 510906 B,011-606-562-595-903,2002-11-21,2002,TW 89101189 A,1997-09-11,GB 9619081 A;;GB 9714386 A,1996-09-12,Process for the polymerisation of ethylene or copolymerisation of ethylene and alpha-olefin and method for preparing complexes,"A catalyst composition suitable for use in the polymerisation of olefins comprises a discrete metal complex having chelating ligands comprising at least one atom from O, S, N and P bound directly to the metal. The complexes are used in the presence of Lewis acids and may be exemplified by bis(cyclopentadienyl) zirconium complexes. Typical chelating ligands include acetylacetonate and the complexes have the particular advantage of not requiring traditional activators such as MAO.",BP CHEM INT LTD,DORER BIRGIT ANGELIKA;;LITTLE IAN RAYMOND;;SHARP CHRISTOPHER;;STICHBURY JOANNE CLARE,,https://lens.org/011-606-562-595-903,Granted Patent,no,0,0,11,14,0,C08F10/00;;C07F17/00;;C08F4/61908;;C08F4/61912;;C08F110/02,C07F7/00;;C07F7/28;;C07F17/00;;C08F4/60;;C08F4/619;;C08F4/64;;C08F10/00,,0,0,,,,EXPIRED
174,US,S,US D0729270 S,018-984-446-016-276,2015-05-12,2015,US 201329459441 F,2013-06-28,US 201329459441 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,CLARE CHRISTOPHER JAMES;;REZENDE ANTONIO PEDRO PERNAMBUCO;;WATT LYNDSAY;;IZOTOV DMYTRO,MICROSOFT CORPORATION (2013-08-19),https://lens.org/018-984-446-016-276,Design Right,no,0,57,1,1,0,,,1404;;D14/486,0,0,,,,ACTIVE
175,US,S,US D0745895 S,032-293-064-348-712,2015-12-22,2015,US 201329459444 F,2013-06-28,US 201329459444 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,CLARE CHRISTOPHER JAMES;;REZENDE ANTONIO PEDRO PERNAMBUCO;;WATT LYNDSAY;;IZOTOV DMYTRO,MICROSOFT CORPORATION (2013-08-19),https://lens.org/032-293-064-348-712,Design Right,no,0,29,1,1,0,,,1404;;D14/495,0,0,,,,ACTIVE
176,AU,A,AU 1999/014554 A,049-634-929-623-075,1999-07-05,1999,AU 1999/014554 A,1998-11-10,US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/049-634-929-623-075,Patent Application,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
177,EP,A1,EP 1045834 A1,094-091-970-273-322,2000-10-25,2000,EP 98958528 A,1998-11-10,US 9823991 W;;US 6977397 P;;US 10490498 P,1997-12-16,"4(3)SUBSTITUTED-4(3)-AMINOMETHYL-(THIO)PYRAN OR -PIPERIDINE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/094-091-970-273-322,Patent Application,yes,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
178,GB,A,GB 2497442 A,100-536-039-028-678,2013-06-12,2013,GB 201301893 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filtering particulate matter from exhaust gas,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine comprises a porous substrate 10 having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores 12 of a first mean pore size. The porous structure is coated with a catalytic washcoat 14 comprising a plurality of solid particles, wherein the porous structure of the washcoated porous substrate contains pores 18 of a second mean pore size. The second mean pore size is less than the first mean pore size. The catalytic washcoat is a three-way catalyst comprising: platinum and rhodium; palladium and rhodium; or platinum, palladium and rhodium as active components supported on a high surface area oxide; and an oxygen storage component. The pores at a surface of the porous structure comprise a pore opening and the washcoat causes a narrowing of substantially all the surface pore openings. Alternatively, the washcoat sits substantially within the porous structure. An exhaust system comprising the filter, a positive ignition engine comprising the exhaust system and a method of trapping particulate matter is also claimed.",JOHNSON MATTHEY PLC,GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH;;ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES,,https://lens.org/100-536-039-028-678,Patent Application,no,6,6,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J23/46;;B01J29/06;;B01J29/08;;B01J29/12;;B01J29/14;;B01J29/16;;B01J29/40;;B01J29/44;;B01J29/46;;B01J29/50;;B01J29/54;;B01J29/56;;B01J29/70;;B01J29/72;;B01J29/74;;B01J29/76;;B01J29/78;;B01J35/02;;B01J35/04;;B01J35/10;;F01N3/035;;F01N3/10,,0,0,,,,ACTIVE
179,BR,A2,BR PI1013395 A2,148-271-724-419-758,2016-03-29,2016,BR PI1013395 A,2010-02-26,GB 2010050334 W;;GB 0903262 A;;GB 0922612 A,2009-02-26,"filtro para a filtração de matéria particulada proveniente de gás de escapamento emitido de um motor de ignição positiva, sistema de escapamento para um motor de ignição positiva, motor de ignição positiva, e , método de captura de matéria particulada proveniente de gás de escapamento emitido de um motor de ignição positiva.",,JOHNSON MATTHEY PLC,MORGAN CHRISTOPHER GOUGH;;GREENWELL DAVID ROBERT;;ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES,,https://lens.org/148-271-724-419-758,Patent Application,no,0,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/08;;B01J29/10;;B01J29/40;;B01J29/46;;B01J35/02;;B01J35/04;;B01J35/10;;F01N3/035,,0,0,,,,ACTIVE
180,US,A1,US 2010/0239478 A1,149-379-004-451-101,2010-09-23,2010,US 71268110 A,2010-02-25,GB 0903262 A;;GB 0922612 A,2009-02-26,FILTER,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2010-05-07),https://lens.org/149-379-004-451-101,Patent Application,yes,17,24,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/34;;B01D53/56,423/213.2;;422/180,0,0,,,,ACTIVE
181,GB,B,GB 2497442 B,035-348-338-611-173,2013-12-11,2013,GB 201301893 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Positive ignition engine comprising an exhaust system including a filter therefor,,JOHNSON MATTHEY PLC,GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH;;ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES,,https://lens.org/035-348-338-611-173,Granted Patent,no,7,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J23/40;;B01J23/46;;B01J29/06;;B01J29/08;;B01J29/12;;B01J29/14;;B01J29/16;;B01J29/40;;B01J29/44;;B01J29/46;;B01J29/50;;B01J29/54;;B01J29/56;;B01J29/70;;B01J29/72;;B01J29/74;;B01J29/76;;B01J29/78;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/03;;F01N3/035;;F01N3/10,,0,0,,,,ACTIVE
182,US,B2,US 11023091 B2,073-618-219-009-599,2021-06-01,2021,US 201815978116 A,2018-05-12,US 201815978116 A;;US 201762514564 P,2017-06-02,"Device, method, and graphical user interface for improving visibility of affordances","An electronic device displays a user interface that includes a plurality of affordances including a first affordance. The first affordance is selectable to perform a respective operation. The first affordance is displayed at a first size. The device receives a user input at a location corresponding to the first affordance. In response to receiving the user input and in accordance with a determination that a text display setting has a first value, the device displays an overlay that includes an enlarged representation of the first affordance. The enlarged representation of the first affordance has a second size that is bigger than the first size. In response to receiving the user input and in accordance with a determination that the text display setting has a second value that is different from the first value, the device forgoes display of the enlarged representation of the first affordance.",APPLE INC,CRANFILL ELIZABETH CAROLINE;;HUGHES CONOR;;TROTTIER LAUREN;;KASEMSET CLARE;;FLEIZACH CHRISTOPHER B,APPLE INC (2018-06-05),https://lens.org/073-618-219-009-599,Granted Patent,yes,24,0,2,2,0,G06F3/0481;;G06F3/0481;;G06F3/0482;;G06F3/04847;;G06F3/04847;;G06F3/04883;;G06F3/04883;;G06F3/04886;;G06F40/103;;G06F40/103;;G06F2203/04805;;G06F2203/04805;;G06F2203/04806;;G06F2203/04806,G06F3/0481;;G06F3/0482;;G06F3/0484;;G06F3/0488;;G06F40/103,,1,0,,,"Immich, T. (“Immich”), “Resolution Independent Icon Design—Part 2: Pixels vs. Vectors,” published on Sep. 5, 2008. <URL=https://www.centigrade.de/en/blog/resolution-independent-icon-design-part-2/> (Year: 2008).",ACTIVE
183,DE,B4,DE 102010002425 B4,196-441-414-718-736,2016-03-31,2016,DE 102010002425 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filter,"Filter zum Filtern von Schwebstoffen (PM) aus von einem Motor mit Funkenzündung ausgestoßenem Abgas, wobei das Filter ein poröses Substrat mit Einlassoberflächen und Auslassoberflächen umfasst, wobei die Einlassoberflächen durch eine poröse Struktur von den Auslassoberflächen getrennt sind, die Poren mit einer ersten durchschnittlichen Porengröße enthält, wobei das poröse Substrat mit einer katalytischen Oberflächengrundierung auf den Einlassoberflächen und den Auslassoberflächen, umfassend eine Vielzahl von Feststoffen, beschichtet ist, wobei die katalytische Grundierungslage im Wesentlichen die Oberflächenporen der porösen Struktur bedeckt, wobei die poröse Struktur des grundierten porösen Substrats Poren mit einer zweiten durchschnittlichen Porengröße enthält, wobei die Poren des grundierungsbeschichteten porösen Substrats teilweise durch Abstände zwischen den Partikeln (Zwischenpartikelporen) in der Grundierung definiert sind, wobei die zweite durchschnittliche Porengröße geringer ist als die erste durchschnittliche Porengröße, wobei die zweite durchschnittliche Porengröße (die durchschnittliche Zwischenpartikelgröße) der porösen Grundierung von 5,0 nm bis 5,0 μm beträgt, wobei 90% der anwesenden Partikel (D90) in der Grundierung einen Durchmesser in einem Bereich von 10 bis 40 μm aufweisen und wobei die katalytische Grundierung ein Dreiwege-Katalysator ist, der Platin und Rhodium; Palladium und Rhodium oder Platin, Palladium und Rhodium als aktive Komponenten, aufgetragen auf ein Oxid mit großer Oberfläche, sowie eine Sauerstoffspeicherkomponente umfasst.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/196-441-414-718-736,Granted Patent,no,18,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,F01N3/035;;B01D46/42;;F01N3/021,,0,0,,,,ACTIVE
184,US,B1,US 7418596 B1,043-823-701-785-224,2008-08-26,2008,US 20092202 A,2002-07-23,US 20092202 A;;US 36720302 P,2002-03-26,"Secure, efficient, and mutually authenticated cryptographic key distribution","Systems and methods disclosed herein provide secure, efficient, and mutually authenticated cryptographic key distribution. A client or client manufacturer may pre-generate and pre-encrypt the cryptographic keys, store the encrypted keys within the client, and deliver such keys to the serving network's access server via the client, while also relying upon, if available, the authentication performed by a trusted access server of an intermediate network which the client must traverse in order to obtain access the serving network. If not available, a client password stored within the client may be used to enable client authentication by the serving network prior to acceptance of the delivered cryptographic keys.",CELLCO PARTNERSHIP DBA VERIZON,CARROLL CHRISTOPHER;;CLARE VARSHA;;FLYNN GERRY;;GREEN BRIAN;;RADOS STEVE;;THOMAS STEVE,CELLCO PARTNERSHIP D/B/A VERIZON WIRELESS (2002-07-09),https://lens.org/043-823-701-785-224,Granted Patent,yes,16,161,1,1,0,H04L63/068;;H04L63/068;;H04L9/0891;;H04L9/0891;;H04L9/302;;H04L9/302;;H04L9/3273;;H04L9/3273;;H04L63/0428;;H04L63/0428;;H04L63/0869;;H04L63/0869;;H04L67/2876;;H04L67/2876;;H04L2209/80;;H04L2209/80;;H04L2463/062;;H04L2463/062;;H04W12/03;;H04W12/03;;H04W12/04;;H04W12/04;;H04W12/06;;H04W12/06;;H04W80/04;;H04W80/04,H04L9/00;;G06F7/04;;H04K1/00;;H04M1/66,713/169;;713/171;;713/182;;726/5;;380/247;;380/278;;380/282;;380/44;;455/410;;455/411,5,3,083-123-413-602-685;;076-727-503-296-304;;007-443-663-830-126,10.1109/wocn.2006.1666571;;10.1145/1352533.1352550;;10.1145/1352533.1352538,"Praveena et al, Achieving energy efficient and secure communication in wireless sensor networks, 2006, IEEE, pp. 1-5□□.;;Bruschi et al, Secure Multicast in Wireless Networks of Mobile Hosts: Protocols and Issues, 2002, ACM, pp. 503-511.;;Nilsson et al, Key Management and Secure Software Updates in Wireless Process Control Environments, 2008, ACM, pp. 100-108.;;Harding et al, Wireless Authentication using Remote Passwords, 2008, ACM, pp. 24-29.;;""3rd Generation Partnership Project 2"" ""3GPP2"" Wireless IP Network Standard.",ACTIVE
185,GB,A,GB 2497440 A,041-814-884-978-901,2013-06-12,2013,GB 201301760 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filtering particulate matter from exhaust gas,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine comprises a porous substrate 10 having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores 12 of a first mean pore size. The porous structure is coated with a catalytic washcoat 14 comprising a plurality of solid particles, wherein the porous structure of the washcoated porous substrate contains pores 16 of a second mean pore size. The second mean pore size is less than the first mean pore size. The catalytic washcoat comprises a lean NOx catalyst selected from the group consisting of Pt/Al2O3; Cu, Pt, Fe, Co or Ir exchanged ZSM-5; protonated zeolites such as H-ZSM-5 or H-Y zeolites; perovskites; Ag/Al2O3; and at least one molecular sieve metallised with Cu, Pt, Mn, Fe, Co, Ni, Zn, Ag, Ce or Ga. An exhaust system comprising the filter, a positive ignition engine comprising the exhaust system and a method of trapping particulate matter is also claimed.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/041-814-884-978-901,Patent Application,no,6,1,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/06;;B01J29/40;;B01J29/44;;B01J29/46;;B01J29/50;;B01J29/54;;B01J29/56;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/02;;F01N3/035,,0,0,,,,ACTIVE
186,IS,A,IS 5434 A,025-648-192-908-725,2000-04-07,2000,IS 5434 A,2000-04-07,US 9823991 W;;US 6977397 P;;US 10490498 P,1997-12-16,4(3)-staðgengar-4(3)-amínómetýl-(þíó)pýran eða píperidín afleiður (=GABA-hliðstæður) smíði þeirra og notkun við meðferð á taugameinum,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/025-648-192-908-725,Patent Application,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
187,WO,A1,WO 2010/097634 A1,100-555-817-332-080,2010-09-02,2010,GB 2010050334 W,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,FILTER FOR FILTERING PARTICULATE MATTER FROM EXHAUST GAS EMITTED FROM A POSITIVE IGNITION ENGINE,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a wash coat comprising a plurality of solid particles wherein the porous structure of the wash coated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",JOHNSON MATTHEY PLC;;ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/100-555-817-332-080,Patent Application,yes,26,26,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01J29/08;;B01D53/94;;B01J29/10;;B01J29/40;;B01J29/46;;B01J35/02;;B01J35/04;;B01J35/10;;F01N3/035,,1,0,,,"PRELIMINARY DISCUSSION PAPER - AMENDMENTS TO CALIFORNIA'S LOW-EMISSION VEHICLE [LEV] REGULATIONS FOR CRITERIA POLLUTANTS - LEV III, 8 February 2010 (2010-02-08)",PENDING
188,DE,A1,DE 102010002425 A1,062-951-369-158-004,2010-09-23,2010,DE 102010002425 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filter,"Filter zum Filtern von Schwebstoffen (PM) aus dem von einem Motor mit positiver Zündung ausgestoßenen Abgas, wobei das Filter ein poröses Substrat mit Einlassoberflächen und Auslassoberflächen umfasst, wobei die Einlassoberflächen durch eine poröse Struktur von den Auslassoberflächen getrennt ist, die Poren einer ersten durchschnittlichen Porengröße enthält, wobei das poröse Substrat mit einer Grundierung, umfassend eine Vielzahl an festen Partikeln, beschichtet ist, wobei die poröse Struktur des grundierten porösen Substrats Poren einer zweiten durchschnittlichen Porengröße enthält und wobei die zweite durchschnittliche Porengröße geringer als die erste durchschnittliche Porengröße ist.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/062-951-369-158-004,Patent Application,no,15,2,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,F01N3/021;;B01D46/42,,18,0,,,"SAE 980525;;SAE 2001-01-0201;;SAE 1999-01-3530;;SAE Dokument Nr. 2009-01-0292;;1. September 2014 (Euro 6);;Euro 6;;""Vorläufiges Diskussionsdokument - Änderungen zu den Bestimmungen Kaliforniens von schadstoffarmen Kraftfahrzeugen [LEV] für Kriterienschadstoffe - LEV III"" heraus (Freigabetermin 8. Februar 2010);;Euro 6 Emissionsnorm;;Euro 6 PM-Anzahlnorm;;SAE 810114;;SAE 1999-01-3530;;Euro 6 Normen;;Euro 5;;Jahr 2000 (Euro 3 Emissionsnorm);;Euro 5/6-Implementierungsgesetzgebung;;Euro 5/6-Gesetzgebung;;Euro 4;;Euro 6 NMHC-Norm",ACTIVE
189,HU,A2,HU P0100069 A2,065-025-602-052-051,2001-12-28,2001,HU P0100069 A,1998-11-10,US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"4(3)SUBSTITUTED-4(3)-AMINOMETHYL-PYRAN, OR -THIOPYRAN-PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/065-025-602-052-051,Patent Application,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
190,WO,A1,WO 1999/031057 A1,128-245-341-743-812,1999-06-24,1999,US 9823991 W,1998-11-10,US 6977397 P;;US 10490498 P,1997-12-16,"4(3)SUBSTITUTED-4(3)-AMINOMETHYL-(THIO)PYRAN OR -PIPERIDINE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas (1D) and (1E), or a pharmaceutically acceptable salt thereof, wherein: n is an integer of from 0 to 2; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; and X is -O-, -S-, -S(O)-, -S(O)2-, or NR'1 wherein R'1 is hydrogen, straight or branched alkyl of from 1 to 6 carbons, or benzyl, -C(O)R'2 wherein R'2 is straight or branched alkyl of 1 to 6 carbons, benzyl or phenyl or -CO2R'3 wherein R'3 is straight or branched alkyl of from 1 to 6 carbons, or benzyl wherein the benzyl or phenyl groups can be unsubstituted or substituted by from 1 to 3 substituents selected from halogen, trifluoromethyl, and nitro, are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS.",WARNER LAMBERT CO;;BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/128-245-341-743-812,Patent Application,yes,2,66,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,9,9,000-111-881-703-461;;088-815-685-885-040;;038-875-658-416-362;;016-104-907-551-650;;000-457-771-937-337;;059-853-041-601-212;;025-044-536-456-332;;109-983-916-535-316;;035-230-547-171-641,5958960;;10.1021/jm00319a012;;10.1007/bf00534473;;10.1016/0223-5234(96)80445-4;;6405400;;10.1016/s0031-6989(83)80060-5;;1763185;;10.1007/978-3-0348-7139-6_7;;1331633;;10.1002/med.2610120604;;10.1016/0922-4106(93)90155-3;;8384570;;10.1016/s0960-894x(01)81218-x;;10.1021/cr950066q;;11848856,"HERMANS B. ET AL.: ""4-Substituted piperidines. III. Reduction of 1-benzyl-4-cyano-4-t-aminopiperidines with lithium aluminium hydride"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 9, no. 1, January 1966 (1966-01-01), pages 49 - 52, XP002096770;;AIRAPETYAN G.K. ET AL.: ""Derivatives of isoquinoline. 30. Synthesis of 4-spirosubstituted dioxinoisoquinolines"", CHEM. HETEROCYCL. COMPD. (ENGL. TRANSL.), vol. 29, no. 5, May 1993 (1993-05-01), pages 578 - 581, XP002096771;;BELLEMIN R. ET AL.: ""New indole derivatives as ACAT inhibitors: Synthesis and structure-activity relationships"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 31, no. 2, 1996, pages 123 - 132, XP004040999;;KRAUS J.L.: ""Isosterism and molecular modification in drug design: Tetrazole analogue of GABA: Effects on enzymes of the .gamma.-aminobutyrate system"", PHARMACOLOGICAL RESEARCH COMMUNICATIONS, vol. 15, no. 2, 1983, pages 183 - 189, XP002096228;;BURGER A.: ""Isosterism and bioisosterism in drug design"", PROGRESS IN DRUG DESIGN, vol. 37, 1991, pages 287 - 371, XP002096229;;KERR D.I.B. & ONG J.: ""GABA agonists and antagonists"", MEDICINAL RESEARCH REVIEWS, vol. 12, no. 6, 6 November 1992 (1992-11-06), pages 593 - 636, XP002080823;;SUMAN-CHAUHAN N. ET AL.: ""Characterisation of [3H]gabapentin binding to a novel site in rat brain: Homogenate binding studies"", EUROPEAN JOURNAL OF PHARMACOLOGY - MOLECULAR PHARMACOLOGY SECTION, vol. 244, no. 3, 1993, pages 293 - 301, XP002096653;;HOWSON W. ET AL.: ""Biological activity of 3-aminopropyl (methyl) phosphinic acid, a potent and selective GABA(B) agonist with CNS activity"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 3, no. 4, 1993, pages 515 - 518, XP002096230;;PATANI G.A. & LA VOIE E.J.: ""Bioisosterism: A rational approach in drug design"", CHEMICAL REVIEWS, vol. 96, no. 8, 1996, pages 3147 - 3176, XP000652176",PATENTED
191,KR,A,KR 20110119748 A,009-792-147-453-756,2011-11-02,2011,KR 20117019710 A,2010-02-26,GB 0903262 A;;GB 0922612 A;;GB 2010050334 W,2009-02-26,FILTER FOR FILTERING PARTICULATE MATTER FROM EXHAUST GAS EMITTED FROM A POSITIVE IGNITION ENGINE,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/009-792-147-453-756,Patent Application,no,0,3,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J35/02;;B01J39/08;;F01N3/035,,0,0,,,,ACTIVE
192,GB,B,GB 2485260 B,087-064-946-151-723,2013-12-11,2013,GB 201118038 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,SCR catalysed filter for positive ignition engine,,JOHNSON MATTHEY PLC,GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH;;ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES,,https://lens.org/087-064-946-151-723,Granted Patent,no,4,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/06;;B01J29/12;;B01J29/14;;B01J29/16;;B01J29/40;;B01J29/46;;B01J29/50;;B01J29/56;;B01J29/70;;B01J29/72;;B01J29/76;;B01J29/78;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/02;;B01J37/03;;F01N3/035,,0,0,,,,ACTIVE
193,EP,B1,EP 2589427 B1,070-942-378-534-046,2022-09-21,2022,EP 13153896 A,2010-02-26,GB 0903262 A;;GB 0922612 A;;EP 10706346 A;;GB 2010050334 W,2009-02-26,POSITIVE IGNITION ENGINE WITH FILTER FOR FILTERING PARTICULATE MATTER FROM EXHAUST GAS EMITTED FROM THE POSITIVE IGNITION ENGINE,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/070-942-378-534-046,Granted Patent,yes,1,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J23/40;;B01J23/46;;B01J29/06;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/00;;B01J37/02;;B01J37/03;;F01N3/035,,0,0,,,,ACTIVE
194,PL,A1,PL 341231 A1,143-890-111-309-733,2001-03-26,2001,PL 34123198 A,1998-11-10,US 9823991 W;;US 6977397 P;;US 10490498 P,1997-12-16,"4(3)-SUBSTITUTE DERIVATIVES OF 4(3)AMINOMETHYL(THIO)PYRANE OR PIPERIDINE DERIVATIVES (ANALOGUES OF GARBAPENTIN), THEIR PRODUCTION AND APPLICATION IN TREATING NEUROLOGICAL DISORDERS",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/143-890-111-309-733,Patent Application,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
195,BR,A,BR 9814287 A,006-877-076-570-536,2000-10-03,2000,BR 9814287 A,1998-11-10,US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"""4(3)-aminometil-(tio)piran 4(3) substituìdo ou derivados da piperidina (= análogos da gabapentina), sua preparação e seu uso no tratamento de desordens neurológicas""","Patente de Invenção: <B>""4(3)-AMINOMETIL-(TIO)PIRAN 4(3) SUBSTITUìDO OU DERIVADOS DA PIPERIDINA (= ANáLOGOS DA GABAPENTINA), SUA PREPARAçãO E SEU USO NO TRATAMENTO DE DESORDENS NEUROLóGICAS""<D>. São reveladas aminas inéditas de fórmulas (1D) e (1E) ou um sal farmaceuticamente aceitável delas, em que n é um número inteiro de 0 a 2; R é sulfonamida, amida, ácido fosfórico, heterociclo, ácido sulfónico ou ácido hidroxâmico e X é -O-, -S-, -S(O)-, -S(O)~ 2~- ou NR'~ 1~ em que R'~ 1~ é hidrogênio, alquila reta ou ramificada de 1 a 6 átomos de carbono, benzila, -C(O)R'~ 2~ em que R'~ 2~ é alquila reta ou ramificada de 1 a 6 átomos de carbono, benzila ou fenila ou -CO~ 2~R'~ 3~ em que R'~ 3~ é alquila reta ou ramificada de 1 a 6 átomos de carbono ou benzila em que os grupos benzila ou fenila podem ser não-substituídos ou substituídos por de 1 a 3 substituintes selecionados de halogênio, trifluorometila e nitro, e são úteis como agentes no tratamento da epilepsia, ataques de debilidade, hipocinésia, desordens cranianas, desordens neurodegenerativas, depressão, ansiedade, pânico, dor, desordens neuropatológicas, doenças inflamatórias, e desordens gastrintestinais, especialmente IBS.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/006-877-076-570-536,Patent Application,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
196,GB,B,GB 2497440 B,116-445-921-320-980,2013-12-11,2013,GB 201301760 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filter including lean NOx catalyst for positive ignition engine,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/116-445-921-320-980,Granted Patent,no,6,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/06;;B01J29/12;;B01J29/40;;B01J29/44;;B01J29/46;;B01J29/50;;B01J29/54;;B01J29/56;;B01J29/70;;B01J29/72;;B01J29/74;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/02;;B01J37/03;;F01N3/035,,0,0,,,,ACTIVE
197,EP,A3,EP 2589427 A3,138-468-705-160-994,2014-08-27,2014,EP 13153896 A,2010-02-26,GB 0903262 A;;GB 0922612 A;;EP 10706346 A;;GB 2010050334 W,2009-02-26,Filter for filtering particulate matter from exhaust gas emitted from a positive ignition engine,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine comprises a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a catalytic surface washcoat layer comprising a plurality of solid particles, wherein the catalytic surface washcoat layer substantially covers surface pores of the porous structure, wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size provided by the catalytic surface washcoat layer, wherein the pores of the washcoated porous substrate are defined in part by spaces between the particles (interparticle pores) in the washcoat, wherein the second mean pore size is less than the first mean pore size and wherein the catalytic washcoat is a three-way catalyst comprising: platinum and rhodium; palladium and rhodium; or platinum, palladium and rhodium as active components supported on a high surface area oxide; and an oxygen storage component.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/138-468-705-160-994,Search Report,yes,9,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J23/46;;B01J35/04;;B01J35/10;;F01N3/035,,0,0,,,,ACTIVE
198,US,B1,US 6545022 B1,150-190-887-466-652,2003-04-08,2003,US 52905500 A,2000-04-07,US 52905500 A;;US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders","
    Novel amines of formulas 1D and 1E 

    are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS. Processes for the preparation and intermediates useful in the preparation are also disclosed. 
",PFIZER,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/150-190-887-466-652,Granted Patent,yes,11,20,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,514/326;;514/315;;514/317;;514/331;;514/432;;514/459;;546/208;;546/209;;546/210;;546/235;;546/245;;546/246;;548/131;;548/134;;548/250;;549/13;;549/18;;549/426,8,4,000-111-881-703-461;;016-104-907-551-650;;000-457-771-937-337;;035-230-547-171-641,5958960;;10.1021/jm00319a012;;6405400;;10.1016/s0031-6989(83)80060-5;;1763185;;10.1007/978-3-0348-7139-6_7;;10.1021/cr950066q;;11848856,"Airapetyan et al. ""Isoquinoline derivatives . . ."" CA 120:217470 (1994).*;;Bellemin et al. ""New indole derivatives as ACAT inhibitors . . ."" CA 125:10543 (1996).*;;Hermans et al. ""4-Substituted piperidines . . ."" J. Med. Chem. v.9, (1966) p. 49-52.*;;Howson et al. ""Biological activity of 3-aminopropyl . . ."" Bioorg. Med. Chem Lett v.3, (1993) p/515-518.*;;Krauds ""Isostreism and molecular modification i drug design"" Phar. Res. Commun. v.15, p. 183-189 (1983).*;;Burger ""Isosterism and bioisosterism in drug design"" Progress in drug design, v. 37, p. 287-371 (1991).*;;Patani et al. ""Bioisosterism: a rational approach in drug design"" Chem. Rev. v.96, p.3147-3176 (1996).*;;copies not provided. cited on PCT reports.",EXPIRED
199,GB,A,GB 2487850 A,186-622-978-049-187,2012-08-08,2012,GB 201204258 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filtering particulate matter from exhaust gas,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine comprises a porous substrate 10 having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores 12 of a first mean pore size. The porous substrate is coated with a catalytic surface washcoat layer 14 comprising a plurality of solid particles, wherein the washcoat layer covers surface pores of the porous substrate and the pores of the washcoated porous substrate are defined in part by spaces between the particles in the washcoat. The porous structure of the washcoated porous substrate contains pores 16 of a second mean pore size and the second mean pore size is less than the first mean pore size. The catalytic washcoat is a NOx absorber catalyst. The washcoat may comprise at least one molecular sieve. The molecular sieve can be metallised. An exhaust system comprises the filter and may have a low thermal mass three-way catalyst disposed downstream of the filter.. A method of trapping particulate matter is also claimed.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/186-622-978-049-187,Patent Application,no,5,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/06;;B01J35/02;;B01J35/04;;B01J35/10;;F01N3/08,,0,0,,,,ACTIVE
200,NO,L,NO 20003038 L,013-348-509-512-471,2000-06-14,2000,NO 20003038 A,2000-06-14,US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"4(3)Substituerte-4(3)-aminometyl-(tio)pyran eller - piperidinderivater (=gabapentinanaloger), deres fremstilling og deres anvendelse ved behandling av neurologiske lidelser",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/013-348-509-512-471,Abstract,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
201,GB,A,GB 2485260 A,014-322-311-212-44X,2012-05-09,2012,GB 201118038 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filtering particulate matter from exhaust gas,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine comprises a porous substrate 10 having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores 12 of a first mean pore size. The porous substrate is coated with a catalytic surface washcoat layer 14 comprising a plurality of solid particles, wherein the washcoat layer covers surface pores of the porous substrate and the pores of the washcoated porous substrate are defined in part by spaces between the particles in the washcoat. The porous structure of the washcoated porous substrate contains pores 16 of a second mean pore size and the second mean pore size is less than the first mean pore size. The catalytic washcoat is a selective catalytic reduction (SCR) catalyst. The washcoat may comprise at least one molecular sieve. The molecular sieve can be metallised. An exhaust system comprises the filter and may have a NOx absorber catalyst disposed upstream of the filter. A method of trapping particulate matter is also claimed.",JOHNSON MATTHEY PLC,GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH;;ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES,,https://lens.org/014-322-311-212-44X,Patent Application,no,2,1,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/06;;B01J29/40;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/02;;F01N3/035,,0,0,,,,ACTIVE
202,CA,C,CA 2304967 C,044-474-089-986-735,2005-06-14,2005,CA 2304967 A,1998-11-10,US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"4(3)SUBSTITUTED-4(3)-AMINOMETHYL-(THIO)PYRAN OR -PIPERIDINE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas (1D) and (1E), or a pharmaceutically acceptable sal t thereof, wherein: n is an integer of from 0 to 2; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; and X is -O-, -S-, -S(O)-, -S(O)2-, or NR'1 wherein R'1 is hydrogen, straight or branched alkyl of from 1 to 6 carbons, or benzyl, -C(O)R'2 wherein R'2 is straight or branched alkyl of 1 to 6 carbons, benzyl or phenyl or -CO2R'3 wherein R'3 is straight or branched alkyl of from 1 to 6 carbons, or benzyl wherein the benzyl or phenyl groups can be unsubstituted or substituted by from 1 to 3 substituents selected from halogen, trifluoromethyl, and nitro, are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS.",WARNER LAMBERT CO,KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN,,https://lens.org/044-474-089-986-735,Granted Patent,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
203,CN,A,CN 102333579 A,030-402-699-429-492,2012-01-25,2012,CN 201080009348 A,2010-02-26,GB 2010050334 W;;GB 0903262 A;;GB 0922612 A,2009-02-26,Filter for filtering particulate matter from exhaust gas emitted from a positive ignition engine,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a wash coat comprising a plurality of solid particles wherein the porous structure of the wash coated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",JOHNSON MATTHEY PLC,CLARE ARNOLD LOUISE;;JAMES BRISLEY ROBERT;;ROBERT GREENWELL DAVID;;GOUGH MORGAN CHRISTOPHER,,https://lens.org/030-402-699-429-492,Patent Application,no,4,14,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/08;;B01J29/10;;B01J29/40;;B01J29/46;;B01J35/02;;B01J35/04;;B01J35/10;;F01N3/035,,0,0,,,,DISCONTINUED
204,NZ,A,NZ 503980 A,030-279-186-970-899,2002-09-27,2002,NZ 50398098 A,1998-11-10,US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (= gabapentin analogues), pharmaceuticals thereof, and their use in the treatment of neurological disorders","Compounds of formula ID or IE, wherein: n is 0 to 2. R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid or hydroxamic acid. X is -O-, -S-, -S(O)-, -S(O)2 or NR'1 wherein R'1 is H, alkyl, benzyl, -C(O)R'2 wherein R'2 is alkyl, benzyl or phenyl or -CO2R'3 wherein R'3 is alkyl, or benzyl wherein the benzyl or phenyl groups can be unsubstituted or substituted by 1 to 3 substituents selected from halogen, trifluroromethyl, and nitro. With the proviso that when X is NR'1 and R'1 is benzyl, R cannot be morpholino or piperidino. Also described is a pharmaceutical composition that comprises the compound of formula ID or IE. The compounds of formulae ID and IE are useful for treating epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders and gastrointestinal damage.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/030-279-186-970-899,Patent Application,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
205,TR,T2,TR 200001800 T2,056-274-778-954-586,2001-03-21,2001,TR 200001800 T,1998-11-10,US 6977397 P;;US 10490498 P,1997-12-16,"-4(3)-İkameli -4(3)- aminometil-(tio) piran veya- piperidin türevleri (=Gabapentin analogları), hazırlanmaları ve nörolojik hastalıkların tedavisinde kullanımları","n'nin 0-2 arasinda bir tam sayi; R' nin sülfonamid, amid, fosfonik asit, heterosikl, sülfonik asi. veya hidroksamik asit; ve X2' in-O-, -S-(O)2-, veya R1' in hidrojen, düz veya dalli 1-6 karbonlu alkil, benzin oldugu NR1, R'2 nin, düz 1-6 karbonlu alkil, benzil veya fenil oldugu -C(O)R'3 ün, düz veya dalli 1-6 karbonlu alkil, veya benzil veya fenil gruplarinin halojen, triflorometil ve nitro dan seçilen 1-3 ikameyle ikameli veya ikamesiz olabildigi -CO2R'3 oldugu formül: Yeni aminleri açiklanmakta olup, bu bilesimler, epilepsi bayilma nöbetleri hipokinezi, ve kafatasi tranvalari: nörodejeneratif bozukluklar, depresyon anksiyete, panik, agri nöropatolojik bozukluklar, enflamasyon ve mide-bagirsak tahribati hastaliklari tedavisinde yararli maddelerdir.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/056-274-778-954-586,Patent Application,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
206,NO,D0,NO 20003038 D0,062-193-209-114-985,2000-06-14,2000,NO 20003038 A,2000-06-14,US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"4(3)Substituerte-4(3)-aminometyl-(tio)pyran eller - piperidinderivater (=gabapentinanaloger), deres fremstilling og deres anvendelse ved behandling av neurologiske lidelser",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/062-193-209-114-985,Patent Application,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
207,EP,A1,EP 3320964 A1,161-711-109-355-964,2018-05-16,2018,EP 17209664 A,2010-02-26,GB 0903262 A;;GB 0922612 A;;EP 13153896 A;;EP 10706346 A,2009-02-26,EXHAUST SYSTEM FOR A POSITIVE IGNITION ENGINE,"An exhaust system for a positive ignition engine, which system comprising a filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated only on the outlet surfaces with a catalytic three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, wherein the second mean pore size is less than the first mean pore size and wherein the three-way catalyst comprises platinum and rhodium; palladium and rhodium; platinum, palladium and rhodium; or palladium only as active components supported on a high surface area oxide, and an oxygen storage component",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/161-711-109-355-964,Patent Application,yes,8,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J23/46;;B01J35/04;;B01J35/10;;F01N3/035,,0,0,,,,PENDING
208,GB,B,GB 2487850 B,161-825-727-734-027,2013-09-25,2013,GB 201204258 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filter including NOx absorber catalyst for positive ignition engine,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/161-825-727-734-027,Granted Patent,no,5,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J23/40;;B01J29/06;;B01J29/12;;B01J29/44;;B01J29/54;;B01J29/70;;B01J29/74;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/02;;B01J37/03;;F01N3/035;;F01N3/08,,0,0,,,,ACTIVE
209,US,A1,US 2018/0348962 A1,185-437-750-067-898,2018-12-06,2018,US 201815978116 A,2018-05-12,US 201815978116 A;;US 201762514564 P,2017-06-02,"Device, Method, and Graphical User Interface for Improving Visibility of Affordances","An electronic device displays a user interface that includes a plurality of affordances including a first affordance. The first affordance is selectable to perform a respective operation. The first affordance is displayed at a first size. The device receives a user input at a location corresponding to the first affordance. In response to receiving the user input and in accordance with a determination that a text display setting has a first value, the device displays an overlay that includes an enlarged representation of the first affordance. The enlarged representation of the first affordance has a second size that is bigger than the first size. In response to receiving the user input and in accordance with a determination that the text display setting has a second value that is different from the first value, the device forgoes display of the enlarged representation of the first affordance.",APPLE INC,CRANFILL ELIZABETH CAROLINE;;HUGHES CONOR;;TROTTIER LAUREN;;KASEMSET CLARE;;FLEIZACH CHRISTOPHER B,APPLE INC (2018-06-05),https://lens.org/185-437-750-067-898,Patent Application,yes,0,6,2,2,0,G06F3/0481;;G06F3/0481;;G06F3/0482;;G06F3/04847;;G06F3/04847;;G06F3/04883;;G06F3/04883;;G06F3/04886;;G06F40/103;;G06F40/103;;G06F2203/04805;;G06F2203/04805;;G06F2203/04806;;G06F2203/04806,G06F3/0481;;G06F3/0482;;G06F3/0484,,0,0,,,,ACTIVE
210,BR,B1,BR PI1013395 B1,024-345-354-054-853,2020-03-31,2020,BR PI1013395 A,2010-02-26,GB 2010050334 W;;GB 0903262 A;;GB 0922612 A,2009-02-26,"filtro para a filtração de matéria particulada proveniente de gás de escapamento emitido de um motor de ignição positiva, sistema de escapamento para um motor de ignição positiva, e , método de captura de matéria particulada proveniente de gás de escapamento emitido de um motor de ignição positiva","filtro para a filtração de matéria particulada proveniente de gás de escapamento emitido de um motor de ignição positiva, sistema de escapamento para um motor de ignição positiva, e, método de captura de matéria particulada proveniente de gás de escapamento emitido de um motor de ignição positiva um filtro para a filtração de matéria particulada (pm) de gás de escapamento emitido de um motor de ignição positiva, cujo filtro compreendendo um substrato poroso tendo superfícies de entrada e superfícies de saída, em que as superfícies de entrada são separadas das superfícies de saída por uma estrutura porosa contendo poros de um primeiro tamanho médio de poro, em que o substrato poroso é revestido com uma camada de lavagem compreendendo uma pluralidade de partículas sólidas em que a estrutura porosa do substrato poroso revestido de lavagem contém poros de um segundo tamanho médio de poro, e em que o segundo tamanho médio de poro é menor do que o primeiro tamanho médio de poro.",JOHNSON MATTHEY PLC,CHRISTOPHER GOUGH MORGAN;;DAVID ROBERT GREENWELL;;LOUISE CLARE ARNOLD;;ROBERT JAMES BRISLEY,,https://lens.org/024-345-354-054-853,Granted Patent,no,0,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/08;;B01J29/10;;B01J29/40;;B01J29/46;;B01J35/02;;B01J35/04;;B01J35/10;;F01N3/035,,0,0,,,,ACTIVE
211,EP,A2,EP 2589427 A2,134-157-796-458-345,2013-05-08,2013,EP 13153896 A,2010-02-26,GB 0903262 A;;GB 0922612 A;;EP 10706346 A;;GB 2010050334 W,2009-02-26,Filter for filtering particulate matter from exhaust gas emitted from a positive ignition engine,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine comprises a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a catalytic surface washcoat layer comprising a plurality of solid particles, wherein the catalytic surface washcoat layer substantially covers surface pores of the porous structure, wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size provided by the catalytic surface washcoat layer, wherein the pores of the washcoated porous substrate are defined in part by spaces between the particles (interparticle pores) in the washcoat, wherein the second mean pore size is less than the first mean pore size and wherein the catalytic washcoat is a three-way catalyst comprising: platinum and rhodium; palladium and rhodium; or platinum, palladium and rhodium as active components supported on a high surface area oxide; and an oxygen storage component.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/134-157-796-458-345,Patent Application,yes,0,2,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J23/46;;B01J35/04;;B01J35/10;;F01N3/035,,0,0,,,,ACTIVE
212,CA,A1,CA 2304967 A1,172-490-535-525-834,1999-06-24,1999,CA 2304967 A,1998-11-10,US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"4(3)SUBSTITUTED-4(3)-AMINOMETHYL-(THIO)PYRAN OR -PIPERIDINE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas (1D) and (1E), or a pharmaceutically acceptable salt thereof, wherein: n is an integer of from 0 to 2; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; and X is -O-, -S-, -S(O)-, -S(O)2-, or NR'1 wherein R'1 is hydrogen, straight or branched alkyl of from 1 to 6 carbons, or benzyl, -C(O)R'2 wherein R'2 is straight or branched alkyl of 1 to 6 carbons, benzyl or phenyl or -CO2R'3 wherein R'3 is straight or branched alkyl of from 1 to 6 carbons, or benzyl wherein the benzyl or phenyl groups can be unsubstituted or substituted by from 1 to 3 substituents selected from halogen, trifluoromethyl, and nitro, are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS.",WARNER LAMBERT CO,KNEEN CLARE OCTAVIA;;HORWELL DAVID CHRISTOPHER;;WUSTROW DAVID JUERGEN;;BRYANS JUSTIN STEPHEN,,https://lens.org/172-490-535-525-834,Patent Application,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
213,AU,B2,AU 759392 B2,042-864-200-930-416,2003-04-10,2003,AU 1999/014554 A,1998-11-10,US 6977397 P;;US 10490498 P;;US 9823991 W,1997-12-16,"4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/042-864-200-930-416,Granted Patent,no,0,0,20,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D211/26;;C07D271/07;;C07D309/04;;C07D335/02;;C07D257/04;;C07D273/02;;C07D285/08;;C07D291/04;;C07D401/06;;C07D405/06;;C07D407/06;;C07F9/655363;;C07F9/3808;;C07C309/25;;C07D417/06;;C07F9/383;;C07D335/02;;C07C311/09;;C07C259/06;;C07D271/07;;C07D413/06;;C07C311/05;;C07D211/26;;C07D405/06;;C07D257/04;;C07D407/06;;C07D401/06;;C07C233/36;;C07C239/14;;C07D285/18;;C07D419/06;;C07D409/06;;C07F9/6552;;C07D309/04;;C07C311/33;;C07C2601/18;;C07C2601/14;;C07C2603/74;;C07C2602/46;;C07C2601/04;;C07C2601/08;;C07F9/59,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
214,CN,A,CN 105642116 A,071-521-188-020-889,2016-06-08,2016,CN 201610103865 A,2010-02-26,GB 0903262 A;;GB 0922612 A;;CN 201080009348 A,2009-02-26,Filter for filtering particulate matter from exhaust gas emitted from positive ignition engine,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine is disclosed and comprises a porous substrate having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size. The porous structure is coated with a washcoat comprising a plurality of solid particles, wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size. The second mean pore size is less than the first mean pore size.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/071-521-188-020-889,Patent Application,no,7,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;F01N3/022;;F01N3/035,,0,0,,,,ACTIVE
215,ZA,B,ZA 9811474 B,005-846-749-013-737,1999-06-15,1999,ZA 9811474 A,1998-12-14,US 6977397 P,1997-12-16,Novel amines of pharmaceutical agents,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;HORWELL DAVID CHRISTOPHER;;WUSTROW DAVID JUERGEN,,https://lens.org/005-846-749-013-737,Granted Patent,no,0,0,3,92,0,,A61K/;;C07C/;;C07D/,,0,0,,,,EXPIRED
216,EP,B1,EP 2401056 B1,019-142-617-953-957,2016-04-13,2016,EP 10706346 A,2010-02-26,GB 2010050334 W;;GB 0903262 A;;GB 0922612 A,2009-02-26,FILTER FOR FILTERING PARTICULATE MATTER FROM EXHAUST GAS EMITTED FROM A POSITIVE IGNITION ENGINE,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/019-142-617-953-957,Granted Patent,yes,11,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/06;;B01J29/14;;B01J29/40;;B01J29/46;;B01J29/50;;B01J29/56;;B01J29/70;;B01J29/76;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/00;;B01J37/02;;F01N3/035;;F01N3/28,,4,1,087-016-378-424-108,10.4271/2001-24-0072,"B. HARRISON ET AL: ""controlling nitrogen oxide emissions from industrial sources"", PLATINUM METALS REVIEW, vol. 29, no. 2, 1 April 1985 (1985-04-01), pages 50 - 56, XP055030930, ISSN: 0032-1400;;M. VOTSMEIER ET AL.: ""Automobile Exhaust Control"", ULLMANN'S ENCYCLOPEDIA OF INDUSTRIAL CHEMISTRY, vol. 4, 2003, pages 225 - 239, XP055343854;;L. RUBINO ET AL.: ""Experimental Evaluation of a Wall-Flow Filter for Gasoline Engine Particulate Emission Control"", SAE INTERNATIONAL, 23 September 2001 (2001-09-23), pages 59 - 65, XP055343859;;R.M. HECK ET AL.: ""Catalytic Air Pollution Control"", 1995, OHN WILEY & SONS, article ""10. reduction of NOx"", pages: 161 - 178, XP055343866",ACTIVE
217,KR,A,KR 20180021243 A,077-053-655-236-093,2018-02-28,2018,KR 20187004972 A,2010-02-26,GB 0903262 A;;GB 0922612 A;;GB 2010050334 W,2009-02-26,FILTER FOR FILTERING PARTICULATE MATTER FROM EXHAUST GAS EMITTED FROM A POSITIVE IGNITION ENGINE,"본 발명은, 입구 표면 및 출구 표면을 갖는 다공성 기재를 포함하고, 여기서 입구 표면은 제1 평균 기공 크기의 기공을 보유하는 다공성 구조에 의해 출구 표면으로부터 분리되어 있고, 다공성 기재는 복수의 고체 입자를 포함하는 워시코트로 코팅되어 있으며, 워시코팅된 다공성 기재의 다공성 구조는 제2 평균 기공 크기의 기공을 보유하고, 제2 평균 기공 크기는 제1 평균 기공 크기보다 작은, 강제 점화 엔진으로부터 배출되는 배기 가스로부터 미립자 물질 (PM)의 여과를 위한 필터에 관한 것이다.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/077-053-655-236-093,Patent Application,no,0,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01D53/00;;B01J35/02;;B01J39/08;;F01N3/035,,0,0,,,,ACTIVE
218,GB,A,GB 2497441 A,197-564-811-952-055,2013-06-12,2013,GB 201301761 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filtering particulate matter from exhaust gas,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine comprises a porous substrate 10 having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores 12 of a first mean pore size. The porous structure is coated with a catalytic washcoat 14 comprising a plurality of solid particles, wherein the porous structure of the washcoated porous substrate contains pores 16 of a second mean pore size. The second mean pore size is less than the first mean pore size. The catalytic washcoat is a hydrocarbon trap comprising at least one molecular sieve which is un-metallised. Alternatively, the molecular sieve is catalysed with a platinum group metal. The washcoat may substantially cover surface pores of the porous structure or may sit substantially within the porous structure of the porous substrate. An exhaust system comprising the filter, a positive ignition engine comprising the exhaust system and a method of trapping particulate matter is also claimed.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/197-564-811-952-055,Patent Application,no,7,5,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J23/40;;B01J29/00;;B01J35/02;;B01J35/04;;B01J35/10;;F01N3/035,,0,0,,,,ACTIVE
219,EP,A1,EP 2401056 A1,067-016-257-260-084,2012-01-04,2012,EP 10706346 A,2010-02-26,GB 2010050334 W;;GB 0903262 A;;GB 0922612 A,2009-02-26,FILTER FOR FILTERING PARTICULATE MATTER FROM EXHAUST GAS EMITTED FROM A POSITIVE IGNITION ENGINE,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/067-016-257-260-084,Patent Application,yes,0,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/06;;B01J29/14;;B01J29/40;;B01J29/46;;B01J29/50;;B01J29/56;;B01J29/70;;B01J29/76;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/00;;B01J37/02;;F01N3/035;;F01N3/28,,0,0,,,,ACTIVE
220,US,B2,US 8012439 B2,166-109-828-669-783,2011-09-06,2011,US 71268110 A,2010-02-25,GB 0903262 A;;GB 0922612 A,2009-02-26,Filter,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a positive ignition engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2010-05-07),https://lens.org/166-109-828-669-783,Granted Patent,yes,52,35,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D37/00;;B01D37/02;;B01D39/00;;B01D53/94;;F01N3/10,423/212;;423/213.2;;423/215.5;;55/529;;X 55DIG 30;;95/273;;95/285;;60/272;;60/299,5,5,181-846-970-824-83X;;066-012-318-748-549;;136-018-336-535-98X;;041-473-714-569-707;;056-364-975-278-598,10.4271/2009-01-0292;;10.4271/2001-01-0201;;10.4271/1999-01-3530;;10.4271/980525;;10.4271/810114,"Furuta et al., ""Study on Next Generation Diesel Particulate Filter,""SAE Technical Paper Series, Paper No. 2009-01-0292, presented at SAE World Congress & Exhibition, Apr. 2009, Detroit, MI, USA, published Apr. 20, 2009.;;Wei et al., ""Single-Stage Dilution Tunnel Performance,"" SAE Technical Paper Series, Paper No. 2001-01-0201, presented at SAE 2001 World Congress, Detroit Michigan, Mar. 5-8, 2001, published Mar. 5, 2001.;;Hall et al., ""Measurement of the Number and Size Distribution of Particles Emitted from a Gasoline Direct Injection Vehicle,"" SAE Technical Paper Series, Paper No. 1999-01-3530, presented at International Fuels & Lubricants Meeting & Exposition, Oct. 1999, Toronto, Ontario, Canada, published Oct. 25, 1999.;;Abdul-Khalek et al., ""Diesel Exhaust Particle Size: Measurement Issues and Trends,"" SAE Technical Paper Series, Paper No. 980525, presented at International Congress & Exposition, Feb. 1998, Detroit, MI, USA, published Feb. 23, 1998.;;Howitt et al., ""Cellular Ceramic Diesel Particulate Filter,"" SAE Technical Paper Series, Paper No. 810114, Feb. 1, 1981.",ACTIVE
221,GB,B,GB 2497441 B,131-003-116-806-123,2013-12-11,2013,GB 201301761 A,2010-02-26,GB 0903262 A;;GB 0922612 A,2009-02-26,Filter including hydrocarbon trap for positive ignition engine,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/131-003-116-806-123,Granted Patent,no,7,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J23/40;;B01J29/00;;B01J29/06;;B01J29/12;;B01J29/44;;B01J29/54;;B01J29/70;;B01J29/72;;B01J29/74;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/02;;B01J37/03;;F01N3/035,,0,0,,,,ACTIVE
222,US,S,US D0725669 S,151-594-139-798-202,2015-03-31,2015,US 201329459417 F,2013-06-28,US 201329459417 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,CLARE CHRISTOPHER JAMES;;LOXHA LYRA XHARRA;;IZOTOV DMYTRO;;ABATE UMBERTO;;REHBERG TORSTEN,MICROSOFT CORPORATION (2013-08-19),https://lens.org/151-594-139-798-202,Design Right,no,0,7,1,1,0,,,1404;;D14/486,0,0,,,,ACTIVE
223,DE,D1,DE 69826151 D1,130-400-144-751-724,2004-10-14,2004,DE 69826151 T,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-SUBSTITUIERTE-1-AMINOMETHYL-CYCLOALKAN DERIVATE (= GABAPENTIN ANALOGA), DEREN HERSTELLUNG UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW JUERGEN,,https://lens.org/130-400-144-751-724,Granted Patent,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;C07D285/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
224,DE,T2,DE 69826151 T2,159-959-530-528-328,2005-01-27,2005,DE 69826151 T,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-SUBSTITUIERTE-1-AMINOMETHYL-CYCLOALKAN DERIVATE (= GABAPENTIN ANALOGA), DEREN HERSTELLUNG UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW JUERGEN,,https://lens.org/159-959-530-528-328,Granted Patent,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;C07D285/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
225,US,A,US 5019505 A,139-449-285-670-236,1991-05-28,1991,US 7594187 A,1987-07-22,GB 8618469 A,1986-07-29,"Enzymes having alpha-glycerol-3-phosphate oxidase activity, production and use thereof","An enzyme having .alpha.-glycerol-3-phosphate oxidase activity characterized in that it has a Km of less than 2.5 mM is disclosed, as is the production and use thereof. More particularly, such enzymes may be obtained from Propionibacterium species and may have Km values of less than 50 .mu.M, hence are advantageous for triglyceride/glycerol/.alpha.-glycerol-3-phosphate determinations and test kits.",GENZYME LTD,FERGUSON CLARE H R;;MACADAM ANNE M;;INCE JANE E;;KNOWLES CHRISTOPHER J,GENZYME (U.K.) LTD (1987-07-23),https://lens.org/139-449-285-670-236,Granted Patent,yes,4,9,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,435/148;;435/190;;435/25,6,3,179-916-816-333-02X;;083-001-048-844-655;;003-297-641-101-717,4116353;;10.1093/oxfordjournals.jbchem.a129864;;10.1093/oxfordjournals.jbchem.a129908;;4345429;;4128321;;10.1093/oxfordjournals.jbchem.a130247,"Sone, N. (1972) J. Biochem. 71, 931 940.;;Sone, N. et al. (1972) J. Biochem 72, 291 297.;;Sone, N. (1973) J. Biochem. 74, 297 305.;;Fairlamb, A. H. et al. (1978) Chem. Abst. 88:146007w.;;Hill, G. C. et al. (1980) Chem. Abst. 93:64601z.;;Chemical Abstracts, vol. 101, Nov. 1984, p. 538, Abstract No. 169098c.",EXPIRED
226,AU,A,AU 1994/054465 A,137-510-045-996-912,1994-05-09,1994,AU 1994/054465 A,1993-10-22,US 9310089 W;;US 96491792 A,1992-10-22,Large surface area electrode,,PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;IMRAN MIR A;;BARNETT DONALD J JR;;HIGHE ALBERT J,,https://lens.org/137-510-045-996-912,Patent Application,no,0,0,3,3,0,A61N1/046;;A61N1/0492;;A61N1/046;;A61N1/0492,A61N1/04,,0,0,,,,PENDING
227,AT,T1,AT E361909 T1,198-085-724-777-47X,2007-06-15,2007,AT 97945516 T,1997-10-07,US 2960196 P;;US 5990097 P,1996-10-23,SUBSTITUIERTE GAMMA-AMINOBUTTERSÄUREDERIVATE ALS ARZNEIMITTEL,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID;;THORPE ANDREW,,https://lens.org/198-085-724-777-47X,Granted Patent,no,0,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,EXPIRED
228,WO,A1,WO 1994/008508 A1,129-576-472-089-550,1994-04-28,1994,US 9310089 W,1993-10-22,US 96491792 A,1992-10-22,LARGE SURFACE AREA ELECTRODE,"The large surface area electrode for use with a power supply having a more uniform current density distribution comprises a layer of flexible conductive material (31) of a predetermined geometrical shape and having first and second surfaces. The layer (31) is relatively flat and is capable of assuming contours of the skin of the body when the electrode is placed in contact with the body with the first surface of the layer engaging the exposed surface of the body. The layer of conductive material has a central portion (31a) and a surrounding ring portion (31b). A flexible carrier layer (12) is provided to support the central portion (31a) and the said surrounding portion (31b) so that the surrounding portion is insulated from the central portion. A connector (72) is connected to the surrounding ring portion (31b) and is adapted to the power supply (77) for controlling the current density at the edges. The connector forms a direct connection to the central portion (31a) and includes a resistor (46, 41) connected to the surrounding ring (31b).",PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;IMRAN MIR A;;BARNETT DONALD J JR;;HIGHE ALBERT J,,https://lens.org/129-576-472-089-550,Patent Application,yes,4,0,3,3,0,A61N1/046;;A61N1/0492;;A61N1/046;;A61N1/0492,A61N1/04,,0,0,,,,PENDING
229,ES,T3,ES 2052568 T3,032-905-129-364-700,1994-07-16,1994,ES 87306648 T,1987-07-28,GB 8618469 A,1986-07-29,"ENZIMAS QUE TIENEN ACTIVIDAD ALFA-GLICEROL-3-FOSFATO OXIDASA, PRODUCCION Y USO DE LAS MISMAS.","SE PRESENTA UN ENZIMA QUE TIENE ACTIVIDAD DE ALFAGLICERO-3-FOSFATOOXIDASA QUE SE CARACTERIZA POR TENER MAS DE 2,5 MM DEKM. TAMBIEN SE DESCRIBE SU OBTENCION Y USO. MAS EN PARTICULAR DICHAS ENZIMAS PUEDEN OBTENERSE DE ESPECIES DE PROPIOBACTERIUM Y PUEDEN TENER VALORES DE KM DE MENOS DE 50 MICRO M SIENDO PUES VENTAJOSOS PARA CONJUNTOS DE VALORACIONES Y PRUEBAS DE TRIGLICERIDOS/GLICERINA/ALFA-GLICERO-3-FOSFATO.",GENZYME LTD,FERGUSON CLARE HARRIET RUSSELL;;INCE JANE ELIZABETH;;MACADAM ANNE MARIE;;KNOWLES CHRISTOPHER JOHN,,https://lens.org/032-905-129-364-700,Granted Patent,no,0,0,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,,0,0,,,,EXPIRED
230,DE,T2,DE 3782694 T2,035-476-910-996-489,1993-04-01,1993,DE 3782694 T,1987-07-28,GB 8618469 A,1986-07-29,"ENZYME MIT DER ALPHA-GLYCEROL-3-PHOSPHAT-AKTIVITAET, DEREN HERSTELLUNG UND DEREN VERWENDUNG.",,GENZYME LTD,FERGUSON CLARE HARRIET RUSSELL;;INCE JANE ELIZABETH;;MACADAM ANNE MARIE;;KNOWLES CHRISTOPHER JOHN,,https://lens.org/035-476-910-996-489,Granted Patent,no,0,0,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,,0,0,,,,EXPIRED
231,EP,A3,EP 0255334 A3,133-492-374-105-840,1989-05-24,1989,EP 87306648 A,1987-07-28,GB 8618469 A,1986-07-29,"ENZYMES HAVING ALPHA-GLYCEROL-3-PHOSPHATE OXIDASE ACTIVITY, PRODUCTION AND USE THEREOF","An enzyme having α-glycerol-3-phosphate oxidase activity characterised in that it has a Km of less then 2.5mM is disclosed, as is the production and use thereof. More particularly, such enzymes may be obtained from  Propionibacterium  species and may have Km values of less than 50µM, hence are advantageous for triglyceride/­glycerol/α-glycerol-3-phosphate determinations and test kits.  ",GENZYME (U.K.) LTD.,"FERGUSON, CLARE HARRIET RUSSELL;;INCE, JANE ELIZABETH;;MACADAM, ANNE MARIE;;KNOWLES, CHRISTOPHER JOHN",GENZYME LIMITED (1992-06-24),https://lens.org/133-492-374-105-840,Search Report,yes,3,0,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,,1,0,,,"CHEMICAL ABSTRACTS, vol. 101, November 1984, page 538, abstract no. 169098c, Columbus, Ohio, US; & JP-A-59 82 086 (TOYO JOZO CO., LTD) 09-08-1983",EXPIRED
232,AU,A,AU 1987/076057 A,139-557-144-876-941,1988-02-04,1988,AU 1987/076057 A,1987-07-23,GB 8618469 A,1986-07-29,ENZYMES HAVING ALPHA-GLYCEROL-3-PHOSPHATE OXIDASE ACTIVITY,,GENZYME LTD,FERGUSON CLARE HARRIET RUSSELL;;MACADAM ANNE MARIE;;INCE JANE ELIZABETH;;KNOWLES CHRISTOPHER JOHN,,https://lens.org/139-557-144-876-941,Patent Application,no,0,0,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,,0,0,,,,EXPIRED
233,TW,A,TW 200800927 A,137-610-128-340-140,2008-01-01,2008,TW 95127970 A,2006-07-31,GB 0516706 A,2005-08-15,Chemical compounds,"The use of a compound of formula I wherein X is (i), (ii) or (iii) Y is O, S(O)m, NR3, CR5R6, CR5R6-CR7R8, O-CR7R8, S(O)m-CR7R8, NR3-CR7R8, CR5R6-O, CR5R6-S(O)m, CR5R6-NR3, SO2-NR3, NR3-SO2, NR3-O or O-NR3;m is 0, 1, or 2; the ring(T) is a 5- or 6-membered aromatic or heteroaromatic ring; R1 to R10 are specified organic groups and n is 0, 1, 2, 3 or 4; or salts or N-oxides thereof or compositions containing them in controlling insects, acarines, nematodes or molluscs. Novel compounds are also provided.",SYNGENTA PARTICIPATIONS AG;;SYNGENTA LTD,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN;;LUETHY CHRISTOPH;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,,https://lens.org/137-610-128-340-140,Patent of Addition,no,0,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D283/00;;A01N43/78,,0,0,,,,PENDING
234,US,A,US 5295482 A,060-505-874-472-237,1994-03-22,1994,US 96491792 A,1992-10-22,US 96491792 A,1992-10-22,Large surface area electrode,Large surface area electrode for use with a power supply having a more uniform current density distribution for contacting the exposed surface of a living body having a contour. The electrode comprises a layer of flexible conductive material of a predetermined geometrical shape and having first and second surfaces. The layer is normally relatively flat and is capable of assuming contours of the skin of the body when the electrode is placed in contact with the body with the first surface of the layer engaging the exposed surface of the body. The layer of conductive material has a central portion and a surrounding ring portion. The central portion and the surrounding ring portion have outer margins with edges. A flexible carrier layer is provided which is secured to the second surface of the layer of flexible conductive material and serves to support the central portion and the said surrounding portion so that the surrounding portion is spaced from and insulated from the central portion. A connector is provided which is connected to the surrounding ring portion and is adapted to be coupled to the power supply for controlling the current density at the edges so that the current density at the edges does not exceed a predetermined value. The connector forms a direct connection to the central portion and includes a resistor connected to the surrounding ring.,PHYSIOMETRIX INC,CLARE CHRISTOPHER R;;IMRAN MIR A;;BARNETT JR DONALD E;;HIGHE ALBERT J,PHYSIOMETRIX INC. A DELAWARE CORPORATION (1996-04-24),https://lens.org/060-505-874-472-237,Granted Patent,yes,11,72,3,3,0,A61N1/046;;A61N1/0492;;A61N1/046;;A61N1/0492,A61N1/04,128/639;;607/142,5,5,099-593-704-904-314;;020-675-512-119-090;;022-194-400-741-219;;059-938-454-714-39X;;104-371-320-975-231,6476544;;10.1016/s0196-0644(84)80440-0;;10.1007/bf02441629;;3747631;;3619167;;10.1016/s0196-0644(87)80525-5;;10.1016/s0735-1097(84)80258-2;;6693652;;10.1109/tbme.1982.324910;;7084970,"Richard E. Kerber, MD, External Defibrillation: New Technologies, Annals of Emergency Medicine, Sep. 1984 (Part 2), 13:9, pp. 794 796.;;M. Aubry Frize, Y. Poussart, Modelling of thermal patterns of electrosurgical dispersive electrodes, Med. & Biol. Engineering & Computing, May 1986, pp. 311 315.;;Stults et al., Self Adhesive Monitor/Defibrillation Pads Improve Prehospital Defibrillation Success, Annals of Emergency Medicine, Aug. 1987, 16:8, pp. 872 877.;;Kerber et al., Self Adhesive Preapplied Electrode Pads for Defibrillation and Cardioversion, JACC, Mar. 1984, 3:3, pp. 815 820.;;J. D. Wiley, J. G. Webster, Analysis and Control of the Current Distribution under Circular Dispersive Electrodes, IEEE Transactions on Biomed. Eng., May 1982, 29:5, pp. 381 389.",EXPIRED
235,AT,T1,AT E82589 T1,094-550-635-808-406,1992-12-15,1992,AT 87306648 T,1987-07-28,EP 87306648 A;;GB 8618469 A,1986-07-29,"ENZYME MIT DER ALPHA-GLYCEROL-3-PHOSPHATAKTIVIT|T, DEREN HERSTELLUNG UND DEREN VERWENDUNG.",,GENZYME LTD,FERGUSON CLARE HARRIET RUSSELL;;INCE JANE ELIZABETH;;MACADAM ANNE MARIE;;KNOWLES CHRISTOPHER JOHN,,https://lens.org/094-550-635-808-406,Granted Patent,no,0,0,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,,0,0,,,,DISCONTINUED
236,EP,A2,EP 0255334 A2,189-883-005-285-436,1988-02-03,1988,EP 87306648 A,1987-07-28,GB 8618469 A,1986-07-29,"Enzymes having alpha-glycerol-3-phosphate oxidase activity, production and use thereof.","An enzyme having α-glycerol-3-phosphate oxidase activity characterised in that it has a Km of less then 2.5mM is disclosed, as is the production and use thereof. More particularly, such enzymes may be obtained from  Propionibacterium  species and may have Km values of less than 50µM, hence are advantageous for triglyceride/­glycerol/α-glycerol-3-phosphate determinations and test kits.  ",GENZYME LTD,FERGUSON CLARE HARRIET RUSSELL;;INCE JANE ELIZABETH;;MACADAM ANNE MARIE;;KNOWLES CHRISTOPHER JOHN,GENZYME LIMITED (1992-06-24),https://lens.org/189-883-005-285-436,Patent Application,yes,0,1,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,,0,0,,,,EXPIRED
237,AU,B2,AU 599399 B2,117-533-159-774-96X,1990-07-19,1990,AU 1987/076057 A,1987-07-23,GB 8618469 A,1986-07-29,ENZYMES HAVING ALPHA-GLYCEROL-3-PHOSPHATE OXIDASE ACTIVITY,,GENZYME LTD,FERGUSON CLARE HARRIET RUSSELL;;MACADAM ANNE MARIE;;INCE JANE ELIZABETH;;KNOWLES CHRISTOPHER JOHN,,https://lens.org/117-533-159-774-96X,Granted Patent,no,0,0,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,,0,0,,,,EXPIRED
238,EP,B1,EP 0255334 B1,166-037-237-013-010,1992-11-19,1992,EP 87306648 A,1987-07-28,GB 8618469 A,1986-07-29,"ENZYMES HAVING ALPHA-GLYCEROL-3-PHOSPHATE OXIDASE ACTIVITY, PRODUCTION AND USE THEREOF",,GENZYME LIMITED,"FERGUSON, CLARE HARRIET RUSSELL;;INCE, JANE ELIZABETH;;MACADAM, ANNE MARIE;;KNOWLES, CHRISTOPHER JOHN",GENZYME LIMITED (1992-06-24),https://lens.org/166-037-237-013-010,Granted Patent,yes,3,0,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,,1,0,,,"CHEMICAL ABSTRACTS, vol. 101, November 1984, page 538, abstract no. 169098c, Columbus, Ohio, US; & JP-A-59 82 086 (TOYO JOZO CO., LTD) 09-08-1983",EXPIRED
239,DE,D1,DE 3782694 D1,022-889-726-120-341,1992-12-24,1992,DE 3782694 T,1987-07-28,GB 8618469 A,1986-07-29,"ENZYME MIT DER ALPHA-GLYCEROL-3-PHOSPHAT-AKTIVITAET, DEREN HERSTELLUNG UND DEREN VERWENDUNG.",,GENZYME LTD,FERGUSON CLARE HARRIET RUSSELL;;INCE JANE ELIZABETH;;MACADAM ANNE MARIE;;KNOWLES CHRISTOPHER JOHN,,https://lens.org/022-889-726-120-341,Granted Patent,no,0,0,13,13,0,C12N9/0006;;C12Q1/26;;C12N9/0006;;C12Q1/26,C12N9/04;;C12Q1/26;;C12Q1/28;;C12R1/01,,0,0,,,,EXPIRED
240,CA,C,CA 2304974 C,067-354-630-496-59X,2005-10-25,2005,CA 2304974 A,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas (1), (1C), (1F), (1G) and (1H) or a pharmaceutical acceptable salt thereof wherein n is an integer of from 0 to 2; m is an integer of from 0 to 3; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; A' is a bridged ring selected from (1), (2), (3), (4), (5) wherein is the point of attachment; Z1 to Z4 are each independently selected from hydrogen and methyl; o is an integer of from 1 to 4; and p is an integer of from 0 to 2. In formula (1) above R cannot be sulfonic acid when m is 2 and n is 1 are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially irritable bowel syndrome.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;WUSTROW DAVID JUERGEN;;CAPIRIS THOMAS;;KNEEN CLARE OCTAVIA;;HORWELL DAVID CHRISTOPHER,,https://lens.org/067-354-630-496-59X,Granted Patent,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,C07D285/08;;A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
241,DE,D1,DE 602006017396 D1,038-262-061-027-469,2010-11-18,2010,DE 602006017396 T,2006-08-02,GB 0516706 A;;GB 2006002886 W,2005-08-15,CHEMISCHE VERBINDUNGEN,,SYNGENTA LTD;;SYNGENTA PARTICIPATIONS AG,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPHE;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,,https://lens.org/038-262-061-027-469,Granted Patent,no,0,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D283/00;;A01N43/78;;A01P5/00;;A01P7/04;;A01P9/00,,0,0,,,,ACTIVE
242,KR,A,KR 20080034160 A,065-786-270-828-162,2008-04-18,2008,KR 20087003754 A,2008-02-15,GB 0516706 A,2005-08-15,CHEMICAL COMPOUNDS,"The use of a compound of formula (I) wherein X is (i), (ii) or (iii), formula (i),formula (ii), formula (iii) Y is O, S(O)m, NR3, CR5R6, CR5R6-CR7 R8, O-CR7R8, S(O)m-CR 7R8, NR3-CR7R8, CR 5R6 -O, CR5R6-S(O)m, CR5R6-NR3, SO2-NR3, NR3-SO2, NR3-O or O-NR3; m is 0, 1, or 2; the ring (T) formula (T) is a 5-or 6-membered aromatic or heteroaromatic ring; R1 to R10 are specified organic groups and n and is 0, 1, 2, 3 or 4; or salts or N-oxides thereof or compositions containing them in controlling insects, acarines, nematodes or molluscs. Novel compounds are also provided.",SYNGENTA PARTICIPATIONS AG;;SYNGENTA LTD,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPHE;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,,https://lens.org/065-786-270-828-162,Patent Application,no,0,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D417/02;;A01N43/78;;A01P5/00;;C07D283/00,,0,0,,,,DISCONTINUED
243,US,B1,US 6518289 B1,181-017-873-896-956,2003-02-11,2003,US 50990500 A,2000-04-03,US 50990500 A;;US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders","
    Novel amines of formulas (1), (1C), (1F), (1G) and (1H) or a pharmaceutical acceptable salt thereof wherein n is an integer of from 0 to 2; m is an integer of from 0 to 3; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; A is a bridged ring selected from (1), (2), (3), (4), (5) wherein is the point of attachment; Z _{ 1 } to Z _{ 4 } are each independently selected from hydrogen and methyl; o is an integer of from 1 to 4; and p is an integer of from 0 to 2. In formula (1) above R cannot be sulfonic acid when m is 2 and n is 1 are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, especially irritable bowel syndrome. 
",PFIZER,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/181-017-873-896-956,Granted Patent,yes,10,24,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;C07D285/08;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,514/364;;514/360;;514/361;;514/381;;548/122;;548/129;;548/132;;548/254,0,0,,,,EXPIRED
244,EP,B1,EP 1047678 B1,191-998-534-066-986,2004-09-08,2004,EP 98957745 A,1998-11-10,US 9823918 W;;US 6977397 P;;US 10500598 P,1997-12-16,"1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,WARNER-LAMBERT COMPANY LLC (2004-04-28),https://lens.org/191-998-534-066-986,Granted Patent,yes,13,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;C07D285/08;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,10,0,,,"WALKER G.N. ET AL.: ""Synthesis of new 3-(pyridylmethylene)- 3-(pyridylmethyl)-, 3-(piperidylmethyl)-, and 3-(.beta.-alkylaminomethyl)-2-indolinones. The reduction of isoindogenides, nitro compounds, and pyridines in a series of 2-indolinones"" JOURNAL OF MEDICINAL CHEMISTRY, vol. 8, no. 9, September 1965, pages 626-637, XP002102295;;HARPER N.J. ET AL.: ""1-(3,4-Dichlorobenzamidomethyl)cyclohexyl dimethylamine and related compounds as potential analgesics"" JOURNAL OF MEDICINAL CHEMISTRY, vol. 17, no. 11, November 1974, pages 1188-1193, XP002102296;;ABDEL RAHMAN M.O. ET AL.: ""Synthesis of some 1,1-disubstituted cyclohexanes of potential psychotropic activity"" EGYPTIAN JOURNAL OF CHEMISTRY, vol. 18, no. 2, 1975, pages 385-392, XP002102297;;NASSER J. ET AL.: "".alpha.-Functional cycloalkylphosphonates. II. Synthesis of .alpha.-aminomethyl- and .alpha.-(N-substituted)aminomethylcycloalk ylphosphonates"" PHOSPHORUS, SULFUR, AND SILICON AND THE RELATED ELEMENTS, vol. 55, no. 1-4, 1991, pages 137-146, XP002102298;;O'BRIEN P.M. ET AL.: ""Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo"" JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 12, 1 January 1994, pages 1810-1822, XP002082610;;SUMAN-CHAUHAN N. ET AL.: ""Characterisation of [3H]gabapentin binding to a novel site in rat brain: Homogenate binding studies"" EUROPEAN JOURNAL OF PHARMACOLOGY - MOLECULAR PHARMACOLOGY SECTION, vol. 244, no. 3, 15 February 1993, pages 293-301, XP002096653 cited in the application;;CHEMICAL ABSTRACTS, vol. 123, no. 17, 23 October 1995 Columbus, Ohio, US; abstract no. 227978g, ITO Y. ET AL.: ""Urea derivatives as acyl-CoA-cholesterol acyltransferase inhibitors and their preparation"" page 1169; column 1; XP002102300 & JP 07 101929 A (FUJISAWA PHARMACEUTICAL CO.) 18 April 1995;;BOOTH R.J & HODGES J.C.: ""Polymer-supported quenching reagents for parallel purification"" JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 119, no. 21, 1997, pages 4882-4886, XP002102299;;BURGER A.: ""Isosterism and bioisosterism in drug design"" PROGRESS IN DRUG RESEARCH, vol. 37, 1991, pages 287-371, XP002096229;;PATANI G.A. & LA VOIE E.J.: ""Bioisosterism: A rational approach in drug design"" CHEMICAL REVIEWS, vol. 96, no. 8, 1996, pages 3147-3176, XP000652176",EXPIRED
245,SI,T1,SI 1047678 T1,010-088-684-836-687,2005-02-28,2005,SI 9830690 T,1998-11-10,US 9823918 W;;US 6977397 P;;US 10500598 P,1997-12-16,"1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/010-088-684-836-687,Granted Patent,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;C07D285/08;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
246,CN,A,CN 110043350 A,028-794-491-316-839,2019-07-23,2019,CN 201910124188 A,2010-12-23,GB 0922612 A;;GB 201003244 A;;GB 201014027 A;;CN 201080064672 A,2009-12-24,Exhaust system for vehicular positive ignition internal combustion engine,"An exhaust system (10) for a vehicular positive ignition internal combustion engine (12) comprises a filter for filtering particulate matter from exhaust gas emitted from the engine, which filter comprising a porous substrate having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, whereinthe porous substrate is coated with a three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, which is less than the first mean pore size, and a three-way catalyst washcoat disposed on a separate substrate monolith (18) located upstream of the filter, wherein a mass of three-waycatalyst washcoat on the upstream substrate monolith is less than or equal to 75% of the total mass of three-way catalyst washcoat in the exhaust system.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER,,https://lens.org/028-794-491-316-839,Patent Application,no,5,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,F01N3/10;;B01D53/94;;B01J23/46;;B01J29/06;;B01J29/08;;B01J29/12;;B01J29/14;;B01J29/16;;B01J29/40;;B01J29/44;;B01J29/46;;B01J29/50;;B01J29/54;;B01J29/56;;B01J29/70;;B01J29/72;;B01J29/74;;B01J29/76;;B01J29/78;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/00;;B01J37/02;;F01N3/035;;F01N13/00,,0,0,,,,PENDING
247,WO,A1,WO 1999/031075 A1,073-100-295-092-674,1999-06-24,1999,US 9823918 W,1998-11-10,US 6977397 P;;US 10500598 P,1997-12-16,"1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas (1), (1C), (1F), (1G) and (1H) or a pharmaceutical acceptable salt thereof wherein n is an integer of from 0 to 2; m is an integer of from 0 to 3; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; A' is a bridged ring selected from (1), (2), (3), (4), (5) wherein &blank; is the point of attachment; Z1 to Z4 are each independently selected from hydrogen and methyl; o is an integer of from 1 to 4; and p is an integer of from 0 to 2. In formula (1) above R cannot be sulfonic acid when m is 2 and n is 1 are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially irritable bowel syndrome.",WARNER LAMBERT CO;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/073-100-295-092-674,Patent Application,yes,13,86,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;C07D285/08;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,10,8,042-595-482-189-343;;033-777-823-323-24X;;058-135-062-509-535;;065-318-225-707-786;;025-044-536-456-332;;013-469-999-599-848;;000-457-771-937-337;;035-230-547-171-641,10.1021/jm00329a016;;4416926;;10.1021/jm00257a012;;10.1080/10426509108045933;;10.1021/jm00038a010;;8021920;;10.1016/0922-4106(93)90155-3;;8384570;;10.1021/ja9634637;;1763185;;10.1007/978-3-0348-7139-6_7;;10.1021/cr950066q;;11848856,"WALKER G.N. ET AL.: ""Synthesis of new 3-(pyridylmethylene)- 3-(pyridylmethyl)-, 3-(piperidylmethyl)-, and 3-(.beta.-alkylaminomethyl)-2-indolinones. The reduction of isoindogenides, nitro compounds, and pyridines in a series of 2-indolinones"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 8, no. 9, September 1965 (1965-09-01), pages 626 - 637, XP002102295;;HARPER N.J. ET AL.: ""1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 17, no. 11, November 1974 (1974-11-01), pages 1188 - 1193, XP002102296;;ABDEL RAHMAN M.O. ET AL.: ""Synthesis of some 1,1-disubstituted cyclohexanes of potential psychotropic activity"", EGYPTIAN JOURNAL OF CHEMISTRY, vol. 18, no. 2, 1975, pages 385 - 392, XP002102297;;NASSER J. ET AL.: "".alpha.-Functional cycloalkylphosphonates. II. Synthesis of .alpha.-aminomethyl- and .alpha.-(N-substituted)aminomethylcycloalkylphosphonates"", PHOSPHORUS, SULFUR, AND SILICON AND THE RELATED ELEMENTS, vol. 55, no. 1-4, 1991, pages 137 - 146, XP002102298;;O'BRIEN P.M. ET AL.: ""Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 12, 1 January 1994 (1994-01-01), pages 1810 - 1822, XP002082610;;SUMAN-CHAUHAN N. ET AL.: ""Characterisation of [3H]gabapentin binding to a novel site in rat brain: Homogenate binding studies"", EUROPEAN JOURNAL OF PHARMACOLOGY - MOLECULAR PHARMACOLOGY SECTION, vol. 244, no. 3, 15 February 1993 (1993-02-15), pages 293 - 301, XP002096653;;CHEMICAL ABSTRACTS, vol. 123, no. 17, 23 October 1995, Columbus, Ohio, US; abstract no. 227978g, ITO Y. ET AL.: ""Urea derivatives as acyl-CoA-cholesterol acyltransferase inhibitors and their preparation"" page 1169; column 1; XP002102300;;BOOTH R.J & HODGES J.C.: ""Polymer-supported quenching reagents for parallel purification"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 119, no. 21, 1997, pages 4882 - 4886, XP002102299;;BURGER A.: ""Isosterism and bioisosterism in drug design"", PROGRESS IN DRUG RESEARCH, vol. 37, 1991, pages 287 - 371, XP002096229;;PATANI G.A. & LA VOIE E.J.: ""Bioisosterism: A rational approach in drug design"", CHEMICAL REVIEWS, vol. 96, no. 8, 1996, pages 3147 - 3176, XP000652176",PATENTED
248,AU,A,AU 1999/013929 A,096-237-858-867-835,1999-07-05,1999,AU 1999/013929 A,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/096-237-858-867-835,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,C07D285/08;;A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
249,PL,A1,PL 341291 A1,186-872-627-489-414,2001-04-09,2001,PL 34129198 A,1998-11-10,US 9823918 W;;US 6977397 P;;US 10500598 P,1997-12-16,"1-SUBSTITUTED DERIVATIVES OF 1-AMINOMETHYL-CCYCLOALKANES (GABAPENTIN ANALOGUES), THEIR PRODUCTION AND APPLICATION OF THEM IN TREATING NEUROLOGICAL DISORDERS",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/186-872-627-489-414,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;C07D285/08;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
250,NO,L,NO 20041112 L,187-378-190-246-411,2000-06-14,2000,NO 20041112 A,2004-03-17,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-Substituerte-1-aminometyl-cykloalkanderivater (=gabapentinanaloger), deres fremstilling og deres anvendelse ved behandiing av neurologiske lidelser",,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;WUSTROW DAVID JUERGEN;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;CAPIRIS THOMAS,,https://lens.org/187-378-190-246-411,Abstract,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;C07D285/08;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
251,NO,B1,NO 317252 B1,057-471-119-517-680,2004-09-27,2004,NO 20003039 A,2000-06-14,US 10500598 P;;US 6977397 P;;US 9823918 W,1997-12-16,"1-Substituerte-1-aminometyl-cykloalkanderivater (=gabapentinanaloger), deres fremstilling og deres anvendelse ved behandling av neurologiske lidelser",,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;WUSTROW DAVID JUERGEN;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;CAPIRIS THOMAS,,https://lens.org/057-471-119-517-680,Granted Patent,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;C07D285/08;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
252,WO,A3,WO 2007/020377 A3,118-845-797-350-263,2007-07-26,2007,GB 2006002886 W,2006-08-02,GB 0516706 A,2005-08-15,CHEMICAL COMPOUNDS,"The use of a compound of formula (I) wherein X is (i), (ii) or (iii), formula (i),formula (ii), formula (iii) Y is O, S(O) m , NR 3 , CR 5 R 6 , CR 5 R 6 -CR 7 R 8 , O-CR 7 R 8 , S(O) m -CR 7 R 8 , NR 3 -CR 7 R 8 , CR 5 R 6 -O, CR 5 R 6 -S(O) m , CR 5 R 6 -NR 3 , SO 2 -NR 3 , NR 3 -SO 2 , NR 3 -O or O-NR 3 ; m is 0, 1, or 2; the ring (T) formula (T) is a 5- or 6-membered aromatic or heteroaromatic ring; R 1 to R 10 are specified organic groups and n and is 0, 1, 2, 3 or 4; or salts or N-oxides thereof or compositions containing them in controlling insects, acarines, nematodes or molluscs. Novel compounds are also provided.",SYNGENTA PARTICIPATIONS AG;;SYNGENTA LTD;;O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPHE;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPHE;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,,https://lens.org/118-845-797-350-263,Search Report,yes,2,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D283/00;;A01N43/78;;A01P5/00;;A01P7/02;;A01P7/04;;A01P9/00,,0,0,,,,PENDING
253,TR,T2,TR 200001795 T2,026-537-880-333-720,2000-11-21,2000,TR 200001795 T,1998-11-10,US 6977397 P;;US 10500598 P,1997-12-16,"1-İkameli-1-Aminometil-sikloalkan türevleri (=Gabapentin analogları), bunların hazırlanması ve nörolojik bozuklukların tedavisinde kullanımı.","Bu bulusun bilesikleri, yeni aminler ve çesitli rahatsizliklarda faydali olan bunlarin farmasötik olarak kabul edilebilir tuzlaridir. bu rahatsizliklar sunlari kapsar: epilepsi, bayilma nöbetleri, hipokinez, kraniyal rahatsizliklar, nörodejeneratif bozukluklar, depresyon, endise ve huzursuzluk, panik, agri, nöropatolojik bozukluklar, enflamatuvar hastaliklar ve mide-bagirsak bozukluklari, özellikle de iritabl bagirsak sendromu.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/026-537-880-333-720,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;C07D285/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
254,EP,A1,EP 3372301 A1,067-240-368-946-878,2018-09-12,2018,EP 18169129 A,2010-12-23,GB 0922612 A;;GB 201003244 A;;GB 201014027 A;;EP 10801695 A;;GB 2010052209 W,2009-12-24,EXHAUST SYSTEM FOR A VEHICULAR POSITIVE IGNITION INTERNAL COMBUSTION ENGINE,"An exhaust system (10) for a vehicular positive ignition internal combustion engine (12) comprises a filter (20) for filtering particulate matter from exhaust gas emitted from the engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a three-way catalyst washcoat in combination with other catalytic washcoats selected from the group consisting of a hydrocarbon trap, a NO x  absorber, an oxidation catalyst, a selective catalytic reduction (SCR) catalyst, a lean NO x  catalyst and combinations of any two or more thereof, which three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size and a three-way catalyst washcoat disposed on a separate substrate monolith (18) located upstream of the filter, wherein a mass of three-way catalyst washcoat on the upstream substrate monolith is ≤75% of the total mass of three-way catalyst washcoat in the exhaust system.
",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER,,https://lens.org/067-240-368-946-878,Patent Application,yes,6,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,B01D53/94;;F01N3/035,,0,0,,,,DISCONTINUED
255,EP,A1,EP 1475371 A1,129-250-124-199-999,2004-11-10,2004,EP 04006036 A,1998-11-10,EP 98957745 A;;US 6977397 P;;US 10500598 P,1997-12-16,"1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (= GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas 1, 1C, 1F, 1G and 1H
   or a pharmaceutical acceptable salt thereof wherein 
n is an integer of from 0 to 2; 
m is an integer of from 0 to 3; 
R is sulfonamide, 
amide, 
heterocycle, 
sulfonic acid, or 
hydroxamic acid; 
A' is a bridged ring selected from
   wherein 
is the point of attachment; 
Z 1  to Z 4  are each independently selected from hydrogen and methyl; 
o is an integer of from 1 to 4; and 
p is an integer of from 0 to 2. 
In formula (1) above R cannot be sulfonic acid when m is 2 and n is 1 are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially irritable bowel syndrome.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,WARNER-LAMBERT COMPANY LLC (2007-02-21),https://lens.org/129-250-124-199-999,Patent Application,yes,13,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;C07D285/08;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,9,7,042-595-482-189-343;;033-777-823-323-24X;;065-318-225-707-786;;025-044-536-456-332;;013-469-999-599-848;;000-457-771-937-337;;035-230-547-171-641,10.1021/jm00329a016;;4416926;;10.1021/jm00257a012;;10.1021/jm00038a010;;8021920;;10.1016/0922-4106(93)90155-3;;8384570;;10.1021/ja9634637;;1763185;;10.1007/978-3-0348-7139-6_7;;10.1021/cr950066q;;11848856,"WALKER G.N. ET AL.: ""Synthesis of new 3-(pyridylmethylene)- 3-(pyridylmethyl)-, 3-(piperidylmethyl)-, and 3-(.beta.-alkylaminomethyl)-2-indolinones. The reduction of isoindogenides, nitro compounds, and pyridines in a series of 2-indolinones"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 8, no. 9, September 1965 (1965-09-01), pages 626 - 637, XP002102295;;HARPER N.J. ET AL.: ""1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 17, no. 11, November 1974 (1974-11-01), pages 1188 - 1193, XP002102296;;ABDEL RAHMAN M.O. ET AL.: ""Synthesis of some 1,1-disubstituted cyclohexanes of potential psychotropic activity"", EGYPTIAN JOURNAL OF CHEMISTRY, vol. 18, no. 2, 1975, pages 385 - 392, XP002102297;;O'BRIEN P.M. ET AL.: ""Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 12, 1 January 1994 (1994-01-01), pages 1810 - 1822, XP002082610;;SUMAN-CHAUHAN N. ET AL.: ""Characterisation of [3H]gabapentin binding to a novel site in rat brain: Homogenate binding studies"", EUROPEAN JOURNAL OF PHARMACOLOGY - MOLECULAR PHARMACOLOGY SECTION, vol. 244, no. 3, 15 February 1993 (1993-02-15), pages 293 - 301, XP002096653;;CHEMICAL ABSTRACTS, vol. 123, no. 17, 23 October 1995, Columbus, Ohio, US; abstract no. 227978g, ITO Y. ET AL.: ""Urea derivatives as acyl-CoA-cholesterol acyltransferase inhibitors and their preparation"" page 1169; column 1; XP002102300;;BOOTH R.J & HODGES J.C.: ""Polymer-supported quenching reagents for parallel purification"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 119, no. 21, 1997, pages 4882 - 4886, XP002102299;;BURGER A.: ""Isosterism and bioisosterism in drug design"", PROGRESS IN DRUG RESEARCH, vol. 37, 1991, pages 287 - 371, XP002096229;;PATANI G.A. & LA VOIE E.J.: ""Bioisosterism: A rational approach in drug design"", CHEMICAL REVIEWS, vol. 96, no. 8, 1996, pages 3147 - 3176, XP000652176",DISCONTINUED
256,ES,T3,ES 2227896 T3,116-566-411-578-333,2005-04-01,2005,ES 98957745 T,1998-11-10,US 6977397 P;;US 10500598 P,1997-12-16,"DERIVADOS DE 1-AMINOMETIL-CICLOALCANOS SUSTITUIDOS EN 1 (=ANALOGOS DE GABAPENTINA), SU PREPARACION Y SU USO EN EL TRATAMIENTO DE TRASTORNOS NEUROLOGICOS.","Los compuestos de la invención son los de fórmula **(Fórmulas)** o una sal farmacéuticamente aceptable de los mismos, en la que: n es un número entero de 1 a 2; m es un número entero de 0 a 3; R1 a R14 son cada uno de ellos independientemente seleccionados entre hidrógeno o alquilo lineal o ramificado de 1 a 6 átomos de carbono, bencilo o fenilo sin sustituir o sustituidos con sustituyentes seleccionados entre halógeno, alquilo, alcoxilo, hidroxilo, carboxilo, carboalcoxilo, trifluorometilo y nitro.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/116-566-411-578-333,Granted Patent,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;C07D285/08;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
257,ZA,B,ZA 9811464 B,164-645-085-439-878,1999-06-15,1999,ZA 9811464 A,1998-12-14,US 6977397 P,1997-12-16,Novel amines as pharmaceutical agents,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/164-645-085-439-878,Granted Patent,no,0,0,3,92,0,,A61K/;;C07C/;;C07D/,,0,0,,,,EXPIRED
258,HU,A2,HU P0004439 A2,029-578-801-710-883,2001-10-28,2001,HU P0004439 A,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","A találmány (I), (IC), (IF), (IG) vagy (IH) általános képletűvegyületekre és gyógyászatilag elfogadható sóikra, valamint ilyenvegyületeket tartalmazó gyógyszerkészítményekre vonatkozik, aképletekben n értéke 0, 1 vagy 2; m értéke 0, 1, 2 vagy 3; R jelentéseszulfonamid-, amid-, foszfonsav-, heterogyűrűs, szulfonsav- vagyhidroxámsavcsoport; R1-R14 jelentése egymástól függetlenülhidrogénatom vagy egyenes vagy elágazó láncú 1-6 szénatomosalkilcsoport, helyettesítetlen vagy helyettesített benzil- vagyfenilcsoport, ahol a helyettesítőket a halogénatom, alkil-, alkoxi-,hidroxil-, karboxil-, kalkoxikarbonil-, trifluormetil- és anitrocsoport közül választják; A' jelentése (1), (2), (3), (4)általános képletű vagy (5) képletű áthidalt gyűrűs csoport, amelyekbena hullámos vonal a kapcsolódás helyét mutatja; Z1-Z4 jelentéseegymástól függetlenül hidrogénatom vagy metilcsoport, o értéke 1, 2, 3vagy 4; és p értéke 0, 1 vagy 2. Ó",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/029-578-801-710-883,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;C07D285/08;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
259,CA,A1,CA 2304974 A1,151-616-949-199-011,1999-06-24,1999,CA 2304974 A,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas (1), (1C), (1F), (1G) and (1H) or a pharmaceutical acceptable salt thereof wherein n is an integer of from 0 to 2; m is an integer of from 0 to 3; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; A' is a bridged ring selected from (1), (2), (3), (4), (5) wherein \Ablank; is the point of attachment; Z1 to Z4 are each independently selected from hydrogen and methyl; o is an integer of from 1 to 4; and p is an integer of from 0 to 2. In formula (1) above R cannot be sulfonic acid when m is 2 and n is 1 are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially irritable bowel syndrome.",WARNER LAMBERT CO,WUSTROW DAVID JUERGEN;;KNEEN CLARE OCTAVIA;;CAPIRIS THOMAS;;BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER,,https://lens.org/151-616-949-199-011,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,C07D285/08;;A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
260,US,A1,US 2023/0020057 A1,196-211-738-152-173,2023-01-19,2023,US 202217948905 A,2022-09-20,US 202217948905 A;;US 201815928855 A;;US 201762599477 P,2017-12-15,SYSTEMS AND METHODS FOR CONTEXT-BASED KEYWORD SEARCHING,"Systems and methods are provided for performing context-based keyword searching using a search bar. Based on search terms received via the search bar, the system may be configured to provide suggested search parameters to associate with that search term. The suggested search parameters may each include a type of data and/or a filter to associate with the search term (e.g., name, phone number, date of birth, etc.). The one or more suggested search parameters may be identified based on the search term itself, a list of possible types of data or filters, a preliminary search of one or more datasets, a record of one or more previous searches performed, requirements associated with one or more searchable datasets, the format of user input received via the search bar, and/or one or more other factors.",PALANTIR TECHNOLOGIES INC,BEARD MITCHELL;;BAGDIS JEFFREY;;BRAHMS CHRISTOPHER;;EINSPAHR ASHLEY;;ADRIEN CLARE;;RAJU ARVIND;;ELKHERJ MATTHEW,PALANTIR TECHNOLOGIES INC (2018-03-28),https://lens.org/196-211-738-152-173,Patent Application,yes,0,0,3,3,0,G06F16/248;;G06F16/9538;;G06F16/9535;;G06F16/248,G06F16/9535;;G06F16/248,,0,0,,,,ACTIVE
261,NO,D0,NO 20003039 D0,161-592-413-097-067,2000-06-14,2000,NO 20003039 A,2000-06-14,US 10500598 P;;US 6977397 P;;US 9823918 W,1997-12-16,1-Substituerte-1-aminometyl-cykloalkanderivater,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/161-592-413-097-067,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;C07D285/08;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
262,AT,T1,AT E275552 T1,190-193-695-518-82X,2004-09-15,2004,AT 98957745 T,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-SUBSTITUIERTE-1-AMINOMETHYL-CYCLOALKAN DERIVATE (= GABAPENTIN ANALOGA), DEREN HERSTELLUNG UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/190-193-695-518-82X,Granted Patent,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,C07D285/08;;A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
263,NO,L,NO 20003039 L,010-477-274-947-535,2000-06-14,2000,NO 20003039 A,2000-06-14,US 10500598 P;;US 6977397 P;;US 9823918 W,1997-12-16,1-Substituerte-1-aminometyl-cykloalkanderivater,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/010-477-274-947-535,Abstract,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;C07D285/08;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
264,US,A1,US 2011/0218341 A1,014-573-244-383-623,2011-09-08,2011,US 201113105596 A,2011-05-11,US 201113105596 A;;GB 0516706 A;;US 6386908 A;;GB 2006002886 W,2005-08-15,CHEMICAL COMPOUNDS,"The use of a compound of formula I wherein X is (i), (ii) or (iii) Y is O, S(O) m , NR 3 , CR 5 R 6 , CR 5 R 6 —CR 7 R 8 , O—CR 7 R 8 , S(O) m —CR 7 R 8 , NR 3 —CR 7 R 8 , CR 5 R 6 —O, CR 5 R 6 —S(O) m , CR 5 R 6 —NR 3 , SO 2 —NR 3 , NR 3 —SO 2 , NR 3 —O or O—NR 3 ;m is 0, 1, or 2;the ring (T) is a 5- or 6-membered aromatic or heteroaromatic ring; R 1 to R 10 are specified organic groups and n and is 0, 1, 2, 3 or 4; or salts or N-oxides thereof or compositions containing them in controlling insects, acarines, nematodes or molluscs. Novel compounds are also provided.",SYNGENTA CROP PROT INC;;SYNGENTA LTD,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPH;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,SYNGENTA PARTICIPATIONS AG (2008-01-17);;SYNGENTA LIMITED (2008-01-17),https://lens.org/014-573-244-383-623,Patent Application,yes,1,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D277/18;;A01N43/78,548/193;;548/190,1,1,096-264-922-276-102,10.1135/cccc19920415,"Shukla et al., Collection of Czechoslovak Chemical Communications (1992), Vol. 57(2), p.415-424.",INACTIVE
265,WO,A2,WO 2007/020377 A2,022-668-275-953-387,2007-02-22,2007,GB 2006002886 W,2006-08-02,GB 0516706 A,2005-08-15,CHEMICAL COMPOUNDS,"The use of a compound of formula (I) wherein X is (i), (ii) or (iii), formula (i),formula (ii), formula (iii) Y is O, S(O) m , NR 3 , CR 5 R 6 , CR 5 R 6 -CR 7 R 8 , O-CR 7 R 8 , S(O) m -CR 7 R 8 , NR 3 -CR 7 R 8 , CR 5 R 6 -O, CR 5 R 6 -S(O) m , CR 5 R 6 -NR 3 , SO 2 -NR 3 , NR 3 -SO 2 , NR 3 -O or O-NR 3 ; m is 0, 1, or 2; the ring (T) formula (T) is a 5- or 6-membered aromatic or heteroaromatic ring; R 1 to R 10 are specified organic groups and n and is 0, 1, 2, 3 or 4; or salts or N-oxides thereof or compositions containing them in controlling insects, acarines, nematodes or molluscs. Novel compounds are also provided.",SYNGENTA PARTICIPATIONS AG;;SYNGENTA LTD;;O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPHE;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPHE;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,,https://lens.org/022-668-275-953-387,Patent Application,yes,0,31,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D283/00;;A01N43/78;;A01P5/00;;A01P7/04;;A01P9/00,,0,0,,,,PENDING
266,US,A1,US 2008/0300285 A1,010-935-666-735-422,2008-12-04,2008,US 6386906 A,2006-08-02,GB 0516706 A;;GB 2006002886 W,2005-08-15,Chemical Compounds,"The use of a compound of formula (I) wherein X is (i), (ii) or (iii), formula (i), formula (ii), formula (iii) Y is O, S(O) m , NR 3 , CR 5 R 6 , CR 5 R 6 —CR 7 R 8 , O—CR 7 R 8 , S(O) m —CR 7 R 8 , NR 3 —CR 7 R 8 , CR 5 R 6 —O, CR 5 R 6 —S(O) m , CR 5 R 6 —NR 3 , SO 2 —NR 3 , NR 3 —SO 2 , NR 3 —O or O—NR 3 ; m is 0, 1, or 2; the ring (T) formula (T) is a 5- or 6-membered aromatic or heteroaromatic ring; R 1 to R 10 are specified organic groups and n and is 0, 1, 2, 3 or 4; or salts or N-oxides thereof or compositions containing them in controlling insects, acarines, nematodes or molluscs. Novel compounds are also provided.",SYNGENTA CROP PROT INC;;SYNGENTA LTD,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JURGEN HARRY;;LUTHY CHRISTOPHE;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,SYNGENTA PARTICIPATIONS AG (2008-01-17);;SYNGENTA LIMITED (2008-01-17),https://lens.org/010-935-666-735-422,Patent Application,yes,1,3,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,A01N43/78;;A01P7/02;;A01P7/04;;A01P9/00;;C07D277/18;;C07D417/12,514/370;;548/193;;548/190,0,0,,,,INACTIVE
267,US,B2,US 11797627 B2,076-856-902-776-832,2023-10-24,2023,US 202217948905 A,2022-09-20,US 202217948905 A;;US 201815928855 A;;US 201762599477 P,2017-12-15,Systems and methods for context-based keyword searching,"Systems and methods are provided for performing context-based keyword searching using a search bar. Based on search terms received via the search bar, the system may be configured to provide suggested search parameters to associate with that search term. The suggested search parameters may each include a type of data and/or a filter to associate with the search term (e.g., name, phone number, date of birth, etc.). The one or more suggested search parameters may be identified based on the search term itself, a list of possible types of data or filters, a preliminary search of one or more datasets, a record of one or more previous searches performed, requirements associated with one or more searchable datasets, the format of user input received via the search bar, and/or one or more other factors.",PALANTIR TECHNOLOGIES INC,BEARD MITCHELL;;BAGDIS JEFFREY;;BRAHMS CHRISTOPHER;;EINSPAHR ASHLEY;;ADRIEN CLARE;;RAJU ARVIND;;ELKHERJ MATTHEW,PALANTIR TECHNOLOGIES INC (2018-03-28),https://lens.org/076-856-902-776-832,Granted Patent,yes,43,0,3,3,0,G06F16/248;;G06F16/9538;;G06F16/9535;;G06F16/248,G06F16/95;;G06F16/248;;G06F16/9535,,0,0,,,,ACTIVE
268,US,B1,US 11475082 B1,137-600-556-137-414,2022-10-18,2022,US 201815928855 A,2018-03-22,US 201815928855 A;;US 201762599477 P,2017-12-15,Systems and methods for context-based keyword searching,"Systems and methods are provided for performing context-based keyword searching using a search bar. Based on search terms received via the search bar, the system may be configured to provide suggested search parameters to associate with that search term. The suggested search parameters may each include a type of data and/or a filter to associate with the search term (e.g., name, phone number, date of birth, etc.). The one or more suggested search parameters may be identified based on the search term itself, a list of possible types of data or filters, a preliminary search of one or more datasets, a record of one or more previous searches performed, requirements associated with one or more searchable datasets, the format of user input received via the search bar, and/or one or more other factors.",PALANTIR TECHNOLOGIES INC,BEARD MITCHELL;;BAGDIS JEFFREY;;BRAHMS CHRISTOPHER;;EINSPAHR ASHLEY;;ADRIEN CLARE;;RAJU ARVIND;;ELKHERJ MATTHEW,PALANTIR TECHNOLOGIES INC (2018-03-28),https://lens.org/137-600-556-137-414,Granted Patent,yes,35,3,3,3,0,G06F16/248;;G06F16/9538;;G06F16/9535;;G06F16/248,G06F16/24;;G06F16/248;;G06F16/9535,,0,0,,,,ACTIVE
269,IS,A,IS 5435 A,075-165-050-228-529,2000-04-07,2000,IS 5435 A,2000-04-07,US 9823918 W;;US 6977397 P;;US 10500598 P,1997-12-16,1-staðgengnar-1-amínómetýl-sýklóalkan afleiður (=GABA-hliðstæður) smíði þeirra og notkun við meðferð á taugameinum,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIRS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/075-165-050-228-529,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;C07D285/08;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
270,HK,A1,HK 1032966 A1,124-694-481-823-636,2001-08-10,2001,HK 01103570 A,2001-05-23,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"I-substituted-1-aminomethyl-cycloalkan derivatives(=gabapentin analogues), their preparation and their use in the treatment of neurological disorders.",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/124-694-481-823-636,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;C07D285/08;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
271,US,B2,US 8309739 B2,029-280-401-566-593,2012-11-13,2012,US 201113105596 A,2011-05-11,US 201113105596 A;;GB 0516706 A;;US 6386908 A;;GB 2006002886 W,2005-08-15,Chemical compounds,"The use of a compound of formula I wherein X is (i), (ii) or (iii) Y is O, S(O) m , NR 3 , CR 5 R 6 , CR 5 R 6 —CR 7 R 8 , O—CR 7 R 8 , S(O) m —CR 7 R 8 , NR 3 —CR 7 R 8 , CR 5 R 6 —O, CR 5 R 6 —S(O) m , CR 5 R 6 —NR 3 , SO 2 —NR 3 , NR 3 —SO 2 , NR 3 —O or O—NR 3 ;m is 0, 1, or 2;the ring (T) is a 5- or 6-membered aromatic or heteroaromatic ring; R 1 to R 10 are specified organic groups and n and is 0, 1, 2, 3 or 4; or salts or N-oxides thereof or compositions containing them in controlling insects, acarines, nematodes or molluscs. Novel compounds are also provided.",O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPH;;ELLIOTT ALLISON CLARE;;MATHEWS CHRISTOPHER JOHN;;SYNGENTA LTD,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPH;;ELLIOTT ALLISON CLARE;;MATHEWS CHRISTOPHER JOHN,SYNGENTA PARTICIPATIONS AG (2008-01-17);;SYNGENTA LIMITED (2008-01-17),https://lens.org/029-280-401-566-593,Granted Patent,yes,3,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,A01N43/78;;C07D277/18,548/193;;548/190,4,1,096-264-922-276-102,10.1135/cccc19920415,"Shukla et al., Collection of Czechoslovak Chemical Communications (1992), vol. 57(2), p. 415-424.;;Collection of Czechoslovak Chemical Communications (1992); 57(2): 415-24.;;Chapman, Arthur D., ""Numbers of Living Species in Australia and the World,"" (2nd Ed.) Department of the Environment, Water, Heritage and the Arts, p. 1-84 (2009).;;DE 2 658 138 A (Bayer AG) Jul. 6, 1978 (abstract) [online] Dialog IP, [retrieved on Jul. 14, 2010]. Retrieved from DialogSelect, Derwent Accession No. 1519289.",INACTIVE
272,EP,A2,EP 1919886 A2,123-476-006-213-001,2008-05-14,2008,EP 06779070 A,2006-08-02,GB 2006002886 W;;GB 0516706 A,2005-08-15,CHEMICAL COMPOUNDS,,SYNGENTA PARTICIPATIONS AG;;SYNGENTA LTD,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPHE;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,,https://lens.org/123-476-006-213-001,Patent Application,yes,0,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D283/00;;A01N43/78;;A01P5/00;;A01P7/04;;A01P9/00,,0,0,,,,ACTIVE
273,BR,A,BR 9814286 A,005-199-777-575-851,2000-10-03,2000,BR 9814286 A,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"Derivados de 1-substituìdo-1-aminometil-cicloalcano (=análogos de gabapentina), sua preparação e seu uso no tratamento de distúrbios neurológicos","Patente de Invenção: <B>""DERIVADOS DE 1-SUBSTITUìDO-1-AMINOMETIL-CICLOALCANO (=ANáLOGOS DE GABAPENTINA), SUA PREPARAçãO E SEU USO NO TRATAMENTO DE DISTúRBIOS NEUROLóGICOS""<D>. A presente invenção refere-se a novas aminas de fórmulas (1), (1C), (1F), (1G) e (1H), ou a um sal farmaceuticamente aceitável das mesmas, onde n é um número inteiro de 0 a 2; m é um número inteiro de 0 a 3; R é sulfonamida, amida, ácido fosfónico, heterociclo, ácido sulfónico ou ácido hidroxâmico; A' é um anel com pontes selecionado de (1), (2), (3), (4), (5), onde é o ponto de ligação; Z~ 1~ a Z~ 4~ são, cada um independentemente, selecionados de hidrogênio e metila; o é um número inteiro de 1 a 4; e p é um número inteiro de 0 a 2. Na fórmula (1) acima R não pode ser ácido sulfónico quando m é 2 e n é 1 são úteis como agentes no tratamento de epilepsia, ataques de fraqueza, hipocinesia, distúrbios cranianos, distúrbios neurodegenerativos, depressão, ansiedade, pânico, dor, distúrbios neuropatológicos, doenças inflamatórias e distúrbios gastrintestinais, especialmente síndrome de intestinos irritáveis.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/005-199-777-575-851,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,C07D285/08;;A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
274,EP,A1,EP 1047678 A1,035-366-011-407-276,2000-11-02,2000,EP 98957745 A,1998-11-10,US 9823918 W;;US 6977397 P;;US 10500598 P,1997-12-16,"1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,WARNER-LAMBERT COMPANY LLC (2004-04-28),https://lens.org/035-366-011-407-276,Patent Application,yes,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;C07D285/08;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
275,PT,E,PT 1047678 E,048-776-736-178-750,2004-12-31,2004,PT 98957745 T,1998-11-10,US 6977397 P;;US 10500598 P,1997-12-16,DERIVADOS DO 1-AMINOMETIL-CICLOALCANO SUBSTITUIDO EM 1 (=ANALOGOS DA GABAPENTINA) SUA PREPARACAO E SUA UTILIZACAO NO TRATAMENTO DE DISTURBIOS NEUROLOGICOS,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;WUSTROW DAVID JUERGEN;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;KNEEN CLARE OCTAVIA,,https://lens.org/048-776-736-178-750,Granted Patent,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;C07D285/08;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
276,US,B2,US 7960310 B2,041-131-832-000-271,2011-06-14,2011,US 6386906 A,2006-08-02,GB 0516706 A;;GB 2006002886 W,2005-08-15,Method of combating and controlling insects,"The use of a compound of formula (I) wherein X is (i), (ii) or (iii), formula (i), formula (ii), formula (iii) Y is O, S(O) m , NR 3 , CR 5 R 6 , CR 5 R 6 —CR 7 R 8 , O—CR 7 R 8 , S(O) m —CR 7 R 8 , NR 3 —CR 7 R 8 , CR 5 R 6 —O, CR 5 R 6 —S(O) m , CR 5 R 6 —NR 3 , SO 2 —NR 3 , NR 3 —SO 2 , NR 3 —O or O—NR 3 ; m is 0, 1, or 2; the ring (T) formula (T) is a 5- or 6-membered aromatic or heteroaromatic ring; R 1 to R 10 are specified organic groups and n and is 0, 1, 2, 3 or 4; or salts or N-oxides thereof or compositions containing them in controlling insects, acarines, nematodes or molluscs. Novel compounds are also provided.",SYNGENTA PARTICIPATIONS AG;;SYNGENTA LTD,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPH;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,SYNGENTA PARTICIPATIONS AG (2008-01-17);;SYNGENTA LIMITED (2008-01-17),https://lens.org/041-131-832-000-271,Granted Patent,yes,3,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,A01N43/78,504/266;;504/209;;548/190;;548/193,3,0,,,"Collection of Czechoslovak Chemical Communications (1992); 57(2): 415-24.;;Chapman, Arthur D., ""Numbers of Living Species in Australia and the World,"" (2nd. Ed.) Department of the Environment, Water, Heritage and the Arts, p. 1-84 (2009).;;DE 2 658 138 A (Bayer AG) Jul. 6, 1978 (abstract) [online] Dialog IP, [retrieved on Jul. 14, 2010]. Retrieved from DialogSelect, Derwent Accession No. 1519289.",INACTIVE
277,EP,B1,EP 1919886 B1,045-176-407-939-178,2010-10-06,2010,EP 06779070 A,2006-08-02,GB 2006002886 W;;GB 0516706 A,2005-08-15,CHEMICAL COMPOUNDS,,SYNGENTA PARTICIPATIONS AG;;SYNGENTA LTD,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPHE;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,,https://lens.org/045-176-407-939-178,Granted Patent,yes,2,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D283/00;;A01N43/78;;A01P5/00;;A01P7/04;;A01P9/00,,0,0,,,,ACTIVE
278,NZ,A,NZ 503963 A,058-035-424-616-955,2002-09-27,2002,NZ 50396398 A,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-substituted-1-aminomethyl-cycloalkane derivatives, or gabapentin analogues, preparation and use in the treatment of neurological disorders","A range of 1-substituted-aminomethyl-cycloalkane derivatives, or gabapentin analogues, are disclosed. Such compounds are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially irritable bowel syndrome.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/058-035-424-616-955,Patent Application,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;C07D285/08;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
279,AU,B2,AU 765802 B2,065-120-965-806-25X,2003-10-02,2003,AU 1999/013929 A,1998-11-10,US 6977397 P;;US 10500598 P;;US 9823918 W,1997-12-16,"1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders",,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/065-120-965-806-25X,Granted Patent,no,0,0,33,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07D257/04;;C07C2601/04;;C07C239/14;;C07C2601/18;;C07C2603/74;;C07C311/09;;C07C259/06;;C07C311/05;;C07C2602/46;;C07C2601/14;;C07C233/36;;C07C309/25;;C07C2601/08;;C07C311/33;;C07F9/3808;;C07D413/06;;C07D417/06;;C07F9/6552;;C07D211/26;;C07D409/06;;C07D401/06;;C07D271/07;;C07D309/04;;C07F9/383;;C07F9/59;;C07F9/655363;;C07D335/02;;C07D419/06;;C07D405/06;;C07D285/18,C07D285/08;;A61K31/00;;A61K31/16;;A61K31/18;;A61K31/255;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/662;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P29/00;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/00;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
280,BR,A2,BR PI0616727 A2,108-171-122-938-914,2011-06-28,2011,BR PI0616727 A,2006-08-02,GB 0516706 A;;GB 2006002886 W,2005-08-15,compostos quìmicos,"COMPOSTOS QUìMICOS. A invenção refere-se ao uso de um composto da fórmula I onde X é (i), (ii) ou (iiI) Y é O, S(O)m, NR^ 3^, CR^ 5^R^ 6^, CR^ 5^R^ 6^-CR^ 7^R^ 8^, O-CR^ 7^R^ 8^, S(O)~ m~-CR^ 7^R^ 8^, NR^ 3^-CR^ 7^R^ 8^, CR^ 5^R^ 6^-O, CR^ 5^R^ 6^-S(O)~ m~,, CR^ 5^R^ 6^-NR^ 3^, SO~ 2~-NR^ 3^, NR^ 3^-SO~ 2~, NR^ 3^-O ou O-NR^ 3^; m é 0, 1,ou 2; o anel (T) é um anel aromático ou heteroaromático com 5 ou 6 membros; R1 a R10 são grupos orgânicos especificados, e n é 0,1, 2, 3 ou 4; ou seus sais e N-óxidos, ou de composições que os contêm, para controlar insetos, ácaros, nematódeos ou moluscos. Compostos inusitados também são fornecidos.",SYNGENTA PARTICIPATIONS AG;;SYNGENTA LTD,O'SULLIVAN ANTHONY CORNELIUS;;SCHAETZER JUERGEN HARRY;;LUETHY CHRISTOPH;;ELLIOTT ALISON CLARE;;MATHEWS CHRISTOPHER JOHN,,https://lens.org/108-171-122-938-914,Patent Application,no,0,0,19,19,0,A01N43/78;;C07D277/18;;C07D417/12;;C07D417/02;;A01N43/78;;C07D283/00;;A01N43/78;;C07D417/12;;C07D277/18,C07D283/00;;A01N43/78;;A01P5/00;;A01P7/02;;A01P7/04;;A01P9/00,,0,0,,,,DISCONTINUED
281,EP,B1,EP 2516044 B1,056-111-084-510-538,2018-04-25,2018,EP 10801695 A,2010-12-23,GB 0922612 A;;GB 201003244 A;;GB 201014027 A;;GB 2010052209 W,2009-12-24,EXHAUST SYSTEM FOR A VEHICULAR POSITIVE IGNITION INTERNAL COMBUSTION ENGINE,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/056-111-084-510-538,Granted Patent,yes,6,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,B01D53/94;;F01N3/035,,0,0,,,,ACTIVE
282,NO,D0,NO 984204 D0,146-527-529-491-176,1998-09-11,1998,NO 984204 A,1998-09-11,US 1343396 P;;US 9702401 W,1996-03-14,Nye brodannete cykliske aminosyrer som farmasöytiske midler,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART,,https://lens.org/146-527-529-491-176,Patent Application,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/00;;A61K31/195;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,DISCONTINUED
283,CA,C,CA 2245647 C,190-291-178-908-01X,2006-03-21,2006,CA 2245647 A,1997-02-18,US 1343396 P;;US 9702401 W,1996-03-14,NOVEL BRIDGED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,"Novel bridged cyclic amino acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesi a, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;BRYANS JUSTIN STEPHEN;;RATCLIFFE GILES STUART;;MORRELL ANDREW IAN,,https://lens.org/190-291-178-908-01X,Granted Patent,no,0,0,2,29,0,,C07C229/28;;A61K31/195;;C07C233/47,,0,0,,,,EXPIRED
284,US,B2,US 7188787 B2,069-370-250-527-190,2007-03-13,2007,US 77685304 A,2004-02-11,US 77685304 A;;US 71346003 A,2003-11-14,Sprayer with water purifier,"A sprayer with a water purifier, a valve system, and a selector switch for the same are disclosed. In one non-limiting embodiment, when the sprayer is in use, the sprayer includes a purifier for purifying water. The sprayer may be compact and ergonomic. The sprayer may include a valve system that provides a selection of water flow paths and/or nozzles or other output mechanisms for the sprayer, and a selector switch for controlling the valve system. In certain embodiments, the sprayer is provided with a multiple position selector switch that can be controlled by one of the operator's fingers, or by the operator's thumb so that the operator can use the sprayer and select the sprayer setting with one hand.",PROCTER & GAMBLE,CANNON WILLIAM MICHAEL;;WOOTON JOHN ALLEN;;CLARE BENJAMIN JACOB;;KREUZER MELISSA ANN;;MILLER CHRISTOPHER MILES,PROCTER & GAMBLE COMPANY THE (2004-03-08),https://lens.org/069-370-250-527-190,Granted Patent,yes,12,6,7,11,0,B08B3/026;;C02F1/003;;C02F1/42;;C02F2201/006;;Y10T137/86863;;Y10T137/86863;;B08B3/026;;C02F1/42;;C02F1/003;;C02F2201/006,B05B9/01;;B08B3/02;;C02F1/00;;C02F1/42,239/526;;239/443;;239/445;;239/575;;239/581.1;;239/588;;137/625.46,0,0,,,,EXPIRED
285,NO,L,NO 984204 L,077-231-075-453-12X,1998-09-11,1998,NO 984204 A,1998-09-11,US 1343396 P;;US 9702401 W,1996-03-14,Nye brodannete cykliske aminosyrer som farmas°ytiske midler,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART,,https://lens.org/077-231-075-453-12X,Abstract,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/00;;A61P25/08;;A61K31/195;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,DISCONTINUED
286,US,A,US 6020370 A,105-373-633-662-768,2000-02-01,2000,US 6886198 A,1998-05-19,US 6886198 A;;US 9702401 W;;US 1343396 P,1996-03-14,Bridged cyclic amino acids as pharmaceutical agents,"Bridged cyclic amino acids of formula ##STR1## are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,WARNER-LAMBERT COMPANY (1996-05-20),https://lens.org/105-373-633-662-768,Granted Patent,yes,7,113,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/00;;A61P25/08;;A61P25/12;;A61K31/195;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,514/511;;514/561;;560/117;;560/118;;560/120;;560/122;;560/125;;562/499;;562/500;;562/502;;562/504;;562/507,3,1,046-116-520-851-807,5458384;;10.1021/jm00299a030,"Loeffler et al., Bridged . . . Process, J. of Medicinal Chemistry, vol. 13, No. 5, pp. 926 935, Sep. 1970.;;PCT International Search Report, PCT/US97/02401.;;Mann et al., Chemical Abstracts, vol. 114, No. 19, 1991, abstract No. 184942k.",EXPIRED
287,SI,T1,SI 0888285 T1,181-108-248-226-790,2002-04-30,2002,SI 9730235 T,1997-02-18,EP 97906630 A;;US 9702401 W;;US 1343396 P,1996-03-14,NOVEL BRIDGED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/181-108-248-226-790,Granted Patent,no,0,0,1,29,0,,A61K31/195;;C07C229/28,,0,0,,,,EXPIRED
288,GB,A,GB 2476585 A,065-799-933-944-598,2011-06-29,2011,GB 201021957 A,2010-12-24,GB 0922612 A;;GB 201003244 A;;GB 201014027 A,2009-12-24,Exhaust system having a filter with a catalyst washcoat,"An exhaust system 10 for a vehicular positive ignition internal combustion engine 12 comprises a filter 20 for filtering particulate matter from exhaust gas emitted from the engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size and a three-way catalyst washcoat disposed on a separate substrate monolith 18 located upstream of the filter, wherein a mass of three-way catalyst washcoat on the upstream substrate monolith is less than or equal to 75% of the total mass of three-way catalyst washcoat in the exhaust system.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/065-799-933-944-598,Patent Application,no,6,7,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,F01N3/035;;B01D53/94;;B01J29/00;;F01N3/08,,0,0,,,,ACTIVE
289,EP,A2,EP 1262538 A2,115-599-952-886-763,2002-12-04,2002,EP 02076732 A,2002-05-02,EP 02076732 A;;EP 01201752 A;;GB 0128734 A,2001-05-11,Anti-wear and Anti-oxidant Additives for Lubricating Oil Compositions,"The use, in a minor amount, of a detergent composition comprising one or more metal detergents which comprises metal salts of organic acids, wherein the detergent composition comprises more than 50 mole %, based on the moles of the metal salts of organic acids in the detergent composition, of:
 (I) a metal salt of an aromatic carboxylic acid, or (II) a metal salt of a phenol, or (III) both a metal salt of an aromatic carboxylic acid and a metal salt of a phenol, in a lubricating oil composition for improving the oxidation resistance of the lubricating oil composition, wherein the amount of phosphorus and sulfur in the oil composition is less than 0.09 mass % and at most 0.5 mass % respectively, based on the mass of the oil composition. It has also been found that a detergent composition comprising more than 50 mole % of a metal salt of an aromatic carboxylic acid improves the reduction in wear in an engine.",INFINEUM INT LTD,LOCKE CHRISTOPHER JOHN;;STEVENS MARK;;WRENCH PETER;;CASTLE REBECCA CLARE;;ARROWSMITH STEPHEN;;GALSWORTHY JANE RACHEL,,https://lens.org/115-599-952-886-763,Patent Application,yes,0,7,4,17,0,C10M135/30;;C10M129/10;;C10M129/54;;C10M141/02;;C10M141/08;;C10M159/20;;C10M159/22;;C10M163/00;;C10M165/00;;C10M167/00;;C10M169/042;;C10M169/048;;C10M2205/00;;C10M2207/026;;C10M2207/027;;C10M2207/028;;C10M2207/141;;C10M2207/144;;C10M2207/26;;C10M2207/262;;C10M2215/064;;C10M2215/066;;C10M2215/28;;C10M2219/044;;C10M2219/046;;C10M2219/068;;C10M2219/087;;C10M2219/088;;C10M2219/089;;C10M2223/045;;C10N2010/04;;C10N2030/02;;C10N2030/04;;C10N2030/06;;C10N2030/08;;C10N2030/10;;C10N2030/12;;C10N2030/18;;C10N2030/42;;C10N2030/43;;C10N2030/52;;C10N2040/25;;C10N2040/252;;C10N2060/10;;C10N2060/12;;C10N2070/02,C10M129/10;;C10M129/54;;C10M135/30;;C10M141/02;;C10M141/08;;C10M159/20;;C10M159/22;;C10M163/00;;C10M165/00;;C10M167/00;;C10M169/04,,1,0,,,"AMOS, R.; ALBAUGH, E. W.: ""Chromatography in Petroleum Analysis"", 1979, MARCEL DEKKER INC., pages: 417 - 421",EXPIRED
290,NZ,A,NZ 331142 A,129-183-764-646-403,2001-04-27,2001,NZ 33114297 A,1997-02-18,US 1343396 P;;US 9702401 W,1996-03-14,Bridged cyclic amino acids as pharmaceutical agents,"A compound of formula I, a pharmaceutically acceptable salt thereof or a prodrug thereof wherein A is a bridged ring selected from formulae 1-5 wherein, R1 and R2 are each independently selected from hydrogen and methyl, R3 and R4 are each independently selected from hydrogen or methyl, n is an integer of from 1 to 4 and, m is an integer of from 0 to 2. These compounds are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/129-183-764-646-403,Patent Application,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/00;;A61P25/08;;A61K31/195;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,PENDING
291,US,A,US 6153650 A,164-057-515-622-840,2000-11-28,2000,US 25409399 A,1999-03-01,US 25409399 A;;US 5990097 P;;US 2960196 P;;US 9717997 W,1996-10-23,Substituted gamma aminobutyric acids as pharmaceutical agents,"Novel gamma aminobutyric acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;THORPE ANDREW JOHN;;WUSTROW DAVID JUERGEN,WARNER-LAMBERT COMPANY (1997-02-28);;PARKE-DAVIS & CO. LIMITED (1997-02-24),https://lens.org/164-057-515-622-840,Granted Patent,yes,8,2,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,514/561;;562/431;;562/442;;562/443;;562/444;;562/452;;562/505;;562/507;;562/426;;560/16;;560/17;;560/38;;560/39;;560/121;;560/123;;560/124;;560/125;;514/530;;514/531;;514/538;;514/562;;514/564;;514/567,1,1,037-079-218-248-840,10.1016/0040-4020(70)80033-3,"Fujii and Yoshifuji, Lactams. I. Synthesis and acid hydrolysis of 4 and 5 substituted 1 benzyl 2 piperidone derivatives , Tetrahedron , vol. 26, No. 24, 1970, pp. 5953 5958.",EXPIRED
292,KR,A,KR 20120113234 A,148-107-570-549-351,2012-10-12,2012,KR 20127019411 A,2010-12-23,GB 0922612 A;;GB 201003244 A;;GB 201014027 A;;GB 2010052209 W,2009-12-24,EXHAUST SYSTEM FOR A VEHICULAR POSITIVE IGNITION INTERNAL COMBUSTION ENGINE,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/148-107-570-549-351,Patent Application,no,2,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,F01N3/035;;B01D53/94;;F01N3/022;;F01N3/28,,0,0,,,,ACTIVE
293,PT,E,PT 888285 E,179-284-491-115-83X,2002-04-29,2002,PT 97906630 T,1997-02-18,US 134396 P,1996-03-14,NOVOS AMINO ACIDOS CICLICOS EM PONTE COMO AGENTES FARMACEUTICOS,,WARNER LAMBERT CO,KNEEN CLARE O;;BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/179-284-491-115-83X,Granted Patent,no,0,0,1,1,0,,A61K31/195;;C07C229/28,,0,0,,,,EXPIRED
294,GB,B,GB 2476585 B,016-009-493-364-154,2014-04-09,2014,GB 201021957 A,2010-12-24,GB 0922612 A;;GB 201003244 A;;GB 201014027 A,2009-12-24,Exhaust system for a vehicular positive ignition internal combustion engine,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/016-009-493-364-154,Granted Patent,no,6,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,F01N3/035;;B01D53/94;;B01J29/00;;F01N3/08,,0,0,,,,ACTIVE
295,ZA,B,ZA 972199 B,033-807-155-186-634,1997-09-17,1997,ZA 972199 A,1997-03-13,US 1343396 P,1996-03-14,Novel bridged cyclic amino acids as pharmaceutical agents.,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,MORRELL ANDREW I;;HORWELL DAVID CHRISTOPHER;;KEEN CLARE O;;RATCLIFFE GILES S;;BRYANS JUSTIN S,,https://lens.org/033-807-155-186-634,Granted Patent,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/00;;A61P25/08;;A61K31/195;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,EXPIRED
296,BR,A,BR 9708180 A,154-325-169-686-651,1999-07-27,1999,BR 9708180 A,1997-02-18,US 1343396 P;;US 9702401 W,1996-03-14,Amoniácidos cíclicos em pontes como agentes farmacêuticos,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN ESTEPHEN;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART,,https://lens.org/154-325-169-686-651,Patent Application,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,DISCONTINUED
297,CN,A,CN 102762283 A,088-041-468-069-585,2012-10-31,2012,CN 201080064672 A,2010-12-23,GB 2010052209 W;;GB 0922612 A;;GB 201003244 A;;GB 201014027 A,2009-12-24,Exhaust system for a vehicular positive ignition internal combustion engine,"An exhaust system (10) for a vehicular positive ignition internal combustion engine (12) comprises a filter (20) for filtering particulate matter from exhaust gas emitted from the engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size and a three-way catalyst washcoat disposed on a separate substrate monolith (18) located upstream of the filter, wherein a mass of three-way catalyst washcoat on the upstream substrate monolith is =75% of the total mass of three-way catalyst washcoat in the exhaust system.",JOHNSON MATTHEY PLC,CLARE ARNOLD LOUISE;;JAMES BRISLEY ROBERT;;ROBERT COLLINS NEIL;;ROBERT GREENWELL DAVID;;GOUGH MORGAN CHRISTOPHER,,https://lens.org/088-041-468-069-585,Patent Application,no,2,4,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,B01D53/94;;F01N3/035,,0,0,,,,DISCONTINUED
298,EP,A1,EP 1682280 A1,088-883-473-301-642,2006-07-26,2006,EP 04801021 A,2004-11-12,US 2004/0037786 W;;US 71346003 A;;US 77685304 A,2003-11-14,HOSE END SPRAYER WITH WATER PURIFIER AND SELECTOR SWITCH,,PROCTER & GAMBLE,CANNON WILLIAM MICHAEL;;WOOTON JOHN ALLEN;;CLARE BENJAMIN JACOB;;KRUEZER MELISSA ANN;;MILLER CHRISTOPHER MILES,,https://lens.org/088-883-473-301-642,Patent Application,yes,0,0,4,11,0,B05B1/1636;;B05B12/002;;C02F1/42;;B05B12/1472;;C02F2307/06;;C02F2201/006,B05B9/01;;F16K11/074,,0,0,,,,DISCONTINUED
299,EP,A1,EP 2516044 A1,022-741-409-612-579,2012-10-31,2012,EP 10801695 A,2010-12-23,GB 0922612 A;;GB 201003244 A;;GB 201014027 A;;GB 2010052209 W,2009-12-24,EXHAUST SYSTEM FOR A VEHICULAR POSITIVE IGNITION INTERNAL COMBUSTION ENGINE,,JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/022-741-409-612-579,Patent Application,yes,0,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,B01D53/94;;F01N3/035,,0,0,,,,ACTIVE
300,EP,B1,EP 1262538 B1,048-525-766-772-041,2014-11-26,2014,EP 02076732 A,2002-05-02,EP 02076732 A;;EP 01201752 A;;GB 0128734 A,2001-05-11,Anti-wear and Anti-oxidant Additives for Lubricating Oil Compositions,,INFINEUM INT LTD,LOCKE CHRISTOPHER JOHN;;STEVENS MARK;;WRENCH PETER;;CASTLE REBECCA CLARE;;ARROWSMITH STEPHEN;;GALSWORTHY JANE RACHEL,,https://lens.org/048-525-766-772-041,Granted Patent,yes,6,0,4,17,0,C10M135/30;;C10M129/10;;C10M129/54;;C10M141/02;;C10M141/08;;C10M159/20;;C10M159/22;;C10M163/00;;C10M165/00;;C10M167/00;;C10M169/042;;C10M169/048;;C10M2205/00;;C10M2207/026;;C10M2207/027;;C10M2207/028;;C10M2207/141;;C10M2207/144;;C10M2207/26;;C10M2207/262;;C10M2215/064;;C10M2215/066;;C10M2215/28;;C10M2219/044;;C10M2219/046;;C10M2219/068;;C10M2219/087;;C10M2219/088;;C10M2219/089;;C10M2223/045;;C10N2010/04;;C10N2030/02;;C10N2030/04;;C10N2030/06;;C10N2030/08;;C10N2030/10;;C10N2030/12;;C10N2030/18;;C10N2030/42;;C10N2030/43;;C10N2030/52;;C10N2040/25;;C10N2040/252;;C10N2060/10;;C10N2060/12;;C10N2070/02,C10M159/20;;C10M129/10;;C10M129/54;;C10M135/30;;C10M141/02;;C10M141/08;;C10M159/22;;C10M163/00;;C10M165/00;;C10M167/00;;C10M169/04;;C10N10/04;;C10N30/10;;C10N30/12;;C10N40/25,,0,0,,,,EXPIRED
301,US,B2,US 8211393 B2,135-503-103-147-006,2012-07-03,2012,US 97772810 A,2010-12-23,GB 0922612 A;;GB 201003244 A;;GB 201014027 A;;GB 0903262 A,2009-02-26,Exhaust system for a vehicular positive ignition internal combustion engine,"An exhaust system for a vehicular positive ignition internal combustion engine comprises a filter for filtering particulate matter from exhaust gas emitted from the engine, which filter comprising a porous substrate having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, which is less than the first mean pore size, and a three-way catalyst washcoat disposed on a separate substrate monolith located upstream of the filter, wherein a mass of three-way catalyst washcoat on the upstream substrate monolith is ≦75% of the total mass of three-way catalyst washcoat in the exhaust system.",ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH;;JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2011-02-11),https://lens.org/135-503-103-147-006,Granted Patent,yes,28,20,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D46/00;;B01D53/94;;F01N3/10,423/213.2;;423/213.7;;423/215.5;;60/299;;95/285;;X 55DIG 30,7,2,136-018-336-535-98X;;181-846-970-824-83X,10.4271/1999-01-3530;;10.4271/2009-01-0292,"British Search Report for GB1021957.4 dated Apr. 21, 2011.;;D.E. Hall et al., ""Measurement of the Number and Size Distribution of Particles Emitted from a Gasoline Direct Injection Vehicle,"" SAE 1999-1-3530, Copyright 1999 Society of Automotive Engineers, Inc., pp. 1-11.;;I.S. Abdul-Khalek et al., ""Diesel Exhaust Particle Size: Measurement Issues and Trends,"" SAE 980525, Copyright 1998 Society of Automotive Engineers, Inc., pp. 1-14.;;John S. Howitt et al., ""Cellular Ceramic Diesel Particulate Filter,"" SAE 810114, Copyright 1981, Society of Automotive Engineers, Inc., pp. 1-9.;;Preliminary Discussion Paper-Amendments to California's Low-Emission Vehicle Regulations for Criteria Pollutants-LEV III, Date of Release: Feb. 8, 2010.;;Qiang Wei et al.,""Single-Stage Dilution Tunnel Performance,"" SAE 2001-1-0201, Copyright 2001 Society of Automotive Engineers, Inc., pp. 1-14.;;Yasuyuki Furuta et al., ""Study on Next Generation Diesel Particulate Filter,"" SAE 2009-1-0292, Copyright 2009 SAE International, pp. 1-8.",ACTIVE
302,ID,A,ID 25645 A,173-076-698-617-939,2000-10-19,2000,ID 20001539 A,1999-02-04,EP 98301064 A,1998-02-13,PEMBUATAN TEH,,UNILEVER NV,GOODSALL CHRISTOPHER WILLIAM;;HODGES ROSALIND CLARE;;JONES TIMOTHY GRAHAM;;MAWSON JONATHAN DAVID;;STABLER PETER JOSEPH,,https://lens.org/173-076-698-617-939,Patent Application,no,0,0,17,17,0,A23F3/08,A23F3/08,,0,0,,,,PENDING
303,AT,T1,AT E210629 T1,185-562-607-820-077,2001-12-15,2001,AT 97906630 T,1997-02-18,US 1343396 P;;US 9702401 W,1996-03-14,VERBRÜCKTE ZYKLISCHE AMINOSÄUREN ALS PHARMAZEUTISCHE MITTEL,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/185-562-607-820-077,Granted Patent,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,DISCONTINUED
304,AU,B2,AU 733896 B2,019-154-531-778-738,2001-05-31,2001,AU 1997/046697 A,1997-10-07,US 2960196 P;;US 5990097 P;;US 9717997 W,1996-10-23,Substituted gamma aminobutyric acids as pharmaceutical agents,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN,,https://lens.org/019-154-531-778-738,Granted Patent,no,0,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,EXPIRED
305,CA,A1,CA 2545577 A1,080-354-260-936-607,2005-06-02,2005,CA 2545577 A,2004-11-12,US 71346003 A;;US 77685304 A;;US 2004/0037786 W,2003-11-14,HOSE END SPRAYER WITH WATER PURIFIER AND SELECTOR SWITCH,,PROCTER & GAMBLE,CANNON WILLIAM MICHAEL;;WOOTON JOHN ALLEN;;CLARE BENJAMIN JACOB;;MILLER CHRISTOPHER MILES;;KRUEZER MELISSA ANN,,https://lens.org/080-354-260-936-607,Patent Application,no,0,0,4,11,0,B05B1/1636;;B05B12/002;;C02F1/42;;B05B12/1472;;C02F2307/06;;C02F2201/006,B05B9/01;;F16K11/074,,0,0,,,,DISCONTINUED
306,AU,A,AU 1997/046697 A,107-363-302-346-246,1998-05-15,1998,AU 1997/046697 A,1997-10-07,US 2960196 P;;US 5990097 P;;US 9717997 W,1996-10-23,Substituted gamma aminobutyric acids as pharmaceutical agents,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN,,https://lens.org/107-363-302-346-246,Patent Application,no,0,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,EXPIRED
307,US,A1,US 2005/0103897 A1,120-542-840-991-861,2005-05-19,2005,US 77685304 A,2004-02-11,US 77685304 A;;US 71346003 A,2003-11-14,Sprayer with water purifer,"A sprayer with a water purifier, a valve system, and a selector switch for the same are disclosed. In one non-limiting embodiment, when the sprayer is in use, the sprayer includes a purifier for purifying water. The sprayer may be compact and ergonomic. The sprayer may include a valve system that provides a selection of water flow paths and/or nozzles or other output mechanisms for the sprayer, and a selector switch for controlling the valve system. In certain embodiments, the sprayer is provided with a multiple position selector switch that can be controlled by one of the operator's fingers, or by the operator's thumb so that the operator can use the sprayer and select the sprayer setting with one hand.",PROCTER & GAMBLE,CANNON WILLIAM M;;WOOTON JOHN A;;CLARE BENJAMIN J;;KREUZER MELISSA A;;MILLER CHRISTOPHER M,PROCTER & GAMBLE COMPANY THE (2004-03-08),https://lens.org/120-542-840-991-861,Patent Application,yes,7,6,7,11,0,B08B3/026;;C02F1/003;;C02F1/42;;C02F2201/006;;Y10T137/86863;;Y10T137/86863;;B08B3/026;;C02F1/42;;C02F1/003;;C02F2201/006,B05B9/01;;B08B3/02;;C02F1/00;;C02F1/42,239/526;;239/304;;239/305,0,0,,,,EXPIRED
308,WO,A1,WO 1999/040799 A1,147-258-715-952-347,1999-08-19,1999,EP 9900775 W,1999-02-04,EP 98301064 A,1998-02-13,TEA MANUFACTURE,"A method for manufacturing a black leaf tea that ressembles orthodox processed black tea but infuses like CTC processed black tea. The method involves subjecting whole tea leaves to a heat shock at a temperature and for a duration that is sufficient to initiate fermentation, and enabling the tea to ferment for a time and at a temperature that is sufficient to achieve desired liquor properties. An apparatus for manufacturing such a leaf tea is also described.",UNILEVER PLC;;UNILEVER NV;;LEVER HINDUSTAN LTD,GOODSALL CHRISTOPHER WILLIAM;;HODGES ROSALIND CLARE;;JONES TIMOTHY GRAHAM;;MAWSON JONATHAN DAVID;;STABLER PETER JOSEPH,,https://lens.org/147-258-715-952-347,Patent Application,yes,3,32,17,17,0,A23F3/08,A23F3/08,,5,0,,,"DATABASE WPI Section Ch Week 8726, Derwent World Patents Index; Class D13, AN 87-183340, XP002072183;;DATABASE WPI Section Ch Week 8420, Derwent World Patents Index; Class D13, AN 84-125271, XP002072184;;CHEMICAL ABSTRACTS, vol. 81, no. 9, 1974, Columbus, Ohio, US; abstract no. 103275v, XP002104087;;DATABASE WPI Section Ch Week 8827, Derwent World Patents Index; Class D13, AN 88-189125, XP002104088;;PATENT ABSTRACTS OF JAPAN vol. 098, no. 001 30 January 1998 (1998-01-30)",PATENTED
309,EP,A1,EP 0888285 A1,171-229-633-294-755,1999-01-07,1999,EP 97906630 A,1997-02-18,US 9702401 W;;US 1343396 P,1996-03-14,NOVEL BRIDGED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/171-229-633-294-755,Patent Application,yes,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,EXPIRED
310,CN,A,CN 110030064 A,181-487-923-852-30X,2019-07-19,2019,CN 201910124626 A,2010-12-23,GB 0922612 A;;GB 201003244 A;;GB 201014027 A;;CN 201080064672 A,2009-12-24,Exhaust system for a vehicular positive ignition internal combustion engine,"An exhaust system (10) for a vehicular positive ignition internal combustion engine (12) comprises a filter (20) for filtering particulate matter from exhaust gas emitted from the engine, which filtercomprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean poresize, wherein the porous substrate is coated with a three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains poresof a second mean pore size, and wherein the second mean pore size is less than the first mean pore size and a three-way catalyst washcoat disposed on a separate substrate monolith (18) located upstream of the filter, wherein a mass of three-way catalyst washcoat on the upstream substrate monolith is =75% of the total mass of three-way catalyst washcoat in the exhaust system.",JOHNSON MATTHEY PLC,CLARE ARNOLD LOUISE;;JAMES BRISLEY ROBERT;;ROBERT COLLINS NEIL;;ROBERT GREENWELL DAVID;;GOUGH MORGAN CHRISTOPHER,,https://lens.org/181-487-923-852-30X,Patent Application,no,2,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,F01N3/10;;B01D53/94;;B01J23/46;;B01J29/06;;B01J29/08;;B01J29/12;;B01J29/14;;B01J29/16;;B01J29/40;;B01J29/44;;B01J29/46;;B01J29/50;;B01J29/54;;B01J29/56;;B01J29/70;;B01J29/72;;B01J29/74;;B01J29/76;;B01J29/78;;B01J35/02;;B01J35/04;;B01J35/10;;B01J37/00;;B01J37/02;;F01N3/035;;F01N13/00,,0,0,,,,DISCONTINUED
311,ZA,B,ZA 991061 B,012-778-271-479-432,2000-08-18,2000,ZA 991061 A,1999-02-10,EP 98301064 A,1998-02-13,Tea manufacture.,,UNILEVER PLC,GOODSALL CHRISTOPHER WILLIAM;;HODGES ROSALIND CLARE;;JONES TIMOTHY GRAHAM;;MAWSON JONATHAN DAVID;;STABLER PETER JOSEPH,,https://lens.org/012-778-271-479-432,Granted Patent,no,0,0,17,17,0,A23F3/08,A23F3/08,,0,0,,,,EXPIRED
312,DE,D1,DE 69737719 D1,019-737-768-293-725,2007-06-21,2007,DE 69737719 T,1997-10-07,US 2960196 P;;US 5990097 P;;US 9717997 W,1996-10-23,SUBSTITUIERTE GAMMA-AMINOBUTTERSÄUREDERIVATE ALS ARZNEIMITTEL,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN,,https://lens.org/019-737-768-293-725,Granted Patent,no,0,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;C07C229/22;;A61K31/195;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,EXPIRED
313,WO,A1,WO 2005/049218 A1,074-405-856-815-953,2005-06-02,2005,US 2004/0037786 W,2004-11-12,US 71346003 A;;US 77685304 A,2003-11-14,HOSE END SPRAYER WITH WATER PURIFIER AND SELECTOR SWITCH,"A sprayer (20) with a water purifier (34), a valve system, and a selector switch (36) for the same are disclosed. The valve system provides a selection of water flow paths and/or nozzles or other output mechanisms for the sprayer, and a selector switch (36) for controlling the valve system. The selector switch that can be controlled by one of the operator&apos;s fingers, or by the operator&apos;s thumb so that the operator can use the sprayer and select the sprayer (20) setting with one hand.",PROCTER & GAMBLE;;CANNON WILLIAM MICHAEL;;WOOTON JOHN ALLEN;;CLARE BENJAMIN JACOB;;KRUEZER MELISSA ANN;;MILLER CHRISTOPHER MILES,CANNON WILLIAM MICHAEL;;WOOTON JOHN ALLEN;;CLARE BENJAMIN JACOB;;KRUEZER MELISSA ANN;;MILLER CHRISTOPHER MILES,,https://lens.org/074-405-856-815-953,Patent Application,yes,2,0,4,11,0,B05B1/1636;;B05B12/002;;C02F1/42;;B05B12/1472;;C02F2307/06;;C02F2201/006,B05B9/01;;F16K11/074,,0,0,,,,PENDING
314,AU,B2,AU 731279 B2,124-720-049-995-291,2001-03-29,2001,AU 1997/021271 A,1997-02-18,US 1343396 P;;US 9702401 W,1996-03-14,Novel bridged cyclic amino acids as pharmaceutical agents,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/124-720-049-995-291,Granted Patent,no,2,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,EXPIRED
315,EA,B1,EA 001214 B1,136-307-041-769-923,2000-12-25,2000,EA 199800797 A,1997-02-18,US 1343396 P;;US 9702401 W,1996-03-14,NOVEL BRIDGED CYCLIC AMINO ACIDS AS PHARMACEUTICALLY ACCEPTABLE AGENTS,"1. A compound of formula a pharmaceutically acceptable salt thereof or a prodrug thereof wherein A is a bridged ring selected from: wherein R1 and R2 are each independently selected from hydrogen and methyl; R3 and R4 are each independently selected from hydrogen or methyl; n is an integer of from 1 to 4; and m is an integer of from 0 to 2. 2. A compound of formula or a pharmaceutically acceptable salt thereof, wherein A is a bridged ring selected from: wherein n is an integer of from 1 to 4; and m is an integer of from 0 to 2. 3. A compound according to claim 1, wherein A is a group of formula: wherein n is an integer of from 1 to 4, and m is an integer of from 0 to 2. 4. A compound according to claim 3, wherein n is 3 and m is 1. 5. A compound according to claim 1, wherein A is a group of formula: wherein n is an integer of from 1 to 4. 6. A compound according to claim 5, wherein n is 1. 7. A compound according to claim 1, wherein A is a group of formula: wherein n is an integer of from 1 to 4. 8. A compound according to claim 7, wherein n is 1. 9. A compound according to claim 1, wherein A is a group of formula: wherein n is an integer of from 1 to 4. 10. A compound according to claim 9, wherein n is 2. 11. A compound according to claim 8, wherein A is a group of formula: 12. A compound according to claim 1, selected from (2-aminomethyl-bicyclo[2.2.1]hept-2-yl)-acetic acid methyl ester monohydrochloride, [2-(acetylaminomethyl)-bicyclo[2.2.1]hept-2-yl]-acetic acid, and [2-(2-aminomethyl-bicyclo[2.2.1]hept-2-yl)-acetylamino]-acetic acid monohydrochloride. 13. A pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 1 and a pharmaceutically acceptable carrier. 14. A method for treating epilepsy, faintness attacks, hypokinesia, and cranial disorders or neurodegenerative disorders or depression or anxiety or panicky condition or sensations of pain or neuropathological disorders, comprising administering a therapeutically effective amount of a compound according to claim 1 to a mammal in need.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/136-307-041-769-923,Granted Patent,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,EXPIRED
316,ES,T3,ES 2169848 T3,173-120-658-210-929,2002-07-16,2002,ES 97906630 T,1997-02-18,US 1343396 P,1996-03-14,NUEVOS AMINOACIDOS CICLICOS CORONADOS COMO AGENTES FARMACEUTICOS.,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/173-120-658-210-929,Granted Patent,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/00;;A61P25/08;;A61K31/195;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,EXPIRED
317,EP,A1,EP 0937032 A1,038-031-023-471-27X,1999-08-25,1999,EP 97945516 A,1997-10-07,US 9717997 W;;US 2960196 P;;US 5990097 P,1996-10-23,SUBSTITUTED GAMMA AMINOBUTYRIC ACIDS AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN,WARNER-LAMBERT COMPANY LLC (2007-02-21),https://lens.org/038-031-023-471-27X,Patent Application,yes,0,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,EXPIRED
318,EP,B1,EP 0937032 B1,066-764-731-531-214,2007-05-09,2007,EP 97945516 A,1997-10-07,US 9717997 W;;US 2960196 P;;US 5990097 P,1996-10-23,SUBSTITUTED GAMMA AMINOBUTYRIC ACIDS AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN,WARNER-LAMBERT COMPANY LLC (2007-02-21),https://lens.org/066-764-731-531-214,Granted Patent,yes,3,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;C07C229/22;;A61K31/195;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,EXPIRED
319,JP,A,JP 2018159380 A,124-377-103-663-357,2018-10-11,2018,JP 2018092881 A,2018-05-14,GB 0922612 A;;GB 201003244 A;;GB 201014027 A;;GB 0903262 A,2009-02-26,EXHAUST SYSTEM FOR VEHICULAR POSITIVE IGNITION INTERNAL COMBUSTION ENGINE,"PROBLEM TO BE SOLVED: To provide an exhaust system for treating particulate matter (PM) in exhaust gas from a vehicular positive ignition internal combustion engine, which is particularly operable with a theoretical air fuel ratio but also suitable for lean-burn positive ignition engines and comprises a filter for treating the PM.SOLUTION: An exhaust system comprises a filter 20 for filtering particulate matter from exhaust gas emitted from an engine 12. The filter comprises a porous substrate having inlet and outlet surfaces. The inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size. The porous substrate is coated with a three-way catalyst washcoat comprising a plurality of solid particles. The porous structure of the washcoated porous substrate has a second mean pore size, which is less than the first mean pore size.SELECTED DRAWING: Figure 5",JOHNSON MATTHEY PLC,LOUISE CLARE ARNOLD;;ROBERT JAMES BRISLEY;;COLLINS NEIL ROBERT;;DAVID ROBERT GREENWELL;;CHRISTOPHER GOUGH MORGAN,,https://lens.org/124-377-103-663-357,Patent Application,no,5,1,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,F01N3/28;;B01D53/94;;B01J23/44;;B01J23/46;;F01N3/035,,0,0,,,,ACTIVE
320,HU,A2,HU P9902307 A2,140-579-378-980-912,1999-12-28,1999,HU P9902307 A,1997-02-18,HU P9902307 A,1997-02-18,NOVEL BRIDGED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,Bridged ring (bicyclo and quadricyclo) 1-aminomethyl-1-acetic acid derivatives of formula (I) and their salts and prodrugs are new. Ring A = a bridged ring structure of formula (a)-(e): R1-R4 = H or Me; n = 1-4; and m = 0-2.,Warner-Lambert Co.,BRYANS JUSTIN S;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/140-579-378-980-912,Patent Application,no,0,0,2,2,0,,,,0,0,,,,PENDING
321,CA,A1,CA 2263663 A1,155-943-528-121-228,1998-04-30,1998,CA 2263663 A,1997-10-07,US 2960196 P;;US 5990097 P;;US 9717997 W,1996-10-23,SUBSTITUTED GAMMA AMINOBUTYRIC ACIDS AS PHARMACEUTICAL AGENTS,"Novel gamma aminobutyric acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,THORPE ANDREW JOHN;;WUSTROW DAVID JUERGEN;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;HORWELL DAVID CHRISTOPHER,,https://lens.org/155-943-528-121-228,Patent Application,no,0,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,EXPIRED
322,CA,A1,CA 2245647 A1,053-806-660-014-64X,1997-09-18,1997,CA 2245647 A,1997-02-18,US 1343396 P;;US 9702401 W,1996-03-14,NOVEL BRIDGED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,"Novel bridged cyclic amino acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;RATCLIFFE GILES STUART;;HORWELL DAVID CHRISTOPHER;;MORRELL ANDREW IAN,,https://lens.org/053-806-660-014-64X,Patent Application,no,0,0,2,29,0,,A61K31/195;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
323,PL,B1,PL 191549 B1,120-184-486-720-999,2006-06-30,2006,PL 34242699 A,1999-02-04,EP 9900775 W;;EP 98301064 A,1998-02-13,Tea production process,,UNILEVER NV,GOODSALL CHRISTOPHER WILLIAM;;HODGES ROSALIND CLARE;;JONES TIMOTHY GRAHAM;;MAWSON JONATHAN DAVID;;STABLER PETER JOSEPH,,https://lens.org/120-184-486-720-999,Granted Patent,no,0,0,17,17,0,A23F3/08,A23F3/08,,0,0,,,,EXPIRED
324,CO,A1,CO 4920233 A1,123-600-879-697-434,2000-05-29,2000,CO 97062013 A,1997-10-22,US 2960196 P,1996-10-23,ACIDOS AMINOBUTIRICOS GAMMA SUBSTITUIDOS COMO AGENTES FARMACEUTICOS,"Los compuestos de la invención son los de la Fórmula I o una sal farmacéuticamente aceptable de ellos donde: R es H o alquilo inferior (recto o ramificado con 1 a 4 carbonos); R es hidrógeno o alquilo inferior (recto o ramificado con 1 a 4 carbonos); alquilo recto o ramificado de 7 a 11 átomos de carbono, -(CH2 )(1-4) -X-(CH2 )(0-4) -fenil, donde X es -O-, -S-, -NR3 - donde R3 es alquilo de 1 a 6 carbonos, cicloalquilo de 3 a 8 carbonos, bencil, fenil, donde el fenil y el bencil pueden ser sustituidos o sin sustituir con 1 a 3 substituyentes, cada uno seleccionado independientemente de alquilo, alcoxi, halógeno, hidroxi, carboxi, carboalcoxi, trifluorometil, amino y nitro.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;OCTAVIA KNEEN CLARE;;JUERGEN WUSTROW DAVID;;JOHN THORPE ANDREW;;CHRISTOPHER HORWELL DEVID,,https://lens.org/123-600-879-697-434,Patent Application,no,0,0,2,17,0,,A61K/;;A61K31/13;;A61K31/19;;C07C/,,0,0,,,,PENDING
325,HR,B1,HR P970560 B1,189-382-123-979-433,2003-02-28,2003,HR P970560 A,1997-10-23,US 2960196 P;;US 5990097 P,1996-10-23,SUBSTITUTED GAMMA AMINOBUTYRIC ACIDS AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN,,https://lens.org/189-382-123-979-433,Granted Patent,no,0,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,EXPIRED
326,EP,B1,EP 0888285 B1,060-406-216-314-604,2001-12-12,2001,EP 97906630 A,1997-02-18,US 9702401 W;;US 1343396 P,1996-03-14,NOVEL BRIDGED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/060-406-216-314-604,Granted Patent,yes,3,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,1,0,,,"CHEMICAL ABSTRACTS, vol. 114, no. 19, 13 May 1991 Columbus, Ohio, US; abstract no. 184942k, MANN, ANDR  ET AL.: ""Synthesis and biochemical evaluation of baclofen analogs locked in the baclofen solid-state conformation"" page 734; column 1; XP002030507 & JOURNAL OF MEDICINAL CHEMISTRY, vol. 34, no. 4, 1991, WASHINGTON US, pages 1307-1313,",EXPIRED
327,EA,B1,EA 001979 B1,061-292-671-121-859,2001-10-22,2001,EA 200000837 A,1999-02-04,EP 98301064 A;;EP 9900775 W,1998-02-13,TEA MANUFACTURE AND APPARATUS FOR MANUFACTURING THEREOF,"1. A method for manufacturing black tea comprising fermenting unmacerated tea leaves, firing the leaves to arrest fermentation, and drying the leaves to yield black leaf tea, the method characterized in that the fermentation is initiated by heating the unmacerated tea leaves to a temperature between 38 degree and 100 degree C. 2. A method according to claim 1, wherein the leaves are heated to a temperature between 50 degree and 60 degree C to initiate the fermentation. 3. A method according to claim 1 or 2, wherein the leaves are heated at said temperature for 0.5 to 10 minutes. 4. A method according to claim 3, wherein the leaves are heated at said temperature for 1 to 3 minutes. 5. A method according to any preceding claim, wherein at some stage between initiating and arresting the fermentation, the tea leaves are withered. 6. A method according to any preceding claim, wherein at some stage between initiating and arresting the fermentation, the size or shape of the leaves is physically altered. 7. A method according to any preceding claim, wherein the fermented leaf is blended with CTC processed tea or tea granules in order to meet predetermined liquor characteristics. 8. An apparatus for manufacturing whole leaf black tea comprising withering means for withering fresh whole tea leaves, means for heating the unmacerated tea leaves to a temperature between 38 degree and 100 degree C to initiate fermentation, and firing means for arresting the fermentation and drying the black tea leaves.",UNILEVER NV,GOOSALL CHRISTOPHER WILLIAM;;HODGES ROSALIND CLARE;;JONES TIMOTHY GRAHAM;;MAWSON JONATHAN DAVID;;STABLER PETER JOSEPH,,https://lens.org/061-292-671-121-859,Granted Patent,no,0,0,17,17,0,A23F3/08,A23F3/08,,0,0,,,,EXPIRED
328,AU,A,AU 1997/021271 A,009-850-744-043-547,1997-10-01,1997,AU 1997/021271 A,1997-02-18,US 1343396 P;;US 9702401 W,1996-03-14,Novel bridged cyclic amino acids as pharmaceutical agents,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/009-850-744-043-547,Patent Application,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,EXPIRED
329,PL,A1,PL 342426 A1,025-094-108-371-872,2001-06-04,2001,PL 34242699 A,1999-02-04,EP 9900775 W;;EP 98301064 A,1998-02-13,TEA PRODUCTION PROCESS,,UNILEVER NV,GOODSALL CHRISTOPHER WILLIAM;;HODGES ROSALIND CLARE;;JONES TIMOTHY GRAHAM;;MAWSON JONATHAN DAVID;;STABLER PETER JOSEPH,,https://lens.org/025-094-108-371-872,Patent Application,no,0,0,17,17,0,A23F3/08,A23F3/08,,0,0,,,,EXPIRED
330,JP,A,JP 2017006904 A,074-181-933-996-218,2017-01-12,2017,JP 2016063917 A,2016-03-28,GB 0922612 A;;GB 201003244 A;;GB 201014027 A,2009-12-24,EXHAUST SYSTEM FOR VEHICULAR POSITIVE IGNITION INTERNAL COMBUSTION ENGINE,"PROBLEM TO BE SOLVED: To provide an exhaust system for a vehicular positive ignition internal combustion engine which is operated at a stoichiometric air-fuel ratio but is also suitable for lean burn.SOLUTION: An exhaust system 10 comprises a wall-flow filter 20 for filtering particulate matter of exhaust gas discharged from an internal combustion engine. The filter includes a porous substrate having inlet surfaces and outlet surfaces. The inlet surfaces are separated from the outlet surfaces by a porous structure which contains pores having a first mean pore size. The porous substrate is coated with a three-way catalyst washcoat containing a number of solid particles. The porous structure of the coated porous substrate has a second mean pore size. The second mean pore size is smaller than the first mean pore size, and the three-way catalyst washcoat is formed on a separate substrate monolith 18 located upstream of the filter. A mass of the three-way catalyst washcoat on the upstream substrate monolith is less than 75% of the total mass of the three-way catalyst washcoat.SELECTED DRAWING: Figure 5",JOHNSON MATTHEY PLC,LOUISE CLARE ARNOLD;;ROBERT JAMES BRISLEY;;COLLINS NEIL ROBERT;;DAVID ROBERT GREENWELL;;CHRISTOPHER GOUGH MORGAN,,https://lens.org/074-181-933-996-218,Patent Application,no,3,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,B01D53/94;;B01J35/04;;B01J35/10;;F01N3/022;;F01N3/035;;F01N3/28,,0,0,,,,PENDING
331,SK,B6,SK 282848 B6,119-411-545-460-747,2002-12-03,2002,SK 124898 A,1997-02-18,US 1343396 P;;US 9702401 W,1996-03-14,Novel bridged cyclic amino acids as pharmaceutical agents,"Novel bridged cyclic amino acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART,,https://lens.org/119-411-545-460-747,Granted Patent,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/00;;A61P25/08;;A61K31/195;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,EXPIRED
332,CZ,A3,CZ 287598 A3,166-365-710-698-91X,1999-02-17,1999,CZ 287598 A,1997-02-18,US 1343396 P,1996-03-14,BRIDGED CYCLIC AMINO ACIDS,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART,,https://lens.org/166-365-710-698-91X,Patent Application,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,PENDING
333,DK,T3,DK 0888285 T3,196-560-001-288-32X,2002-04-08,2002,DK 97906630 T,1997-02-18,US 1343296 P;;US 9702401 W,1996-03-14,Nye broforbundne cycliske aminosyrer som farmaceutiske midler,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/196-560-001-288-32X,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61K31/195;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
334,WO,A1,WO 1997/033859 A1,196-553-746-208-413,1997-09-18,1997,US 9702401 W,1997-02-18,US 1343396 P,1996-03-14,NOVEL BRIDGED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,"Novel bridged cyclic amino acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO;;HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/196-553-746-208-413,Patent Application,yes,3,65,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/00;;A61P25/08;;A61K31/195;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,1,0,,,"CHEMICAL ABSTRACTS, vol. 114, no. 19, 13 May 1991, Columbus, Ohio, US; abstract no. 184942k, MANN, ANDRÉ ET AL.: ""Synthesis and biochemical evaluation of baclofen analogs locked in the baclofen solid-state conformation"" page 734; column 1; XP002030507",PATENTED
335,PL,A1,PL 328800 A1,006-491-078-985-186,1999-02-15,1999,PL 32880097 A,1997-02-18,US 9702401 W;;US 1343396 P,1996-03-14,NOVEL BRIDGE-TYPE CYCLIC AMINO ACIDS AS PHARMACEUTIC AGENTS,"PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART,,https://lens.org/006-491-078-985-186,Patent Application,no,0,0,26,29,0,C07C229/28;;C07C2602/42;;C07C2602/46;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C2602/46;;C07C2602/42,A61K31/00;;A61P25/08;;A61K31/195;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28,,0,0,,,,EXPIRED
336,MY,A,MY 135971 A,041-286-788-423-870,2008-07-31,2008,MY PI9900481 A,1999-02-11,EP 98301064 A,1998-02-13,TEA MANUFACTURE,"A METHOD FOR MANUFACTURING A BLACK LEAF TEA THAT RESEMBLES ORTHODOX PROCESSED BLACK TEA BUT INFUSES LIKE CTC PROCESSED BLACK TEA. THE METHOD INVOLVES SUBJECTING WHOLE TEA LEAVES TO A HEAT SHOCK AT A TEMPERATURE AND FOR A DURATION THAT IS SUFFICIENT TO INITIATE FERMENTATION, AND ENABLING THE TEA TO FERMENT FOR A TIME AND AT A TEMPERATURE THAT IS SUFFICIENT TO ACHIEVE DESIRED LIQUOR PROPERTIES. AN APPARATUS FOR MANUFACTURING SUCH A LEAF TEA IS ALSO DESCRIBED.",UNILEVER PLC,GOODSALL CHRISTOPHER WILLIAM;;HODGES ROSALIND CLARE;;JONES TIMOTHY GRAHAM;;MAWSON JONATHAN DAVID;;STABLER PETER JOSEPH,,https://lens.org/041-286-788-423-870,Granted Patent,no,0,0,17,17,0,A23F3/08,A23F3/08,,0,0,,,,EXPIRED
337,WO,A1,WO 1998/017627 A1,086-643-646-101-206,1998-04-30,1998,US 9717997 W,1997-10-07,US 2960196 P;;US 5990097 P,1996-10-23,SUBSTITUTED GAMMA AMINOBUTYRIC ACIDS AS PHARMACEUTICAL AGENTS,"Novel gamma aminobutyric acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO;;BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN,,https://lens.org/086-643-646-101-206,Patent Application,yes,3,90,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P1/00;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,PATENTED
338,BR,A2,BR 112012015467 A2,123-497-474-977-996,2016-03-15,2016,BR 112012015467 A,2010-12-23,GB 2010052209 W;;GB 0922612 A;;GB 201003244 A;;GB 201014027 A,2009-12-24,"sistema de escapamento para um motor de combustão interna de ignição positiva veicular, motor de ignição positiva, e, método para prender e comburir matéria particulada de gás de escapamento","sistema de escapamento para um motor de combustão interna de ignição positiva veicular, motor de ignição positiva, e, método para prender e comburir matéria particulada de gás de escapamento. um sistema de exaustão (10) para um motor de combustão interna de ignição positiva veicular (12) compreende um filtro (20) para a filtração de matéria particulada de gás de exaustão emitida do motor, filtro este que compreende um substrato poroso tendo superfícies de entrada e superfícies de saída, em que as superfícies de entrada são separadas das superfícies de saída por uma estrutura porosa contendo poros de um primeiro tamanho de poro médio, em que o substrato poroso é revestido com um washcoat de catalisador de três vias que compreende uma pluralidade de partículas sólidas em que a estrutura porosa do substrato poroso submetido ao washcoat contém poros de um segundo tamanho de poro médio, e em que o segundo tamanho de poro médio é menor do que o primeiro tamanho de poro médio e um washcoat de catalisador de três vias disposto em um mólito de substrato separado (18) localizado a montante do filtro, em que uma masse de washcoat de catalisador de três vias sobre o monólito de substrato a montante é < 75% da massa total de washcoat de catalisador de três vias no sistema de exaustão.",JOHNSON MATTHEY PLC,MORGAN CHRISTOPHER GOUGH;;GREENWELL DAVID ROBERT;;ARNOLD LOUISE CLARE;;COLLINS NEIL ROBERT;;BRISLEY ROBERT JAMES,,https://lens.org/123-497-474-977-996,Patent Application,no,0,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,B01D53/94;;F01N3/035,,0,0,,,,ACTIVE
339,DE,T2,DE 69822214 T2,139-808-085-162-722,2005-03-10,2005,DE 69822214 T,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,"((CYCLO)ALKYL SUBSTITUIERTE)-.GAMMA.-AMINOBUTTERSÄURE DERIVATE (=GABA ANALOGA), DEREN HERSTELLUNG UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN",,WARNER LAMBERT CO,BELLIOTTI RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW JUERGEN,,https://lens.org/139-808-085-162-722,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
340,WO,A1,WO 2011/077168 A1,179-499-729-834-69X,2011-06-30,2011,GB 2010052209 W,2010-12-23,GB 0922612 A;;GB 201003244 A;;GB 201014027 A,2009-12-24,EXHAUST SYSTEM FOR A VEHICULAR POSITIVE IGNITION INTERNAL COMBUSTION ENGINE,"An exhaust system (10) for a vehicular positive ignition internal combustion engine (12) comprises a filter (20) for filtering particulate matter from exhaust gas emitted from the engine, which filter comprising a porous substrate having inlet surfaces and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size and a three-way catalyst washcoat disposed on a separate substrate monolith (18) located upstream of the filter, wherein a mass of three-way catalyst washcoat on the upstream substrate monolith is ≤75% of the total mass of three-way catalyst washcoat in the exhaust system.",JOHNSON MATTHEY PLC;;ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/179-499-729-834-69X,Patent Application,yes,21,9,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,B01D53/94;;F01N3/035,,1,0,,,"PRELIMINARY DISCUSSION PAPER - AMENDMENTS TO CALIFORNIA'S LOW-EMISSION VEHICLE [LEV] REGULATIONS FOR CRITERIA POLLUTANTS - LEV III, February 2010 (2010-02-01)",PENDING
341,NZ,A,NZ 334898 A,190-095-531-741-92X,2000-09-29,2000,NZ 33489897 A,1997-10-07,US 2960196 P;;US 5990097 P;;US 9717997 W,1996-10-23,Substituted gamma aminobutyric acids as pharamceutical agents,"These c aminobutyric acids of formula (I), where R1 and R are H or alkyl and R2 is cycloalkyl-alkyl, alkyl, or (CH2)(1-4)-X-(CH2)(0-4), are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage.",WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN,,https://lens.org/190-095-531-741-92X,Patent Application,no,0,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;A61K31/197;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,PENDING
342,DE,A1,DE 102010056223 A1,030-673-805-163-849,2011-07-28,2011,DE 102010056223 A,2010-12-24,GB 0922612 A;;GB 201003244 A;;GB 201014027 A,2009-12-24,Abgassystem für einen Fahrzeugverbrennungsmotor mit Fremdzündung,"Ein Abgassystem 10 für einen Fahrzeugverbrennungsmotor mit Fremdzündung 12 umfasst ein Filter zum Filtern von Feinstaub aus einem von dem Motor emittierten Abgas, wobei das Filter ein poröses Substrat umfasst, das Einlassoberflächen und Auslassoberflächen aufweist, wobei die Einlassoberflächen von den Auslassoberflächen durch eine poröse Struktur getrennt sind, die Poren einer ersten mittleren Porengröße enthält, wobei das poröse Substrat mit einem Drei-Wege-Katalysator-Washcoat beschichtet ist, der eine Vielzahl von festen Teilchen umfasst, wobei die poröse Struktur des washcoatbeschichteten porösen Substrats Poren einer zweiten mittleren Porengröße enthält und wobei die zweite mittlere Porengröße kleiner als die erste mittlere Porengröße ist und ein Drei-Wege-Katalysator-Washcoat auf einem separaten Substratmonolith 18 angeordnet ist, der stromauf des Filters angeordnet ist, wobei die Masse des Drei-Wege-Katalysator-Washcoats auf dem stromaufseitigen Substratmonolith ≤ 75% der Gesamtmasse des Drei-Wege-Katalysator-Washcoats in dem Abgassystem ist.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,,https://lens.org/030-673-805-163-849,Patent Application,no,15,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,F01N3/02,,7,0,,,SAE 980525;;SAE 2001-01-0201;;SAE 199-01-3530;;SAE-Papier Nr.: 2009-01-0292;;SAE 810114;;SAE 1999-01-3530;;ECE 15,DISCONTINUED
343,BR,B1,BR 112012015467 B1,041-839-985-522-816,2020-09-29,2020,BR 112012015467 A,2010-12-23,GB 2010052209 W;;GB 0922612 A;;GB 201003244 A;;GB 201014027 A,2009-12-24,"sistema de escapamento para um motor de combustão interna de ignição positiva veicular, e, método para prender e comburir matéria particulada de gás de escapamento","sistema de escapamento para um motor de combustão interna de ignição positiva veicular, motor de ignição positiva, e, método para prender e comburir matéria particulada de gás de escapamento. um sistema de exaustão (10) para um motor de combustão interna de ignição positiva veicular (12) compreende um filtro (20) para a filtração de matéria particulada de gás de exaustão emitida do motor, filtro este que compreende um substrato poroso tendo superfícies de entrada e superfícies de saída, em que as superfícies de entrada são separadas das superfícies de saída por uma estrutura porosa contendo poros de um primeiro tamanho de poro médio, em que o substrato poroso é revestido com um revestimento reativo de catalisador de três vias que compreende uma pluralidade de partículas sólidas em que a estrutura porosa do substrato poroso submetido ao revestimento reativo contém poros de um segundo tamanho de poro médio, e em que o segundo tamanho de poro médio é menor do que o primeiro tamanho de poro médio e um revestimento reativo de catalisador de três vias disposto em um monólito de substrato separado (18) localizado a montante do filtro, em que uma massa de revestimento reativo de catalisador de três vias sobre o monólito de substrato a montante é (menor) 75% da massa total de revestimento reativo de catalisador de três vias no sistema de exaustão.",JOHNSON MATTHEY PLC,CHRISTOPHER GOUGH MORGAN;;DAVID ROBERT GREENWELL;;LOUISE CLARE ARNOLD;;NEIL ROBERT COLLINS;;ROBERT JAMES BRISLEY,,https://lens.org/041-839-985-522-816,Granted Patent,no,0,0,19,19,0,B01D53/944;;B01D53/9454;;B01D2255/206;;B01D2255/20738;;B01D2255/20761;;B01D2255/50;;B01D2255/92;;B01D2258/012;;B01D2258/014;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N3/101;;F01N2310/06;;F01N2510/0682;;F01N13/009;;Y02A50/20;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/94;;B01J29/00;;F01N3/035;;F01N3/0821,B01D53/94;;F01N3/035,,0,0,,,,ACTIVE
344,CA,C,CA 2263663 C,040-661-141-487-641,2006-05-30,2006,CA 2263663 A,1997-10-07,US 2960196 P;;US 5990097 P;;US 9717997 W,1996-10-23,SUBSTITUTED GAMMA AMINOBUTYRIC ACIDS AS PHARMACEUTICAL AGENTS,"Novel gamma aminobutyric acids of formula (I) are disclosed and are useful a s agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,WUSTROW DAVID JUERGEN;;THORPE ANDREW JOHN;;KNEEN CLARE OCTAVIA;;HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN,,https://lens.org/040-661-141-487-641,Granted Patent,no,0,0,15,17,0,C07C229/22;;C07C323/58;;C07C2601/14;;A61P1/00;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C323/58;;C07C229/22;;C07C2601/14,A61P1/00;;C07C229/04;;A61K31/19;;A61K31/197;;A61K31/215;;A61P1/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;C07C229/22;;C07C229/28;;C07C229/34;;C07C323/58,,0,0,,,,EXPIRED
345,US,A1,US 2011/0158871 A1,138-949-672-484-956,2011-06-30,2011,US 97772810 A,2010-12-23,GB 0922612 A;;GB 201003244 A;;GB 201014027 A;;GB 0903262 A,2009-02-26,EXHAUST SYSTEM FOR A VEHICULAR POSITIVE IGNITION INTERNAL COMBUSTION ENGINE,"An exhaust system for a vehicular positive ignition internal combustion engine comprises a filter for filtering particulate matter from exhaust gas emitted from the engine, which filter comprising a porous substrate having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, which is less than the first mean pore size, and a three-way catalyst washcoat disposed on a separate substrate monolith located upstream of the filter, wherein a mass of three-way catalyst washcoat on the upstream substrate monolith is ≦75% of the total mass of three-way catalyst washcoat in the exhaust system.",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT JAMES;;COLLINS NEIL ROBERT;;GREENWELL DAVID ROBERT;;MORGAN CHRISTOPHER GOUGH,JOHNSON MATTHEY PUBLIC LIMITED COMPANY (2011-02-11),https://lens.org/138-949-672-484-956,Patent Application,yes,11,54,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01D50/00,423/212;;422/171,0,0,,,,ACTIVE
346,DE,D1,DE 69822214 D1,181-786-320-595-535,2004-04-08,2004,DE 69822214 T,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,"((CYCLO)ALKYL SUBSTITUIERTE)-.GAMMA.-AMINOBUTTERSÄURE DERIVATE (=GABA ANALOGA), DEREN HERSTELLUNG UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN",,WARNER LAMBERT CO,BELLIOTTI RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW JUERGEN,,https://lens.org/181-786-320-595-535,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
347,ZA,B,ZA 979457 B,184-168-440-110-126,1998-05-12,1998,ZA 979457 A,1997-10-22,US 2960196 P,1996-10-23,Substituted gamma aminobutyric acids as pharmaceutical agents.,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;THORPE ANDREW JOHN;;HORWELL DAVID CHRISTOPHER;;WUSTROW DAVID JUERGEN,,https://lens.org/184-168-440-110-126,Granted Patent,no,0,0,2,17,0,,A61K/;;C07C/,,0,0,,,,EXPIRED
348,WO,A1,WO 2019/157168 A1,189-623-421-584-696,2019-08-15,2019,US 2019/0017030 W,2019-02-07,US 201862628781 P;;US 201862712634 P,2018-02-09,ACCESSORIES FOR A SURFACE TREATMENT APPARATUS,"A surface treatment apparatus may include a coupling, a handle, an accessory coupled to the coupling, and a toggle proximate the handle. The accessory may have at least two operational states. An actuation of the toggle may cause the accessory to transition between operational states.",SHARKNINJA OPERATING LLC,SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;COTTRELL LEE M;;JAMES SAM;;DOUGLAS MICHAEL JAMES;;CLARE DAVID S,,https://lens.org/189-623-421-584-696,Patent Application,yes,6,0,7,22,0,A46B15/0095;;A47L5/24;;A47L9/248;;A47L9/242;;A47L9/0063;;A47L9/30;;A47L5/225;;A47L9/0653;;A47L9/0054;;A47L9/0027;;A46B15/0095;;A47L9/322,A47L5/24;;A47L9/28;;A47L9/32,,1,0,,,See also references of EP 3749159A4,PENDING
349,EP,A4,EP 3749159 A4,136-569-386-704-877,2022-03-16,2022,EP 19750309 A,2019-02-07,US 201862628781 P;;US 201862712634 P;;US 2019/0017030 W,2018-02-09,ACCESSORIES FOR A SURFACE TREATMENT APPARATUS,,SHARKNINJA OPERATING LLC,SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;COTTRELL LEE M;;JAMES SAM;;DOUGLAS MICHAEL JAMES;;CLARE DAVID S,,https://lens.org/136-569-386-704-877,Search Report,no,7,0,7,22,0,A46B15/0095;;A47L5/24;;A47L9/248;;A47L9/242;;A47L9/0063;;A47L9/30;;A47L5/225;;A47L9/0653;;A47L9/0054;;A47L9/0027;;A46B15/0095;;A47L9/322,A47L5/24;;A47L5/22;;A47L9/00;;A47L9/06;;A47L9/28;;A47L9/32,,1,0,,,See also references of WO 2019157168A1,PENDING
350,EP,A1,EP 3777998 A1,108-427-937-239-141,2021-02-17,2021,EP 20197465 A,2010-02-26,GB 0903262 A;;GB 0922612 A;;EP 10707949 A;;GB 2010050347 W,2009-02-26,FILTER,"A filter for filtering particulate matter (PM) from exhaust gas emitted from a compression ignition engine, which filter comprising a porous substrate (10) having inlet surfaces (16) and outlet surfaces, wherein the inlet surfaces (16) are separated from the outlet surfaces by a porous structure containing pores (12) of a first mean pore size, wherein the porous substrate (10) is coated with a washcoat (14) coated on inlet and/or outlet surfaces and also within the porous structure of the porous substrate (10), wherein pores at a surface of the porous structure comprise a pore opening and the washcoat (14) causes a narrowing of substantially all the surface pore openings, which washcoat (14) comprising a plurality of solid particles comprising a molecular sieve promoted with at least one transition metal wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, and wherein the second mean pore size is less than the first mean pore size
",JOHNSON MATTHEY PLC,ARNOLD LOUISE CLARE;;BRISLEY ROBERT;;CHANDLER GUY;;CHIFFEY ANDREW;;FLANAGAN KEITH ANTHONY;;GREENWELL DAVID;;MORGAN CHRISTOPHER,,https://lens.org/108-427-937-239-141,Patent Application,yes,21,0,74,74,0,B01D53/9418;;F01N3/0222;;F01N3/035;;F01N3/022;;F01N3/2803;;B01D53/9477;;B01D2255/207;;B01D2255/2065;;B01D2255/20761;;B01D2255/2073;;B01D2255/20738;;B01D2255/50;;B01D2255/9155;;B01D2255/92;;B01D2275/30;;B01D2279/30;;F01N2510/06;;F01N2510/068;;F01N2310/06;;F01N2330/12;;F01N2330/00;;F01N2330/06;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;Y10S55/30;;B01D53/9477;;B01D2255/908;;Y02A50/20;;B01D53/9445;;Y02T10/12;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/9454;;B01J29/061;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J37/0246;;F01N3/035;;B01J23/40;;B01J29/00;;B01J23/464;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7615;;B01J29/7815;;F01N3/101;;B01D46/2403;;B01D53/944;;B01J29/06;;B01J37/0217;;B01J37/038;;F01N3/022;;B01D53/9409;;F01N3/0842;;B01D53/9418;;B01D53/9477;;B01D53/945;;B01D2255/502;;B01D2255/50;;B01D2255/504;;B01D2255/1025;;B01D2255/1023;;B01D2255/1021;;B01D2255/915;;B01D2255/9155;;B01D2255/92;;B01D2255/912;;B01D2255/91;;B01D2255/908;;B01D2258/014;;B01D2275/30;;B01D2279/30;;F01N2310/06;;F01N2510/06;;F01N2510/068;;B01J35/56;;B01J35/60;;B01J35/40;;B01D53/00;;B01D53/94;;B01J39/08;;F01N3/035;;B01J35/00;;B01J35/30;;B01D2255/50;;B01D2255/92;;B01D2275/30;;B01D2279/30;;B01J23/464;;B01J29/06;;B01J29/061;;B01J29/082;;B01J29/088;;B01J29/126;;B01J29/146;;B01J29/166;;B01J29/405;;B01J29/44;;B01J29/46;;B01J29/505;;B01J29/54;;B01J29/56;;B01J29/7007;;B01J29/7057;;B01J29/7215;;B01J29/7415;;B01J29/7815;;B01J37/0036;;B01J37/0217;;B01J37/0246;;F01N3/035;;F01N2310/06;;F01N2510/06;;B01J37/038;;B01J23/40;;B01D2255/1021;;B01D2255/1023;;B01D2255/1025;;B01D2255/9155;;F01N2510/068;;B01D53/9445;;B01D53/9477;;B01D2255/908;;Y10S55/30;;Y02A50/20;;Y02T10/12;;B01J35/19;;B01J35/40;;B01J35/56;;B01J35/60;;B01J29/7615;;F01N3/2803;;B01J23/10;;B01J23/42;;B01J23/44;;B01J23/72;;B01J23/745,B01D53/94;;B01J29/06;;B01J29/08;;B01J29/10;;B01J29/44,,0,0,,,,DISCONTINUED
351,US,S,US D0746857 S,076-158-223-847-338,2016-01-05,2016,US 201329459430 F,2013-06-28,US 201329459430 F,2013-06-28,Display screen with animated graphical user interface,,MICROSOFT CORP,RAYIT BALJINDER PAL;;PHILLIPS JOSEPH STANLEY;;REZENDE ANTONIO PEDRO PERNAMBUCO;;CLARE CHRISTOPHER JAMES;;FARIS JAMES PAUL,MICROSOFT CORPORATION (2013-08-19),https://lens.org/076-158-223-847-338,Design Right,no,0,63,1,1,0,,,1404;;D14/488,0,0,,,,ACTIVE
352,US,A1,US 2014/0040116 A1,148-183-219-317-718,2014-02-06,2014,US 201313747256 A,2013-01-22,US 201313747256 A;;US 201261678037 P,2012-07-31,TECHNIQUE FOR PERFORMING A FINANCIAL TRANSACTION,"During a financial technique, an instance of an application executing on an initiating electronic device initiates the financial transaction by communicating information with a receiving electronic device. Then, the application selects a financial account that provides funds for the financial transaction. This financial account may be one of multiple different types of financial accounts that are associated with different providers. Moreover, the application conducts the financial transaction by providing a message to the receiving electronic device, where the message includes an amount of funds transferred in the financial transaction. After receiving the message, an instance of the application executing on the receiving electronic device selects another financial account that receives the funds for the financial transaction, where the other financial account is one of multiple different types of financial accounts that are associated with different providers.",INTUIT INC,CLARE CHRISTOPHER M F;;WATSON WILLIAM A;;YONG AARON J;;DURAND DUSTIN D;;CASTAGNA NATALIA E,INTUIT INC (2012-10-08),https://lens.org/148-183-219-317-718,Patent Application,yes,8,2,1,1,0,G06Q20/105;;G06Q20/223;;G06Q20/327;;G06Q20/105;;G06Q20/223,G06Q20/32,705/39,0,0,,,,DISCONTINUED
353,CN,A,CN 111885951 A,131-606-767-725-362,2020-11-03,2020,CN 201980020798 A,2019-02-07,US 201862628781 P;;US 201862712634 P;;US 2019/0017030 W,2018-02-09,ACCESSORIES FOR SURFACE TREATMENT APPARATUS,"A surface treatment apparatus may include a coupling, a handle, an accessory coupled to the coupling, and a toggle proximate the handle. The accessory may have at least two operational states. An actuation of the toggle may cause the accessory to transition between operational states.",SHARKNINJA OPERATING LLC,SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;COTTRELL LEE M;;JAMES SAM;;DOUGLAS MICHAEL JAMES;;CLARE DAVID S,,https://lens.org/131-606-767-725-362,Patent Application,no,5,0,7,22,0,A46B15/0095;;A47L5/24;;A47L9/248;;A47L9/242;;A47L9/0063;;A47L9/30;;A47L5/225;;A47L9/0653;;A47L9/0054;;A47L9/0027;;A46B15/0095;;A47L9/322,A47L5/24;;A47L9/28;;A47L9/32,,0,0,,,,ACTIVE
354,EP,A1,EP 3749159 A1,135-234-248-927-633,2020-12-16,2020,EP 19750309 A,2019-02-07,US 201862628781 P;;US 201862712634 P;;US 2019/0017030 W,2018-02-09,ACCESSORIES FOR A SURFACE TREATMENT APPARATUS,,SHARKNINJA OPERATING LLC,SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;COTTRELL LEE M;;JAMES SAM;;DOUGLAS MICHAEL JAMES;;CLARE DAVID S,,https://lens.org/135-234-248-927-633,Patent Application,yes,0,0,7,22,0,A46B15/0095;;A47L5/24;;A47L9/248;;A47L9/242;;A47L9/0063;;A47L9/30;;A47L5/225;;A47L9/0653;;A47L9/0054;;A47L9/0027;;A46B15/0095;;A47L9/322,A47L5/24;;A47L9/28;;A47L9/32,,0,0,,,,PENDING
355,US,A1,US 2021/0123856 A1,055-657-321-487-422,2021-04-29,2021,US 201816497300 A,2018-03-21,EP 17163597 A;;EP 2018057202 W,2017-03-29,APPARATUS AND METHOD FOR MEASURING WET FRICTION OF HAIR,"A system for the measurement of wet friction of a bundle of hair fibres, comprising: i) a friction probe, having a contact surface, said probe fitted with a weight in the range of from 10 to 500 g;ii) a means for securing the bundle of hair; andiii) a water bath; wherein the friction probe is connected to a texture analyser; and wherein the securing means and friction probe are positioned in the water bath below the fill line; and wherein, the contact surface of the friction probe comprises surfactant; and a method of measuring wet friction of hair, using the system.",CONOPCO INC DBA UNILEVER,BARNES ANDREW ANTHONY HOWARD;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID;;MOGHADAM SOPHIA PARASKEVI CLARE;;ZHOU RONGRONG,,https://lens.org/055-657-321-487-422,Patent Application,yes,0,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,G01N19/02;;A61K8/41;;G01N33/483,,0,0,,,,ACTIVE
356,EA,B1,EA 037634 B1,134-516-720-858-037,2021-04-23,2021,EA 201991934 A,2018-03-21,EP 17163597 A;;EP 2018057202 W,2017-03-29,APPARATUS AND METHOD FOR MEASURING WET FRICTION OF HAIR,"A system for the measurement of wet friction of a bundle of hair fibres, comprising: i) a friction probe, having a contact surface, said probe fitted with a weight in the range of from 10 to 500 g; ii) a means for securing the bundle of hair; and iii) a water bath; wherein the friction probe is connected to a texture analyser; and wherein the securing means and friction probe are positioned in the water bath below the fill line; and wherein the contact surface of the friction probe comprises surfactant; and a method of measuring wet friction of hair using the system.",UNILEVER IP HOLDINGS B V,BARNES ANDREW ANTHONY HOWARD;;ZHOU RONGRONG;;MOGHADAM SOPHIA PARASKEVI CLARE;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID,,https://lens.org/134-516-720-858-037,Granted Patent,no,10,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,G01N19/04;;A61K8/04;;G01N19/02,,1,1,070-639-066-646-696,10.1016/j.wear.2004.12.026,"BHARAT ET AL: ""Friction and wear studies of human hair and skin"", WEAR, vol. 259, 28 January 2005 (2005-01-28), pages 1012 - 1021, XP002774198",ACTIVE
357,US,B2,US 11105732 B2,149-035-457-219-189,2021-08-31,2021,US 201816497300 A,2018-03-21,EP 17163597 A;;EP 2018057202 W,2017-03-29,Apparatus and method for measuring wet friction of hair,"A system for the measurement of wet friction of a bundle of hair fibres includes a friction probe, a means for securing a bundle of hair fibres, and a water bath. The friction probe includes a contact surface. The friction probe is fitted with a weight in the range of from 10 g to 500 g, inclusive. The friction probe is connected to a texture analyser. The means and the friction probe are positioned in the water bath below a fill line. The contact surface of the friction probe comprises surfactant.",CONOPCO INC,BARNES ANDREW ANTHONY HOWARD;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID;;MOGHADAM SOPHIA PARASKEVI CLARE;;ZHOU RONGRONG,,https://lens.org/149-035-457-219-189,Granted Patent,yes,67,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,G01N19/02;;A61K8/41;;G01N33/483,,10,4,015-134-665-551-412;;010-110-910-941-871;;165-027-523-173-909;;070-639-066-646-696,10.5650/jos.ess15250;;27181247;;10.1007/978-3-642-25611-0_9;;19450415;;10.1016/j.wear.2004.12.026,"Yuuki Aita et al., “Friction and Surface Temperature of Wet Hair Containing Water, Oil, or Oil-in-Water Emulsion”, Journal of Oleo Science, No. 65, 2016. (Year: 2016).;;Janusz Jachowicz et al., “Using Texture Analysis to Substantiate Hair Care Claims”, Cosmetics & Toiletries Magazine, vol. 121, No. 9, Sep. 2006. (Year: 2006).;;Walter Newman et al., “A Quantitative Characterization of Combing Force”, Journal of Cosmetic Science, No. 24, Dec. 9, 1973. (Year: 1973).;;Clarence Robbins, “Chapter 9—The Physical Properties of Hair Fibers”, Chemical and Physical Behavior of Human Hair, 5th Edition ,2012. (Year: 2012).;;K. Abraham Vaynberg et al., “The Aquaion SLT: A Novel Device for Measuring Hair Stiffness and Lubricity”, Journal of Cosmetic Science, No. 60, Mar.-Apr. 2009. (Year: 2009).;;Clarence R. Robbins; Chemical and physical behavior of human; Chemical and physical behavior of human; pp. 439-441; United States of America, 2002.;;BHARAT ET AL: ""Friction and wear studies of human hair and skin"", WEAR, vol. 259, 28 January 2005 (2005-01-28), pages 1012 - 1021, XP002774198;;Search Report and Written Opinion in PCTEP2018057202; dated May 30, 2018.;;Search Report and Written Opinion in EP17163597; dated Jan. 12, 2018.;;Search Report and Written Opinion in EP17163626; dated Oct. 9, 2017.",ACTIVE
358,MX,A,MX 2019011449 A,155-606-904-794-825,2019-11-01,2019,MX 2019011449 A,2018-03-21,EP 17163597 A;;EP 2018057202 W,2017-03-29,APPARATUS AND METHOD FOR MEASURING WET FRICTION OF HAIR.,"A system for the measurement of wet friction of a bundle of hair fibres, comprising: i) a friction probe, having a contact surface, said probe fitted with a weight in the range of from 10 to 500 g; ii) a means for securing the bundle of hair; and iii) a water bath; wherein the friction probe is connected to a texture analyser; and wherein the securing means and friction probe are positioned in the water bath below the fill line; and wherein, the contact surface of the friction probe comprises surfactant; and a method of measuring wet friction of hair, using the system.",UNILEVER NV,COLIN CHRISTOPHER DAVID GILES;;ANDREW ANTHONY HOWARD BARNES;;FRASER IAN BELL;;SOPHIA PARASKEVI CLARE MOGHADAM;;RONGRONG ZHOU,,https://lens.org/155-606-904-794-825,Patent Application,no,0,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,G01N19/04;;A61K8/04;;G01N19/02,,0,0,,,,PENDING
359,MX,A,MX 2019011397 A,144-285-441-323-272,2019-11-07,2019,MX 2019011397 A,2018-03-21,EP 17163626 A;;EP 2018057210 W,2017-03-29,METHOD FOR MEASURING WET FRICTION OF HAIR.,"A method of measuring wet friction of hair, using a system comprising: i) a friction probe, having a contact surface, said probe fitted with a weight in the range of from 10 to 500 g; ii) a means for securing the bundle of hair; and iii) a water bath; wherein the friction probe is connected to a texture analyser;, said method comprising the steps of: i) providing a bundle of hair fibres; ii) aligning the hair fibres; iii) securing the bundle of hair fibres; iv) immersing the bundle of hair fibres under water in the water bath; v) contacting the hair fibres with the contact surface of the friction probe, which is fitted with the weight; vi) moving the probe along the hair fibres; and vii) recording the friction generated under step vi); wherein steps v) - vii) take place under water; and wherein steps vi) - vii) are repeated until a constant value is obtained, without lifting the probe from the hair.",UNILEVER NV,COLIN CHRISTOPHER DAVID GILES;;ANDREW ANTHONY HOWARD BARNES;;FRASER IAN BELL;;SOPHIA PARASKEVI CLARE MOGHADAM;;RONGRONG ZHOU,,https://lens.org/144-285-441-323-272,Patent Application,no,0,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,G01N19/02;;A61K8/04,,0,0,,,,PENDING
360,AU,B2,AU 759619 B2,178-998-286-179-760,2003-04-17,2003,AU 1999/017962 A,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,Novel amines as pharmaceutical agents,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/178-998-286-179-760,Granted Patent,no,2,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,C07D285/08;;A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
361,EP,A3,EP 1400526 A3,043-567-896-974-809,2004-03-31,2004,EP 03027569 A,1998-11-10,EP 98962805 A;;US 6977397 P;;US 10492498 P,1997-12-16,"((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders","Novel amines of formulas (1A) and (1B) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS. Processes for the preparation and intermediates useful in the preparation are also disclosed.  R is sulfonamide,  amide,  sulfonic acid,  or phosphonic acid.",WARNER LAMBERT CO,BELLIOTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,WARNER-LAMBERT COMPANY LLC (2007-02-21),https://lens.org/043-567-896-974-809,Search Report,yes,2,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;A61K31/351;;C07D285/08;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,3,3,053-942-294-175-609;;059-853-041-601-212;;109-983-916-535-316,513066;;10.1021/jm00196a007;;1331633;;10.1002/med.2610120604;;10.1016/s0960-894x(01)81218-x,"TENTHOREY P A ET AL: ""New antiarrhythmic agents. 3. Primary.beta.-amino anilides"", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 22, no. 10, October 1979 (1979-10-01), pages 1182 - 1186, XP002098852, ISSN: 0022-2623;;KERR ET AL: ""GABA Agonists and Antagonists"", MEDICINAL RESEARCH REVIEWS, NEW YORK, NY, US, vol. 12, no. 6, 6 November 1992 (1992-11-06), pages 593 - 636, XP002080823, ISSN: 0198-6325;;HOWSON W ET AL: ""Biological activity of 3-aminopropyl (methyl) phosphinic acid, a potent and selective GABA(B) agonist with CNS activity"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 3, no. 4, 1993, pages 515 - 518, XP002096230, ISSN: 0960-894X",DISCONTINUED
362,CU,A3,CU 23028 A3,041-370-689-703-852,2005-02-23,2005,CU 20000139 A,1998-11-10,US 9823917 W;;US 6977397 P;;US 10492498 P,1997-12-16,AMINAS NOVEDOSAS COMO AGENTES FARMACEUTICOS.,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/041-370-689-703-852,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,C07D285/08;;A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
363,ES,T3,ES 2216338 T3,095-981-254-620-849,2004-10-16,2004,ES 98962805 T,1998-11-10,US 6977397 P;;US 10492498 P,1997-12-16,AMINAS NOVEDOSAS COMO AGENTES FARMACEUTICOS.,"Los compuestos de la invención tienen la fórmula **(fórmula)** o una sal farmacéuticamente aceptable de los mismos, en los que: n es un número entero de 0 a 2; R es ácido fosfónico, ácido hidroxámico o un heterociclo seleccionado entre **(fórmula)** A es hidrógeno o metilo; y B es **(fórmula)** alquilo lineal o ramificado de 1 a 11 carbonos, o -(CH2)1-4-Y-(CH2)0~4-fenilo en el que Y es -O-, -S-, -NR¿3, siendo R¿3 alquilo de 1 a 6 carbonos, cicloalquilo de 3 a 8 carbonos, bencilo o fenilo, en el que el bencilo o fenilo pueden estar sustituidos o insustituidos con 1 a 3 sustituyentes cada uno de ellos seleccionado independientemente entre alquilo, en el que el alquilo es un grupo lineal o ramificado de 1 a 11 carbonos, alcoxi, en el que el alcoxi es un grupo lineal o ramificado de 1 a 11 carbonos, halógeno, hidroxi, carboxi, carboalcoxi, trifluorometilo y nitro.",WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/095-981-254-620-849,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
364,EP,B1,EP 3602005 B1,135-573-599-932-975,2022-07-06,2022,EP 18711143 A,2018-03-21,EP 17163597 A;;EP 2018057202 W,2017-03-29,APPARATUS FOR MEASURING WET FRICTION OF HAIR,,UNILEVER IP HOLDINGS B V;;UNILEVER GLOBAL IP LTD,BARNES ANDREW ANTHONY HOWARD;;ZHOU RONGRONG;;MOGHADAM SOPHIA PARASKEVI CLARE;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID,UNILEVER GLOBAL IP LIMITED (2022-02-23);;UNILEVER IP HOLDINGS B.V. (2022-02-23),https://lens.org/135-573-599-932-975,Granted Patent,yes,10,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,G01N19/04;;A61K8/04;;G01N19/02,,1,0,,,"BHARAT ET AL: ""Friction and wear studies of human hair and skin"", WEAR, vol. 259, 28 January 2005 (2005-01-28), pages 1012-1021, XP002774198,",ACTIVE
365,PH,A1,PH 12019502206 A1,177-004-424-717-409,2020-12-07,2020,PH 12019502206 A,2019-09-25,EP 17163597 A;;EP 2018057202 W,2017-03-29,APPARATUS AND METHOD FOR MEASURING WET FRICTION OF HAIR,"A system for the measurement of wet friction of a bundle of hair fibres, comprising: i) a friction probe, having a contact surface, said probe fitted with a weight in the range of from 10 to 500 g; ii) a means for securing the bundle of hair; and iii) a water bath; wherein the friction probe is connected to a texture analyser; and wherein the securing means and friction probe are positioned in the water bath below the fill line; and wherein, the contact surface of the friction probe comprises surfactant; and a method of measuring wet friction of hair, using the system.",UNILEVER NV,BARNES ANDREW ANTHONY HOWARD;;ZHOU RONGRONG;;MOGHADAM SOPHIA PARASKEVI CLARE;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID,,https://lens.org/177-004-424-717-409,Patent Application,no,0,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,A61K8/04;;G01N19/02;;G01N19/04,,0,0,,,,PENDING
366,MX,A,MX 9806069 A,073-291-823-776-717,1998-11-30,1998,MX 9806069 A,1998-07-28,US 1343296 P,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS.,"Novel substituted cyclic amino acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES,,https://lens.org/073-291-823-776-717,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
367,ZA,B,ZA 9811472 B,084-083-753-864-06X,1999-07-07,1999,ZA 9811472 A,1998-12-14,US 6977397 P,1997-12-16,Novel amines as pharmaceutical agents.,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/084-083-753-864-06X,Granted Patent,no,0,0,3,92,0,,A61K/;;C07C/;;C07D/,,0,0,,,,EXPIRED
368,CA,C,CA 2244912 C,142-233-960-990-045,2005-07-12,2005,CA 2244912 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,"Novel substituted cyclic amino acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,RATCLIFFE GILES STUART;;MORRELL ANDREW IAN;;HORWELL DAVID CHRISTOPHER;;HARTENSTEIN JOHANNES;;KNEEN CLARE OCTAVIA;;BRYANS JUSTIN STEPHEN,,https://lens.org/142-233-960-990-045,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
369,US,B2,US 11879831 B2,149-300-837-387-736,2024-01-23,2024,US 201816497441 A,2018-03-21,EP 17163626 A;;EP 2018057210 W,2017-03-29,Method for measuring wet friction of hair,"A method of measuring a wet friction of a bundle of hair, using a system which includes a friction probe having a contact surface and fitted with a weight in the range of from 10 g to 500 g, inclusive, a means for securing the bundle of hair, and a water bath, the friction probe being connected to a texture analyser, the method including the step of i) providing a bundle of hair fibres. The method also includes the steps of ii) aligning the bundle of hair fibres; iii) securing the bundle of hair fibres; iv) immersing the bundle of hair fibres under water in the water bath; v) contacting the bundle of hair fibres with the contact surface of the friction probe, which is fitted with the weight; vi) moving the probe along the hair fibres; and vii) recording the friction generated under step vi).",CONOPCO INC,BARNES ANDREW ANTHONY HOWARD;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID;;MOGHADAM SOPHIA PARASKEVI CLARE;;ZHOU RONGRONG,CONOPCO INC. D/B/A UNILEVER (2018-04-20),https://lens.org/149-300-837-387-736,Granted Patent,yes,80,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,G01N19/02;;A61K8/41;;A61Q5/12,,10,4,070-639-066-646-696;;015-134-665-551-412;;010-110-910-941-871;;165-027-523-173-909,10.1016/j.wear.2004.12.026;;10.5650/jos.ess15250;;27181247;;10.1007/978-3-642-25611-0_9;;19450415,"Bharat et al.; Friction and wear studies of human hair and skin; Wear; 2005; 1012-1021; XP002774198; vol. 259.;;Search Report and Written Opinion in PCTEP2018057202; dated May 30, 2018.;;Search Report and Written Opinion in EP17163597; dated Jan. 12, 2018.;;Search Report and Written Opinion in EP17163626; dated Oct. 9, 2017.;;Clarence R. Robbins; Chemical and physical behavior of human; Chemical and physical behavior of human; pp. 439-441; United States of America.;;Aita et al.; Friction and Surface Temperature of Wet Hair Containing Water, Oil, or Oil-in-Water Emulsion; Journal of Oleo Science; Jan. 22, 2016; pp. 493-498; No. 65(6); Japan Oil Chemists Society.;;Jachowicz et al.; “Using Texture Analysis to Substantiate Hair Care Claims”; Cosmetics & Toiletries Magazine; Sep. 2006; pp. 69-76; vol. 121, No. 9.;;Newman et al.; “A Quantitative Characterization of Combing Force”; Journal of Cosmetic Science; Dec. 9, 1973; pp. 773-782; No. 24.;;Clarence Robbins; “Chapter 9—The Physical Properties of Hair Fibers”; Chemical and Physical Behavior of Human Hair, 5th Edition; 2012; pp. 537-640; .; Springer-Verlag Berlin Heidelberg.;;K. Abraham Vaynberg et al., “The Aqualon SL T: A Novel Device for Measuring Hair Stiffness and Lubricity”, Journal of Cosmetic Science, No. 60, Mar.-Apr. 2009.",ACTIVE
370,SK,B6,SK 283295 B6,170-641-887-097-098,2003-05-02,2003,SK 123898 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,"Substituted cyclic amino acid, use and pharmaceutical composition based on it","Novel substituted cyclic amino acids of formula (I) are disclosed, wherein R1 to R10 are independently selected from the group, comprising C 1-3 alkyl group, non-substituted or substituted benzyl or phenyl group, wherein the substituents are selected from the group comprising halogen, alkoxy group, alkyl group, hydroxy group, carboxy group, carboalkoxyl group, trifluoromethyl group and nitro group, and any of the R1 to R10 symbols, if has not got the said meaning, represent H. They are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES,,https://lens.org/170-641-887-097-098,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
371,US,A1,US 2021/0041349 A1,184-785-384-897-326,2021-02-11,2021,US 201816497441 A,2018-03-21,EP 17163626 A;;EP 2018057210 W,2017-03-29,METHOD FOR MEASURING WET FRICTION OF HAIR,"A method of measuring a wet friction of a bundle of hair, using a system which includes a friction probe having a contact surface and fitted with a weight in the range of from 10 g to 500 g, inclusive, a means for securing the bundle of hair, and a water bath, the friction probe being connected to a texture analyser, the method including the step of i) providing a bundle of hair fibres. The method also includes the steps of ii) aligning the bundle of hair fibres; iii) securing the bundle of hair fibres; iv) immersing the bundle of hair fibres under water in the water bath; v) contacting the bundle of hair fibres with the contact surface of the friction probe, which is fitted with the weight vi) moving the probe along the hair fibres; and vii) recording the friction generated under step vi).",CONOPCO INC DBA UNILEVER,BARNES ANDREW ANTHONY HOWARD;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID;;MOGHADAM SOPHIA PARASKEVI CLARE;;ZHOU RONGRONG,CONOPCO INC. D/B/A UNILEVER (2018-04-20),https://lens.org/184-785-384-897-326,Patent Application,yes,2,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,G01N19/02;;A61K8/41;;A61Q5/12,,0,0,,,,ACTIVE
372,US,A,US 6103932 A,197-799-243-130-366,2000-08-15,2000,US 6887498 A,1998-05-20,US 6887498 A;;US 1343296 P;;US 9702295 W,1996-03-14,Substituted cyclic amino acids as pharmaceutical agents,"Substituted cyclic amino acids of formula ##STR1## are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,WARNER-LAMBERT COMPANY (1996-05-20),https://lens.org/197-799-243-130-366,Granted Patent,yes,29,101,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61K31/195;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,562/507;;562/508;;514/561,7,4,002-741-813-725-094;;053-482-354-814-931;;046-157-403-965-355;;025-044-536-456-332,9121725;;10.1016/s0304-3940(97)13331-6;;10.1021/jm00019a006;;7562907;;10.1002/hlca.19910740208;;10.1016/0922-4106(93)90155-3;;8384570,"Silverman, The Organic Chemistry of Drug Design and Drug Action, pp. 15 21, 1992 no month provided.;;Shimoyama et al., Spinal gabapentin . . . test, Neuroscience Letters, vol. 222, Issue 1, pp. 65 67, Jan. 1997.;;PCT International Search Report, PCT/US97/02295, May 1997.;;Smith et al., New Spiropiperidines as Potent and Selective Non Peptide Tachykinin NK 2 Receptor Antagonists , J. Med. Chem. , 1995, vol. 38, No. 9, 3772 3779 no month provided.;;Griffiths et al., 28. Novel Syntheses of Gabapentin via Addition of Hydrocyanic Acid to Cyclohexylidenemalonate or Cyano(cyclohexylidene)acetate , Helvetica Chimica Acta , 1991, vol. 74, 309 314 no month provided.;;Suman Chauhan et al., Characterization of 3 H gabapentin binding to a novel site in rat brain: homogenate binding studies , European Journal of Pharmacology , 1993, vol. 244, 293 301 no month provided.;;Mellick and Seng, The use of gabapentin in the treatment of reflex sympathetic dystrophy and a phobic disorder , American Journal of Pain Management , 1995, vol. 5, No. 1, 7 9 no month provided.",EXPIRED
373,BR,A2,BR 112019019900 A2,034-248-176-808-285,2020-04-22,2020,BR 112019019900 A,2018-03-21,EP 2018057202 W;;EP 17163597 A,2017-03-29,sistema para a medição de fricção e método para medição de fricção de cabelo molhado,"um sistema para a medição de fricção de um feixe de fibras capilares molhado, caracterizado pelo fato de compreender: i) uma sonda de fricção, que tem uma superfície de contato, a dita sonda equipada com um peso na faixa de 10 a 500 g; ii) um meio para prender o feixe de cabelo; e iii) um banho de água; em que a sonda de fricção é conectada a um analisador de textura; e em que os meios de fixação e a sonda de fricção são posicionados no banho de água abaixo da linha de preenchimento; e em que a superfície de contato da sonda de fricção compreende tensoativo; e um método de medição de fricção de cabelo molhado, com o uso do sistema.",UNILEVER NV,ANDREW ANTHONY HOWARD BARNES;;COLIN CHRISTOPHER DAVID GILES;;FRASER IAN BELL;;RONGRONG ZHOU;;SOPHIA PARASKEVI CLARE MOGHADAM,UNILEVER IP HOLDINGS B.V. (PB) (2021-04-20),https://lens.org/034-248-176-808-285,Patent Application,no,0,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,G01N19/04;;A61K8/04;;G01N19/02,,0,0,,,,ACTIVE
374,IS,B,IS 1990 B,043-219-752-051-780,2005-02-15,2005,IS 4819 A,1998-08-10,US 9702295 W;;US 1343296 P,1996-03-14,Nýstárlegar staðgengnar hringamínósýrur notaðar til lyfjagerðar,,WARNER LAMBERT COMPANY A DELAW,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES,,https://lens.org/043-219-752-051-780,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
375,TR,T2,TR 199801807 T2,073-271-677-284-723,1998-12-21,1998,TR 9801807 T,1997-02-18,US 1343296 P,1996-03-14,Farmasötik maddeler olarak yeni ikame edilmis siklik amino asitler.,"(I) formülünün yeni ikame edilmis siklik amino asitleri anlatilmistir ve bu amino asitler, sara bayginlik nöbetleri, hipokinezi, kafatasi düzensizlikleri, nörodejeneratif düzensizlikler, depresyon, kaygi, panik, aci ve nötapatolojik düzensizliklerin tedavisinde yararli maddelerdir. Hazirlamada yararli ara-maddeler ve hazirlama islemleri de anlatilmistir.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES,,https://lens.org/073-271-677-284-723,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,PENDING
376,EP,A2,EP 1400526 A2,176-080-470-569-839,2004-03-24,2004,EP 03027569 A,1998-11-10,EP 98962805 A;;US 6977397 P;;US 10492498 P,1997-12-16,"((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders","Novel amines of formulas (1A) and (1B) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS. Processes for the preparation and intermediates useful in the preparation are also disclosed.
   R is sulfonamide, 
amide, 
sulfonic acid, 
or phosphonic acid.",WARNER LAMBERT CO,BELLIOTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,WARNER-LAMBERT COMPANY LLC (2007-02-21),https://lens.org/176-080-470-569-839,Patent Application,yes,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;C07D285/08;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
377,US,B1,US 6521650 B1,070-265-099-131-505,2003-02-18,2003,US 50991700 A,2000-04-04,US 50991700 A;;US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,Amines as pharmaceutical agents,"
    Novel gamma aminobutyric acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage. Processes for the preparation and intermediates useful in the preparation are also disclosed. 
",PFIZER,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/070-265-099-131-505,Granted Patent,yes,9,8,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;C07D285/08;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,514/364;;514/360;;514/361;;514/381;;548/122;;548/129;;548/132;;548/254,0,0,,,,EXPIRED
378,ZA,B,ZA 201906401 B,083-432-695-906-888,2021-01-27,2021,ZA 201906401 A,2019-09-27,EP 17163597 A;;EP 2018057202 W,2017-03-29,APPARATUS AND METHOD FOR MEASURING WET FRICTION OF HAIR,,UNILEVER PLC,ANDREW ANTHONY HOWARD BARNES;;RONGRONG ZHOU;;SOPHIA PARASKEVI CLARE MOGHADAM;;FRASER IAN BELL;;COLIN CHRISTOPHER DAVID GILES,,https://lens.org/083-432-695-906-888,Granted Patent,no,0,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,,,0,0,,,,ACTIVE
379,SI,T1,SI 1045839 T1,119-306-997-481-384,2004-06-30,2004,SI 9830620 T,1998-11-10,US 9823917 W;;US 6977397 P;;US 10492498 P,1997-12-16,NOVEL AMINES AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/119-306-997-481-384,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
380,US,A1,US 2020/0371504 A1,152-395-160-633-001,2020-11-26,2020,US 201916418044 A,2019-05-21,US 201916418044 A,2019-05-21,SYSTEMS AND METHODS USING AN AUTOMATED MODEL,An asset management system that includes a field asset management system; a maintenance management system; and a digital avatar associated with a specific asset. The digital avatar has an automatic Model that is customized for the associated asset. The digital avatar automatically receives information from at least one of the field asset management system or maintenance management system as information associated with the asset is entered into the at least one of the field asset management system or maintenance management system. The automatic Model automatically runs with the new information and provides a new operating parameter for use by at least the field asset management system.,SCHLUMBERGER TECHNOLOGY CORP,FAY JAMES;;DEL CAMPO CHRISTOPHER;;LI KE;;CORMIER PAUL;;LOPEZ LUIS;;ELSTROP STEPHANIE;;SCHOENE CLARE;;SONG FEI,SCHLUMBERGER TECHNOLOGY CORPORATION (2019-05-28),https://lens.org/152-395-160-633-001,Patent Application,yes,0,0,2,4,0,B23Q17/007;;B23Q17/007;;G05B19/4188;;G05B19/4183;;G05B19/4187;;G05B19/41885;;Y02P90/02,G05B19/418;;B23Q17/00,,0,0,,,,ACTIVE
381,BR,B1,BR 112019019889 B1,005-739-759-358-276,2023-10-03,2023,BR 112019019889 A,2018-03-21,EP 2018057210 W;;EP 17163626 A,2017-03-29,Método para medir a fricção dos cabelos molhados,"método para medir o atrito úmido dos cabelos, usando um sistema que compreende: (i) uma sonda de atrito, com uma superfície de contato, dita sonda equipada com um peso na faixa de 10 a 500 g; (ii) um meio para fixar a mecha de cabelo; e (iii) um banho-maria; em que a sonda de atrito está conectada a um analisador de textura, em que o referido método compreende as etapas de: (i) fornecer uma mecha de fibras capilares; (ii) alinhar as fibras capilares; (iii) fixar a mecha de fibras capilares; (iv) imergir a mecha de fibras capilares sob água no banho-maria; (v) colocar as fibras capilares em contato com a superfície de contato da sonda de atrito, a qual está equipada com o peso; (vi) mover a sonda ao longo das fibras capilares; e (vii) registrar o atrito gerado na etapa (vi); em que as etapas (v)- (vii) ocorrem sob água; e em que as etapas (vi)- (vii) são repetidas até que um valor constante seja obtido, sem levantar a sonda dos cabelos.",UNILEVER IP HOLDINGS B V;;UNILEVER NV,ANDREW ANTHONY HOWARD BARNES;;COLIN CHRISTOPHER DAVID GILES;;FRASER IAN BELL;;ZHOU RONGRONG;;SOPHIA PARASKEVI CLARE MOGHADAM,UNILEVER IP HOLDINGS B.V. (PB) (2021-04-20),https://lens.org/005-739-759-358-276,Granted Patent,no,0,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,G01N19/02;;A61K8/04,,0,0,,,,ACTIVE
382,CA,C,CA 2304965 C,076-959-568-375-380,2007-08-21,2007,CA 2304965 A,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,"((CYCLO)ALKYL SUBSTITUTED)-GAMMA-AMINOBUTYRIC ACID DERIVATIVES (=GABA ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas (1A) and (1B) are disclosed and are useful as agent s in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,KNEEN CLARE OCTAVIA;;HORWELL DAVID CHRISTOPHER;;CAPIRIS THOMAS;;BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;WUSTROW DAVID JUERGEN,,https://lens.org/076-959-568-375-380,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,C07D257/04;;C07D285/08;;A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
383,CA,A1,CA 2304965 A1,092-681-531-440-421,1999-06-24,1999,CA 2304965 A,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,"((CYCLO)ALKYL SUBSTITUTED)-GAMMA-AMINOBUTYRIC ACID DERIVATIVES (=GABA ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas (1A) and (1B) or a pharmaceutically acceptable salt thereof wherein: n is an integer of from 0 to 2; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; A is hydrogen or methyl; and B is (a), straight or branched alkyl of from 1 to 11 carbons, or -(CH2)1-4-Y-(CH2)0-4-phenyl wherein Y is -O-, -S-, -NR'3 wherein R'3 is alkyl of from 1 to 6 carbons, cycloalkyl of from 3 to 8 carbons, benzyl or phenyl wherein benzyl or phenyl can be unsubstituted or substituted with from 1 to 3 substituents each independently selected from alkyl, alkoxy, halogen, hydroxy, carboxy, carboalkoxy, trifluoromethyl, and nitro are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,CAPIRIS THOMAS;;KNEEN CLARE OCTAVIA;;HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN;;BELLIOTTI THOMAS RICHARD;;WUSTROW DAVID JUERGEN,,https://lens.org/092-681-531-440-421,Patent Application,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,C07D285/08;;A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
384,IS,A,IS 4819 A,125-440-378-984-075,1998-08-10,1998,IS 4819 A,1998-08-10,US 9702295 W;;US 1343296 P,1996-03-14,Nýstárlegar staðgengnar hringamínósýrur notaðar til lyfjagerðar,,WARNER LAMBERT COMPANY A DELAW,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES,,https://lens.org/125-440-378-984-075,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
385,EP,A1,EP 0888286 A1,159-583-263-886-004,1999-01-07,1999,EP 97908655 A,1997-02-18,US 9702295 W;;US 1343296 P,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/159-583-263-886-004,Patent Application,yes,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61K31/195;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
386,TR,T2,TR 200001794 T2,179-241-107-697-557,2000-10-23,2000,TR 200001794 T,1998-11-10,US 6977397 P;;US 10492498 P,1997-12-16,Farmasötik maddeler olarak yeni aminler,"Yeni formül (1A) ve (1B) aminleri, epilepsi, bayilma nöbetleri; hipokinezi, ve kafatasi travmalari; nörodejeneratif bozukluklar, depresyon, anksiyete, panik agri, nöropatolojik bozukluklar, enflamasyon ve mide-barsak tahribati özellikle IBS tedavisinde faydali maddelerdir. Hazirlanma yöntemi ve hazirlanmada kullanilan ara ürünler de açiklanmistir.",WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/179-241-107-697-557,Patent Application,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;C07D285/08;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
387,PL,A1,PL 348305 A1,047-387-347-818-288,2002-05-20,2002,PL 34830598 A,1998-11-10,US 9823917 W;;US 6977397 P;;US 10492498 P,1997-12-16,NOVEL AMINES AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/047-387-347-818-288,Patent Application,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;C07D285/08;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
388,US,A1,US 2019/0246853 A1,153-412-120-098-364,2019-08-15,2019,US 201916270078 A,2019-02-07,US 201916270078 A;;US 201862628781 P;;US 201862712634 P,2018-02-09,ACCESSORIES FOR A SURFACE TREATMENT APPARATUS HAVING A PLURALITY OF OPERATIONAL STATES AND SURFACE TREATMENT APPARATUS CONFIGURED TO ACTUATE THE SAME,"A surface treatment apparatus may include a coupling, a handle, an accessory coupled to the coupling, and a toggle proximate the handle. The accessory may have at least two operational states. An actuation of the toggle may cause the accessory to transition between operational states.",SHARKNINJA OPERATING LLC,SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;COTTRELL LEE M;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;CLARE DAVID S,SHARKNINJA OPERATING LLC (2019-04-15),https://lens.org/153-412-120-098-364,Patent Application,yes,0,3,7,22,0,A46B15/0095;;A47L5/24;;A47L9/248;;A47L9/242;;A47L9/0063;;A47L9/30;;A47L5/225;;A47L9/0653;;A47L9/0054;;A47L9/0027;;A46B15/0095;;A47L9/322,A47L9/00;;A46B15/00;;A47L9/32,,0,0,,,,ACTIVE
389,BR,B1,BR 112019019900 B1,066-169-920-437-124,2023-10-03,2023,BR 112019019900 A,2018-03-21,EP 2018057202 W;;EP 17163597 A,2017-03-29,Sistema para a medição de fricção e método para medição de fricção de cabelo molhado,"um sistema para a medição de fricção de um feixe de fibras capilares molhado, caracterizado pelo fato de compreender: i) uma sonda de fricção, que tem uma superfície de contato, a dita sonda equipada com um peso na faixa de 10 a 500 g; ii) um meio para prender o feixe de cabelo; e iii) um banho de água; em que a sonda de fricção é conectada a um analisador de textura; e em que os meios de fixação e a sonda de fricção são posicionados no banho de água abaixo da linha de preenchimento; e em que a superfície de contato da sonda de fricção compreende tensoativo; e um método de medição de fricção de cabelo molhado, com o uso do sistema.",UNILEVER IP HOLDINGS B V;;UNILEVER NV,ANDREW ANTHONY HOWARD BARNES;;COLIN CHRISTOPHER DAVID GILES;;FRASER IAN BELL;;ZHOU RONGRONG;;SOPHIA PARASKEVI CLARE MOGHADAM,UNILEVER IP HOLDINGS B.V. (PB) (2021-04-20),https://lens.org/066-169-920-437-124,Granted Patent,no,0,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,G01N19/04;;A61K8/04;;G01N19/02,,0,0,,,,ACTIVE
390,ZA,B,ZA 972200 B,167-517-855-740-767,1997-09-17,1997,ZA 972200 A,1997-03-13,US 1343296 P,1996-03-14,Novel bridged cyclic amino acids as pharmaceutical agents.,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/167-517-855-740-767,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61K31/195;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
391,WO,A2,WO 1999/031074 A2,102-350-728-018-990,1999-06-24,1999,US 9823917 W,1998-11-10,US 6977397 P;;US 10492498 P,1997-12-16,NOVEL AMINES AS PHARMACEUTICAL AGENTS,"Novel amines of formulas (1A) and (1B) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO;;BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/102-350-728-018-990,Patent Application,no,0,63,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PATENTED
392,EA,B1,EA 037963 B1,113-174-125-104-215,2021-06-16,2021,EA 201991938 A,2018-03-21,EP 17163626 A;;EP 2018057210 W,2017-03-29,METHOD FOR MEASURING WET FRICTION OF HAIR,"A method of measuring wet friction of hair, using a system comprising: i) a friction probe, having a contact surface, said probe fitted with a weight in the range of from 10 to 500 g; ii) a means for securing the bundle of hair; and iii) a water bath; wherein the friction probe is connected to a texture analyser; said method comprising the steps of: i) providing a bundle of hair fibres; ii) aligning the hair fibres; iii) securing the bundle of hair fibres; iv) immersing the bundle of hair fibres under water in the water bath; v) contacting the hair fibres with the contact surface of the friction probe, which is fitted with the weight; vi) moving the probe along the hair fibres; and vii) recording the friction generated under step vi); wherein steps v)-vii) take place under water; and wherein steps vi)-vii) are repeated until a constant value is obtained, without lifting the probe from the hair.",UNILEVER IP HOLDINGS B V,BARNES ANDREW ANTHONY HOWARD;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID;;MOGHADAM SOPHIA PARASKEVI CLARE;;ZHOU RONGRONG,,https://lens.org/113-174-125-104-215,Granted Patent,no,9,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,G01N19/02;;A61K8/04,,0,0,,,,ACTIVE
393,US,B2,US 11617482 B2,133-991-298-968-295,2023-04-04,2023,US 201916270078 A,2019-02-07,US 201916270078 A;;US 201862628781 P;;US 201862712634 P,2018-02-09,Accessories for a surface treatment apparatus having a plurality of operational states and surface treatment apparatus configured to actuate the same,"A surface treatment apparatus may include a coupling, a handle, an accessory coupled to the coupling, and a toggle proximate the handle. The accessory may have at least two operational states. An actuation of the toggle may cause the accessory to transition between operational states.",SHARKNINJA OPERATING LLC,SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;COTTRELL LEE M;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;CLARE DAVID S,SHARKNINJA OPERATING LLC (2019-04-15),https://lens.org/133-991-298-968-295,Granted Patent,yes,39,0,7,22,0,A46B15/0095;;A47L5/24;;A47L9/248;;A47L9/242;;A47L9/0063;;A47L9/30;;A47L5/225;;A47L9/0653;;A47L9/0054;;A47L9/0027;;A46B15/0095;;A47L9/322,A47L9/00;;A46B15/00;;A47L9/32,,10,0,,,"PCT Search Report and Written Opinion dated Apr. 26, 2019, received in corresponding PCT Application No. PCT/US19/17030, 9 pgs.;;Chinese Office Action with English translation dated Jun. 2, 2021, received in Chinese Patent Application No. 201980020798.7, 11 pages.;;PCT Search Report and Written Opinion dated Oct. 25, 2019, received in PCT Application No. PCT/US19/44483, 9 pgs.;;Chinese Office Action with English translation dated Sep. 13, 2021, received in Chinese Patent Application No. 201980062711.2, 11 pages.;;U.S. Office Action dated Nov. 3, 2021, received in U.S. Appl. No. 16/528,212, 21 pages.;;European Extended Search Report dated Feb. 10, 2022, received in European Patent Application No. 19750309.7, 10 pages.;;Chinese Office Action with English translation dated Mar. 2, 2022, received in Chinese Patent Application No. 201980020798.7, 5 pages.;;Australian Examination Report dated Mar. 3, 2022, received in Australian Patent Application No. 2019312591, 3 pages.;;European Extended Search Report dated May 10, 2022, received in European Patent Application No. 19845568.5, 8 pages.;;Canadian Examiner Report dated Jun. 23, 2022, received in Canadian Patent Application No. 3,112,975, 4 pages.",ACTIVE
394,PH,A1,PH 12019502205 A1,142-949-446-176-28X,2020-12-07,2020,PH 12019502205 A,2019-09-25,EP 17163626 A;;EP 2018057210 W,2017-03-29,METHOD FOR MEASURING WET FRICTION OF HAIR,"A method of measuring wet friction of hair, using a system comprising: i) a friction probe, having a contact surface, said probe fitted with a weight in the range of from 10 to 500 g; ii) a means for securing the bundle of hair; and iii) a water bath; wherein the friction probe is connected to a texture analyser;, said method comprising the steps of: i) providing a bundle of hair fibres; ii) aligning the hair fibres; iii) securing the bundle of hair fibres; iv) immersing the bundle of hair fibres under water in the water bath; v) contacting the hair fibres with the contact surface of the friction probe, which is fitted with the weight; vi) moving the probe along the hair fibres; and vii) recording the friction generated under step vi); wherein steps v) - vii) take place under water; and wherein steps vi) - vii) are repeated until a constant value is obtained, without lifting the probe from the hair.",UNILEVER NV,BARNES ANDREW ANTHONY HOWARD;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID;;MOGHADAM SOPHIA PARASKEVI CLARE;;ZHOU RONGRONG,,https://lens.org/142-949-446-176-28X,Patent Application,no,0,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,A61K8/04;;G01N19/02,,0,0,,,,PENDING
395,AT,T1,AT E207878 T1,146-293-879-218-971,2001-11-15,2001,AT 97908655 T,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,ZYKLISCHE AMINOSÄURE ALS PHARMAZEUTISCHE WIRKSTOFFE,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/146-293-879-218-971,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,DISCONTINUED
396,BR,A2,BR 112019019889 A2,169-935-534-877-740,2020-04-22,2020,BR 112019019889 A,2018-03-21,EP 2018057210 W;;EP 17163626 A,2017-03-29,método para medir o atrito úmido dos cabelos,"método para medir o atrito úmido dos cabelos, usando um sistema que compreende: (i) uma sonda de atrito, com uma superfície de contato, dita sonda equipada com um peso na faixa de 10 a 500 g; (ii) um meio para fixar a mecha de cabelo; e (iii) um banho-maria; em que a sonda de atrito está conectada a um analisador de textura, em que o referido método compreende as etapas de: (i) fornecer uma mecha de fibras capilares; (ii) alinhar as fibras capilares; (iii) fixar a mecha de fibras capilares; (iv) imergir a mecha de fibras capilares sob água no banho-maria; (v) colocar as fibras capilares em contato com a superfície de contato da sonda de atrito, a qual está equipada com o peso; (vi) mover a sonda ao longo das fibras capilares; e (vii) registrar o atrito gerado na etapa (vi); em que as etapas (v)- (vii) ocorrem sob água; e em que as etapas (vi)- (vii) são repetidas até que um valor constante seja obtido, sem levantar a sonda dos cabelos.",UNILEVER NV,ANDREW ANTHONY HOWARD BARNES;;COLIN CHRISTOPHER DAVID GILES;;FRASER IAN BELL;;RONGRONG ZHOU;;SOPHIA PARASKEVI CLARE MOGHADAM,UNILEVER IP HOLDINGS B.V. (PB) (2021-04-20),https://lens.org/169-935-534-877-740,Patent Application,no,0,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,G01N19/02;;A61K8/04,,0,0,,,,ACTIVE
397,CZ,B6,CZ 293759 B6,183-382-204-874-192,2004-07-14,2004,CZ 286398 A,1997-02-18,US 1343296 P,1996-03-14,"Substituted cyclic amino acid, its use and pharmaceutical composition based thereon","In the present invention, there is disclosed a substituted cyclic amino acid of the general formula I and a pharmaceutically acceptable salt thereof or a prodrug thereof wherein Ri1 to Ri10 are each independently selected from alkyl containing 1 to 6 carbon atoms, or optionally substituted benzyl or optionally substituted phenyl, which substituents are selected from halogen, alkoxy having 1 to 6 carbon atoms, alkyl containing 1 to 6 carbon atoms, hydroxy, carboxy, carboalkoxy containing 1 to 6 carbon atoms in the alkoxy moiety, trifluoromethyl, and nitro, and any Ri1 to Ri10, which is not one of the above, is hydrogen with the proviso that at least one of the Ri1 to Ri10 substituents differs from hydrogen. Further disclosed is the use of the above-described compound in the preparation of medicaments intended for treating epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES,,https://lens.org/183-382-204-874-192,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
398,CZ,A3,CZ 286398 A3,021-254-143-751-525,1999-03-17,1999,CZ 286398 A,1997-02-18,US 1343296 P,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACIDS FUNCTIONING AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES,,https://lens.org/021-254-143-751-525,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
399,EE,A,EE 9800309 A,048-253-767-336-00X,1999-02-15,1999,EE 9800309 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,Uued asendatud tsüklilised aminohapped kui farmatseutilised toimeained,,WARNER LAMBERT CO,JUSTIN STEPHEN BRYANS;;CLARE OCTAVIA KNEEN;;GILES STUART RATCLIFFE;;DAVID CHRISTOPHER HORWELL;;ANDREW IAN MORRELL;;JOHANNES HARTENSTEIN,,https://lens.org/048-253-767-336-00X,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,PENDING
400,DK,T3,DK 1045839 T3,046-372-445-508-744,2004-07-05,2004,DK 98962805 T,1998-11-10,US 6977397 P;;US 10492498 P,1997-12-16,Hidtil ukendte aminer som farmaceutiske midler,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/046-372-445-508-744,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;C07D285/08;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
401,WO,A1,WO 1997/033858 A1,084-366-514-980-266,1997-09-18,1997,US 9702295 W,1997-02-18,US 1343296 P,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,"Novel substituted cyclic amino acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO;;HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/084-366-514-980-266,Patent Application,yes,3,85,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,PATENTED
402,CN,A,CN 110520711 A,018-843-645-192-505,2019-11-29,2019,CN 201880022654 A,2018-03-21,EP 17163597 A;;EP 2018057202 W,2017-03-29,APPARATUS AND METHOD FOR MEASURING WET FRICTION OF HAIR,"A system for the measurement of wet friction of a bundle of hair fibers comprises: i) a friction probe, having a contact surface, said probe fitted with a weight in the range of from 10 to 500 g; ii)a means for securing the bundle of hair; and iii) a water bath; wherein the friction probe is connected to a texture analyzer; and wherein the securing means and friction probe are positioned in the water bath below the fill line; and wherein, the contact surface of the friction probe comprises surfactant; and a method of measuring wet friction of hair, using the system.",UNILEVER PLC,BARNES ANDREW ANTHONY HOWARD;;ZHOU RONGRONG;;MOGHADAM SOPHIA PARASKEVI CLARE;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID,,https://lens.org/018-843-645-192-505,Patent Application,no,6,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,G01N19/04;;A61K8/04;;G01N19/02,,0,0,,,,ACTIVE
403,EP,B1,EP 0888286 B1,038-124-556-309-93X,2001-10-31,2001,EP 97908655 A,1997-02-18,US 9702295 W;;US 1343296 P,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/038-124-556-309-93X,Granted Patent,yes,3,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
404,NZ,A,NZ 331143 A,057-214-866-245-597,2001-06-29,2001,NZ 33114397 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,Substituted cyclic amino acids as pharmaceutical agents,"A compound of formula I, a pharmaceutically acceptable salt thereof or a prodrug thereof wherein, R1 to R10 are each independently selected from straight or branched alkyl of from 1 to 6 carbon atoms, unsubstituted or substituted benzyl or phenyl which substituents are selected from halogen, alkyl, alkoxy, hydroxy, carboxy, carboalkoxy, trifluoromethyl, and nitro, and any R1 to R10, which is not one of the above, is hydrogen, provided that R1 to R10 are not all hydrogen. Pharmaceutical compositions comprising the aforementioned compounds are also described as is the use of these compounds in the manufacture of medicaments for the treatment of a variety of disorders including: epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/057-214-866-245-597,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,PENDING
405,PL,A1,PL 328816 A1,080-271-751-518-553,1999-02-15,1999,PL 32881697 A,1997-02-18,US 9702295 W;;US 1343296 P,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACIDS AS PHARMACEUTIC AGENTS,,WARNER LAMBERT CO,BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES,,https://lens.org/080-271-751-518-553,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61K31/195;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
406,BR,A,BR 9813656 A,085-288-806-717-326,2000-10-10,2000,BR 9813656 A,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,Aminas como agentes farmacêuticos,"Patente de Invenção: <B>""AMINAS COMO AGENTES FARMACêUTICOS""<D>. Apresentam-se novas aminas de fórmula (1A) e (1B) que são de utilidade como agentes no tratamento da epilepsia, ataques de desfalecimento, hipocinesia, distúrbios cranianos, distúrbios neurodegenerativos, depressão, ansiedade, pânico, dor, distúrbios neuropatológicos, doenças infamatórias, e distúrbios gastrintestinais, especialmente IBS. Processos para preparação e intermediários úteis na preparação também são apresentados.",WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/085-288-806-717-326,Patent Application,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,C07D285/08;;A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
407,HU,A2,HU P9902136 A2,123-005-607-103-333,1999-10-28,1999,HU P9902136 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,"SUBSTITUTED CYCLIC AMINO ACID DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS","A találmány szerinti vegyületek (I) általánős képletében R1, R2, R3,R4, R5, R6, R7, R8, R9 és R10 mindegyikének jelentése alkilcsőpőrt,adőtt esetben szűbsztitűált benzil- vagy fenilcsőpőrt, ahől a benzil-és fenilcsőpőrt szűbsztitűensei a következő atőmők és csőpőrtők közülkerülnek kiválasztásra: halőgénatőm, alkőxi-, alkil-, hidrőxi-,karbőxil-, alkőxi-karbőnil-, triflűőr-metil- és nitrőcsőpőrt; ésbármely R1-R10, amely nem a fentiek egyike, hidrőgénatőmőt jelent -, Atalálmány tárgya tővábbá a fenti vegyületek gyógyászatila elfőgadhatósói és prődrőgjai is. A találmány szerinti vegyületek példáűl akövetkező rendellenességek kezelésére alkalmazhatók: epilepszia,ájűlásős rőhamők, hipőkinézis, kőpőnya-rendellenességek,neűrődegeneratív rendellenességek, depresszió, anxietas, pánik,fájdalőm és neűrőpatőlógiás rendellenességek. (I) ŕ",WARNER LAMBERT CO,BRYANS JUSTIN S;;HARTENSTEIN JOHANNES;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/123-005-607-103-333,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
408,NZ,A,NZ 503981 A,129-830-893-825-780,2002-12-20,2002,NZ 50398198 A,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,"Novel amines, pharmaceutical compositions containing these amines, and uses thereof","The compounds are amines and their pharmaceutically acceptable salts useful in a variety of disorders. The disorders include: epilepsy, faintness attacks, hypokinenia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal disorders.",WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/129-830-893-825-780,Patent Application,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;C07D285/08;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
409,SI,T1,SI 0888286 T1,010-375-864-508-252,2002-04-30,2002,SI 9730212 T,1997-02-18,EP 97908655 A;;US 9702295 W;;US 1343296 P,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/010-375-864-508-252,Granted Patent,no,0,0,1,46,0,,A61K31/16;;A61K31/195;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
410,AU,B2,AU 734173 B2,043-959-060-411-056,2001-06-07,2001,AU 1997/020511 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,Novel substituted cyclic amino acids as pharmaceutical agents,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/043-959-060-411-056,Granted Patent,no,3,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
411,NO,L,NO 20040817 L,044-313-786-203-524,2004-02-24,2004,NO 20040817 A,2004-02-24,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,Nye aminer som farmasoytiske midler.,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;WUSTROW DAVID JUERGEN;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;BELLIOTTI THOMAS RICHARD;;CAPIRIS THOMAS,,https://lens.org/044-313-786-203-524,Abstract,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;A61K31/351;;C07D285/08;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
412,NO,L,NO 20003037 L,062-533-456-212-951,2000-06-14,2000,NO 20003037 A,2000-06-14,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,Nye aminer som farmasøytiske midler,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/062-533-456-212-951,Abstract,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;C07D285/08;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
413,AU,A,AU 1999/017962 A,151-660-925-094-483,1999-07-05,1999,AU 1999/017962 A,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,Novel amines as pharmaceutical agents,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/151-660-925-094-483,Patent Application,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,C07D285/08;;A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
414,EP,A2,EP 1045839 A2,140-112-597-589-447,2000-10-25,2000,EP 98962805 A,1998-11-10,US 9823917 W;;US 6977397 P;;US 10492498 P,1997-12-16,NOVEL AMINES AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,WARNER-LAMBERT COMPANY LLC (2004-01-28),https://lens.org/140-112-597-589-447,Patent Application,yes,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
415,PT,E,PT 1045839 E,191-829-214-603-685,2004-07-30,2004,PT 98962805 T,1998-11-10,US 6977397 P;;US 10492498 P,1997-12-16,NOVAS AMINAS COMO AGENTES FARMACEUTICOS,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BELLIOTTI THOMAS RICHARD;;WUSTROW DAVID JUERGEN;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;KNEEN CLARE OCTAVIA,,https://lens.org/191-829-214-603-685,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
416,EP,A1,EP 3602004 A1,009-915-708-437-121,2020-02-05,2020,EP 18711146 A,2018-03-21,EP 17163626 A;;EP 2018057210 W,2017-03-29,METHOD FOR MEASURING WET FRICTION OF HAIR,,UNILEVER PLC;;UNILEVER NV,BARNES ANDREW ANTHONY HOWARD;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID;;MOGHADAM SOPHIA PARASKEVI CLARE;;ZHOU RONGRONG,UNILEVER GLOBAL IP LIMITED (2022-02-23);;UNILEVER IP HOLDINGS B.V. (2022-02-23),https://lens.org/009-915-708-437-121,Patent Application,yes,0,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,G01N19/02;;A61K8/04,,0,0,,,,ACTIVE
417,ES,T3,ES 2167717 T3,061-824-178-351-33X,2002-05-16,2002,ES 97908655 T,1997-02-18,US 1343296 P,1996-03-14,NUEVOS AMINOACIDOS CICLICOS SUSTITUIDOS COMO AGENTES FARMACEUTICOS.,"LA INVENCION SE REFIERE A NUEVOS AMINOACIDOS CICLICOS SUSTITUIDOS DE FORMULA (I), QUE SON UTILES COMO AGENTES PARA EL TRATAMIENTO DE LA EPILEPSIA, ATAQUE DE DEBILIDAD, HIPOQUINESIA, ALTERACIONES CRANEALES, ALTERACIONES NEURODEGENERATIVAS, DEPRESION, ANSIEDAD, PANICO, DOLOR Y ALTERACIONES NEUROPATOLOGICAS. SE PRESENTAN ASIMISMO PROCEDIMIENTOS PARA LA PREPARACION E INTERMEDIARIOS UTILIZADOS EN DICHA PREPARACION.",WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/061-824-178-351-33X,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
418,ZA,B,ZA 201906403 B,066-175-243-202-336,2022-06-29,2022,ZA 201906403 A,2019-09-27,EP 17163626 A;;EP 2018057210 W,2017-03-29,METHOD FOR MEASURING WET FRICTION OF HAIR,,UNILEVER PLC,ANDREW ANTHONY HOWARD BARNES;;FRASER IAN BELL;;COLIN CHRISTOPHER DAVID GILES;;SOPHIA PARASKEVI CLARE MOGHADAM;;RONGRONG ZHOU,,https://lens.org/066-175-243-202-336,Granted Patent,no,0,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,,,0,0,,,,ACTIVE
419,EP,A1,EP 3602005 A1,080-879-054-813-384,2020-02-05,2020,EP 18711143 A,2018-03-21,EP 17163597 A;;EP 2018057202 W,2017-03-29,APPARATUS AND METHOD FOR MEASURING WET FRICTION OF HAIR,,UNILEVER PLC;;UNILEVER NV,BARNES ANDREW ANTHONY HOWARD;;ZHOU RONGRONG;;MOGHADAM SOPHIA PARASKEVI CLARE;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID,UNILEVER GLOBAL IP LIMITED (2022-02-23);;UNILEVER IP HOLDINGS B.V. (2022-02-23),https://lens.org/080-879-054-813-384,Patent Application,yes,0,0,16,16,0,A61K8/41;;A61K8/416;;A61K2800/805;;A61Q5/00;;G01N19/02;;G01N19/02;;A61K8/41;;A61K8/416;;A61Q5/00;;A61K2800/805;;A61K8/416;;G01N19/02;;G01N33/4833,G01N19/04;;A61K8/04;;G01N19/02,,0,0,,,,ACTIVE
420,GE,B,GE P20012413 B,089-209-497-917-849,2001-04-25,2001,GE AP1997004526 A,1997-02-18,US 1343296 P,1996-03-14,Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents,"1. Technical Result Increase in assortment of therapeutic preparations. 2. Essence Derivatives of cyclic amino acid of the formula (1) wherein the values R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are disclosed in the application, pharmaceutical composition on its basis and method for its treatment. 3. Field of Application Pharmaco-chemistry and medicine.",WARNER LAMBERT CO,RATCLIFFE GILLWS S;;KNEEN CLARE O;;HORWELL DAVID CHRISTOPHER;;HARTENSTEIN JOHANNES;;MORREL ANDREW I;;BRYANS JUSTIN S,,https://lens.org/089-209-497-917-849,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/195;;A61K31/00;;C07C229/28;;A61K31/16;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47,,0,0,,,,EXPIRED
421,US,A1,US 2003/0229054 A1,140-759-974-162-199,2003-12-11,2003,US 36734903 A,2003-02-14,US 36734903 A;;US 50991700 A;;US 6977397 P;;US 10492498 P,1997-12-16,Novel amines as pharmaceutical agents,"
    Novel amines of formulas 1A and 1B 

   are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS. Processes for the preparation and intermediates useful in the preparation are also disclosed. 
",BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/140-759-974-162-199,Patent Application,yes,1,18,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;C07D285/08;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,514/114;;514/361;;514/363;;514/364;;514/381;;548/122;;548/132;;548/136;;548/254;;562/11,0,0,,,,DISCONTINUED
422,NO,B1,NO 317251 B1,017-003-253-243-248,2004-09-27,2004,NO 20003037 A,2000-06-14,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,Nye aminer som farmasoytiske midler,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;WUSTROW DAVID JUERGEN;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;BELLIOTTI THOMAS RICHARD;;CAPIRIS THOMAS,,https://lens.org/017-003-253-243-248,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;C07D285/08;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
423,AT,T1,AT E260904 T1,045-555-083-959-139,2004-03-15,2004,AT 98962805 T,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,"((CYCLO)ALKYL SUBSTITUIERTE)-.GAMMA.- AMINOBUTTERSÄURE DERIVATE (=GABA ANALOGA), DEREN HERSTELLUNG UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN",,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/045-555-083-959-139,Granted Patent,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,C07D285/08;;A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
424,IS,A,IS 5436 A,055-384-885-502-818,2000-04-07,2000,IS 5436 A,2000-04-07,US 9823917 W;;US 6977397 P;;US 10492498 P,1997-12-16,Nýstárleg amín notuð sem efni í lyf,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;HORWELL DAVID CHRISTOPHER;;CAPIRIS THOMAS;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/055-384-885-502-818,Patent Application,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,PENDING
425,BR,A,BR 9708200 A,058-629-144-978-511,1999-07-27,1999,BR 9708200 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,Aminoácidos cíclicos substituídos como agentes farmacéuticos,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN ETEPHEN;;KENEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES,,https://lens.org/058-629-144-978-511,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,DISCONTINUED
426,PT,E,PT 888286 E,087-863-230-043-082,2002-04-29,2002,PT 97908655 T,1997-02-18,US 1343296 P,1996-03-14,NOVOS AMINO ACIDOS CICLICOS SUBSTITUIDOS COMO AGENTES FARMACEUTICOS,,WARNER LAMBERT CO,KNEEN CLARE O;;HARTENSTEIN JOHANNES;;HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;MORRELL ANDREW I;;RATCLIFFE GILES S,,https://lens.org/087-863-230-043-082,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61K31/195;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
427,EP,B1,EP 1045839 B1,101-694-130-829-986,2004-03-03,2004,EP 98962805 A,1998-11-10,US 9823917 W;;US 6977397 P;;US 10492498 P,1997-12-16,NOVEL AMINES AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,WARNER-LAMBERT COMPANY LLC (2004-01-28),https://lens.org/101-694-130-829-986,Granted Patent,yes,8,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,18,0,,,"RIEMSCHNEIDER R. & KAMPFER H.: ""Zur Kenntnis der cis-trans-Asymmetrie. XI. Optische Aktivität von cis,trans-1,3-Bis-[.alpha.-phenylcinnamoyl amino]-2-methyl-2-n-propyl-propan"" JUSTUS LIEBIEGS ANNALEN DER CHEMIE, vol. 665, 1963, pages 35-42, XP002098848;;MARKOV V.I. & BURMISTROV S.I.: ""1-(Arylsulfonyl)-2,2-dimethylaziridines. II. Reactions with ammonia amines, arenesulfonamides, and phthalimide"" THE JOURNAL OF GENERAL CHEMISTRY, USSR, vol. 35, no. 1, January 1965, pages 158-161, XP002098849;;BOSNICH B. & DWYER F.P.: ""Mixed bidentate and tridentate complexes of cobalt"" AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 19, 1966, pages 2045-2050, XP002098850;;VINOT N.: ""No. 683. Synthèse de cyanométhyl-2 benzimidazoles .alpha.-substitués. Leur utilisation à la préparation de benzimidazoles possédant d'autres fonctions"" BULLETIN DE LA SOCI T  CHIMIQUE DE FRANCE, no. 12, 1966, pages 3989-3993, XP002098851;;TENTHOREY P.A. ET AL.: ""New antiarrhythmic agents. 3. Primary .beta.-amino anilides"" JOURNAL OF MEDICINAL CHEMISTRY, vol. 22, no. 10, October 1979, pages 1182-1186, XP002098852;;FOKIN A.V. ET AL.: ""The fluoroacylation of diamines"" BULL. ACAD. SCI. USSR, DIV. CHEM. SCI., vol. 30, no. 4, April 1981, pages 643-646, XP002098853;;CHEMICAL ABSTRACTS, vol. 103, no. 15, 14 October 1985 Columbus, Ohio, US; abstract no. 122998x, ""Aminoalkylsulfonic acids"" page 683; column 2; XP002098857 & JP 60 023360 A (MITSUI TOATSU CHEMICALS, INC.) 5 February 1985;;HANKOVSZKY O.H. ET AL.: ""New antiarrhythmic agents. 2,2,5,5-tetramethyl-3-pyrroline-3-carboxam ides and 2,2,5,5-tetramethylpyrrolidine-3-carboxami des"" JOURNAL OF MEDICINAL CHEMISTRY, vol. 29, no. 7, 1986, pages 1138-1152, XP002068557;;SERGEEV G.B. & KOMAROV V.S.: ""Organic reactions in the solid phase prepared by co-deposition of reagent vapours onto cold surface"" MOLECULAR CRYSTALS AND LIQUID CRYSTALS (INC. NONLINEAR OPTICS), vol. 156, 1988, pages 129-138, XP002098854;;O'BRIEN P.M. ET AL.: ""Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo"" JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 12, 1994, pages 1810-1822, XP002082610;;BELLEMIN R. ET AL.: ""New indole derivatives as ACAT inhibitors: Synthesis and structure-activity relationships"" EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, CHIM. THER., vol. 31, no. 2, 1996, pages 123-132, XP004040099;;LUCET D. ET AL.: ""Highly stereoselective conjugate addition of (R)- or (S)-4-phenyl-2-oxazolidinone to nitroalkenes"" JOURNAL OF ORGANIC CHEMISTRY, vol. 62, no. 9, April 1997, pages 2682-2683, XP002098855;;WHITLOCK G.A. & CARREIRA E.M.: ""Enantioselective synthesis of ent-Stellettamide A via a novel dipolar cycloaddition reaction of (trimethylsilyl)diazomethane"" JOURNAL OF ORGANIC CHEMISTRY, vol. 62, no. 23, November 1997, pages 7916-7917, XP002098856;;KRAUS J.L.: ""Isosterism and molecular modification in drug design: Tetrazole analogue of GABA: Effects on enzymes of the .gamma.-aminobutyrate system"" PHARMACOLOGICAL RESEARCH COMMUNICATIONS, vol. 15, no. 2, 1983, pages 183-189, XP002096228;;BURGER A.: ""Isosterism and bioisosterism in drug design"" PROGRESS IN DRUG DESIGN, vol. 37, 1991, pages 287-371, XP002096229;;KERR D.I.B. & ONG J.: ""GABA agonists and antagonists"" MEDICINAL RESEARCH REVIEWS, vol. 12, no. 6, 6 November 1992, pages 593-636, XP002080823;;HOWSON W. ET AL.: ""Biological activity of 3-aminopropyl (methyl) phosphinic acid, a potent and selective GABA(B) agonist with CNS activity"" BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 3, no. 4, 1993, pages 515-518, XP002096230;;PATANI G.A. & LA VOIE E.J.: ""Bioisosterism: A rational approach in drug design"" CHEMICAL REVIEWS, vol. 96, no. 8, 1996, pages 3147-3176, XP000652176",EXPIRED
428,EP,B1,EP 3602004 B1,113-298-546-063-401,2022-01-26,2022,EP 18711146 A,2018-03-21,EP 17163626 A;;EP 2018057210 W,2017-03-29,METHOD FOR MEASURING WET FRICTION OF HAIR,,UNILEVER IP HOLDINGS B V;;UNILEVER GLOBAL IP LTD,BARNES ANDREW ANTHONY HOWARD;;BELL FRASER IAN;;GILES COLIN CHRISTOPHER DAVID;;MOGHADAM SOPHIA PARASKEVI CLARE;;ZHOU RONGRONG,UNILEVER GLOBAL IP LIMITED (2022-02-23);;UNILEVER IP HOLDINGS B.V. (2022-02-23),https://lens.org/113-298-546-063-401,Granted Patent,yes,9,0,16,16,0,A61K8/342;;A61K8/416;;A61K8/42;;A61K2800/20;;A61Q5/12;;G01N19/02;;G01N19/02;;A61K8/342;;A61K8/416;;A61K8/42;;A61Q5/12;;A61K2800/20;;A61K8/416;;A61Q5/12;;G01N19/02,G01N19/02;;A61K8/04,,0,0,,,,ACTIVE
429,DK,T3,DK 0888286 T3,199-772-068-685-809,2002-02-18,2002,DK 97908655 T,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,Nye substituerede cykliske aminosyrer som farmaceutiske midler,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/199-772-068-685-809,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61K31/195;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
430,HU,A2,HU P0100472 A2,031-307-437-447-771,2001-09-28,2001,HU P0100472 A,1998-11-10,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,NOVEL AMINES AS PHARMACEUTICAL AGENTS,"A találmány (IA) és (IB) általános képletű vegyületekre, a vegyületekgyógyászatilag elfogadható sóira és gyógyszerek hatóanyagaként valóalkalmazásra vonatkozik, a képletekben n értéke 0, 1 vagy 2; Rjelentése szulfonamid-, amid-, foszfonsav-, heterogyűrűs, szulfonsav-vagy hidroxámsavcsoport; A jelentése hidrogénatom vagy metilcsoport;és B jelentése (f) általános képletű csoport, egyenes vagy elágazóláncú 1-11 szénatomos alkilcsoport vagy -(CH2)1-4,-Y-(CH2)0-4-feniláltalános képletű csoport, ahol Y jelentése -O-, -S-, -NR'3 általánosképletű csoport, amelyben R'3 jelentése 1-6 szénatomos alkil-, 3-8szénatomos cikloalkil-, benzil- vagy fenilcsoport, ahol a benzil- vagyfenilcsoport helyettesítetlen vagy a halogén atom, az alkil-, alkoxi-,hidroxil-, karboxil-, alkoxi-karbonit-, trifluor-metil- ésnitrocsoport közül egymástól függetlenül választott 1-3 csoporttalhelyettesített lehet. A fenti vegyületek geriátriai betegségekkezelésében használhatók. Ó",WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/031-307-437-447-771,Patent Application,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,DISCONTINUED
431,US,B2,US 11150637 B2,059-513-909-495-186,2021-10-19,2021,US 201916418044 A,2019-05-21,US 201916418044 A,2019-05-21,Systems and methods for asset management using a digital avatar,An asset management system that includes a field asset management system; a maintenance management system; and a digital avatar associated with a specific asset. The digital avatar has an automatic Model that is customized for the associated asset. The digital avatar automatically receives information from at least one of the field asset management system or maintenance management system as information associated with the asset is entered into the at least one of the field asset management system or maintenance management system. The automatic Model automatically runs with the new information and provides a new operating parameter for use by at least the field asset management system.,SCHLUMBERGER TECHNOLOGY CORP,FAY JAMES;;DEL CAMPO CHRISTOPHER;;LI KE;;CORMIER PAUL;;LOPEZ LUIS;;ELSTROP STEPHANIE;;SCHOENE CLARE;;SONG FEI,SCHLUMBERGER TECHNOLOGY CORPORATION (2019-05-28),https://lens.org/059-513-909-495-186,Granted Patent,yes,3,0,2,4,0,B23Q17/007;;B23Q17/007;;G05B19/4188;;G05B19/4183;;G05B19/4187;;G05B19/41885;;Y02P90/02,G05B19/418;;B23Q17/00,,0,0,,,,ACTIVE
432,AU,A,AU 1997/020511 A,071-474-124-197-512,1997-10-01,1997,AU 1997/020511 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,Novel substituted cyclic amino acids as pharmaceutical agents,,WARNER LAMBERT CO,HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;KNEEN CLARE O;;MORRELL ANDREW I;;RATCLIFFE GILES S;;HARTENSTEIN JOHANNES,,https://lens.org/071-474-124-197-512,Patent Application,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
433,WO,A3,WO 1999/031074 A3,114-670-576-945-573,1999-11-04,1999,US 9823917 W,1998-11-10,US 6977397 P;;US 10492498 P,1997-12-16,"((CYCLO)ALKYL SUBSTITUTED)-.GAMMA.-AMINOBUTYRIC ACID DERIVATIVES (=GABA ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS","Novel amines of formulas (1A) and (1B) or a pharmaceutically acceptable salt thereof wherein: n is an integer of from 0 to 2; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; A is hydrogen or methyl; and B is (a), straight or branched alkyl of from 1 to 11 carbons, or -(CH2)1-4-Y-(CH2)0-4-phenyl wherein Y is -O-, -S-, -NR'3 wherein R'3 is alkyl of from 1 to 6 carbons, cycloalkyl of from 3 to 8 carbons, benzyl or phenyl wherein benzyl or phenyl can be unsubstituted or substituted with from 1 to 3 substituents each independently selected from alkyl, alkoxy, halogen, hydroxy, carboxy, carboalkoxy, trifluoromethyl, and nitro are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially IBS. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO;;BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/114-670-576-945-573,Search Report,yes,8,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;C07D285/08;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,18,14,114-422-374-816-738;;095-873-532-751-841;;053-942-294-175-609;;025-779-953-448-357;;037-440-379-886-83X;;065-318-225-707-786;;038-875-658-416-362;;091-231-160-593-298;;116-236-104-226-889;;016-104-907-551-650;;000-457-771-937-337;;059-853-041-601-212;;109-983-916-535-316;;035-230-547-171-641,10.1002/jlac.19636650105;;10.1071/ch9662045;;513066;;10.1021/jm00196a007;;3806567;;10.1021/jm00157a005;;10.1080/00268948808070562;;10.1021/jm00038a010;;8021920;;10.1016/0223-5234(96)80445-4;;10.1021/jo970390g;;11671625;;11671891;;10.1021/jo971571l;;6405400;;10.1016/s0031-6989(83)80060-5;;1763185;;10.1007/978-3-0348-7139-6_7;;1331633;;10.1002/med.2610120604;;10.1016/s0960-894x(01)81218-x;;10.1021/cr950066q;;11848856,"RIEMSCHNEIDER R. & KAMPFER H.: ""Zur Kenntnis der cis-trans-Asymmetrie. XI. Optische Aktivität von cis,trans-1,3-Bis-[.alpha.-phenylcinnamoylamino]-2-methyl-2-n-propyl-propan"", JUSTUS LIEBIEGS ANNALEN DER CHEMIE, vol. 665, 1963, pages 35 - 42, XP002098848;;MARKOV V.I. & BURMISTROV S.I.: ""1-(Arylsulfonyl)-2,2-dimethylaziridines. II. Reactions with ammonia amines, arenesulfonamides, and phthalimide"", THE JOURNAL OF GENERAL CHEMISTRY, USSR, vol. 35, no. 1, January 1965 (1965-01-01), pages 158 - 161, XP002098849;;BOSNICH B. & DWYER F.P.: ""Mixed bidentate and tridentate complexes of cobalt"", AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 19, 1966, pages 2045 - 2050, XP002098850;;VINOT N.: ""No. 683. Synthèse de cyanométhyl-2 benzimidazoles .alpha.-substitués. Leur utilisation à la préparation de benzimidazoles possédant d'autres fonctions"", BULLETIN DE LA SOCIÉTÉ CHIMIQUE DE FRANCE, no. 12, 1966, pages 3989 - 3993, XP002098851;;TENTHOREY P.A. ET AL.: ""New antiarrhythmic agents. 3. Primary .beta.-amino anilides"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 22, no. 10, October 1979 (1979-10-01), pages 1182 - 1186, XP002098852;;FOKIN A.V. ET AL.: ""The fluoroacylation of diamines"", BULL. ACAD. SCI. USSR, DIV. CHEM. SCI., vol. 30, no. 4, April 1981 (1981-04-01), pages 643 - 646, XP002098853;;CHEMICAL ABSTRACTS, vol. 103, no. 15, 14 October 1985, Columbus, Ohio, US; abstract no. 122998x, ""Aminoalkylsulfonic acids"" page 683; column 2; XP002098857;;HANKOVSZKY O.H. ET AL.: ""New antiarrhythmic agents. 2,2,5,5-tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5-tetramethylpyrrolidine-3-carboxamides"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 29, no. 7, 1986, pages 1138 - 1152, XP002068557;;SERGEEV G.B. & KOMAROV V.S.: ""Organic reactions in the solid phase prepared by co-deposition of reagent vapours onto cold surface"", MOLECULAR CRYSTALS AND LIQUID CRYSTALS (INC. NONLINEAR OPTICS), vol. 156, 1988, pages 129 - 138, XP002098854;;O'BRIEN P.M. ET AL.: ""Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 12, 1994, pages 1810 - 1822, XP002082610;;BELLEMIN R. ET AL.: ""New indole derivatives as ACAT inhibitors: Synthesis and structure-activity relationships"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, CHIM. THER., vol. 31, no. 2, 1996, pages 123 - 132, XP004040099;;LUCET D. ET AL.: ""Highly stereoselective conjugate addition of (R)- or (S)-4-phenyl-2-oxazolidinone to nitroalkenes"", JOURNAL OF ORGANIC CHEMISTRY, vol. 62, no. 9, April 1997 (1997-04-01), pages 2682 - 2683, XP002098855;;WHITLOCK G.A. & CARREIRA E.M.: ""Enantioselective synthesis of ent-Stellettamide A via a novel dipolar cycloaddition reaction of (trimethylsilyl)diazomethane"", JOURNAL OF ORGANIC CHEMISTRY, vol. 62, no. 23, November 1997 (1997-11-01), pages 7916 - 7917, XP002098856;;KRAUS J.L.: ""Isosterism and molecular modification in drug design: Tetrazole analogue of GABA: Effects on enzymes of the .gamma.-aminobutyrate system"", PHARMACOLOGICAL RESEARCH COMMUNICATIONS, vol. 15, no. 2, 1983, pages 183 - 189, XP002096228;;BURGER A.: ""Isosterism and bioisosterism in drug design"", PROGRESS IN DRUG DESIGN, vol. 37, 1991, pages 287 - 371, XP002096229;;KERR D.I.B. & ONG J.: ""GABA agonists and antagonists"", MEDICINAL RESEARCH REVIEWS, vol. 12, no. 6, 6 November 1992 (1992-11-06), pages 593 - 636, XP002080823;;HOWSON W. ET AL.: ""Biological activity of 3-aminopropyl (methyl) phosphinic acid, a potent and selective GABA(B) agonist with CNS activity"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 3, no. 4, 1993, pages 515 - 518, XP002096230;;PATANI G.A. & LA VOIE E.J.: ""Bioisosterism: A rational approach in drug design"", CHEMICAL REVIEWS, vol. 96, no. 8, 1996, pages 3147 - 3176, XP000652176",PATENTED
434,CA,A1,CA 2244912 A1,129-829-609-751-238,1997-09-18,1997,CA 2244912 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS,"Novel substituted cyclic amino acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.",WARNER LAMBERT CO,RATCLIFFE GILES STUART;;HARTENSTEIN JOHANNES;;BRYANS JUSTIN STEPHEN;;KNEEN CLARE OCTAVIA;;MORRELL ANDREW IAN;;HORWELL DAVID CHRISTOPHER,,https://lens.org/129-829-609-751-238,Patent Application,no,0,1,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/195;;A61K31/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C229/28;;C07C233/47,,0,0,,,,EXPIRED
435,NO,D0,NO 20003037 D0,192-199-946-293-742,2000-06-14,2000,NO 20003037 A,2000-06-14,US 6977397 P;;US 10492498 P;;US 9823917 W,1997-12-16,Nye aminer som farmasøytiske midler,,WARNER LAMBERT CO,BELLIOTTI THOMAS RICHARD;;BRYANS JUSTIN STEPHEN;;CAPIRIS THOMAS;;HORWELL DAVID CHRISTOPHER;;KNEEN CLARE OCTAVIA;;WUSTROW DAVID JUERGEN,,https://lens.org/192-199-946-293-742,Patent Application,no,0,0,36,92,0,C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D211/26;;C07D257/04;;C07D271/07;;C07D285/18;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/3808;;C07F9/383;;C07F9/6552;;C07F9/655363;;C07C2601/04;;C07C2601/08;;C07C2601/14;;C07C2601/18;;C07C2602/46;;C07C2603/74;;C07F9/59;;C07D407/06;;A61P1/00;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;A61P9/10;;C07D257/04;;C07D285/08;;C07D271/07;;C07D291/04;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07F9/3808;;C07F9/383;;C07C311/32;;C07D401/06;;C07D405/06;;C07C2601/18;;C07C311/33;;C07D309/04;;C07F9/655363;;C07C2601/08;;C07D257/04;;C07C309/25;;C07C311/05;;C07D417/06;;C07F9/3808;;C07C2601/04;;C07F9/383;;C07C2602/46;;C07D407/06;;C07D271/07;;C07D413/06;;C07F9/6552;;C07C2601/14;;C07D211/26;;C07C239/14;;C07C311/09;;C07D335/02;;C07D285/18;;C07D419/06;;C07C233/36;;C07F9/59;;C07D409/06;;C07C259/06;;C07C2603/74,A61K/;;C07D285/08;;A61K31/35;;A61K31/351;;A61K31/38;;A61K31/382;;A61K31/41;;A61K31/4245;;A61K31/433;;A61K31/4427;;A61K31/443;;A61K31/4433;;A61K31/445;;A61K31/4465;;A61K31/454;;A61K31/66;;A61K31/665;;A61P1/00;;A61P9/10;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;A61P29/00;;A61P43/00;;C07C/;;C07C233/36;;C07C239/14;;C07C259/06;;C07C309/25;;C07C311/05;;C07C311/09;;C07C311/32;;C07C311/33;;C07D/;;C07D211/26;;C07D211/28;;C07D211/54;;C07D257/04;;C07D271/06;;C07D271/07;;C07D285/18;;C07D291/04;;C07D309/04;;C07D335/02;;C07D401/06;;C07D405/06;;C07D407/06;;C07D409/06;;C07D413/06;;C07D417/06;;C07D419/06;;C07F9/38;;C07F9/59;;C07F9/655;;C07F9/6553,,0,0,,,,EXPIRED
436,US,B2,US 10613739 B2,135-912-768-006-483,2020-04-07,2020,US 201715609738 A,2017-05-31,US 201715609738 A;;US 201662348884 P,2016-06-11,"Device, method, and graphical user interface for controlling multiple devices in an accessibility mode","In accordance with some embodiments, a method is performed at a first device with one or more processors, non-transitory memory, and a display. The method includes displaying, on the display, a device control transfer affordance while operating the first device based on user input from an input device that is in communication with the first device. The method includes receiving a device control transfer user input from the input device selecting the device control transfer affordance that is displayed on the display of the first device. In response to receiving the device control transfer user input, the method includes configuring a second device to be operated based on user input from the input device and ceasing to operate the first device based on user input from the input device.",APPLE INC,FLEIZACH CHRISTOPHER BRIAN;;KASEMSET CLARE T;;MINIFIE DARREN CHRISTOPHER;;HUGHES GREGORY F;;YUSUF IBRAHIM G;;CARTWRIGHT JAMES NATHAN;;CRAIG JAMES PLOWDEN;;HOA PATTI P,APPLE INC (2017-06-12),https://lens.org/135-912-768-006-483,Granted Patent,yes,4,1,4,4,0,G06F3/0489;;G06F1/1671;;G06F3/012;;G06F3/0219;;G06F3/0231;;G06F3/0485;;G09B21/00;;G06F3/04892;;G09B5/06;;G06F3/1423;;G06F3/1454;;G09G2354/00;;G06F3/0488;;G06F3/0482;;H04M1/72415;;H04M1/72475;;G06F3/0488;;G06F3/0482;;G09B21/00;;G06F3/0485;;G06F3/0489;;G06F1/1671;;G06F3/04892;;G06F3/012;;G06F3/0219;;G06F3/0231;;G09G2354/00;;G09B5/06;;G06F3/1423;;G06F3/1454;;H04M1/72475;;H04M1/72415,G06F3/0488;;G06F1/16;;G06F3/01;;G06F3/02;;G06F3/023;;G06F3/041;;G06F3/0482;;G06F3/0485;;G06F3/0489;;G06F3/14;;G09B5/06;;G09B21/00;;H04M1/72415;;H04M1/72475,,0,0,,,,ACTIVE
437,US,B2,US 11650733 B2,153-977-830-812-225,2023-05-16,2023,US 202016822112 A,2020-03-18,US 202016822112 A;;US 201715609738 A;;US 201662348884 P,2016-06-11,"Device, method, and graphical user interface for controlling multiple devices in an accessibility mode","In accordance with some embodiments, a method is performed at a first device with one or more processors, non-transitory memory, and a display. The method includes displaying, on the display, a device control transfer affordance while operating the first device based on user input from an input device that is in communication with the first device. The method includes receiving a device control transfer user input from the input device selecting the device control transfer affordance that is displayed on the display of the first device. In response to receiving the device control transfer user input, the method includes configuring a second device to be operated based on user input from the input device and ceasing to operate the first device based on user input from the input device.",APPLE INC,FLEIZACH CHRISTOPHER BRIAN;;KASEMSET CLARE T;;MINIFIE DARREN CHRISTOPHER;;HUGHES GREGORY F;;YUSUF IBRAHIM G;;CARTWRIGHT JAMES NATHAN;;CRAIG JAMES PLOWDEN;;HOA PATTI P,,https://lens.org/153-977-830-812-225,Granted Patent,yes,10,0,4,4,0,G06F3/0489;;G06F1/1671;;G06F3/012;;G06F3/0219;;G06F3/0231;;G06F3/0485;;G09B21/00;;G06F3/04892;;G09B5/06;;G06F3/1423;;G06F3/1454;;G09G2354/00;;G06F3/0488;;G06F3/0482;;H04M1/72415;;H04M1/72475;;G06F3/0488;;G06F3/0482;;G09B21/00;;G06F3/0485;;G06F3/0489;;G06F1/1671;;G06F3/04892;;G06F3/012;;G06F3/0219;;G06F3/0231;;G09G2354/00;;G09B5/06;;G06F3/1423;;G06F3/1454;;H04M1/72475;;H04M1/72415,G06F3/0488;;G06F1/16;;G06F3/01;;G06F3/02;;G06F3/023;;G06F3/0482;;G06F3/0485;;G06F3/0489;;G06F3/04892;;G06F3/14;;G09B5/06;;G09B21/00;;H04M1/72415;;H04M1/72475,,0,0,,,,ACTIVE
438,US,A1,US 2020/0218417 A1,135-984-735-204-806,2020-07-09,2020,US 202016822112 A,2020-03-18,US 202016822112 A;;US 201715609738 A;;US 201662348884 P,2016-06-11,"Device, Method, and Graphical User Interface for Controlling Multiple Devices in an Accessibility Mode","In accordance with some embodiments, a method is performed at a first device with one or more processors, non-transitory memory, and a display. The method includes displaying, on the display, a device control transfer affordance while operating the first device based on user input from an input device that is in communication with the first device. The method includes receiving a device control transfer user input from the input device selecting the device control transfer affordance that is displayed on the display of the first device. In response to receiving the device control transfer user input, the method includes configuring a second device to be operated based on user input from the input device and ceasing to operate the first device based on user input from the input device.",APPLE INC,FLEIZACH CHRISTOPHER BRIAN;;KASEMSET CLARE T;;MINIFIE DARREN CHRISTOPHER;;HUGHES GREGORY F;;YUSUF IBRAHIM G;;CARTWRIGHT JAMES NATHAN;;CRAIG JAMES PLOWDEN;;HOA PATTI P,,https://lens.org/135-984-735-204-806,Patent Application,yes,6,1,4,4,0,G06F3/0489;;G06F1/1671;;G06F3/012;;G06F3/0219;;G06F3/0231;;G06F3/0485;;G09B21/00;;G06F3/04892;;G09B5/06;;G06F3/1423;;G06F3/1454;;G09G2354/00;;G06F3/0488;;G06F3/0482;;H04M1/72415;;H04M1/72475;;G06F3/0488;;G06F3/0482;;G09B21/00;;G06F3/0485;;G06F3/0489;;G06F1/1671;;G06F3/04892;;G06F3/012;;G06F3/0219;;G06F3/0231;;G09G2354/00;;G09B5/06;;G06F3/1423;;G06F3/1454;;H04M1/72475;;H04M1/72415,G06F3/0488;;G06F1/16;;G06F3/01;;G06F3/02;;G06F3/023;;G06F3/041;;G06F3/0482;;G06F3/0485;;G06F3/0489;;G06F3/14;;G09B5/06;;G09B21/00;;H04M1/72415;;H04M1/72475,,0,0,,,,ACTIVE
439,US,A1,US 2017/0357401 A1,028-204-012-683-701,2017-12-14,2017,US 201715609738 A,2017-05-31,US 201715609738 A;;US 201662348884 P,2016-06-11,"Device, Method, and Graphical User Interface for Controlling Multiple Devices in an Accessibility Mode","In accordance with some embodiments, a method is performed at a first device with one or more processors, non-transitory memory, and a display. The method includes displaying, on the display, a device control transfer affordance while operating the first device based on user input from an input device that is in communication with the first device. The method includes receiving a device control transfer user input from the input device selecting the device control transfer affordance that is displayed on the display of the first device. In response to receiving the device control transfer user input, the method includes configuring a second device to be operated based on user input from the input device and ceasing to operate the first device based on user input from the input device.",APPLE INC,FLEIZACH CHRISTOPHER BRIAN;;KASEMSET CLARE T;;MINIFIE DARREN CHRISTOPHER;;HUGHES GREGORY F;;YUSUF IBRAHIM G;;CARTWRIGHT JAMES NATHAN;;CRAIG JAMES PLOWDEN;;HOA PATTI P,APPLE INC (2017-06-12),https://lens.org/028-204-012-683-701,Patent Application,yes,0,10,4,4,0,G06F3/0489;;G06F1/1671;;G06F3/012;;G06F3/0219;;G06F3/0231;;G06F3/0485;;G09B21/00;;G06F3/04892;;G09B5/06;;G06F3/1423;;G06F3/1454;;G09G2354/00;;G06F3/0488;;G06F3/0482;;H04M1/72415;;H04M1/72475;;G06F3/0488;;G06F3/0482;;G09B21/00;;G06F3/0485;;G06F3/0489;;G06F1/1671;;G06F3/04892;;G06F3/012;;G06F3/0219;;G06F3/0231;;G09G2354/00;;G09B5/06;;G06F3/1423;;G06F3/1454;;H04M1/72475;;H04M1/72415,G06F3/0488;;G06F3/02;;G06F3/041;;G06F3/0482;;G06F3/0484;;G06F3/14;;G06F3/16;;H04M1/72415;;H04M1/72475,,0,0,,,,ACTIVE
440,CN,A,CN 115484950 A,169-020-030-258-756,2022-12-16,2022,CN 202180029318 A,2021-02-18,GB 202002299 A;;EP 2021054071 W,2020-02-19,Agents for use in treatment of tissue damage,"The invention comprises an agent for medical use wherein the agent comprises a compound of formula (I): B-L-B 'wherein: B and B' are independently selected from formula (B-I) wherein: Z is selected from-COOH,-CH2COOH,-PO (OH) (OR1) or-CH2PO (OH) (OR1) wherein R1 is H or a phosphate protecting group; w is an alicyclic amine group having 5 to 12 carbon atoms and at least one amine nitrogen atom; w'is H, or W 'is linked to W to form the alicyclic amine group, and Y is selected from-NH-,-N (CH3)-,-CH2-,-NHCO-,-CH2CONH-,-CONH-, CH2NHCO-or-NHCH2-, and L is a linker group.",UCL BUSINESS PLC,PEPYS MARK BRIAN;;SWAIN CHRISTOPHER;;TAYLOR GEOFF W;;WOOD STEWART P;;GLOSSOP MICHAEL S;;LANE CLARE ANN LOUISE,,https://lens.org/169-020-030-258-756,Patent Application,no,4,0,18,18,0,A61K31/438;;A61K45/06;;A61K31/438;;A61K45/06;;A61K31/439;;A61P29/00;;A61P9/10;;A61P31/00;;A61P19/02;;A61P17/02;;A61K31/439;;A61K45/06;;A61K31/4025;;A61K31/662,A61K31/438;;A61K45/06,,0,0,,,,PENDING
441,HU,B1,HU 224720 B1,194-066-111-591-243,2006-01-30,2006,HU P9902136 A,1997-02-18,US 1343296 P;;US 9702295 W,1996-03-14,NOVEL SUBSTITUTED CYCLIC AMINO ACID DERIVATIVES USE AS PHARMACEUTICAL AGENTS,,WARNER LAMBERT CO,HARTENSTEIN JOHANNES DR;;HORWELL DAVID CHRISTOPHER;;BRYANS JUSTIN S;;MORRELL ANDREW I;;RATCLIFFE GILES S;;KNEEN CLARE O,,https://lens.org/194-066-111-591-243,Granted Patent,no,0,0,45,46,0,C07C229/28;;C07C233/47;;C07C2601/14;;A61P25/00;;A61P25/08;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47;;C07C229/28;;C07C2601/14,A61K31/00;;A61K31/195;;A61P25/08;;C07C229/28;;A61P25/12;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/22;;A61P25/24;;A61P25/28;;C07C233/47,,0,0,,,,EXPIRED
442,ZA,B,ZA 201204823 B,009-460-700-900-910,2013-03-27,2013,ZA 201204823 A,2012-06-28,AU 2009/905865 A;;AU 2010/001616 W,2009-12-01,WATER SWELLABLE POLYMER MATERIALS,,UNIV SYDNEY,BAKER MATTHEW PAUL;;DAVEY TIMOTHY WARREN;;HAWKETT BRIAN STANLEY;;NGUYEN DUC NGOC;;O'BRIEN CAITLIN CLARE;;SUCH CHRISTOPHER HENRY,,https://lens.org/009-460-700-900-910,Granted Patent,no,0,0,11,11,0,C01P2004/04;;C01P2006/60;;C09B67/0013;;C09C1/3072;;C09C1/3676;;C09C1/46;;C09C3/10;;C09D11/00;;Y10T428/249953;;Y10T428/2998;;Y10S977/734;;Y10T428/249953;;Y10T428/2998;;C01P2004/04;;C01P2006/60;;C09B67/0013;;C09C1/3072;;C09C1/3676;;C09C1/46;;C09C3/10;;C09D11/00;;B82Y30/00;;C08L13/02;;C09D113/02;;Y10S977/734,C09C/;;C09B/,,0,0,,,,ACTIVE
443,CN,A,CN 115484949 A,146-179-134-684-530,2022-12-16,2022,CN 202180025388 A,2021-02-18,GB 202002299 A;;EP 2021054072 W,2020-02-19,Agent 2 for use in treatment of tissue damage,"An agent for medical use wherein the agent comprises a compound of formula (I): wherein Ar is an aryl linker group, such as 1, 4-phenyl, including their individual pharmaceutically acceptable salts, solvates, prodrugs or derivatives. The compounds of formula (I) are inhibitors of human C-reactive protein (CRP), and can be used to treat medical conditions mediated by CRP. Also provided are processes for preparing the compounds of formula (I) and chemical intermediates thereof.",UCL BUSINESS PLC,PEPYS MARK BRIAN;;SWAIN CHRISTOPHER;;TAYLOR GEOFF W;;WOOD STEWART P;;GLOSSOP MICHAEL S;;LANE CLARE ANN LOUISE,,https://lens.org/146-179-134-684-530,Patent Application,no,1,0,18,18,0,A61K31/438;;A61K45/06;;A61K31/438;;A61K45/06;;A61K31/439;;A61P29/00;;A61P9/10;;A61P31/00;;A61P19/02;;A61P17/02;;A61K31/439;;A61K45/06;;A61K31/4025;;A61K31/662,A61K31/438;;A61K45/06,,2,0,,,"""1544321-05-2 REGISTRY"", STN, pages 1;;""Methyl 2-amino-2-(1-azabicyclo[2.2.2]octan-3-yl)acetate"", pages 1 - 10, Retrieved from the Internet <URL:https://pubchem.ncbi.nlm.nih.gov/compound/83985947>",PENDING
444,US,S,US D0734344 S,114-833-262-559-518,2015-07-14,2015,US 201329459447 F,2013-06-28,US 201329459447 F,2013-06-28,Display screen with graphical user interface,,MICROSOFT CORP,CLARE CHRISTOPHER JAMES;;RAYIT BALJINDER PAL;;REZENDE ANTONIO PEDRO PERNAMBUCO;;LOXHA LYRA XHARRA;;PEARCE STEVE JAMES;;FARIS JAMES PAUL,MICROSOFT CORPORATION (2013-08-19),https://lens.org/114-833-262-559-518,Design Right,no,0,4,1,1,0,,,1404;;D14/485,0,0,,,,ACTIVE
445,WO,A1,WO 2022/192558 A1,071-556-692-244-427,2022-09-15,2022,US 2022/0019776 W,2022-03-10,US 202163159107 P;;US 202163208641 P,2021-03-10,SALT AND SOLID FORMS OF A KINASE INHIBITOR,"Various salt forms and free base solid forms of Compound (I) represented by the following formula are disclosed. Pharmaceutical compositions comprising the same, methods of treating disorders and conditions associated with oncogenic KIT and PDGFRA alterations using the same, and methods for making the salt forms of Compound (I) and crystalline forms thereof are also disclosed.",BLUEPRINT MEDICINES CORP;;HEINRICH BRIAN;;LI HUI;;LEE CHRISTOPHER;;MEDENDORP CLARE AUBREY;;MACEACHERN LAUREN;;BUTLER ERIKA,HEINRICH BRIAN;;LI HUI;;LEE CHRISTOPHER;;MEDENDORP CLARE;;MACEACHERN LAUREN;;BUTLER ERIKA;;KINKEMA CAITLIN;;DAVE NIMITA;;DONG SI TUAN,,https://lens.org/071-556-692-244-427,Patent Application,yes,2,0,8,8,18,C07D487/04;;A61P35/00;;C07D487/04;;A61P35/00,C07D487/04;;A61K31/53;;A61P35/00,,7,7,042-064-062-603-955;;009-214-187-079-899;;044-541-969-748-572;;104-949-654-022-72X;;000-914-752-154-709;;000-401-418-258-357;;018-742-135-737-824,10.1016/j.addr.2007.05.010;;17619064;;10.1023/a:1016241927429;;7494814;;10.1016/b978-012744481-9/50039-8;;10.1007/3-540-69178-2_5;;23642289;;10.1016/j.clinthera.2013.04.001;;28780942;;10.1016/j.jaci.2017.06.007;;10.1111/all.12842;;26797792,"SERAJUDDIN ET AL: ""Salt formation to improve drug solubility"", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM , NL, vol. 59, no. 7, 24 August 2007 (2007-08-24), pages 603 - 616, XP022211982, ISSN: 0169-409X, DOI: 10.1016/J.ADDR.2007.05.010;;STEPHEN BYRN ET AL: ""Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations"", PHARMACEUTICAL RESEARCH, vol. 12, no. 7, 1 July 1995 (1995-07-01), pages 945 - 954, XP055531015, Retrieved from the Internet <URL:https://link.springer.com/article/10.1023/A:1016241927429> DOI: 10.1023/A:1016241927429;;HEINRICH STAHL P ED - WERMUTH C G: ""The Practice of Medicinal Chemistry; 35 Preparation of water-soluble compounds through salt formation"", 1 January 2003, THE PRACTICE OF MEDICINAL CHEMISTRY, ELSEVIER, NL, PAGE(S) 601 - 615, ISBN: 978-0-12-744481-9, XP002566271;;MINO R CAIRA ED - MONTCHAMP JEAN-LUC: ""Crystalline Polymorphism of Organic Compounds"", TOPICS IN CURRENT CHEMISTRY; [TOPICS IN CURRENT CHEMISTRY], SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP008166276, ISSN: 0340-1022, [retrieved on 19990226], DOI: 10.1007/3-540-69178-2_5;;PICARD CLIN. THER., vol. 35, no. 5, May 2013 (2013-05-01), pages 548;;AKIN, J. ALLERGY CLIN. IMMUNO., vol. 140, no. 2, pages 349;;SIEBENHAAR, F. ET AL., ALLERGY, vol. 71, no. 6, 2016, pages 869 - 77",PENDING
446,EP,A1,EP 3928329 A1,105-172-045-506-418,2021-12-29,2021,EP 19793164 A,2019-04-23,US 201862661496 P;;US 2019/0028796 W,2018-04-23,TECHNIQUES FOR BOUNDING CLEANING OPERATIONS OF A ROBOTIC SURFACE CLEANING DEVICE WITHIN A REGION OF INTEREST,,SHARKNINJA OPERATING LLC,THORNE JASON B;;BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES,,https://lens.org/105-172-045-506-418,Patent Application,yes,0,0,6,6,0,G05D1/0016;;G05D1/0033;;G05D1/0274;;A47L2201/022;;A47L2201/04;;A47L5/24;;A47L9/2894;;A47L9/2852;;G05D1/0274;;G05D1/0276;;A47L2201/04,G16Z99/00,,0,0,,,,PENDING
447,CA,A1,CA 3211477 A1,017-938-141-986-278,2022-09-15,2022,CA 3211477 A,2022-03-10,US 202163159107 P;;US 202163208641 P;;US 2022/0019776 W,2021-03-10,SALT AND SOLID FORMS OF A KINASE INHIBITOR,"Various salt forms and free base solid forms of Compound (I) represented by the following formula are disclosed. Pharmaceutical compositions comprising the same, methods of treating disorders and conditions associated with oncogenic KIT and PDGFRA alterations using the same, and methods for making the salt forms of Compound (I) and crystalline forms thereof are also disclosed.",BLUEPRINT MEDICINES CORP,KINKEMA CAITLIN;;HEINRICH BRIAN;;LI HUI;;LEE CHRISTOPHER;;MEDENDORP CLARE AUBREY;;DAVE NIMITA;;DONG SI TUAN;;MACEACHERN LAUREN;;BUTLER ERIKA,,https://lens.org/017-938-141-986-278,Patent Application,no,0,0,8,8,0,C07D487/04;;A61P35/00;;C07D487/04;;A61P35/00,C07D487/04,,0,0,,,,PENDING
448,CN,A,CN 112334051 A,171-670-215-803-825,2021-02-05,2021,CN 201980039583 A,2019-04-23,US 201862661504 P;;US 2019/0028798 W,2018-04-23,ASSISTED DRIVE FOR SURFACE CLEANING DEVICES,"In general, the present disclosure is directed to a force-sensing arrangement for use in surface cleaning devices, such as a vacuum device, that allows a user-supplied force to be translated into a command signal to cause the surface cleaning device to accelerate forward, reverse or to veer/turn in a desired direction. In an embodiment, the surface cleaning device includes a nozzle, wheels, motor(s) to drive the wheels, and an upright handle portion. The surface cleaning device includes a force-sensing arrangement with load cells coupled at a position where user force is transferred from the upright portion to the nozzle. The force-sensing arrangement detects the user supplying a relatively small amount of force and translates the same into measurement signals. A controller coupled to theload cells utilizes the measurement signals to determine or ""infer"" a desired direction of travel.",SHARKNINJA OPERATING LLC,BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;THORNE JASON B,,https://lens.org/171-670-215-803-825,Patent Application,no,5,1,9,9,0,A47L5/30;;A47L9/2842;;A47L9/2852;;A47L9/2857;;A47L9/2821;;A47L5/24;;A47L5/28;;A47L5/30;;A47L9/2821;;A47L9/2852;;A47L9/2842;;A47L9/2857,A47L5/28;;A47L5/24;;A47L5/30,,0,0,,,,ACTIVE
449,CN,A,CN 112352244 A,064-839-513-053-956,2021-02-09,2021,CN 201980040485 A,2019-04-23,US 201862661496 P;;US 2019/0028796 W,2018-04-23,TECHNIQUES FOR BOUNDING CLEANING OPERATIONS OF ROBOTIC SURFACE CLEANING DEVICE WITHIN REGION OF INTEREST,"In general, the present disclosure is directed to a hand-held surface cleaning device that includes circuitry to communicate with a robotic surface cleaning device to cause the same to target an area/region of interest for cleaning. Thus, a user may utilize the hand-held surface cleaning device to perform targeted cleaning and conveniently direct a robotic surface cleaning device to focus on a region of interest. Moreover, the hand-held surface cleaning device may include sensory such as a camera device for extracting three-dimensional information from a field of view. This information may beutilized to map locations of walls, stairs, obstacles, changes in surface types, and other features in a given location. Thus, a robotic surface cleaning device may utilize the mapping information from the hand-held surface cleaning device as an input in a real-time control loop, e.g., as an input to a Simultaneous Localization and Mapping (SLAM) routine.",SHARKNINJA OPERATING LLC,THORNE JASON B;;BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES,,https://lens.org/064-839-513-053-956,Patent Application,no,6,1,6,6,0,G05D1/0016;;G05D1/0033;;G05D1/0274;;A47L2201/022;;A47L2201/04;;A47L5/24;;A47L9/2894;;A47L9/2852;;G05D1/0274;;G05D1/0276;;A47L2201/04,G06K9/32,,0,0,,,,PENDING
450,EP,A1,EP 4305036 A1,017-995-379-170-069,2024-01-17,2024,EP 22714289 A,2022-03-10,US 202163159107 P;;US 202163208641 P;;US 2022/0019776 W,2021-03-10,SALT AND SOLID FORMS OF A KINASE INHIBITOR,,BLUEPRINT MEDICINES CORP,KINKEMA CAITLIN;;HEINRICH BRIAN;;LI HUI;;LEE CHRISTOPHER;;MEDENDORP CLARE AUBREY;;DAVE NIMITA;;DONG SI TUAN;;MACEACHERN LAUREN;;BUTLER ERIKA,,https://lens.org/017-995-379-170-069,Patent Application,yes,0,0,8,8,0,C07D487/04;;A61P35/00;;C07D487/04;;A61P35/00,C07D487/04;;A61K31/53;;A61P35/00,,0,0,,,,PENDING
451,GB,A,GB 2586193 A,082-339-045-856-986,2021-02-10,2021,GB 202017950 A,2019-04-23,US 2019/0028798 W;;US 201862661504 P,2018-04-23,Assisted drive for surface cleaning devices,"In general, the present disclosure is directed to a force-sensing arrangement for use in surface cleaning devices, such as a vacuum device, that allows a user-supplied force to be translated into a command signal to cause the surface cleaning device to accelerate forward, reverse or to veer/turn in a desired direction. In an embodiment, the surface cleaning device includes a nozzle, wheels, motor(s) to drive the wheels, and an upright handle portion. The surface cleaning device includes a force-sensing arrangement with load cells coupled at a position where user force is transferred from the upright portion to the nozzle. The force-sensing arrangement detects the user supplying a relatively small amount of force and translates the same into measurement signals. A controller coupled to the load cells utilizes the measurement signals to determine or ""infer"" a desired direction of travel.",SHARKNINJA OPERATING LLC,ANDRE D BROWN;;DAVID S CLARE;;NICHOLAS SARDAR;;CHRISTOPHER P PINCHES;;SAMUEL EMRYS JAMES;;MICHAEL JAMES DOUGLAS;;JASON B THORNE,,https://lens.org/082-339-045-856-986,Patent Application,no,6,0,9,9,0,A47L5/30;;A47L9/2842;;A47L9/2852;;A47L9/2857;;A47L9/2821;;A47L5/24;;A47L5/28;;A47L5/30;;A47L9/2821;;A47L9/2852;;A47L9/2842;;A47L9/2857,A47L5/28;;A47L5/24;;A47L5/30,,0,0,,,,ACTIVE
452,BR,A2,BR 112023018246 A2,029-011-171-120-995,2024-01-30,2024,BR 112023018246 A,2022-03-10,US 2022/0019776 W;;US 202163159107 P;;US 202163208641 P,2021-03-10,Formas de sal e sólidas de um inibidor de cinase,"formas de sal e sólidas de um inibidor de cinase. várias formas de sal e formas sólidas de base livre do composto (i) representadas pela seguinte fórmula são divulgadas. composições farmacêuticas compreendendo as mesmas, métodos de tratamento de distúrbios e condições associadas a kit oncogênico e alterações de pdgfra usando as mesmas, e métodos para fazer as formas de sal do composto (i) e formas cristalinas das mesmas também são divulgados.",BLUEPRINT MEDICINES CORP,HEINRICH BRIAN;;KINKEMA CAITLIN;;LEE CHRISTOPHER;;CLARE AUBREY MEDENDORP;;BUTLER ERIKA;;LI HUI;;MACEACHERN LAUREN;;DAVE NIMITA;;TUAN DONG SI,,https://lens.org/029-011-171-120-995,Patent Application,no,0,0,8,8,0,C07D487/04;;A61P35/00;;C07D487/04;;A61P35/00,A61K31/53;;A61P35/00;;C07D487/04,,0,0,,,,PENDING
453,GB,B,GB 2586193 B,044-272-480-456-985,2021-09-15,2021,GB 202017950 A,2019-04-23,US 2019/0028798 W;;US 201862661504 P,2018-04-23,Assisted drive for surface cleaning devices,,SHARKNINJA OPERATING LLC,ANDRE D BROWN;;DAVID S CLARE;;NICHOLAS SARDAR;;CHRISTOPHER P PINCHES;;SAMUEL EMRYS JAMES;;MICHAEL JAMES DOUGLAS;;JASON B THORNE,,https://lens.org/044-272-480-456-985,Granted Patent,no,6,0,9,9,0,A47L5/30;;A47L9/2842;;A47L9/2852;;A47L9/2857;;A47L9/2821;;A47L5/24;;A47L5/28;;A47L5/30;;A47L9/2821;;A47L9/2852;;A47L9/2842;;A47L9/2857,A47L5/28;;A47L5/24;;A47L5/30,,0,0,,,,ACTIVE
454,IL,A,IL 305791 A,032-968-529-894-856,2023-11-01,2023,IL 30579123 A,2023-09-10,US 202163159107 P;;US 202163208641 P;;US 2022/0019776 W,2021-03-10,Salt and solid forms of a kinase inhibitor,,BLUEPRINT MEDICINES CORP;;KINKEMA CAITLIN;;HEINRICH BRIAN;;LI HUI;;LEE CHRISTOPHER;;MEDENDORP CLARE AUBREY;;DAVE NIMITA;;DONG SI TUAN;;MACEACHERN LAUREN;;BUTLER ERIKA,KINKEMA CAITLIN;;HEINRICH BRIAN;;LI HUI;;LEE CHRISTOPHER;;MEDENDORP CLARE AUBREY;;DAVE NIMITA;;DONG SI TUAN;;MACEACHERN LAUREN;;BUTLER ERIKA,,https://lens.org/032-968-529-894-856,Patent Application,no,0,0,8,8,0,C07D487/04;;A61P35/00;;C07D487/04;;A61P35/00,A61P35/00,,0,0,,,,PENDING
455,KR,A,KR 20240013720 A,032-776-515-942-697,2024-01-30,2024,KR 20237034550 A,2022-03-10,US 202163159107 P;;US 202163208641 P;;US 2022/0019776 W,2021-03-10,키나아제 저해제의 염 및 고체 형태,"하기 화학식으로 표시되는 화합물 (I)의 다양한 염 형태 및 유리 염기 고체 형태가 개시된다. JPEGpct00080.jpg7477 이를 포함하는 약제학적 조성물, 이를 사용하여 발암성 KIT 및 PDGFRA 변형과 관련된 장애 및 병태를 치료하는 방법, 및 화합물 (I)의 염 형태 및 이의 결정질 형태를 제조하기 위한 방법이 또한 개시된다.",BLUEPRINT MEDICINES CORP,KINKEMA CAITLIN;;HEINRICH BRIAN;;LI HUI;;LEE CHRISTOPHER;;MEDENDORP CLARE AUBREY;;DAVE NIMITA;;DONG SI TUAN;;MACEACHERN LAUREN;;BUTLER ERIKA,,https://lens.org/032-776-515-942-697,Patent Application,no,0,0,8,8,0,C07D487/04;;A61P35/00;;C07D487/04;;A61P35/00,C07D487/04;;A61K31/53;;A61P35/00,,0,0,,,,PENDING
456,US,B2,US 11687092 B2,113-826-166-681-159,2023-06-27,2023,US 201916392452 A,2019-04-23,US 201916392452 A;;US 201862661496 P,2018-04-23,Techniques for bounding cleaning operations of a robotic surface cleaning device within a region of interest,"A hand-held surface cleaning device includes circuitry to communicate with a robotic surface cleaning device to cause the same to target an area/region of interest for cleaning. Thus, a user may utilize the hand-held surface cleaning device to perform targeted cleaning and conveniently direct a robotic surface cleaning device to focus on a region of interest. Moreover, the hand-held surface cleaning device may include sensory such as a camera device for extracting three-dimensional information from a field of view. This information may be utilized to map locations of walls, stairs, obstacles, changes in surface types, and other features in a given location. Thus, a robotic surface cleaning device may utilize the mapping information from the hand-held surface cleaning device as an input in a real-time control loop, e.g., as an input to a Simultaneous Localization and Mapping (SLAM) routine.",SHARKNINJA OPERATING LLC,THORNE JASON B;;BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES,SHARKNINJA OPERATING LLC (2018-10-23),https://lens.org/113-826-166-681-159,Granted Patent,yes,143,0,6,6,0,G05D1/0016;;G05D1/0033;;G05D1/0274;;A47L2201/022;;A47L2201/04;;A47L5/24;;A47L9/2894;;A47L9/2852;;G05D1/0274;;G05D1/0276;;A47L2201/04,G05D1/02,,12,0,,,"KR-20140066850-A Translation (Year: 2014).;;CN-106863305-A Translation (Year: 2017).;;US 8,271,129 B2, 09/2012, Halloran et al. (withdrawn);;Chinese Office Action with English translation dated Jul. 1, 2020, received in Chinese Patent Application No. 201811114067.2, 16 pages.;;Korean Office Action with English translation dated Aug. 31, 2020, received in Korean Patent Application No. 10-2020-7005226, 15 pages.;;Korean Office Action with English translation dated Aug. 31, 2020, received in Korean Patent Application No. 10-2020-7014700, 15 pages.;;Japanese Office Action with English translation dated Oct. 14, 2020, received in Japanese Patent Application No. 2020-516621, 6 pages.;;U.S. Office Action dated Feb. 5, 2021, received in U.S. Appl. No. 16/649,469, 23 pages.;;Korean Office Action with English translation dated Feb. 25, 2021, received in Korean Patent Application No. 10-2020-7014700, 7 pages.;;PCT Search Report and Written Opinion dated Jul. 25, 2019, received in corresponding PCT Application No. PCT/US19/28796, 10 pgs.;;PCT Search Report and Written Opinion dated Nov. 30, 2022, received in PCT Application No. PCT/US22/40180, 8 pages.;;Extended European Search Report dated Nov. 23, 2022, received in European Patent Application No. 19793164.5, 8 pages.",ACTIVE
457,AU,A1,AU 2022/234314 A1,158-248-630-469-858,2023-09-28,2023,AU 2022/234314 A,2022-03-10,US 202163159107 P;;US 202163208641 P;;US 2022/0019776 W,2021-03-10,SALT AND SOLID FORMS OF A KINASE INHIBITOR,"Various salt forms and free base solid forms of Compound (I) represented by the following formula are disclosed. Pharmaceutical compositions comprising the same, methods of treating disorders and conditions associated with oncogenic KIT and PDGFRA alterations using the same, and methods for making the salt forms of Compound (I) and crystalline forms thereof are also disclosed.",BLUEPRINT MEDICINES CORP,KINKEMA CAITLIN;;HEINRICH BRIAN;;LI HUI;;LEE CHRISTOPHER;;MEDENDORP CLARE AUBREY;;DAVE NIMITA;;DONG SI TUAN;;MACEACHERN LAUREN;;BUTLER ERIKA,,https://lens.org/158-248-630-469-858,Patent Application,no,0,0,8,8,0,C07D487/04;;A61P35/00;;C07D487/04;;A61P35/00,C07D487/04;;A61K31/53;;A61P35/00,,0,0,,,,PENDING
458,EP,A4,EP 3928329 A4,191-185-503-555-930,2022-12-21,2022,EP 19793164 A,2019-04-23,US 201862661496 P;;US 2019/0028796 W,2018-04-23,TECHNIQUES FOR BOUNDING CLEANING OPERATIONS OF A ROBOTIC SURFACE CLEANING DEVICE WITHIN A REGION OF INTEREST,,SHARKNINJA OPERATING LLC,PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;THORNE JASON B;;BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS,,https://lens.org/191-185-503-555-930,Search Report,no,3,0,6,6,0,G05D1/0016;;G05D1/0033;;G05D1/0274;;A47L2201/022;;A47L2201/04;;A47L5/24;;A47L9/2894;;A47L9/2852;;G05D1/0274;;G05D1/0276;;A47L2201/04,G05D1/00;;G05D1/02,,1,0,,,See also references of WO 2019209877A1,PENDING
459,US,B2,US 11039722 B2,175-753-994-220-731,2021-06-22,2021,US 201916392480 A,2019-04-23,US 201916392480 A;;US 201862661504 P,2018-04-23,Assisted drive for surface cleaning devices,"In general, the present disclosure is directed to a force-sensing arrangement for use in surface cleaning devices, such as a vacuum device, that allows a user-supplied force to be translated into a command signal to cause the surface cleaning device to accelerate forward, reverse or to veer/turn in a desired direction. In an embodiment, the surface cleaning device includes a nozzle, wheels, motor(s) to drive the wheels, and an upright handle portion. The surface cleaning device includes a force-sensing arrangement with load cells coupled at a position where user force is transferred from the upright portion to the nozzle. The force-sensing arrangement detects the user supplying a relatively small amount of force and translates the same into measurement signals. A controller coupled to the load cells utilizes the measurement signals to determine or “infer” a desired direction of travel.",SHARKNINJA OPERATING LLC,BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;THORNE JASON B,SHARKNINJA OPERATING LLC (2018-10-23),https://lens.org/175-753-994-220-731,Granted Patent,yes,14,0,9,9,0,A47L5/30;;A47L9/2842;;A47L9/2852;;A47L9/2857;;A47L9/2821;;A47L5/24;;A47L5/28;;A47L5/30;;A47L9/2821;;A47L9/2852;;A47L9/2842;;A47L9/2857,A47L9/28,,2,0,,,"PCT Search Report and Written Opinion dated Aug. 16, 2019, received in PCT Application No. PCT/US19/28798, 9 pgs.;;Examination Report dated Jan. 5, 2021, received in Application No. GB2017950.3, 3 pgs.",ACTIVE
460,US,S,US D0882832 S,181-785-863-757-444,2020-04-28,2020,US 201729617151 F,2017-09-12,US 201729617151 F,2017-09-12,Panel,,DOLBY LABORATORIES LICENSING CORP,FRICK PAUL ARNULF;;MICHAELIAN PETER;;VORON VINCENT;;CLARE MATTHEW WILLIAM;;SIJEN PASCAL;;GORNY DOUGLAS J;;KUKSHTEL CHRISTOPHER ROY;;LEE GILBERT K,DOLBY LABORATORIES LICENSING CORPORATION (2017-09-26),https://lens.org/181-785-863-757-444,Design Right,no,72,3,2,2,0,,,2501;;D25/138,8,0,,,"Alexander Wong, UA Shenzhen, images 5-10 at <http://www.alexanderwong.com.hk/ua_shenzhen.htm>, available at least as early as Oct. 16, 2013.;;Cinema City Cotroceni Megaplex Opens in Bucharest; Global city Holdings at <http://globalcityholdings.com/a/761,cinema-city-cotroceni-megaplex-opers-in-bucharest-23-november-2009->, available at least as early as Nov. 23, 2009.;;Panasonic Center Osaka, Case Study—Projector, Panasonic available at least as early as Nov. 30, 2014.;;http://archpaper.com/2011/11/wris-allen-theater-renovation-eventscape/ Posted Nov. 4, 2011.;;http://www.photonics.com/Article.aspx?AID=57609 Available Aug. 2015.;;http://www.behance.net/gallery/3806845/Photoshoot-Allen-Theatre-Cleveland-Ohio Published May 1, 2012.;;http://www.youtube.com/watch?v=jvehbm4Qz-c Posted Dec. 5, 2014.;;U.S. Appl. No. 29/568,630 of Paul Frick, titled “Panel,” filed Jun. 20, 2016. (Unpublished).",ACTIVE
461,US,S,US D0951487 S,183-934-196-007-533,2022-05-10,2022,US 202029730268 F,2020-04-02,US 202029730268 F;;US 201729617151 F,2017-09-12,Panel,,DOLBY LABORATORIES LICENSING CORP,FRICK PAUL ARNULF;;MICHAELIAN PETER;;VORON VINCENT;;CLARE MATTHEW WILLIAM;;SIJEN PASCAL;;GORNY DOUGLAS J;;KUKSHTEL CHRISTOPHER ROY;;LEE GILBERT K,DOLBY LABORATORIES LICENSING CORPORATION (2017-01-29),https://lens.org/183-934-196-007-533,Design Right,no,85,0,2,2,0,,,2501;;D25/138,7,0,,,"Alexander Wong, UA Shenzhen, images 5-10 at <http://www.alexanderwong.com.hk/ua_shenzhen.htm>, available at least as early as Oct. 16, 2013.;;Cinema City Cotroceni Megaplex Opens in Bucharest; Global city Holdings at <http://globalcityholdings.com/a/761,cinema-city-cotroceni-megaplex-opens-in-bucharest-23-november-2009->, available at least as early as Nov. 23, 2009.;;Panasonic Center Osaka, Case Study—Projector, Panasonic, available at least as early as Nov. 30, 2014.;;http://archpaper.com/2011/11/wris-allen-theater-renovation-eventscape/ Posted Nov. 4, 2011.;;http://www.photonics.com/Artide.aspx?AID=57609 Available Aug. 2015.;;http://www.behance.net/gallery/3806845/Photoshoot-Allen-Theatre-Cleveland-Ohio Published May 1, 2012.;;http://www.youtube.com/watch?v=jvehbm4Qz-c Posted Dec. 5, 2014.",ACTIVE
462,WO,A1,WO 2012/103990 A1,150-795-154-476-572,2012-08-09,2012,EP 2011073987 W,2011-12-23,EP 10197017 A,2010-12-27,PHOSPHORAMIDATES OF MONOSACCHARIDES,"The present invention relates novel phosphorainidates of monosaccharides of formula (I), wherein R1 is a monosaccharide group selected from A and B: R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 and X are as defined herein. Preferably X is -0-. The present invention also provides processes for the production of compounds of formula (I), pharmaceutical compositions comprising these compounds, as well as to the use thereof in medical therapy, preferably in the treatment of osteoarthritis. Formula (I) wherein: R 1 is selected from A and B.",BIOIBERICA;;MCGUIGAN CHRISTOPHER;;CATERSON BRUCE;;ALAEZ VERSON CARLOS RAUL;;TORRENT GIBERT ANA MARIA;;RUHI ROURA RAMON;;HUGHES CLARE E;;ESCAICH FERRER JOSEP,MCGUIGAN CHRISTOPHER;;CATERSON BRUCE;;ALAEZ VERSON CARLOS RAUL;;TORRENT GIBERT ANA MARIA;;RUHI ROURA RAMON;;HUGHES CLARE E;;ESCAICH FERRER JOSEP,,https://lens.org/150-795-154-476-572,Patent Application,yes,1,1,2,2,0,A61P19/02;;A61P29/00;;C07H11/04;;C07H13/04,C07H11/04;;A61K31/7024;;A61P19/02;;C07H13/04,,1,1,040-895-383-437-294,10.1021/jm800594c;;18714981,"MCGUIGAN C. ET AL: ""Phosphate Prodrugs Derived from N-Acetylglucosamine Have Enhanced Chondroprotective Activity in Explant Cultures and Represent a New Lead in Antiosteoarthritis Drug Discovery"", J. MED. CHEM., vol. 51, no. 18, 21 August 2008 (2008-08-21), pages 5807 - 5812, XP002626819, DOI: 10.1021/jm800594c",PENDING
463,EP,A1,EP 2471802 A1,150-148-278-916-700,2012-07-04,2012,EP 10197017 A,2010-12-27,EP 10197017 A,2010-12-27,Phosphoramidates of monosaccharides,"The present invention relates novel phosphoramidates of monosaccharides of formula (I), wherein R 1  is a monosaccharide group selected from A and B; R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16  and X are as defined herein. Preferably X is -O-. The present invention also provides processes for the production of compounds of formula (I), pharmaceutical compositions comprising these compounds, as well as to the use thereof in medical therapy, preferably in the treatment of osteoarthritis.
  
wherein: 
R 1  is selected from A and B,
 ",BIOIBERICA,MCGUIGAN CHRISTOPHER;;CATERSON BRUCE;;ALAEZ VERSON CARLOS RAUL;;TORRENT GIBERT ANA MARIA;;RUHI ROURA RAMON;;HUGHES CLARE E;;ESCAICH FERRER JOSEP,,https://lens.org/150-148-278-916-700,Patent Application,yes,3,0,2,2,0,A61P19/02;;A61P29/00;;C07H11/04;;C07H13/04,C07H11/04;;A61K31/7024;;A61P29/00,,14,10,040-895-383-437-294;;178-298-017-933-588;;078-620-792-757-033;;093-503-778-733-431;;113-819-776-215-782;;023-707-634-404-212;;040-895-383-437-294;;026-437-475-542-23X;;045-227-696-933-422;;043-574-997-583-319,10.1021/jm800594c;;18714981;;9274595;;10.1016/s0140-6736(97)07226-7;;10.1038/nrd1693;;15803196;;10648040;;14644851;;10.1136/ard.2003.011742;;pmc1754382;;16857394;;10.1016/j.joca.2006.06.010;;10.1021/jm800594c;;18714981;;19364121;;10.1021/cr800323s;;15280959;;10.1039/b406280a;;10.1021/jo00129a036,"MCGUIGAN C. ET AL: ""Phosphate Prodrugs Derived from N-Acetylglucosamine Have Enhanced Chondroprotective Activity in Explant Cultures and Represent a New Lead in Antiosteoarthritis Drug Discovery"", J. MED. CHEM., vol. 51, no. 18, 21 August 2008 (2008-08-21), pages 5807 - 5812, XP002626819, DOI: 10.1021/jm800594c;;P. CREAMER ET AL., LANCET, vol. 350, 1997, pages 503 - 509;;H.A. WIELAND ET AL., NATURE REV. DRUG DISCOV., vol. 4, 2005, pages 331 - 344;;M.G. LEQUESNE, REV. RHUM. (ENG./ED.), vol. 61, 1994, pages 69 - 73;;B.F. LEEB ET AL., J. RHEUMATOL., vol. 27, 2000, pages 205 - 211;;K.M. JORDAN ET AL., ANN. RHEUM. DIS., vol. 62, 2003, pages 1145 - 1155;;H. NAKAMURA ET AL., CLIN. EXP. RHEUMATOL., vol. 22, no. 3, 2004, pages 293 - 9;;G. HERRERO-BEAUMONT ET AL., ARTHRITIS RHEUM., vol. 52, 2005, pages 460;;R. D. ALTMAN ET AL., OSTEOARTHRITIS & CARTILAGE, vol. 14, 2006, pages 963 - 966;;""Remington: The Science and Practice of Pharmacy"", 2000, LIPPINCOTT WILLIAMS AND WILKINS;;C. MCGUIGAN ET AL., J. MED. CHEM., vol. 51, 2008, pages 5807 - 5812;;A. ISIDRO-LLOBET ET AL., CHEM. REV, vol. 109, 2009, pages 2455 - 2504;;P. PERLMUTTER ET AL., ORG. BIOMOL. CHEM., vol. 2, 2004, pages 2220 - 2228;;R. MADSEN ET AL., J. ORG. CHEM., vol. 60, 1995, pages 7920 - 7926",DISCONTINUED
464,US,B2,US 9792013 B2,003-762-528-435-37X,2017-10-17,2017,US 201313782843 A,2013-03-01,US 201313782843 A;;US 201361757052 P,2013-01-25,Interface scanning for disabled users,"Systems and processes for scanning a user interface are disclosed. One process can include scanning multiple elements within a user interface by highlighting the elements. The process can further include receiving a selection while one of the elements is highlighted and performing an action on the element that was highlighted when the selection was received. The action can include scanning the contents of the selected element or performing an action associated with the selected element. The process can be used to navigate an array of application icons, a menu of options, a standard desktop or laptop operating system interface, or the like. The process can also be used to perform gestures on a touch-sensitive device or mouse and track pad gestures (e.g., flick, tap, or freehand gestures).",APPLE INC,FLEIZACH CHRISTOPHER;;SEYMOUR ERIC T;;KASEMSET CLARE;;WHITE SAMUEL;;MINIFIE DARREN C;;FISCH IAN;;HUGHES GREGORY F;;KAUFMAN JUSTIN;;HOA PATTI P,APPLE INC (2013-02-26),https://lens.org/003-762-528-435-37X,Granted Patent,yes,22,8,6,6,0,G06F3/0487;;G06F3/04842;;G06F3/04842;;H04M1/2474;;G06F3/0487;;H04M1/72475,G06F3/048;;G06F3/0484;;G06F3/0487;;H04M1/72475,,14,5,096-358-871-652-282;;034-628-830-311-287;;004-200-502-889-228;;109-902-125-211-49X;;043-777-150-357-260,10.1145/1806923.1806925;;10.1109/86.808950;;10609634;;10.1109/icalt.2005.32;;10.1145/317456.317461;;10.1145/142750.143072,"“WiVik User Guide,” 2003, Bloorview MacMillan Children's Center.;;I. Scott Mackenzie and Torsten Felzer, “SAK: Scanning Ambiguous Keyboard for Efficient One-Key Text Entry,” Jul. 2010, ACM Transactions on Computer-Human Interaction, vol. 17, No. 3, Article 11.;;Peter E. Jones, “Virtual keyboard with scanning and augmented by prediction,” 1998, Proc. 2nd Euro. Conf. Disability, Virtual Reality and Assoc. Tech.;;Richard C. Simpson and Heidi Horstmann Koester, “Adaptive One-Switch Row-Column Scanning,” Dec. 1999, IEEE Transactions on Rehabilitation Engineering, vol. 7, No. 4.;;Mukherjee, Animesh, et al. “A virtual predictive keyboard as a learning aid for people with neuro-motor disorders.” Advanced Learning Technologies, 2005. ICALT 2005. Fifth IEEE International Conference on. IEEE, 2005.;;Siobhan Long, “Click2Phone,” Youtube, Jul. 26 2007, available at https://www.youtube.com/watch?v=NCufj0HyWc.;;Burton, D. et al. (Mar. 2012). “Cell Phone Accessibility: Android Ice Cream Sandwich: Evaluating the Accessibility of Android 4.0,” AccessWorld 13(3), located at <http://www.afb.org/afbpress/pub.asp?DocID=aw130302&Mode=Print>, last visited Feb. 19, 2013, 8 pages.;;Miró-Borrás, J. et al. (2008). “E-Everything for All: Text Entry for People with Severe Motor Disabilities,” CollECTeR lberoamérica, 7 pages.;;Anonymous. (2013). “ClickToPhone for Android Phone or Tablet Configurator,” located at <http://www.broadenedhorizons.com/clicktophone>, last visited Feb. 19, 2013, 7 pages.;;Shein, G.F. (1997). “Towards Task Transparency in Alternative Computer Access: Selection of Text Through Switch-Based Scanning,” Doctor of Philosophy Degree Thesis, Graduate Department of Mechanical and Industrial Engineering, University of Toronto, 252 pages.;;Lee, S.K. et al. (Apr. 1985). “A Multi-Touch Three Dimensional Touch-Sensitive Tablet,” Proceedings of CHI: ACM Conference on Human Factors in Computing Systems, pp. 21-25.;;Rubine, D.H. (Dec. 1991). “The Automatic Recognition of Gestures,” CMU-CS-91-202, Submitted in Partial Fulfillment of the Requirements of the Degree of Doctor of Philosophy in Computer Science at Carnegie Mellon University, 285 pages.;;Rubine, D.H. (May 1992). “Combining Gestures and Direct Manipulation,” CHI '92, pp. 659-660.;;Westerman, W. (Spring 1999). “Hand Tracking, Finger Identification, and Chordic Manipulation on a Multi-Touch Surface,” A Dissertation Submitted to the Faculty of the University of Delaware in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Electrical Engineering, 364 pages.",ACTIVE
465,US,A1,US 2018/0039395 A1,086-564-938-263-527,2018-02-08,2018,US 201715785375 A,2017-10-16,US 201715785375 A;;US 201313782843 A;;US 201361757052 P,2013-01-25,INTERFACE SCANNING FOR DISABLED USERS,"Systems and processes for scanning a user interface are disclosed. One process can include scanning multiple elements within a user interface by highlighting the elements. The process can further include receiving a selection while one of the elements is highlighted and performing an action on the element that was highlighted when the selection was received. The action can include scanning the contents of the selected element or performing an action associated with the selected element. The process can be used to navigate an array of application icons, a menu of options, a standard desktop or laptop operating system interface, or the like. The process can also be used to perform gestures on a touch-sensitive device or mouse and track pad gestures (e.g., flick, tap, or freehand gestures).",APPLE INC,FLEIZACH CHRISTOPHER;;SEYMOUR ERIC T;;KASEMSET CLARE;;WHITE SAMUEL;;MINIFIE DARREN C;;FISCH IAN;;HUGHES GREGORY F;;KAUFMAN JUSTIN;;HOA PATTI P,,https://lens.org/086-564-938-263-527,Patent Application,yes,0,2,6,6,0,G06F3/0487;;G06F3/04842;;G06F3/04842;;H04M1/2474;;G06F3/0487;;H04M1/72475,G06F3/0484;;G06F3/0487;;H04M1/72475,,0,0,,,,ACTIVE
466,US,B2,US 11036372 B2,180-366-677-504-096,2021-06-15,2021,US 201916716436 A,2019-12-16,US 201916716436 A;;US 201715785375 A;;US 201313782843 A;;US 201361757052 P,2013-01-25,Interface scanning for disabled users,"Systems and processes for scanning a user interface are disclosed. One process can include scanning multiple elements within a user interface by highlighting the elements. The process can further include receiving a selection while one of the elements is highlighted and performing an action on the element that was highlighted when the selection was received. The action can include scanning the contents of the selected element or performing an action associated with the selected element. The process can be used to navigate an array of application icons, a menu of options, a standard desktop or laptop operating system interface, or the like. The process can also be used to perform gestures on a touch-sensitive device or mouse and track pad gestures (e.g., flick, tap, or freehand gestures).",APPLE INC,FLEIZACH CHRISTOPHER;;SEYMOUR ERIC T;;KASEMSET CLARE;;WHITE SAMUEL;;MINIFIE DARREN C;;FISCH IAN;;HUGHES GREGORY F;;KAUFMAN JUSTIN;;HOA PATTI P,,https://lens.org/180-366-677-504-096,Granted Patent,yes,28,0,6,6,0,G06F3/0487;;G06F3/04842;;G06F3/04842;;H04M1/2474;;G06F3/0487;;H04M1/72475,G06F3/0484;;G06F3/0487;;H04M1/72475,,21,6,031-487-033-584-252;;057-168-006-950-160;;096-358-871-652-282;;004-200-502-889-228;;043-777-150-357-260;;034-628-830-311-287,10.1145/1296843.1296850;;10.1145/1165385.317461;;10.1145/1806923.1806925;;10.1109/icalt.2005.32;;10.1145/142750.143072;;10.1109/86.808950;;10609634,"Anonymous, “ClickToPhone for Android Phone or Tablet Configurator”, Available online at: <http://www.broadenedhorizons.com/clicktophone>, 2013, 7 pages.;;Burton et al., “Cell Phone Accessibility: Android Ice Cream Sandwich: Evaluating the Accessibility of Android 4.0”, AccessWorld, vol. 13, No. 3, Available online at: <http://www.afb.org/afbpress/pub.asp?DocID=aw130302&Mode=Print>, Mar. 2012, 8 pages.;;Final Office Action received for U.S. Appl. No. 13/782,843, dated Feb. 25, 2016, 11 pages.;;Harada et al., “VoiceDraw: A Hands-Free Voice-Driven Drawing Application for People with Motor Impairments”, ACM ASSETS, Oct. 2007.;;Jones, Peter E., “Virtual Keyboard with Scanning and Augmented by Prediction”, Proc. 2nd Euro. Conf. Disability, Virtual Reality & Assoc. Tech., Skovde, Sweden, 1998, pp. 45-51.;;Lee et al., “A Multi-Touch Three Dimensional Touch-Sensitive Tablet”, CHI'85 Proceedings, Apr. 1985, pp. 21-25.;;Long, Siobhan, “Click2Phone”, Youtube, Available online at: <https://www.youtube.com/watch?v=NCufj0HyWc>, Jul. 26, 2007.;;Mackenzie et al., “SAK: Scanning Ambiguous Keyboard for Efficient One-Key Text Entry”, ACM Transactions on Computer-Human Interaction, vol. 17, No. 3, Article 11, Jul. 2010, 39 pages.;;Miro-Borras et al., “E-Everything for All: Text Entry for People With Severe Motor Disabilities”, ColIECTeR Iberoamerica, 2008, 7 pages.;;Mukherjee et al., “A Virtual Predictive Keyboard As a Learning Aid for People with Neuro-Motor Disorders”, Advanced Learning Technologies, (ICALT—2005), Fifth IEEE International Conference, Kaohsiung, Taiwan, 2005.;;Non-Final Office Action received for U.S. Appl. No. 13/782,843, dated Aug. 14, 2015, 11 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/782,843, dated Dec. 19, 2016, 14 pages.;;Notice of Allowance received for U.S. Appl. No. 13/782,843, dated Jun. 15, 2017, 7 pages.;;Notice of Allowance received for U.S. Appl. No. 15/785,375, dated Aug. 16, 2019, 9 pages.;;Restriction Requirement received for U.S. Appl. No. 13/782,843, dated Apr. 7, 2015, 5 pages.;;Rubine, Dean H., “Combining Gestures and Direct Manipulation”, CHI'92, May 3-7, 1992, pp. 659-660.;;Rubine, Dean H., “The Automatic Recognition of Gestures”, CMU-CS-91-202, Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Computer Science at Carnegie Mellon University, Dec. 1991, 285 pages.;;Shein, G.F., “Towards Task Transparency in Alternative Computer Access: Selection of Text Through Switch-Based Scanning”, Doctor of Philosophy Degree Thesis, Graduate Department of Mechanical and Industrial Engineering, University of Toronto, 1997, 252 pages.;;Simpson et al., “Adaptive One-Switch Row-Column Scanning”, IEEE Transactions on Rehabilitation Engineering, vol. 7, No. 4, Dec. 4, 1999, 10 pages.;;Westerman, Wayne, “Hand Tracking, Finger Identification, and Chordic Manipulation on a Multi-Touch Surface”, A Dissertation Submitted to the Faculty of the University of Delaware in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Electrical Engineering, 1999, 363 pages.;;“WiVik User Guide”, Bloorview MacMillan Children's Center, 2003.",ACTIVE
467,US,A1,US 2014/0215398 A1,110-149-134-467-903,2014-07-31,2014,US 201313782843 A,2013-03-01,US 201313782843 A;;US 201361757052 P,2013-01-25,INTERFACE SCANNING FOR DISABLED USERS,"Systems and processes for scanning a user interface are disclosed. One process can include scanning multiple elements within a user interface by highlighting the elements. The process can further include receiving a selection while one of the elements is highlighted and performing an action on the element that was highlighted when the selection was received. The action can include scanning the contents of the selected element or performing an action associated with the selected element. The process can be used to navigate an array of application icons, a menu of options, a standard desktop or laptop operating system interface, or the like. The process can also be used to perform gestures on a touch-sensitive device or mouse and track pad gestures (e.g., flick, tap, or freehand gestures).",APPLE INC,FLEIZACH CHRISTOPHER;;SEYMOUR ERIC T;;KASEMEST CLARE;;WHITE SAMUEL;;MINIFIE DARREN C;;FISCH IAN;;HUGHES GREGORY F;;KAUFMAN JUSTIN;;HOA PATTI P,APPLE INC (2013-02-26),https://lens.org/110-149-134-467-903,Patent Application,yes,3,19,6,6,0,G06F3/0487;;G06F3/04842;;G06F3/04842;;H04M1/2474;;G06F3/0487;;H04M1/72475,G06F3/0484;;H04M1/72475,715/823,6,3,096-358-871-652-282;;034-628-830-311-287;;004-200-502-889-228,10.1145/1806923.1806925;;10.1109/86.808950;;10609634;;10.1109/icalt.2005.32,"""WiVik User Guide,"" 2003, Bloorview MacMillan Children's Center.;;I. Scott Mackenzie and Torsten Felzer, ""SAK: Scanning Ambiguous Keyboard for Efficient One-Key Text Entry,"" July 2010, ACM Transactions on Computer-Human Interaction, Vol. 17, No. 3, Article 11.;;Peter E. Jones, ""Virtual keyboard with scanning and augmented by prediction,"" 1998, Proc. 2nd Euro. Conf. Disability, Virtual Reality and Assoc. Tech.;;Richard C. Simpson and Heidi Horstmann Koester, ""Adaptive One-Switch Row-Column Scanning,"" Dec. 1999, IEEE Transactions on Rehabilitation Engineering, Vol. 7, No. 4.;;Mukherjee, Animesh, et al. ""A virtual predictive keyboard as a learning aid for people with neuro-motor disorders."" Advanced Learning Technologies, 2005. ICALT 2005. Fifth IEEE International Conference on. IEEE, 2005.;;Siobhan Long, ""Click2Phone,"" Youtube, Jul. 26 2007, available at https://www.youtube.com/watch?v=NCufj0HyWc",ACTIVE
468,US,A1,US 2020/0117346 A1,085-610-291-403-282,2020-04-16,2020,US 201916716436 A,2019-12-16,US 201916716436 A;;US 201715785375 A;;US 201313782843 A;;US 201361757052 P,2013-01-25,INTERFACE SCANNING FOR DISABLED USERS,"Systems and processes for scanning a user interface are disclosed. One process can include scanning multiple elements within a user interface by highlighting the elements. The process can further include receiving a selection while one of the elements is highlighted and performing an action on the element that was highlighted when the selection was received. The action can include scanning the contents of the selected element or performing an action associated with the selected element. The process can be used to navigate an array of application icons, a menu of options, a standard desktop or laptop operating system interface, or the like. The process can also be used to perform gestures on a touch-sensitive device or mouse and track pad gestures (e.g., flick, tap, or freehand gestures).",APPLE INC,FLEIZACH CHRISTOPHER;;SEYMOUR ERIC T;;KASEMSET CLARE;;WHITE SAMUEL;;MINIFIE DARREN C;;FISCH IAN;;HUGHES GREGORY F;;KAUFMAN JUSTIN;;HOA PATTI P,,https://lens.org/085-610-291-403-282,Patent Application,yes,0,0,6,6,0,G06F3/0487;;G06F3/04842;;G06F3/04842;;H04M1/2474;;G06F3/0487;;H04M1/72475,G06F3/0484;;G06F3/0487;;H04M1/72475,,0,0,,,,ACTIVE
469,US,B2,US 10509549 B2,072-590-913-474-177,2019-12-17,2019,US 201715785375 A,2017-10-16,US 201715785375 A;;US 201313782843 A;;US 201361757052 P,2013-01-25,Interface scanning for disabled users,"Systems and processes for scanning a user interface are disclosed. One process can include scanning multiple elements within a user interface by highlighting the elements. The process can further include receiving a selection while one of the elements is highlighted and performing an action on the element that was highlighted when the selection was received. The action can include scanning the contents of the selected element or performing an action associated with the selected element. The process can be used to navigate an array of application icons, a menu of options, a standard desktop or laptop operating system interface, or the like. The process can also be used to perform gestures on a touch-sensitive device or mouse and track pad gestures (e.g., flick, tap, or freehand gestures).",APPLE INC,FLEIZACH CHRISTOPHER;;SEYMOUR ERIC T;;KASEMSET CLARE;;WHITE SAMUEL;;MINIFIE DARREN C;;FISCH IAN;;HUGHES GREGORY F;;KAUFMAN JUSTIN;;HOA PATTI P,,https://lens.org/072-590-913-474-177,Granted Patent,yes,25,0,6,6,0,G06F3/0487;;G06F3/04842;;G06F3/04842;;H04M1/2474;;G06F3/0487;;H04M1/72475,G06F3/0484;;G06F3/0487;;H04M1/72475,,19,6,031-487-033-584-252;;109-902-125-211-49X;;004-200-502-889-228;;034-628-830-311-287;;043-777-150-357-260;;096-358-871-652-282,10.1145/1296843.1296850;;10.1145/317456.317461;;10.1109/icalt.2005.32;;10.1109/86.808950;;10609634;;10.1145/142750.143072;;10.1145/1806923.1806925,"Susumu Harada, Jacob Wobbrock, and James Landay, “VoiceDraw: A Hands-Free Voice-Driven Drawing Application for People with Motor Impairments,” Oct. 2007, ACM Assets. (Year: 2007).;;Anonymous. (2013). “ClickToPhone for Android Phone or Tablet Configurator,” located at <http://www.broadenedhorizons.com/clicktophone>, last visited Feb. 19, 2013, 7 pages.;;Burton, D. et al. (Mar. 2012). “Cell Phone Accessibility: Android Ice Cream Sandwich: Evaluating the Accessibility of Android 4.0,” AccessWorld 13(3), located at <http://www.afb.org/afbpress/pub.asp?DocID=aw130302&Mode=Print>, last visited Feb. 19, 2013, 8 pages.;;Final Office Action dated Feb. 25, 2016, for U.S. Appl. No. 13/782,843, filed Mar. 1, 2013, ten pages.;;Lee, S.K. et al. (Apr. 1985). “A Multi-Touch Three Dimensional Touch-Sensitive Tablet,” Proceedings of CHI: ACM Conference on Human Factors in Computing Systems, pp. 21-25.;;Miró-Borrás, J. et al. (2008). “E-Everything for All: Text Entry for People with Severe Motor Disabilities,” CollECTeR Iberoamérica, 7 pages.;;Mukherjee, Animesh, et al. “A virtual predictive keyboard as a learning aid for people with neuro-motor disorders.” Advanced Learning Technologies, 2005. ICALT 2005. Fifth IEEE International Conference on. IEEE, 2005.;;Non-Final Office Action dated Aug. 14, 2015, for U.S. Appl. No. 13/782,843, filed Mar. 1, 2013, ten pages.;;Non-Final Office Action dated Dec. 19, 2016, for U.S. Appl. No. 13/782,843, filed Mar. 1, 2013, thirteen pages.;;Notice of Allowance dated Jun. 15, 2017, for U.S. Appl. No. 13/782,843, filed Mar. 1, 2013, seven pages.;;Peter E. Jones, “Virtual keyboard with scanning and augmented by prediction,” 1998, Proc. 2nd Euro. Conf. Disability, Virtual Reality and Assoc. Tech.;;Richard C. Simpson and Heidi Horstmann Koester, “Adaptive One-Switch Row-Column Scanning,” Dec. 1999, IEEE Transactions on Rehabilitation Engineering, vol. 7, No. 4.;;Rubine, D.H. (Dec. 1991). “The Automatic Recognition of Gestures,” CMU-CS-91-202, Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Computer Science at Carnegie Mellon University, 285 pages.;;Rubine, D.H. (May 1992). “Combining Gestures and Direct Manipulation,” CHI '92, pp. 659-660.;;Scott Mackenzie and Torsten Felzer, “SAK: Scanning Ambiguous Keyboard for Efficient One-Key Text Entry,” Jul. 2010, ACM Transactions on Computer-Human Interaction, vol. 17, No. 3, Article 11.;;Shein, G.F. (1997). “Towards Task Transparency in Alternative Computer Access: Selection of Text Through Switch-Based Scanning,” Doctor of Philosophy Degree Thesis, Graduate Department of Mechanical and Industrial Engineering, University of Toronto, 252 pages.;;Siobhan Long, “Click2Phone,” Youtube, Jul. 26 2007, available at https://www.youtube.com/watch?v=NCufjOHyWc.;;Westerman, W. (Spring 1999). “Hand Tracking, Finger Identification, and Chordic Manipulation on a Multi-Touch Surface,” A Dissertation Submitted to the Faculty of the University of Delaware in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Electrical Engineering, 364 pages.;;WiVik User Guide, 2003, Bloorview MacMillan Children's Center.",ACTIVE
470,US,A1,US 2023/0393865 A1,040-496-053-581-551,2023-12-07,2023,US 202318204840 A,2023-06-01,US 202318204840 A;;US 202263348670 P;;US 202363502236 P,2022-06-03,METHOD OF ACTIVATING AND MANAGING DUAL USER INTERFACE OPERATING MODES,"The present disclosure generally relates to activating and managing dual user interface modes for an operating system. An electronic device configured to run an operating system in a first mode including a first user interface receives, while operating in the first user interface mode, a predefined sequence of inputs, and in response to receiving the predefined sequence of inputs, transitions the operating system from the first user interface mode to a second user interface mode. The second user interface mode has different input capabilities with respect to the first user interface mode.",APPLE INC,FLEIZACH CHRISTOPHER B;;ROMNEY CHRISTOPHER J;;KASEMSET CLARE T;;LOBO FERREIRA DA SILVA JOAQUIM GONCALO;;SEYMOUR ERIC T;;RAMÍREZ MOLERES ISIS NAOMI;;WHEARRY JR ALLEN;;CHAMBERS ADRIAN T;;ZAKIROVA MARGARITA,APPLE INC (2023-08-28),https://lens.org/040-496-053-581-551,Patent Application,yes,0,1,2,2,0,G06F21/6218;;G06F2221/2149;;H04M1/72463;;H04M1/72448;;G06F3/0481;;G06F3/04817;;G06F3/0482;;G06F3/04842;;G06F2203/04806;;G06F9/451;;G06F3/0482,G06F9/451;;G06F3/0482,,0,0,,,,PENDING
471,WO,A9,WO 2019/209879 A9,025-387-482-217-241,2019-11-21,2019,US 2019/0028798 W,2019-04-23,US 201862661504 P,2018-04-23,ASSISTED DRIVE FOR SURFACE CLEANING DEVICES,"In general, the present disclosure is directed to a force-sensing arrangement for use in surface cleaning devices, such as a vacuum device, that allows a user-supplied force to be translated into a command signal to cause the surface cleaning device to accelerate forward, reverse or to veer/turn in a desired direction. In an embodiment, the surface cleaning device includes a nozzle, wheels, motor(s) to drive the wheels, and an upright handle portion. The surface cleaning device includes a force-sensing arrangement with load cells coupled at a position where user force is transferred from the upright portion to the nozzle. The force-sensing arrangement detects the user supplying a relatively small amount of force and translates the same into measurement signals. A controller coupled to the load cells utilizes the measurement signals to determine or ""infer"" a desired direction of travel.",SHARKNINJA OPERATING LLC,BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;CROGGON HUGH J;;THORNE JASON B,,https://lens.org/025-387-482-217-241,Search Report,yes,0,0,9,9,0,A47L5/30;;A47L9/2842;;A47L9/2852;;A47L9/2857;;A47L9/2821;;A47L5/24;;A47L5/28;;A47L5/30;;A47L9/2821;;A47L9/2852;;A47L9/2842;;A47L9/2857,A47L5/28;;A47L5/24;;A47L5/30,,0,0,,,,PENDING
472,US,B2,US 8389547 B2,170-496-660-010-244,2013-03-05,2013,US 29839407 A,2007-04-25,US 29839407 A;;US 79533106 P;;GB 2007050213 W,2006-04-26,Piperidines and related compounds for the treatment of Alzheimer's disease,"Compounds of formula (I) are modulators of gamma-secretase, and hence are useful in treatment of Alzheimer's disease.",GARCIA YUDITH;;HANNAM JOANNE CLARE;;HARRISON TIMOTHY;;HAMBLETT CHRISTOPHER L;;HUBBS JED L;;KULAGOWSKI JANUSZ JOSEF;;MADIN ANDREW;;RIDGILL MARK PETER;;SEWARD EILEEN,GARCIA YUDITH;;HANNAM JOANNE CLARE;;HARRISON TIMOTHY;;HAMBLETT CHRISTOPHER L;;HUBBS JED L;;KULAGOWSKI JANUSZ JOSEF;;MADIN ANDREW;;RIDGILL MARK PETER;;SEWARD EILEEN,MERCK SHARP & DOHME (UK) LIMITED (2020-11-01);;MERCK SHARP & DOHME LLC (2022-04-07);;MERCK SHARP & DOHME CORP (2012-05-02);;MERCK SHARP & DOHME LIMITED (2008-11-13),https://lens.org/170-496-660-010-244,Granted Patent,yes,7,0,8,8,0,A61P3/00;;A61P9/00;;A61P25/00;;A61P25/28;;C07D211/34;;C07D211/34;;C07D241/04;;C07D241/04;;C07F7/0812;;C07F7/0812,A61K31/445;;C07D211/34,514/317;;514/326;;546/210;;546/237,6,5,012-994-617-927-80X;;086-287-476-399-91X;;074-059-139-010-627;;057-683-930-918-576;;045-768-765-643-181,10.1039/b504668h;;16027897;;10.1038/35017062;;10878808;;10.1517/13543776.18.7.693;;20503989;;10.1021/jm1003073;;10.1080/09540260701797944;;18092245,"Braga et al. ""Making crystals from . . . "" J. Roy. Soc. Chem. Chem. Commun. p. 3635-3645 (2005).;;Esler et al. ""Transition state . . . "" Nature Cell Biol. v.2, p. 428-434 (2000).;;Garofalo ""Patents targeting . . . "" Exp. Opinion Ther. Patents 18(7) 693-703 (2008).;;Heike et al. ""Design synthesis . . . "" J. Med. Chem. v.53, p. 4691-4700 (2010).;;Szekely et al. ""Prevention of Alzheimer . . . "" Int. Rev. Psych. v. 19(6) p. 693-706 (2007).;;Communication pursuant to Article 94(3) EPC dated Mar. 11, 2010 for EP Application No. 07 733 634.5.",ACTIVE
473,EP,B1,EP 2013171 B1,092-479-635-933-424,2013-05-15,2013,EP 07733634 A,2007-04-25,GB 2007050213 W;;US 79533106 P,2006-04-26,PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER S DISEASE,,MERCK SHARP & DOHME;;MERCK SHARP & DOHME,GARCIA YUDITH;;HANNAM JOANNE CLARE;;HARRISON TIMOTHY;;HAMBLETT CHRISTOPHER L;;HUBBS JED L;;KULAGOWSKI JANUSZ JOSEF;;MADIN ANDREW;;RIDGILL MARK PETER;;SEWARD EILEEN,"MERCK SHARP & DOHME CORP., RAHWAY, US (2022-04-01);;SCHERING CORPORATION (2012-08-08);;MERCK SHARP & DOHME ( UK) LTD., GB (2022-09-29);;MERCK SHARP & DOHME ( UK) LTD., HODDESDON, GB (2021-08-17);;MERCK SHARP & DOHME LLC, RAHWAY, US (2022-09-29);;MERCK SHARP & DOHME CORP. (2012-08-15);;MERCK SHARP & DOHME LIMITED (2012-08-15)",https://lens.org/092-479-635-933-424,Granted Patent,yes,2,0,8,8,0,A61P3/00;;A61P9/00;;A61P25/00;;A61P25/28;;C07D211/34;;C07D211/34;;C07D241/04;;C07D241/04;;C07F7/0812;;C07F7/0812,C07D211/34;;A61K31/445;;C07D241/04,,0,0,,,,ACTIVE
474,US,A1,US 2019/0320866 A1,148-343-414-121-649,2019-10-24,2019,US 201916392452 A,2019-04-23,US 201916392452 A;;US 201862661496 P,2018-04-23,TECHNIQUES FOR BOUNDING CLEANING OPERATIONS OF A ROBOTIC SURFACE CLEANING DEVICE WITHIN A REGION OF INTEREST,"In general, the present disclosure is directed to a hand-held surface cleaning device that includes circuitry to communicate with a robotic surface cleaning device to cause the same to target an area/region of interest for cleaning. Thus, a user may utilize the hand-held surface cleaning device to perform targeted cleaning and conveniently direct a robotic surface cleaning device to focus on a region of interest. Moreover, the hand-held surface cleaning device may include sensory such as a camera device for extracting three-dimensional information from a field of view. This information may be utilized to map locations of walls, stairs, obstacles, changes in surface types, and other features in a given location. Thus, a robotic surface cleaning device may utilize the mapping information from the hand-held surface cleaning device as an input in a real-time control loop, e.g., as an input to a Simultaneous Localization and Mapping (SLAM) routine.",SHARKNINJA OPERATING LLC,THORNE JASON B;;BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;CROGGON HUGH J,SHARKNINJA OPERATING LLC (2018-10-23),https://lens.org/148-343-414-121-649,Patent Application,yes,0,13,6,6,0,G05D1/0016;;G05D1/0033;;G05D1/0274;;A47L2201/022;;A47L2201/04;;A47L5/24;;A47L9/2894;;A47L9/2852;;G05D1/0274;;G05D1/0276;;A47L2201/04,A47L9/28;;A47L5/24;;B25J9/16;;B25J11/00,,0,0,,,,ACTIVE
475,US,A1,US 2010/0048623 A1,099-402-490-902-81X,2010-02-25,2010,US 29839407 A,2007-04-25,US 29839407 A;;US 79533106 P;;GB 2007050213 W,2006-04-26,PIPERIDINES AND RELATED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE,"Compounds of formula (I) are modulators of gamma-secretase, and hence are useful in treatment of Alzheimer's disease.",GARCIA YUDITH;;HANNAM JOANNE CLARE;;HARRISON TIMOTHY;;HAMBLETT CHRISTOPHER L;;HUBBS JED L;;KULAGOWSKI JANUSZ JOSEF;;MADIN ANDREW;;RIDGILL MARK PETER;;SEWARD EILEEN,GARCIA YUDITH;;HANNAM JOANNE CLARE;;HARRISON TIMOTHY;;HAMBLETT CHRISTOPHER L;;HUBBS JED L;;KULAGOWSKI JANUSZ JOSEF;;MADIN ANDREW;;RIDGILL MARK PETER;;SEWARD EILEEN,MERCK SHARP & DOHME (UK) LIMITED (2020-11-01);;MERCK SHARP & DOHME LLC (2022-04-07);;MERCK SHARP & DOHME CORP (2012-05-02);;MERCK SHARP & DOHME LIMITED (2008-11-13),https://lens.org/099-402-490-902-81X,Patent Application,yes,3,1,8,8,0,A61P3/00;;A61P9/00;;A61P25/00;;A61P25/28;;C07D211/34;;C07D211/34;;C07D241/04;;C07D241/04;;C07F7/0812;;C07F7/0812,A61K31/451;;A61P25/00;;C07D211/34,514/317;;546/238,5,5,012-994-617-927-80X;;086-287-476-399-91X;;074-059-139-010-627;;057-683-930-918-576;;045-768-765-643-181,10.1039/b504668h;;16027897;;10.1038/35017062;;10878808;;10.1517/13543776.18.7.693;;20503989;;10.1021/jm1003073;;10.1080/09540260701797944;;18092245,"Braga et al. ""Making crystals from....."" J. Roy. Soc. Chem. Chem. Commun. p.3635-3645 (2005);;Esler et al. ""Transition state....."" Nature Cell Biol. v.2, p.428-434 (2000);;Garofalo ""Patents targeting......"" Exp. Opinion Ther. Patents 18(7) 693-703 (2008);;Heike et al. ""Design synthesis...."" J. Med. Chem. v.53, p.4691-4700 (2010);;Szekely et al. ""Prevention of Alzheimer ...."" Int. Rev. Psych. v. 19(6) p.693-706 (2007)",ACTIVE
476,WO,A1,WO 2019/209877 A1,198-711-204-412-130,2019-10-31,2019,US 2019/0028796 W,2019-04-23,US 201862661496 P,2018-04-23,TECHNIQUES FOR BOUNDING CLEANING OPERATIONS OF A ROBOTIC SURFACE CLEANING DEVICE WITHIN A REGION OF INTEREST,"In general, the present disclosure is directed to a hand-held surface cleaning device that includes circuitry to communicate with a robotic surface cleaning device to cause the same to target an area/region of interest for cleaning. Thus, a user may utilize the hand-held surface cleaning device to perform targeted cleaning and conveniently direct a robotic surface cleaning device to focus on a region of interest. Moreover, the hand-held surface cleaning device may include sensory such as a camera device for extracting three-dimensional information from a field of view. This information may be utilized to map locations of walls, stairs, obstacles, changes in surface types, and other features in a given location. Thus, a robotic surface cleaning device may utilize the mapping information from the hand-held surface cleaning device as an input in a real-time control loop, e.g., as an input to a Simultaneous Localization and Mapping (SLAM) routine.",SHARKNINJA OPERATING LLC,THORNE JASON B;;BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;CROGGON HUGH J,,https://lens.org/198-711-204-412-130,Patent Application,yes,7,1,6,6,0,G05D1/0016;;G05D1/0033;;G05D1/0274;;A47L2201/022;;A47L2201/04;;A47L5/24;;A47L9/2894;;A47L9/2852;;G05D1/0274;;G05D1/0276;;A47L2201/04,G06F19/00,,1,0,,,See also references of EP 3928329A4,PENDING
477,WO,A1,WO 2007/125364 A1,199-674-801-031-64X,2007-11-08,2007,GB 2007050213 W,2007-04-25,US 79533106 P,2006-04-26,PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE,"Compounds of formula (I) are modulators of gamma-secretase, and hence are useful in treatment of Alzheimer’s disease.",MERCK SHARP & DOHME;;MERCK & CO INC;;GARCIA YUDITH;;HANNAM JOANNE CLARE;;HARRISON TIMOTHY;;HAMBLETT CHRISTOPHER L;;HUBBS JED L;;KULAGOWSKI JANUSZ JOSEF;;MADIN ANDREW;;RIDGILL MARK PETER;;SEWARD EILEEN,GARCIA YUDITH;;HANNAM JOANNE CLARE;;HARRISON TIMOTHY;;HAMBLETT CHRISTOPHER L;;HUBBS JED L;;KULAGOWSKI JANUSZ JOSEF;;MADIN ANDREW;;RIDGILL MARK PETER;;SEWARD EILEEN,,https://lens.org/199-674-801-031-64X,Patent Application,yes,2,11,8,8,0,A61P3/00;;A61P9/00;;A61P25/00;;A61P25/28;;C07D211/34;;C07D211/34;;C07D241/04;;C07D241/04;;C07F7/0812;;C07F7/0812,C07D211/34;;A61K31/445;;C07D241/04,,0,0,,,,PENDING
478,WO,A1,WO 2019/209879 A1,171-779-189-372-521,2019-10-31,2019,US 2019/0028798 W,2019-04-23,US 201862661504 P,2018-04-23,ASSISTED DRIVE FOR SURFACE CLEANING DEVICES,"In general, the present disclosure is directed to a force-sensing arrangement for use in surface cleaning devices, such as a vacuum device, that allows a user-supplied force to be translated into a command signal to cause the surface cleaning device to accelerate forward, reverse or to veer/turn in a desired direction. In an embodiment, the surface cleaning device includes a nozzle, wheels, motor(s) to drive the wheels, and an upright handle portion. The surface cleaning device includes a force-sensing arrangement with load cells coupled at a position where user force is transferred from the upright portion to the nozzle. The force-sensing arrangement detects the user supplying a relatively small amount of force and translates the same into measurement signals. A controller coupled to the load cells utilizes the measurement signals to determine or ""infer"" a desired direction of travel.",SHARKNINJA OPERATING LLC,BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;CROGGON HUGH J;;THORNE JASON B,,https://lens.org/171-779-189-372-521,Patent Application,yes,6,0,9,9,0,A47L5/30;;A47L9/2842;;A47L9/2852;;A47L9/2857;;A47L9/2821;;A47L5/24;;A47L5/28;;A47L5/30;;A47L9/2821;;A47L9/2852;;A47L9/2842;;A47L9/2857,A47L5/28;;A47L5/24;;A47L5/30,,0,0,,,,PENDING
479,EP,A1,EP 2013171 A1,106-207-322-157-88X,2009-01-14,2009,EP 07733634 A,2007-04-25,GB 2007050213 W;;US 79533106 P,2006-04-26,PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER S DISEASE,,MERCK SHARP & DOHME;;MERCK & CO INC,GARCIA YUDITH;;HANNAM JOANNE CLARE;;HARRISON TIMOTHY;;HAMBLETT CHRISTOPHER L;;HUBBS JED L;;KULAGOWSKI JANUSZ JOSEF;;MADIN ANDREW;;RIDGILL MARK PETER;;SEWARD EILEEN,"MERCK SHARP & DOHME CORP., RAHWAY, US (2022-04-01);;SCHERING CORPORATION (2012-08-08);;MERCK SHARP & DOHME ( UK) LTD., GB (2022-09-29);;MERCK SHARP & DOHME ( UK) LTD., HODDESDON, GB (2021-08-17);;MERCK SHARP & DOHME LLC, RAHWAY, US (2022-09-29);;MERCK SHARP & DOHME CORP. (2012-08-15);;MERCK SHARP & DOHME LIMITED (2012-08-15)",https://lens.org/106-207-322-157-88X,Patent Application,yes,0,0,8,8,0,A61P3/00;;A61P9/00;;A61P25/00;;A61P25/28;;C07D211/34;;C07D211/34;;C07D241/04;;C07D241/04;;C07F7/0812;;C07F7/0812,C07D211/34;;A61K31/445;;C07D241/04,,1,0,,,See references of WO 2007125364A1,ACTIVE
480,AU,A1,AU 2007/245435 A1,174-252-435-250-641,2007-11-08,2007,AU 2007/245435 A,2007-04-25,US 79533106 P;;GB 2007050213 W,2006-04-26,Piperidines and related compounds for treatment of Alzheimer's disease,,MERCK & CO INC;;MERCK SHARP & DOHME,SEWARD EILEEN;;MADIN ANDREW;;HUBBS JED L;;HAMBLETT CHRISTOPHER L;;HANNAM JOANNE CLARE;;KULAGOWSKI JANUSZ JOSEF;;HARRISON TIMOTHY;;RIDGILL MARK PETER;;GARCIA YUDITH,,https://lens.org/174-252-435-250-641,Patent Application,no,0,0,8,8,0,A61P3/00;;A61P9/00;;A61P25/00;;A61P25/28;;C07D211/34;;C07D211/34;;C07D241/04;;C07D241/04;;C07F7/0812;;C07F7/0812,C07D211/34;;A61K31/445;;C07D241/04,,0,0,,,,DISCONTINUED
481,CA,A1,CA 2649996 A1,023-187-482-354-263,2007-11-08,2007,CA 2649996 A,2007-04-25,US 79533106 P;;GB 2007050213 W,2006-04-26,PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE,,MERCK & CO INC;;MERCK SHARP & DOHME,HANNAM JOANNE CLARE;;GARCIA YUDITH;;HARRISON TIMOTHY;;RIDGILL MARK PETER;;HUBBS JED L;;SEWARD EILEEN;;HAMBLETT CHRISTOPHER L;;KULAGOWSKI JANUSZ JOSEF;;MADIN ANDREW,,https://lens.org/023-187-482-354-263,Patent Application,no,0,0,8,8,0,A61P3/00;;A61P9/00;;A61P25/00;;A61P25/28;;C07D211/34;;C07D211/34;;C07D241/04;;C07D241/04;;C07F7/0812;;C07F7/0812,C07D211/34;;A61K31/445;;C07D241/04,,0,0,,,,DISCONTINUED
482,US,A1,US 2019/0320865 A1,039-790-081-559-847,2019-10-24,2019,US 201916392480 A,2019-04-23,US 201916392480 A;;US 201862661504 P,2018-04-23,ASSISTED DRIVE FOR SURFACE CLEANING DEVICES,"In general, the present disclosure is directed to a force-sensing arrangement for use in surface cleaning devices, such as a vacuum device, that allows a user-supplied force to be translated into a command signal to cause the surface cleaning device to accelerate forward, reverse or to veer/turn in a desired direction. In an embodiment, the surface cleaning device includes a nozzle, wheels, motor(s) to drive the wheels, and an upright handle portion. The surface cleaning device includes a force-sensing arrangement with load cells coupled at a position where user force is transferred from the upright portion to the nozzle. The force-sensing arrangement detects the user supplying a relatively small amount of force and translates the same into measurement signals. A controller coupled to the load cells utilizes the measurement signals to determine or “infer” a desired direction of travel.",SHARKNINJA OPERATING LLC,BROWN ANDRE D;;CLARE DAVID S;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;JAMES SAMUEL EMRYS;;DOUGLAS MICHAEL JAMES;;CROGGON HUGH J;;THORNE JASON B,SHARKNINJA OPERATING LLC (2018-10-23),https://lens.org/039-790-081-559-847,Patent Application,yes,0,5,9,9,0,A47L5/30;;A47L9/2842;;A47L9/2852;;A47L9/2857;;A47L9/2821;;A47L5/24;;A47L5/28;;A47L5/30;;A47L9/2821;;A47L9/2852;;A47L9/2842;;A47L9/2857,A47L9/28,,0,0,,,,ACTIVE
483,WO,A1,WO 2023/235364 A1,095-974-973-589-467,2023-12-07,2023,US 2023/0023944 W,2023-05-31,US 202263348670 P;;US 202363502236 P,2022-06-03,METHOD OF ACTIVATING AND MANAGING DUAL USER INTERFACE OPERATING MODES,"The present disclosure generally relates to activating and managing dual user interface modes for an operating system. An electronic device configured to run an operating system in a first mode including a first user interface receives, while operating in the first user interface mode, a predefined sequence of inputs, and in response to receiving the predefined sequence of inputs, transitions the operating system from the first user interface mode to a second user interface mode. The second user interface mode has different input capabilities with respect to the first user interface mode.",APPLE INC,FLEIZACH CHRISTOPHER B;;ROMNEY CHRISTOPHER J;;KASEMSET CLARE T;;LOBO FERREIRA DA SILVA JOAQUIM GONCALO;;SEYMOUR ERIC T;;RAMIREZ MOLERES ISIS NAOMI;;WHEARRY JR ALLEN;;CHAMBERS ADRIAN T;;ZAKIROV MARGARITA;;PANAGE SOMMER,,https://lens.org/095-974-973-589-467,Patent Application,yes,32,0,2,2,0,G06F21/6218;;G06F2221/2149;;H04M1/72463;;H04M1/72448;;G06F3/0481;;G06F3/04817;;G06F3/0482;;G06F3/04842;;G06F2203/04806;;G06F9/451;;G06F3/0482,H04M1/72463;;G06F3/048;;G06F21/53;;G06F21/62,,0,0,,,,PENDING
484,US,B2,US 11860358 B2,141-272-167-055-006,2024-01-02,2024,US 202217878634 A,2022-08-01,US 202217878634 A;;US 202163232674 P,2021-08-13,Angular light sensor and eye-tracking,Angular sensors that may be used in eye-tracking systems are disclosed. An eye-tracking system may include a plurality of light sources to emit illumination light and a plurality of angular light sensors to receive returning light that is the illumination light reflecting from an eyebox region. The angular light sensors may output angular signals representing an angle of incidence of the returning light.,META PLATFORMS TECH LLC,DIAZ LILIANA RUIZ;;HUANG RUITING;;SHARMA ROBIN;;PETERSON JONATHAN ROBERT;;LIAO CHRISTOPHER YUAN TING;;OUDERKIRK ANDREW JOHN;;NUCCI GIANCARLO SIGURD SANTE;;ROBINSON CLARE JOYCE,META PLATFORMS TECHNOLOGIES LLC (2022-08-19),https://lens.org/141-272-167-055-006,Granted Patent,yes,11,0,2,4,0,G02B27/0093;;G02B27/0093;;G02B2027/0187;;G02B27/0179,G02B27/00;;G02B27/01,,7,5,065-935-924-143-215;;064-037-094-575-412;;020-671-717-445-131;;043-116-055-790-834;;090-691-967-105-364,pmc6928734;;31766345;;10.3390/s19235081;;10.1364/ao.48.005897;;19881658;;pmc2892475;;24784060;;10.1364/ol.39.002618;;10.1364/ol.38.004554;;24322072;;10.23940/ijpe.19.09.p7.23462355,"Carvalho F. F., et al., “A Novel Hybrid Polarization-Quadrature Pixel Cluster for Local Light Angle and Intensity Detection,” Association of Computing machinery, 2017, 7 pages.;;Qu L., et al., “Analysis and Adjustment of Positioning Error of PSD System for Mobile SOF-FTIR,” Sensors, 2019, vol. 19, No. 23, 16 pages.;;Wang A., et al., “Light Field Image Sensors Based on the Talbot Effect,” Applied Optics, Nov. 1, 2009, vol. 48, No. 31, pp. 5897-5905.;;Wang H., et al., “CMOS Self-Powered Monolithic Light-Direction Sensor with Digitalized Output,” Optics Letters, May 1, 2014, vol. 39, No. 9, pp. 2618-2621.;;Wang H., et al., “On-Chip Sensor for Light Direction Detection,” Optics Letters, Nov. 15, 2013, vol. 38, No. 22, pp. 4554-4557.;;Wang Y., et al., “Analog Detection of PSD Sensor and Sunshine Position Tracking Performance in Four Quadrant Arrays,” International Journal of Performability Engineering, Sep. 2019, vol. 15, No. 9, pp. 2346-2355.;;International Search report and Written Opinion for International Application No. PCT/US2022/040335, dated Dec. 12, 2022, 15 pages.",ACTIVE
485,EP,A1,EP 3696110 A1,190-347-070-974-699,2020-08-19,2020,EP 20156515 A,2020-02-11,US 201962804318 P,2019-02-12,APPARATUS FOR APPLYING A MATERIAL ONTO ARTICLES USING A TRANSFER COMPONENT,"An apparatus for transferring a transfer material (22) from a transfer component (24) to an article (10, 210, 220), the apparatus comprising: 
an array (38) of cavities (42), wherein each cavity of the array of cavities comprises: 
a frame (80), wherein the frame comprises a front face (82) having a first side portion (83), a second side portion (84) opposite the first side portion, an upper portion (85), and a lower portion (86) opposite the upper portion and a frame body (88) joined to the front face; 
a chamber (89) defined by the frame body, wherein the front face substantially surrounds an opening (87) to the chamber; 
a sealing portion (120) extending about at least a portion of the front face and adjacent to the opening; 
a vacuum portion comprising one or more conduits (104) in fluid communication with the chamber; and 
a first support member (140) disposed within the opening, wherein the support member is adjacent to the front face, wherein the first support member is configured to move in a first direction and a second direction opposite the first direction.
",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL,,https://lens.org/190-347-070-974-699,Patent Application,yes,28,0,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B65C3/14;;B41F16/00;;B41J3/407;;B41M3/12;;B44C1/10;;B65C3/08;;B65C3/16;;B65C9/18;;B65C9/26;;B65C9/46,,0,0,,,,DISCONTINUED
486,CN,A,CN 111546760 A,004-949-784-718-914,2020-08-18,2020,CN 202010085812 A,2020-02-11,US 201962804318 P,2019-02-12,Method and apparatus for applying material onto articles using transfer component,"The invention discloses an apparatus and method for applying a transfer material onto one or more surfaces of an article, including an apparatus and method of transfer printing on and/or decorating three-dimensional articles, as well as the articles printed and/or decorated thereby. The apparatus and method may include providing a deposition device, such as a printing device; providing a transfercomponent; depositing a material onto a portion of the transfer component with the deposition device; modifying the portion of the transfer component with the transfer material thereon to conform thetransfer component to at least a portion of one or more surfaces of the three-dimensional article; and transferring the transfer material onto the one or more surfaces of the article.",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL,,https://lens.org/004-949-784-718-914,Patent Application,no,9,0,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B41F16/00;;B41M1/22;;B41M5/025,,0,0,,,,DISCONTINUED
487,US,A1,US 2020/0254792 A1,127-199-158-121-088,2020-08-13,2020,US 202016787065 A,2020-02-11,US 202016787065 A;;US 201962804318 P,2019-02-12,METHOD AND APPARATUS FOR APPLYING A MATERIAL ONTO ARTICLES USING A TRANSFER COMPONENT,"Apparatuses and methods for applying a transfer material onto one or more surfaces of an article are disclosed, including apparatuses and methods of transfer printing on and/or decorating three-dimensional articles, as well as the articles printed and/or decorated thereby. The apparatuses and methods may include providing a deposition device, such as a printing device; providing a transfer component; depositing a material onto a portion of the transfer component with the deposition device; modifying the portion of the transfer component with the transfer material thereon to conform the transfer component to at least a portion of one or more surfaces of the three-dimensional article; and transferring the transfer material onto the one or more surfaces of the article.",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL,,https://lens.org/127-199-158-121-088,Patent Application,yes,0,4,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B41J13/22;;B41J2/01;;B41J3/407,,0,0,,,,DISCONTINUED
488,CN,A,CN 111546762 A,079-786-290-578-912,2020-08-18,2020,CN 202010085817 A,2020-02-11,US 201962804318 P,2019-02-12,Method and apparatus for applying material onto articles using transfer component,"The invention discloses an apparatus and method for applying a transfer material onto one or more surfaces of an article, including an apparatus and method of transfer printing on and/or decorating three-dimensional articles, as well as the articles printed and/or decorated thereby. The apparatus and method may include providing a deposition device, such as a printing device; providing a transfercomponent; depositing a material onto a portion of the transfer component with the deposition device; modifying the portion of the transfer component with the transfer material thereon to conform thetransfer component to at least a portion of one or more surfaces of the three-dimensional article; and transferring the transfer material onto the one or more surfaces of the article.",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL,,https://lens.org/079-786-290-578-912,Patent Application,no,14,0,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B41F16/00;;B41M1/22;;B41M5/025,,1,0,,,"陈晓瑜: ""谈谈碳钢发酵罐涂层及其清洗工艺"", 《啤酒科技》",ACTIVE
489,US,A1,US 2020/0254803 A1,056-475-752-167-470,2020-08-13,2020,US 202016787069 A,2020-02-11,US 202016787069 A;;US 201962804318 P,2019-02-12,METHOD AND APPARATUS FOR APPLYING A MATERIAL ONTO ARTICLES USING A TRANSFER COMPONENT,"Apparatuses and methods for applying a transfer material onto one or more surfaces of an article are disclosed, including apparatuses and methods of transfer printing on and/or decorating three-dimensional articles, as well as the articles printed and/or decorated thereby. The apparatuses and methods may include providing a deposition device, such as a printing device; providing a transfer component; depositing a material onto a portion of the transfer component with the deposition device; modifying the portion of the transfer component with the transfer material thereon to conform the transfer component to at least a portion of one or more surfaces of the three-dimensional article; and transferring the transfer material onto the one or more surfaces of the article.",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL,,https://lens.org/056-475-752-167-470,Patent Application,yes,0,4,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B41M5/025,,0,0,,,,DISCONTINUED
490,WO,A1,WO 2023/019014 A1,130-086-457-437-610,2023-02-16,2023,US 2022/0040335 W,2022-08-15,US 202163232674 P;;US 202217878634 A,2021-08-13,ANGULAR LIGHT SENSOR AND EYE TRACKING,Angular sensors (120) that may be used in eye-tracking systems are disclosed. An eye-tracking system may include a plurality of light sources (110) to emit illumination light (113) and a plurality of angular light sensors (120) to receive returning light (117) that is the illumination light reflecting from an eyebox region (195). The angular light sensors (120) may output angular signals representing an angle of incidence of the returning light.,META PLATFORMS TECH LLC,DIAZ LILIANA RUIZ;;HUANG RUITING;;PETERSON JONATHAN ROBERT;;LIAO CHRISTOPHER YUAN TING;;OUDERKIRK ANDREW JOHN;;NUCCI GIANCARLO SIGURD SANTE;;ROBINSON CLARE JOYCE;;SHARMA ROBIN,,https://lens.org/130-086-457-437-610,Patent Application,yes,5,0,2,4,0,G02B27/0093;;G02B27/0172;;G06F3/013,G02B27/01;;G02B27/00;;G06F3/01,,0,0,,,,PENDING
491,EP,A1,EP 3696109 A1,090-021-024-665-603,2020-08-19,2020,EP 20156509 A,2020-02-11,US 201962804318 P,2019-02-12,APPARATUS FOR APPLYING A MATERIAL ONTO ARTICLES USING A TRANSFER COMPONENT,"An apparatus for transferring a transfer material (22) from a transfer component (24) to an article (10, 210, 220), the apparatus comprising: 
an array (38) of cavities (42), wherein each cavity of the array of cavities comprises: 
a frame (80), wherein the frame comprises a front face (82) having a first side portion (83), a second side portion (84) opposite the first side portion, an upper portion (85), and a lower portion (86) opposite the upper portion and a frame body (88) joined to the front face; 
a chamber (89) defined by the frame body, wherein the front face substantially surrounds an opening to the chamber; 
a sealing portion (120) extending about at least a portion of the front face and adjacent to the opening; 
a clamp (76) disposed within the cavity; and 
a first support member (140) disposed within the opening, wherein the first support member is adjacent to the front face, and wherein the first support member is configured to move in a first direction and a second direction opposite the first direction.
",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL,,https://lens.org/090-021-024-665-603,Patent Application,yes,26,0,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B65C3/14;;B41F16/00;;B41J3/407;;B41M3/12;;B44C1/10;;B65C3/08;;B65C3/16;;B65C9/18;;B65C9/26;;B65C9/46,,0,0,,,,PENDING
492,US,A1,US 2023/0053107 A1,193-249-845-169-709,2023-02-16,2023,US 202217878634 A,2022-08-01,US 202217878634 A;;US 202163232674 P,2021-08-13,ANGULAR LIGHT SENSOR AND EYE-TRACKING,Angular sensors that may be used in eye-tracking systems are disclosed. An eye-tracking system may include a plurality of light sources to emit illumination light and a plurality of angular light sensors to receive returning light that is the illumination light reflecting from an eyebox region. The angular light sensors may output angular signals representing an angle of incidence of the returning light.,META PLATFORMS TECH LLC,DIAZ LILIANA RUIZ;;HUANG RUITING;;SHARMA ROBIN;;PETERSON JONATHAN ROBERT;;LIAO CHRISTOPHER YUAN TING;;OUDERKIRK ANDREW JOHN;;NUCCI GIANCARLO SIGURD SANTE;;ROBINSON CLARE JOYCE,META PLATFORMS TECHNOLOGIES LLC (2022-08-19),https://lens.org/193-249-845-169-709,Patent Application,yes,6,0,2,4,0,G02B27/0093;;G02B27/0093;;G02B2027/0187;;G02B27/0179,G02B27/00;;G02B27/01,,0,0,,,,ACTIVE
493,TW,A,TW 202312731 A,079-142-833-606-155,2023-03-16,2023,TW 111130233 A,2022-08-11,US 202163232674 P;;US 202217878634 A,2021-08-13,Angular light sensor and eye-tracking,Angular sensors that may be used in eye-tracking systems are disclosed. An eye-tracking system may include a plurality of light sources to emit illumination light and a plurality of angular light sensors to receive returning light that is the illumination light reflecting from an eyebox region. The angular light sensors may output angular signals representing an angle of incidence of the returning light.,META PLATFORMS TECHNOLOGIES LLC,DIAZ LILIANA RUIZ;;HUANG RUI-TING;;PETERSON JONATHAN ROBERT;;LIAO CHRISTOPHER YUAN TING;;OUDERKIRK ANDREW JOHN;;NUCCI GIANCARLO SIGURD SANTE;;ROBINSON CLARE JOYCE;;SHARMA ROBIN,,https://lens.org/079-142-833-606-155,Patent of Addition,no,0,0,2,4,0,G02B27/0093;;G02B27/0172;;G06F3/013,H04N13/383;;G02B27/02,,0,0,,,,PENDING
494,US,A1,US 2020/0254802 A1,097-987-501-500-01X,2020-08-13,2020,US 202016787061 A,2020-02-11,US 202016787061 A;;US 201962804318 P,2019-02-12,METHOD AND APPARATUS FOR APPLYING A MATERIAL ONTO ARTICLES USING A TRANSFER COMPONENT,"Apparatuses and methods for applying a transfer material onto one or more surfaces of an article are disclosed, including apparatuses and methods of transfer printing on and/or decorating three-dimensional articles, as well as the articles printed and/or decorated thereby. The apparatuses and methods may include providing a deposition device, such as a printing device; providing a transfer component; depositing a material onto a portion of the transfer component with the deposition device; modifying the portion of the transfer component with the transfer material thereon to conform the transfer component to at least a portion of one or more surfaces of the three-dimensional article; and transferring the transfer material onto the one or more surfaces of the article.",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL;;SAWIN PHILIP ANDREW,,https://lens.org/097-987-501-500-01X,Patent Application,yes,0,4,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B41M5/025,,0,0,,,,DISCONTINUED
495,US,A1,US 2020/0254751 A1,179-168-961-910-70X,2020-08-13,2020,US 202016787062 A,2020-02-11,US 202016787062 A;;US 201962804318 P,2019-02-12,METHOD AND APPARATUS FOR APPLYING A MATERIAL ONTO ARTICLES USING A TRANSFER COMPONENT,"Apparatuses and methods for applying a transfer material onto one or more surfaces of an article are disclosed, including apparatuses and methods of transfer printing on and/or decorating three-dimensional articles, as well as the articles printed and/or decorated thereby. The apparatuses and methods may include providing a deposition device, such as a printing device; providing a transfer component; depositing a material onto a portion of the transfer component with the deposition device; modifying the portion of the transfer component with the transfer material thereon to conform the transfer component to at least a portion of one or more surfaces of the three-dimensional article; and transferring the transfer material onto the one or more surfaces of the article.",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL;;SAWIN PHILIP ANDREW,,https://lens.org/179-168-961-910-70X,Patent Application,yes,0,5,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B41F16/00,,0,0,,,,DISCONTINUED
496,CN,A,CN 111546761 A,099-881-961-965-421,2020-08-18,2020,CN 202010085816 A,2020-02-11,US 201962804318 P,2019-02-12,Method and apparatus for applying material onto articles using transfer component,"The invention discloses an apparatus and method for applying a transfer material onto one or more surfaces of an article, including an apparatus and method of transfer printing on and/or decorating three-dimensional articles, as well as the articles printed and/or decorated thereby. The apparatus and method may include providing a deposition device, such as a printing device; providing a transfercomponent; depositing a material onto a portion of the transfer component with the deposition device; modifying the portion of the transfer component with the transfer material thereon to conform thetransfer component to at least a portion of one or more surfaces of the three-dimensional article; and transferring the transfer material onto the one or more surfaces of the article.",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL;;SAWIN PHILIP ANDREW,,https://lens.org/099-881-961-965-421,Patent Application,no,9,0,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B41F16/00;;B41M1/22;;B41M5/025,,0,0,,,,DISCONTINUED
497,EP,A1,EP 3696106 A1,175-876-064-610-83X,2020-08-19,2020,EP 20156501 A,2020-02-11,US 201962804318 P,2019-02-12,METHOD FOR APPLYING A MATERIAL ONTO ARTICLES USING A TRANSFER COMPONENT,"A method for transferring a transfer material (22) from a transfer component (24) to an article (10, 210, 220), the method comprising: 
traversing an array (38) of cavities (42) in a machine direction (MD), wherein each cavity of the array of cavities comprises a frame (80) defining an opening (87) and a chamber (89); 
transferring a first article (210) into a first cavity (242) of the array of cavities, wherein the first article comprises a first face (212) and a second face (214); 
operatively engaging a portion of the first article with a clamp (76); 
advancing a transfer component (24) in the machine direction, wherein the transfer component comprises a first transfer material; 
positioning the first article such that the first face is in facing relationship with the transfer component; 
sealing a supported portion of the transfer component to a perimeter of the frame, wherein an unsupported portion of the transfer component is disposed over the opening, and wherein the first transfer material is disposed over the opening in facing relationship with the first face of the first article; 
contacting the first face of the first article to the first transfer material; and 
transferring the first transfer material to the first face of the first article to form a first decorated face of the first article.
",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL;;SAWIN PHILIP ANDREW,,https://lens.org/175-876-064-610-83X,Patent Application,yes,28,0,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B65C3/14;;B41F16/00;;B41J3/407;;B41M3/12;;B44C1/10;;B65C3/08;;B65C3/16;;B65C9/18;;B65C9/26;;B65C9/46,,0,0,,,,DISCONTINUED
498,CN,A,CN 111546759 A,181-926-061-506-105,2020-08-18,2020,CN 202010085810 A,2020-02-11,US 201962804318 P,2019-02-12,METHOD FOR APPLYING MATERIAL ONTO ARTICLES USING TRANSFER COMPONENT,"Apparatuses and methods for applying a transfer material onto one or more surfaces of an article are disclosed, including apparatuses and methods of transfer printing on and/or decorating three-dimensional articles, as well as the articles printed and/or decorated thereby. The apparatuses and methods may include providing a deposition device, such as a printing device; providing a transfer component; depositing a material onto a portion of the transfer component with the deposition device; modifying the portion of the transfer component with the transfer material thereon to conform the transfer component to at least a portion of one or more surfaces of the three-dimensional article; and transferring the transfer material onto the one or more surfaces of the article.",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL;;SAWIN PHILIP ANDREW,,https://lens.org/181-926-061-506-105,Patent Application,no,9,0,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B41F16/00;;B41M1/22;;B41M5/025,,0,0,,,,DISCONTINUED
499,CN,A,CN 106963290 A,014-645-869-283-438,2017-07-21,2017,CN 201610921399 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P,2015-10-21,Surface cleaning head with dual rotating agitators,"A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roll) may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The leading roller is generally positioned adjacent to and in advance of the opening of the suction conduit. The rotating brush roll may be located in the suction conduit with the leading roller located in front of and spaced from the brush roll, forming an inter-roller air passageway therebetween. The leading roller may provide a softer cleaning element than the brush roll and may also have an outside diameter that is less than the outside diameter of the brush roll. The surface cleaning head may also include debriding protrusions contacting the leading roller and/or a leading bumper that extends in front of the leading roller.",SHARKNINJA OPERATING LLC,CATRIONA SUTTER;;CHRISTOPHER PINCHES;;ADAM UDY;;PATRICK CLEARY;;ALEXANDER CALVINO;;LEE COTTRELL;;DAVID CLARE;;ANDRE DAVID BROWN;;DANIEL MEYER;;STEVEN PAUL CARTER;;JOHN FREESE;;DANIEL JOHN INNES,,https://lens.org/014-645-869-283-438,Patent Application,no,8,12,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04,,0,0,,,,ACTIVE
500,EP,A1,EP 3696107 A1,037-134-922-601-029,2020-08-19,2020,EP 20156503 A,2020-02-11,US 201962804318 P,2019-02-12,METHOD FOR APPLYING A MATERIAL ONTO ARTICLES USING A TRANSFER COMPONENT,"A method for transferring a transfer material (22) from a transfer component (24) to an article (10, 210, 220), the method comprising: 
traversing an array (38) of cavities (42) in a machine direction (MD), wherein each cavity of the array of cavities comprises a frame (80) defining an opening (87) and a chamber (89); 
transferring a first article (210) into a first cavity of the array of cavities, wherein the first article comprises a first face (212) and a second face (214); 
operatively engaging a portion of the first article with a clamp (76); 
advancing a transfer component (24) in the machine direction (MD), wherein the transfer component comprises a first transfer material (22); 
positioning the first article such that the first face is in facing relationship with the transfer component; 
sealing a supported portion of the transfer component to a perimeter of the frame, wherein an unsupported portion of the transfer component is disposed over the opening, and wherein the first transfer material is disposed over the opening in facing relationship with the first face of the first article; 
traversing the first article in a first direction and a second direction opposite the first direction; 
contacting the first face of the first article to the first transfer material; and 
transferring the first transfer material to the first face of the first article to form a first decorated face of the first article.
",PROCTER & GAMBLE,CASSONI ROBERT PAUL;;BOURGEOIS MARC RICHARD;;ALLEN MATTHEW RICHARD;;HARGETT MARK MASON;;CLARE BENJAMIN JACOB;;DONNER CHRISTOPHER GERALD;;ORNDORFF JASON MATTHEW;;YEAGLE TODD MICHAEL;;SAWIN PHILIP ANDREW,,https://lens.org/037-134-922-601-029,Patent Application,yes,28,0,18,18,0,B41F16/008;;B41F16/0086;;B41M5/025;;B41M1/22;;B41M3/12;;B65C9/1865;;B41J3/4073;;B65C3/14;;B65C9/1876;;B65C9/26;;B65C9/46;;B41F16/008;;B41F16/0086;;B41F16/0033;;B44C1/105;;B41J3/40733;;B41M5/025;;B41J2/01;;B41J3/4073;;B41J13/22;;B41J2002/012;;B41F16/006;;B41F16/0086;;B41M1/40;;B41F16/008;;B41J3/40733,B65C3/14;;B41F16/00;;B41J3/407;;B41M3/12;;B44C1/10;;B65C3/08;;B65C3/16;;B65C9/18;;B65C9/26;;B65C9/46,,0,0,,,,DISCONTINUED
501,US,A1,US 2018/0256327 A1,152-721-396-221-813,2018-09-13,2018,US 201815915196 A,2018-03-08,US 201815915196 A;;US 201762469646 P,2017-03-10,TRANSSEPTAL MITRAL VALVE DELIVERY SYSTEM,"A delivery device for a prosthetic mitral valve includes five sheaths and a handle. The first sheath is coupled to a first handle portion and is rotatable and bendable. The second sheath is coupled to a second handle portion and extends through the first sheath. The second sheath is bendable, rotatable and translatable relative to the first sheath. The third sheath is coupled to a third handle portion and extends through the first and second sheaths. The third sheath is translatable relative to the second sheath. The second handle portion is coupled to the first and third handle portions. The fourth sheath extends through the third sheath and forms part of a compartment to store the prosthetic valve. The fifth sheath extends through the fourth sheath to a tip and is coupled to a retaining sheath that closes the compartment to retain the valve in a collapsed condition.",ST JUDE MEDICAL CARDIOLOGY DIV INC,PERSZYK BRIAN JOSEPH;;GLIMSDALE MATHIAS CHARLES;;DALE THEODORE PAUL;;HERBERT JUSTIN;;HUNT CHRISTOPHER WILLIAM;;GOH BRYAN CHENG YANG;;BOND NATASHA LOUISE;;PAULSON ROSS DAVID;;PATRICK BRYAN CLARE;;SKEMP BENEDICT,ST. JUDE MEDICAL CARDIOLOGY DIVISION INC (2018-11-15),https://lens.org/152-721-396-221-813,Patent Application,yes,8,33,4,4,0,A61F2/2436;;A61F2/2436;;A61F2/2412;;A61F2/2412;;A61F2/2418;;A61F2/2439;;A61F2/9517;;A61F2/9517,A61F2/24,,0,0,,,,ACTIVE
502,US,B2,US 10842624 B2,045-373-675-366-655,2020-11-24,2020,US 201815915196 A,2018-03-08,US 201815915196 A;;US 201762469646 P,2017-03-10,Transseptal mitral valve delivery system,"A delivery device for a prosthetic mitral valve includes five sheaths and a handle. The first sheath is coupled to a first handle portion and is rotatable and bendable. The second sheath is coupled to a second handle portion and extends through the first sheath. The second sheath is bendable, rotatable and translatable relative to the first sheath. The third sheath is coupled to a third handle portion and extends through the first and second sheaths. The third sheath is translatable relative to the second sheath. The second handle portion is coupled to the first and third handle portions. The fourth sheath extends through the third sheath and forms part of a compartment to store the prosthetic valve. The fifth sheath extends through the fourth sheath to a tip and is coupled to a retaining sheath that closes the compartment to retain the valve in a collapsed condition.",ST JUDE MEDICAL CARDIOLOGY DIV INC,PERSZYK BRIAN JOSEPH;;GLIMSDALE MATHIAS CHARLES;;DALE THEODORE PAUL;;HERBERT JUSTIN;;HUNT CHRISTOPHER WILLIAM;;GOH BRYAN CHENG YANG;;BOND NATASHA LOUISE;;PAULSON ROSS DAVID;;PATRICK BRYAN CLARE;;SKEMP BENEDICT,ST. JUDE MEDICAL CARDIOLOGY DIVISION INC (2018-11-15),https://lens.org/045-373-675-366-655,Granted Patent,yes,76,0,4,4,0,A61F2/2436;;A61F2/2436;;A61F2/2412;;A61F2/2412;;A61F2/2418;;A61F2/2439;;A61F2/9517;;A61F2/9517,A61F2/95;;A61F2/24,,3,1,066-442-172-821-220,10.1016/j.ejcts.2005.01.048;;15848323,"International Search Report including Written Opinion for PCT/US2018/021438 dated May 22, 2018.;;Quaden et al., “Percutaneous aortic valve replacement: resection before implantation”, European J. of Cardio-thoracic Surgery, vol. 27, Issue 5, pp. 836-840, May 2005.;;Ruiz, “Overview of PRE-CE Mark Transcatheter Aortic Valve Technologies”, Euro PCR, dated May 25, 2010.",ACTIVE
503,KR,A,KR 20210057810 A,069-952-087-634-534,2021-05-21,2021,KR 20217011620 A,2019-09-19,US 201862733239 P;;US 201962862436 P;;US 2019/0051889 W,2018-09-19,하나 이상의 스태빌라이저를 갖는 표면 처리 장치용 청소 헤드 및 이를 갖는 표면 처리 장치,"표면 청소 헤드 예시는 본체, 본체에 피봇식으로 결합된 네크부, 스태빌라이저, 및 본체와 스태빌라이저에 피봇식으로 결합된 연결부를 포함할 수 있다. 연결부는 네크부의 피봇 이동에 응답하여 스태빌라이저가 연장 위치와 수축 위치 사이에서 전이되도록 구성될 수 있다.",SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/069-952-087-634-534,Patent Application,no,3,0,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/00;;A47L5/28,,0,0,,,,ACTIVE
504,CN,A,CN 113015473 A,015-637-830-596-468,2021-06-22,2021,CN 201980074896 A,2019-09-19,US 201862733239 P;;US 201962862436 P;;US 2019/0051889 W,2018-09-19,CLEANING HEAD FOR A SURFACE TREATMENT APPARATUS HAVING ONE OR MORE STABILIZERS AND SURFACE TREATMENT APPARATUS HAVING THE SAME,"An example of a surface cleaning head may include a main body, a neck pivotally coupled to the main body, a stabilizer, and a linkage pivotally coupled to the main body and the stabilizer. The linkage may be configured to cause the stabilizer to transition between an extended position and a retracted position in response to a pivotal movement of the neck.",SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/015-637-830-596-468,Patent Application,no,10,0,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/00;;A47L5/00;;A47L7/00;;A47L11/00,,0,0,,,,ACTIVE
505,EP,A4,EP 3852592 A4,010-947-812-321-059,2022-06-29,2022,EP 19863315 A,2019-09-19,US 201862733239 P;;US 201962862436 P;;US 2019/0051889 W,2018-09-19,CLEANING HEAD FOR A SURFACE TREATMENT APPARATUS HAVING ONE OR MORE STABILIZERS AND SURFACE TREATMENT APPARATUS HAVING THE SAME,,SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/010-947-812-321-059,Search Report,no,5,0,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/00;;A47L5/28,,0,0,,,,PENDING
506,EP,A4,EP 2906542 A4,149-958-632-810-255,2016-07-20,2016,EP 13844724 A,2013-10-11,US 201261712534 P;;US 201261731625 P;;US 2013/0064472 W,2012-10-11,SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS GPR120 AGONISTS,,MERCK SHARP & DOHME,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,"MERCK SHARP & DOHME LLC, RAHWAY, US (2022-09-29)",https://lens.org/149-958-632-810-255,Search Report,no,3,0,14,14,0,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,C07D221/20;;C07D401/04,,0,0,,,,ACTIVE
507,CA,A1,CA 3113028 A1,175-585-169-408-89X,2020-03-26,2020,CA 3113028 A,2019-09-19,US 201862733239 P;;US 201962862436 P;;US 2019/0051889 W,2018-09-19,CLEANING HEAD FOR A SURFACE TREATMENT APPARATUS HAVING ONE OR MORE STABILIZERS AND SURFACE TREATMENT APPARATUS HAVING THE SAME,"An example of a surface cleaning head may include a main body, a neck pivotally coupled to the main body, a stabilizer, and a linkage pivotally coupled to the main body and the stabilizer. The linkage may be configured to cause the stabilizer to transition between an extended position and a retracted position in response to a pivotal movement of the neck.",SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/175-585-169-408-89X,Patent Application,no,0,0,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/00;;A47L5/00;;A47L7/00;;A47L11/00,,0,0,,,,PENDING
508,EP,A2,EP 2906542 A2,011-354-465-594-88X,2015-08-19,2015,EP 13844724 A,2013-10-11,US 201261712534 P;;US 201261731625 P;;US 2013/0064472 W,2012-10-11,SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS GPR120 AGONISTS,,MERCK SHARP & DOHME,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,"MERCK SHARP & DOHME LLC, RAHWAY, US (2022-09-29)",https://lens.org/011-354-465-594-88X,Patent Application,yes,0,0,14,14,4,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,C07D221/20;;C07D401/04,,0,0,,,,ACTIVE
509,AU,A1,AU 2013/329064 A1,195-303-561-004-651,2015-04-16,2015,AU 2013/329064 A,2013-10-11,US 201261712534 P;;US 201261731625 P;;US 2013/0064472 W,2012-10-11,Substituted spiropiperidinyl compounds useful as GPR120 agonists,"The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.",MERCK SHARP & DOHME,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,,https://lens.org/195-303-561-004-651,Patent Application,no,0,0,14,14,0,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,C07D221/20;;C07D401/04,,0,0,,,,DISCONTINUED
510,CN,A,CN 105073111 A,051-108-043-516-854,2015-11-18,2015,CN 201380053095 A,2013-10-11,US 2013/0064472 W;;US 201261712534 P;;US 201261731625 P,2012-10-11,Substituted spiropiperidinyl compounds useful as gpr120 agonists,"The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.",MERCK SHARP & DOHME,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,,https://lens.org/051-108-043-516-854,Patent Application,no,9,1,14,14,0,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,A61K31/438,,0,0,,,,DISCONTINUED
511,EP,B1,EP 2906542 B1,070-890-376-884-040,2019-08-07,2019,EP 13844724 A,2013-10-11,US 201261712534 P;;US 201261731625 P;;US 2013/0064472 W,2012-10-11,SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS GPR120 AGONISTS,,MERCK SHARP & DOHME,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,"MERCK SHARP & DOHME LLC, RAHWAY, US (2022-09-29)",https://lens.org/070-890-376-884-040,Granted Patent,yes,9,0,14,14,0,C07D401/04;;C07D401/12;;C07D491/107;;C07D405/10;;C07D221/20;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P3/04;;A61P35/00;;A61P3/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/04;;C07D401/12;;C07D491/107;;C07D221/20;;C07D405/10,C07D401/04;;C07D221/20,,0,0,,,,ACTIVE
512,WO,A3,WO 2014/059232 A3,082-613-672-793-151,2015-07-16,2015,US 2013/0064472 W,2013-10-11,US 201261712534 P;;US 201261731625 P,2012-10-11,SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS GPR120 AGONISTS,"The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.",MERCK SHARP & DOHME;;CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,,https://lens.org/082-613-672-793-151,Search Report,yes,6,0,14,14,4,C07D401/04;;C07D401/12;;C07D491/107;;C07D405/10;;C07D221/20;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P3/04;;A61P35/00;;A61P3/06;;A61P9/00;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/04;;C07D401/12;;C07D491/107;;C07D221/20;;C07D405/10,A61K31/438,,0,0,,,,PENDING
513,AU,B2,AU 2019/342737 B2,166-239-999-575-12X,2023-02-09,2023,AU 2019/342737 A,2019-09-19,US 201862733239 P;;US 201962862436 P;;US 2019/0051889 W,2018-09-19,Cleaning head for a surface treatment apparatus having one or more stabilizers and surface treatment apparatus having the same,"An example of a surface cleaning head may include a main body, a neck pivotally coupled to the main body, a stabilizer, and a linkage pivotally coupled to the main body and the stabilizer. The linkage may be configured to cause the stabilizer to transition between an extended position and a retracted position in response to a pivotal movement of the neck.",SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/166-239-999-575-12X,Granted Patent,no,2,0,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/00;;A47L5/00;;A47L7/00;;A47L11/00,,0,0,,,,ACTIVE
514,WO,A1,WO 2020/061285 A1,193-205-510-587-250,2020-03-26,2020,US 2019/0051889 W,2019-09-19,US 201862733239 P;;US 201962862436 P,2018-09-19,CLEANING HEAD FOR A SURFACE TREATMENT APPARATUS HAVING ONE OR MORE STABILIZERS AND SURFACE TREATMENT APPARATUS HAVING THE SAME,"An example of a surface cleaning head may include a main body, a neck pivotally coupled to the main body, a stabilizer, and a linkage pivotally coupled to the main body and the stabilizer. The linkage may be configured to cause the stabilizer to transition between an extended position and a retracted position in response to a pivotal movement of the neck.",SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/193-205-510-587-250,Patent Application,yes,12,2,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/00;;A47L5/00;;A47L7/00;;A47L11/00,,0,0,,,,PENDING
515,CA,A1,CA 2887348 A1,198-745-071-433-178,2014-04-17,2014,CA 2887348 A,2013-10-11,US 201261712534 P;;US 201261731625 P;;US 2013/0064472 W,2012-10-11,SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS GPR120 AGONISTS,"The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.",MERCK SHARP & DOHME,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,,https://lens.org/198-745-071-433-178,Patent Application,no,0,0,14,14,4,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,C07D221/20;;A61K31/438;;A61P3/04;;A61P3/06;;A61P3/10;;C07D401/04,,0,0,,,,DISCONTINUED
516,AU,A1,AU 2019/342737 A1,120-860-251-473-699,2021-04-15,2021,AU 2019/342737 A,2019-09-19,US 201862733239 P;;US 201962862436 P;;US 2019/0051889 W,2018-09-19,Cleaning head for a surface treatment apparatus having one or more stabilizers and surface treatment apparatus having the same,"An example of a surface cleaning head may include a main body, a neck pivotally coupled to the main body, a stabilizer, and a linkage pivotally coupled to the main body and the stabilizer. The linkage may be configured to cause the stabilizer to transition between an extended position and a retracted position in response to a pivotal movement of the neck.",SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/120-860-251-473-699,Patent Application,no,0,0,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/00;;A47L5/00;;A47L7/00;;A47L11/00,,0,0,,,,ACTIVE
517,CA,C,CA 3113028 C,120-063-314-258-776,2023-09-05,2023,CA 3113028 A,2019-09-19,US 201862733239 P;;US 201962862436 P;;US 2019/0051889 W,2018-09-19,CLEANING HEAD FOR A SURFACE TREATMENT APPARATUS HAVING ONE OR MORE STABILIZERS AND SURFACE TREATMENT APPARATUS HAVING THE SAME,"An example of a surface cleaning head may include a main body, a neck pivotally coupled to the main body, a stabilizer, and a linkage pivotally coupled to the main body and the stabilizer. The linkage may be configured to cause the stabilizer to transition between an extended position and a retracted position in response to a pivotal movement of the neck.",SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/120-063-314-258-776,Granted Patent,no,0,0,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/00;;A47L5/00;;A47L7/00;;A47L11/00,,0,0,,,,PENDING
518,KR,A,KR 20150067184 A,093-067-422-414-95X,2015-06-17,2015,KR 20157009035 A,2013-10-11,US 201261712534 P;;US 201261731625 P;;US 2013/0064472 W,2012-10-11,SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS GPR120 AGONISTS,"본 발명은 하기 화학식 I에 의해 나타내어지는 화합물 및 그의 제약상 허용되는 염에 관한 것이며, <화학식 I>이들은 당뇨병, 고지혈증, 비만, 염증 관련 장애, 및 관련 질환 및 상태의 치료 또는 예방에 유용한 것으로 개시되어 있다. 이 화합물은 G-단백질 커플링된 수용체 GPR120의 효능제로서 유용하다. 제약 조성물 및 치료 방법이 또한 포함된다.",MERCK SHARP & DOHME,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,,https://lens.org/093-067-422-414-95X,Patent Application,no,0,0,14,14,8,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,A61K31/4747;;C07D401/04;;C07D401/12;;C07D491/107,,0,0,,,,DISCONTINUED
519,CN,U,CN 212186355 U,057-129-022-388-284,2020-12-22,2020,CN 201921560474 U,2019-09-19,US 201862733239 P;;US 201962862436 P,2018-09-19,Cleaning head with stabilizer and vacuum cleaner with cleaning head,"The utility model relates to a cleaning head with a stabilizer and a vacuum cleaner with the cleaning head. The surface cleaning head can comprise a main body, a neck part pivotally connected to the main body, the stabilizer and a connecting rod pivotally connected to the main body and the stabilizer. The link may be configured to transition the stabilizer between an extended position and a retracted position in response to pivotable movement of the neck.",SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/057-129-022-388-284,Limited Patent,no,0,1,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L5/12;;A47L9/00;;A47L9/02;;A47L9/10,,0,0,,,,ACTIVE
520,US,B2,US 9708270 B2,077-784-852-261-967,2017-07-18,2017,US 201314434524 A,2013-10-11,US 201314434524 A;;US 2013/0064472 W;;US 201261712534 P;;US 201261731625 P,2012-10-11,Substituted spiropiperidinyl compounds useful as GPR120 agonists,"The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.",MERCK SHARP & DOHME,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SRIKANTH,MERCK SHARP & DOHME LLC (2022-04-07);;MERCK SHARP & DOHME CORP (2013-10-25),https://lens.org/077-784-852-261-967,Granted Patent,yes,13,0,14,14,4,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,C07D401/12;;C07D201/04;;C07D221/20;;C07D401/04;;C07D405/10;;C07D491/107,,2,0,,,"Pandey et al 2001, Spirocyclic Non-peptide IIb-IIIa Antagonists. Part 2: Design of Potent Antagonists containing the 3-azaspiro[5.5]undec-9-yl Template.;;International Search Report and Written Opinion for PCT/US2013/064472; mailed on Mar. 27, 2014; 9 pages.",ACTIVE
521,US,A1,US 2020/0085267 A1,187-260-169-693-31X,2020-03-19,2020,US 201916575891 A,2019-09-19,US 201916575891 A;;US 201862733239 P;;US 201962862436 P,2018-09-19,CLEANING HEAD FOR A SURFACE TREATMENT APPARATUS HAVING ONE OR MORE STABILIZERS AND SURFACE TREATMENT APPARATUS HAVING THE SAME,"An example of a surface cleaning head may include a main body, a neck pivotally coupled to the main body, a stabilizer, and a linkage pivotally coupled to the main body and the stabilizer. The linkage may be configured to cause the stabilizer to transition between an extended position and a retracted position in response to a pivotal movement of the neck.",SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/187-260-169-693-31X,Patent Application,yes,10,1,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/04;;A47L9/00,,1,0,,,JP2003102663_EPO_Machine_Translation (Year: 2003),PENDING
522,US,A1,US 2015/0274672 A1,098-966-988-545-829,2015-10-01,2015,US 201314434524 A,2013-10-11,US 201314434524 A;;US 2013/0064472 W;;US 201261712534 P;;US 201261731625 P,2012-10-11,SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS GPR120 AGONISTS,"The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.",CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;KATRAMAN SKIKANTH;;MERCK SHARP & DOHME,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SRIKANTH,MERCK SHARP & DOHME LLC (2022-04-07);;MERCK SHARP & DOHME CORP (2013-10-25),https://lens.org/098-966-988-545-829,Patent Application,yes,4,12,14,14,4,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,C07D221/20;;C07D401/04;;C07D405/10;;C07D491/107,,1,0,,,"Pandey et al 2001, Spirocyclic Non-peptide IIb-IIIa Antagonists. Part 2: Design of Potent Antagonists containing the 3-azaspiro[5.5]undec-9-yl Template.",ACTIVE
523,WO,A2,WO 2014/059232 A2,103-021-671-885-151,2014-04-17,2014,US 2013/0064472 W,2013-10-11,US 201261712534 P;;US 201261731625 P,2012-10-11,SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS GPR120 AGONISTS,"The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.",MERCK SHARP & DOHME;;CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,CHELLIAH MARIAPPAN;;CHU HONG DONG;;COX JASON M;;DEBENHAM JOHN S;;EAGEN KEITH;;LAN PING;;LONDON CLARE;;PLOTKIN MICHAEL A;;SHAH UNMESH;;SINZ CHRISTOPHER JOSEPH;;SUN ZHONGXIANG;;VACCARO HENRY M;;VENKATRAMAN SKIKANTH,,https://lens.org/103-021-671-885-151,Patent Application,yes,0,16,14,14,4,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,C07D221/20;;C07D401/04,,1,0,,,See references of EP 2906542A4,PENDING
524,EP,A1,EP 3852592 A1,199-281-032-131-226,2021-07-28,2021,EP 19863315 A,2019-09-19,US 201862733239 P;;US 201962862436 P;;US 2019/0051889 W,2018-09-19,CLEANING HEAD FOR A SURFACE TREATMENT APPARATUS HAVING ONE OR MORE STABILIZERS AND SURFACE TREATMENT APPARATUS HAVING THE SAME,,SHARKNINJA OPERATING LLC,THORNE JASON B;;XU KAI;;CHENG BRUCE;;LIU IAN;;XU AIMING;;GAO WENXIU;;BROWN ANDRE D;;JAMES SAMUEL EMRYS;;RIDGLEY JORDAN;;SARDAR NICHOLAS;;PINCHES CHRISTOPHER P;;CLARE DAVID S;;COTTRELL LEE M,,https://lens.org/199-281-032-131-226,Patent Application,yes,0,0,15,15,0,A47L9/009;;A47L5/28;;A47L9/0054;;A47L9/0054;;A47L5/28;;A47L9/009;;A47L9/0455,A47L9/00;;A47L5/00;;A47L7/00;;A47L11/00,,0,0,,,,PENDING
525,BR,A2,BR 112015007818 A2,060-461-820-351-93X,2017-11-28,2017,BR 112015007818 A,2013-10-11,US 2013/0064472 W;;US 201261712534 P;;US 201261731625 P,2012-10-11,"composto, composição farmacêutica, e, uso de um composto e de uma composição farmacêutica","1 / 1 resumo â€œcomposto, composiã‡ãƒo farmacãšutica, uso de um composto, e, mã‰todo para o tratamento de uma condiã‡ãƒoâ€� a presente invenã§ã£o refere-se a um composto representado pela fã³rmula (i): i e sais farmaceuticamente aceitã¡veis do mesmo sã£o descritos como ãºteis para tratamento ou prevenã§ã£o de diabetes, hiperlipidemia, obesidade, distãºrbios relacionados com inflamaã§ã£o, e doenã§as e condiã§ãµes relacionadas. os compostos sã£o ãºteis como agonistas do receptor acoplado ã  proteã­na g gpr120. composiã§ãµes farmacãªuticas e mã©todos de tratamento tambã©m sã£o incluã­dos.",MERCK SHARP & DOHME,CHRISTOPHER JOSEPH SINZ;;CLARE LONDON;;HENRY M VACCARO;;HONG DONG CHU;;JASON M COX;;JOHN S DEBENHAM;;KEITH EAGEN;;MARIAPPAN V CHELLIAH;;MICHAEL A PLOTKIN;;PING LAN;;SKIKANTH VENKATRAMAN;;UNMESH SHAH;;ZHONGXIANG SUN,,https://lens.org/060-461-820-351-93X,Patent Application,no,0,0,14,14,0,A61P3/04;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P25/18;;A61P25/28;;A61P29/00;;A61P35/00;;C07D221/20;;C07D221/20;;C07D401/04;;C07D401/04;;C07D401/12;;C07D401/12;;C07D405/10;;C07D405/10;;C07D491/107;;C07D491/107,C07D221/20;;C07D401/04,,0,0,,,,DISCONTINUED
526,KR,A,KR 20140113944 A,082-640-472-216-230,2014-09-25,2014,KR 20147019409 A,2012-12-11,GB 201200403 A;;GB 2012053082 W,2012-01-10,TURBOCHARGER HAVING A CONNECTOR FOR CONNECTING AN IMPELLER TO A SHAFT,,NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/082-640-472-216-230,Patent Application,no,0,0,10,10,0,F01D5/025;;F16D1/0835;;F04D29/266;;F05D2220/40;;F05D2300/50212;;F04D25/024;;F04D29/023;;F04D29/284;;F05D2300/171;;F05D2300/173;;F05D2300/50212;;F16D1/0835;;F04D29/266;;F01D5/025;;F05D2220/40;;F04D29/284;;F04D25/024;;F04D29/023;;F05D2300/171;;F05D2300/173;;F04D29/5853;;F04D29/601,F01D5/02;;F04D29/26;;F16B39/00;;F16D1/08,,0,0,,,,DISCONTINUED
527,GB,B,GB 2498748 B,166-467-178-633-710,2017-07-26,2017,GB 201201278 A,2012-01-24,GB 201201278 A,2012-01-24,Connection system,,NAPIER TURBOCHARGERS LTD,IAN PINKNEY;;OSAROBO FAMOUS OKHUAHESOGIE;;PAUL EIFION ROACH;;NEIL RYAN THOMAS;;IAN PATRICK CLARE BROWN;;PETER KAY;;STEPHEN WILSON;;DAVID LESLIE SMITH;;ROBERT NEIL GEORGE;;PAUL LESLIE JACKLIN;;GEOFF KINPOY NGAO;;KEVIN JOHN MUSSON;;MATTHEW ELIJAH MOORE;;JAMIE CLARE;;THOMAS JARLATH MURRAY;;STUART MICHAEL POTTER;;CHRISTOPHER JOHN MONAGHAN;;ALAN MARTIN TAYLOR;;FRANCIS JOSEPH GEOFFREY HEYES;;TREVOR KNIGHTON,,https://lens.org/166-467-178-633-710,Granted Patent,no,2,0,3,3,0,F01D5/025;;F01D5/048;;F04D29/266;;F04D29/284;;F01D5/048;;F04D29/266;;F04D29/284,F04D29/26;;F01D5/02;;F01D5/04;;F04D29/28,,0,0,,,,ACTIVE
528,GB,A,GB 2498748 A,177-153-562-480-98X,2013-07-31,2013,GB 201201278 A,2012-01-24,GB 201201278 A,2012-01-24,Impeller to shaft connection system,"A connection system for connecting an impeller 1 to a shaft 2. The impeller has a shaft-side hub extension H with a central hole. The connection system has a connector body 3 which is inserted into the hole. The connector body has a threaded portion 12 which screws onto a corresponding threaded portion 7 of the shaft such that the connection system provides a rotationally fixed connection between the impeller and the shaft. The connection system further has a split collar 21 which surrounds the connector body, and is frictionally connected on an inner side with an outwardly facing surface 14 of the connector body, and is frictionally connected on an outer side with a radially inner surface of the hub extension. The connection system further has a piston-type ring 22 which is housed in respective recesses formed in the outer side of the split collar and the radially inner surface of the hub extension.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/177-153-562-480-98X,Patent Application,no,2,0,3,3,0,F01D5/025;;F01D5/048;;F04D29/266;;F04D29/284;;F01D5/048;;F04D29/266;;F04D29/284,F04D29/26;;F01D5/02;;F01D5/04;;F04D29/28,,0,0,,,,ACTIVE
529,EP,B1,EP 2795065 B1,141-480-717-271-114,2015-08-19,2015,EP 12809313 A,2012-12-12,GB 201122236 A;;GB 2012053097 W,2011-12-23,CONNECTOR,,NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,"WABTEC UK LIMITED (2022-08-16);;WABTEC UK LTD., DONCASTER, GB (2022-08-18)",https://lens.org/141-480-717-271-114,Granted Patent,yes,3,0,14,14,0,F01D5/025;;F01D5/025;;F01D5/026;;F01D5/026;;F04D29/266;;F04D29/266;;F16D1/076;;F16D1/076;;F16D1/0847;;F16D1/0858;;F16D1/0858;;F16D2300/08;;F16D2300/08,F16D1/076,,0,0,,,,ACTIVE
530,GB,A,GB 2514693 A,006-875-369-576-211,2014-12-03,2014,GB 201410999 A,2013-01-11,GB 201201163 A;;GB 2013050044 W,2012-01-24,"Connection system, corresponding impeller and turbocharger",A connection system for connecting an impeller to a shaft is provided. The impeller has a shaft-side hub extension with a central hole. The connection system has a connector body which is inserted into the hole. The connector body has a threaded portion carrying a thread which screws onto a corresponding threaded portion of the shaft such that the connection system provides a rotationally fixed connection between the impeller and the shaft. The connection system further has a plurality of circumferentially distributed elongate threaded members which join the connector body to the hub extension such that the connector body is axially fixed relative to the impeller. The connection system further has plurality of circumferentially distributed torque transfer members which extend between the connector body and the hub extension to transmit a majority of the torque between the shaft and the impeller. Corresponding impeller and turbocharger are also provided.,NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR;;MONAGHAN CHRISTOPHER JOHN,,https://lens.org/006-875-369-576-211,Patent Application,no,8,1,5,5,0,F01D5/025;;F01D5/025;;F04D29/266;;F04D29/266;;F05D2220/40;;F05D2220/40,F01D5/02;;F04D29/26,,0,0,,,,ACTIVE
531,GB,A,GB 2498361 A,132-115-662-066-145,2013-07-17,2013,GB 201200404 A,2012-01-10,GB 201200404 A,2012-01-10,Silicon carbide reinforced aluminium alloy turbocharger impeller,"A turbocharger impeller 1, for connection to a shaft 2, is formed from a metal matrix composite material having an aluminium alloy matrix and silicon carbide particulate reinforcement. The average particle diameter of the particulate reinforcement may be 2 microns or less. The particulate reinforcement may be from 10% to 30% of the composite by volume. The impeller may be fitted with a connector 3. The connector may frictionally engage an inner or outer surface of a shaft-side hub extension H of the impeller. The connector may have a threaded portion 12 which screws onto a corresponding threaded portion 7 of the shaft. The material of the connector may have a coefficient of thermal expansion which is equal to or greater than that of the composite material of the impeller. The material of the connector may have a greater strength than the composite material of the impeller.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/132-115-662-066-145,Patent Application,no,6,3,2,2,0,F01D5/043;;F04D29/023;;F04D29/284;;F01D5/043;;F01D5/048;;F04D29/023;;F04D29/266;;F04D29/284;;F05D2220/40;;F05D2240/24;;F05D2300/121;;F05D2300/173;;F05D2300/222;;F05D2300/2261;;F05D2300/6032;;F05D2300/702,F04D29/02;;F01D5/04;;F04D29/28,,0,0,,,,DISCONTINUED
532,IN,A,IN 1480KON2014 A,144-115-709-780-238,2015-10-23,2015,IN 1480KON2014 A,2014-07-14,GB 201122236 A;;GB 2012053097 W,2011-12-23,CONNECTOR,A connector for connecting an impeller (1) to a shaft (2) is provided. The connector is formed as a unitary body. The connector has a sleeve portion (14) which is frictionally connected on a radially outer surface of a shaft side hub extension (H) of the impeller. The connector further has a threaded portion (12) carrying a thread which screws onto a corresponding threaded portion (7) of the shaft such that the connector provides a rotationally fixed connection between the impeller and the shaft. The hub extension has a central recess and a part (3) of the connector is inserted into the recess. The frictional connection between the sleeve portion and the radially outer surface of the hub extension transmits in use substantially all of the torque be¬ tween the shaft and the impeller.,NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/144-115-709-780-238,Patent Application,no,0,0,14,14,0,F01D5/025;;F01D5/025;;F01D5/026;;F01D5/026;;F04D29/266;;F04D29/266;;F16D1/076;;F16D1/076;;F16D1/0847;;F16D1/0858;;F16D1/0858;;F16D2300/08;;F16D2300/08,F01D5/02;;F04D29/26;;F16D1/08,,0,0,,,,PENDING
533,GB,A,GB 2498377 A,065-763-652-714-476,2013-07-17,2013,GB 201200505 A,2012-01-12,GB 201200505 A,2012-01-12,Impeller to shaft connection,"A connector 3 for connecting an impeller 1 to a shaft 2. The impeller has a shaft-side hub extension H with a central recess. The connector is inserted into the recess to frictionally connect an outwardly facing surface 14 of the connector with a radially inner surface of the hub extension. The connector has a threaded portion 12 which screws onto a corresponding threaded portion 7 of the shaft. The connector has an abutment surface 21 which engages a corresponding abutment surface 4 of the shaft when the thread portions are screwed together. The abutment surfaces are inclined from the radial direction such that, when the abutment surfaces engage as the thread portions are screwed together, the outwardly facing surface of the connector is urged radially outwardly to increase the strength of the frictional connection with the radially inner surface of the hub extension.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/065-763-652-714-476,Patent Application,no,2,1,3,3,0,F01D5/025;;F01D5/048;;F04D29/266;;F04D29/284;;F01D5/04;;F01D5/021;;F04D29/266;;F04D29/284,F04D29/26;;F01D5/02;;F01D5/04;;F04D29/28,,0,0,,,,ACTIVE
534,EP,A1,EP 2795065 A1,104-508-201-583-643,2014-10-29,2014,EP 12809313 A,2012-12-12,GB 201122236 A;;GB 2012053097 W,2011-12-23,CONNECTOR,,NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,"WABTEC UK LIMITED (2022-08-16);;WABTEC UK LTD., DONCASTER, GB (2022-08-18)",https://lens.org/104-508-201-583-643,Patent Application,yes,0,0,14,14,0,F01D5/025;;F01D5/025;;F01D5/026;;F01D5/026;;F04D29/266;;F04D29/266;;F16D1/076;;F16D1/076;;F16D1/0847;;F16D1/0858;;F16D1/0858;;F16D2300/08;;F16D2300/08,F16D1/076,,1,0,,,See references of WO 2013093424A1,ACTIVE
535,MX,A,MX 2013011450 A,083-583-939-510-280,2014-02-03,2014,MX 2013011450 A,2012-04-05,US 201161471937 P;;US 201161541862 P;;US 201161554167 P;;US 2012/0032438 W,2011-04-05,AMINOPYRAZINE COMPOUNDS USEFUL AS INHIBITORS OF TRA KINASE.,"The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (I): wherein the variables are as defined herein.",VERTEX PHARMA,CHARRIER JEANDAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,,https://lens.org/083-583-939-510-280,Patent Application,no,0,0,13,13,0,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,C07D413/14;;A61K31/497;;A61K33/243;;A61P35/00,,0,0,,,,DISCONTINUED
536,GB,B,GB 2498377 B,076-862-275-316-714,2016-10-12,2016,GB 201200505 A,2012-01-12,GB 201200505 A,2012-01-12,Connector,,NAPIER TURBOCHARGERS LTD,IAN PINKNEY;;OSAROBO FAMOUS OKHUAHESOGIE;;PAUL EIFION ROACH;;NEIL RYAN THOMAS;;IAN PATRICK CLARE BROWN;;PETER KAY;;STEPHEN WILSON;;DAVID LESLIE SMITH;;ROBERT NEIL GEORGE;;PAUL LESLIE JACKLIN;;GEOFF KINPOY NGAO;;KEVIN JOHN MUSSON;;MATTHEW ELIJAH MOORE;;JAMIE CLARE;;THOMAS JARLATH MURRAY;;STUART MICHAEL POTTER;;CHRISTOPHER JOHN MONAGHAN;;ALAN MARTIN TAYLOR;;FRANCIS JOSEPH GEOFFREY HEYES;;TREVOR KNIGHTON,,https://lens.org/076-862-275-316-714,Granted Patent,no,2,0,3,3,0,F01D5/025;;F01D5/048;;F04D29/266;;F04D29/284;;F01D5/04;;F01D5/021;;F04D29/266;;F04D29/284,F04D29/26;;F01D5/02;;F01D5/04;;F04D29/28,,0,0,,,,ACTIVE
537,CN,A,CN 103174467 A,182-782-029-254-805,2013-06-26,2013,CN 201210568197 A,2012-12-24,GB 201122236 A,2011-12-23,Connector,"A connector for connecting an impeller to a shaft is provided. The connector is formed as a unitary body. The connector has a sleeve portion which is frictionally connected on a radially outer surface of a shaft-side hub extension of the impeller. The connector further has a threaded portion carrying a thread which screws onto a corresponding threaded portion of the shaft, such that the connector provides a rotationally fixed connection between the impeller and the shaft. The hub extension has a central recess, and a part of the connector is inserted into the recess. The frictional connection between the sleeve portion and the radially outer surface of the hub extension transmits, in use, substantially all of the torque between the shaft and the impeller.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/182-782-029-254-805,Patent Application,no,5,1,14,14,0,F01D5/025;;F01D5/025;;F01D5/026;;F01D5/026;;F04D29/266;;F04D29/266;;F16D1/076;;F16D1/076;;F16D1/0847;;F16D1/0858;;F16D1/0858;;F16D2300/08;;F16D2300/08,F01D5/30;;F01D5/32,,0,0,,,,ACTIVE
538,US,A1,US 2014/0369840 A1,187-165-632-049-37X,2014-12-18,2014,US 201214364874 A,2012-12-12,GB 201122236 A;;GB 2012053097 W,2011-12-23,CONNECTOR,"A connector for connecting an impeller to a shaft is provided. The connector is formed as a unitary body. The connector has a sleeve portion which is frictionally connected on a radially outer surface of a shaft-side hub extension of the impeller. The connector further has a threaded portion carrying a thread which screws onto a corresponding threaded portion of the shaft, such that the connector provides a rotationally fixed connection between the impeller and the shaft. The hub extension has a central recess, and a part of the connector is inserted into the recess. The frictional connection between the sleeve portion and the radially outer surface of the hub extension transmits, in use, substantially all of the torque between the shaft and the impeller.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,WABTEC UK LIMITED (2022-03-15);;NAPIER TURBOCHARGERS LIMITED (2014-10-16),https://lens.org/187-165-632-049-37X,Patent Application,yes,9,7,14,14,0,F01D5/025;;F01D5/025;;F01D5/026;;F01D5/026;;F04D29/266;;F04D29/266;;F16D1/076;;F16D1/076;;F16D1/0847;;F16D1/0858;;F16D1/0858;;F16D2300/08;;F16D2300/08,F01D5/02;;F16D1/08,416204 A,0,0,,,,ACTIVE
539,EP,A1,EP 2802743 A1,067-122-599-538-25X,2014-11-19,2014,EP 12812694 A,2012-12-11,GB 201200403 A;;GB 2012053082 W,2012-01-10,TURBOCHARGER HAVING A CONNECTOR FOR CONNECTING AN IMPELLER TO A SHAFT,,NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/067-122-599-538-25X,Patent Application,yes,0,0,10,10,0,F01D5/025;;F16D1/0835;;F04D29/266;;F05D2220/40;;F05D2300/50212;;F04D25/024;;F04D29/023;;F04D29/284;;F05D2300/171;;F05D2300/173;;F05D2300/50212;;F16D1/0835;;F04D29/266;;F01D5/025;;F05D2220/40;;F04D29/284;;F04D25/024;;F04D29/023;;F05D2300/171;;F05D2300/173;;F04D29/5853;;F04D29/601,F01D5/02;;F04D29/26;;F16D1/08,,0,0,,,,DISCONTINUED
540,WO,A1,WO 2013/110922 A1,195-255-304-077-362,2013-08-01,2013,GB 2013050044 W,2013-01-11,GB 201201163 A,2012-01-24,"CONNECTION SYSTEM, CORRESPONDING IMPELLER AND TURBOCHARGER",A connection system for connecting an impeller to a shaft is provided. The impeller has a shaft-side hub extension with a central hole. The connection system has a connector body which is inserted into the hole. The connector body has a threaded portion carrying a thread which screws onto a corresponding threaded portion of the shaft such that the connection system provides a rotationally fixed connection between the impeller and the shaft. The connection system further has a plurality of circumferentially distributed elongate threaded members which join the connector body to the hub extension such that the connector body is axially fixed relative to the impeller. The connection system further has plurality of circumferentially distributed torque transfer members which extend between the connector body and the hub extension to transmit a majority of the torque between the shaft and the impeller. Corresponding impeller and turbocharger are also provided.,NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/195-255-304-077-362,Patent Application,yes,8,7,5,5,0,F01D5/025;;F01D5/025;;F04D29/266;;F04D29/266;;F05D2220/40;;F05D2220/40,F01D5/02;;F04D29/26,,0,0,,,,PENDING
541,US,B2,US 9074477 B2,000-336-789-134-064,2015-07-07,2015,US 201214364874 A,2012-12-12,GB 201122236 A;;GB 2012053097 W,2011-12-23,Connector,"A connector for connecting an impeller to a shaft is provided. The connector is formed as a unitary body. The connector has a sleeve portion which is frictionally connected on a radially outer surface of a shaft-side hub extension of the impeller. The connector further has a threaded portion carrying a thread which screws onto a corresponding threaded portion of the shaft, such that the connector provides a rotationally fixed connection between the impeller and the shaft. The hub extension has a central recess, and a part of the connector is inserted into the recess. The frictional connection between the sleeve portion and the radially outer surface of the hub extension transmits, in use, substantially all of the torque between the shaft and the impeller.",PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR;;NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,WABTEC UK LIMITED (2022-03-15);;NAPIER TURBOCHARGERS LIMITED (2014-10-16),https://lens.org/000-336-789-134-064,Granted Patent,yes,19,7,14,14,0,F01D5/025;;F01D5/025;;F01D5/026;;F01D5/026;;F04D29/266;;F04D29/266;;F16D1/076;;F16D1/076;;F16D1/0847;;F16D1/0858;;F16D1/0858;;F16D2300/08;;F16D2300/08,F01D5/02;;F04D29/20;;F04D29/26;;F16D1/076;;F16D1/08,,0,0,,,,ACTIVE
542,KR,A,KR 20140091617 A,059-341-830-735-37X,2014-07-21,2014,KR 20147017761 A,2012-12-12,GB 201122236 A;;GB 2012053097 W,2011-12-23,CONNECTOR,,NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/059-341-830-735-37X,Patent Application,no,0,0,14,14,0,F01D5/025;;F01D5/025;;F01D5/026;;F01D5/026;;F04D29/266;;F04D29/266;;F16D1/076;;F16D1/076;;F16D1/0847;;F16D1/0858;;F16D1/0858;;F16D2300/08;;F16D2300/08,F01D5/02;;F02B39/00;;F04D29/26;;F16D1/08,,0,0,,,,ACTIVE
543,CN,U,CN 203296826 U,111-814-559-652-614,2013-11-20,2013,CN 201220720704 U,2012-12-24,GB 201122236 A,2011-12-23,"Connector, impeller and turbocharger","The utility model provides a connector, an impeller and a turbocharger. The connector forms an integral main body. The connector is provided with a sleeve part frictionally connected to a radial outer surface of an extending part of an impeller shaft side wheel hub. The connector is further provided with a thread part; the thread part is screwed onto a corresponding thread part of the shaft, so that a rotationally fixed connection between the impeller and the shaft is formed by the connector; and the wheel hub extending part is provided with a central recession and one part of the extending part connected with the connector is inserted into the recession. While in use, nearly all torques between the shaft and the impeller can be transmitted by the frictional connection between the sleeve part and the radial external surface of the wheel hub extending part.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL BYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/111-814-559-652-614,Limited Patent,no,0,3,14,14,0,F01D5/025;;F01D5/025;;F01D5/026;;F01D5/026;;F04D29/266;;F04D29/266;;F16D1/076;;F16D1/076;;F16D1/0847;;F16D1/0858;;F16D1/0858;;F16D2300/08;;F16D2300/08,F01D5/30;;F01D5/32,,0,0,,,,EXPIRED
544,GB,A,GB 2500167 A,190-493-467-936-311,2013-09-18,2013,GB 201200405 A,2012-01-10,GB 201200405 A,2012-01-10,Impeller to shaft connector,"A connector, for connecting an impeller 1 to a shaft 2, has first second subcomponents. The first subcomponent has a first sleeve portion 3, and the second subcomponent has a second sleeve portion 14 which is sandwiched between the first sleeve portion and the hub extension. The second sleeve portion is frictionally connected on one side with the first sleeve portion and on the opposing side with the hub extension. The first subcomponent further has a threaded portion which screws onto a corresponding threaded portion of the shaft. The second subcomponent is formed of a material having a coefficient of thermal expansion which is intermediate the coefficients of thermal expansion of the materials of the impeller and the first subcomponent. The impeller may be made of an aluminium alloy, the first subcomponent may be made of a high tensile or medium carbon steel, and the second subcomponent may be made of stainless steel, bronze or brass.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/190-493-467-936-311,Patent Application,no,2,1,3,3,0,F01D5/025;;F01D5/048;;F04D29/266;;F04D29/284;;F01D5/025;;F04D29/266;;F05D2220/40;;F05D2300/50212,F04D29/26;;F01D5/02;;F01D5/04;;F04D29/28,,0,0,,,,ACTIVE
545,GB,B,GB 2500167 B,034-374-857-706-580,2017-07-12,2017,GB 201200405 A,2012-01-10,GB 201200405 A,2012-01-10,Connector,,NAPIER TURBOCHARGERS LTD,IAN PINKNEY;;OSAROBO FAMOUS OKHUAHESOGIE;;PAUL EIFION ROACH;;NEIL RYAN THOMAS;;IAN PATRICK CLARE BROWN;;PETER KAY;;STEPHEN WILSON;;DAVID LESLIE SMITH;;ROBERT NEIL GEORGE;;PAUL LESLIE JACKLIN;;GEOFF KINPOY NGAO;;KEVIN JOHN MUSSON;;MATTHEW ELIJAH MOORE;;JAMIE CLARE;;THOMAS JARLATH MURRAY;;STUART MICHAEL POTTER;;CHRISTOPHER JOHN MONAGHAN;;ALAN MARTIN TAYLOR;;FRANCIS JOSEPH GEOFFREY HEYES;;TREVOR KNIGHTON,,https://lens.org/034-374-857-706-580,Granted Patent,no,2,0,3,3,0,F01D5/025;;F01D5/048;;F04D29/266;;F04D29/284;;F01D5/025;;F04D29/266;;F05D2220/40;;F05D2300/50212,F04D29/26;;F01D5/02;;F01D5/04;;F04D29/28,,0,0,,,,ACTIVE
546,WO,A1,WO 2013/093424 A1,133-821-468-542-800,2013-06-27,2013,GB 2012053097 W,2012-12-12,GB 201122236 A,2011-12-23,CONNECTOR,"A connector for connecting an impeller (1) to a shaft (2) is provided. The connector is formed as a unitary body. The connector has a sleeve portion (14) which is frictionally connected on a radially outer surface of a shaft-side hub extension (H) of the impeller. The connector further has a threaded portion (12) carrying a thread which screws onto a corresponding threaded portion (7) of the shaft, such that the connector provides a rotationally fixed connection between the impeller and the shaft. The hub extension has a central recess, and a part (3) of the connector is inserted into the recess. The frictional connection between the sleeve portion and the radially outer surface of the hub extension transmits, in use, substantially all of the torque be¬ tween the shaft and the impeller.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/133-821-468-542-800,Patent Application,no,5,2,14,14,0,F01D5/025;;F01D5/025;;F01D5/026;;F01D5/026;;F04D29/266;;F04D29/266;;F16D1/076;;F16D1/076;;F16D1/0847;;F16D1/0858;;F16D1/0858;;F16D2300/08;;F16D2300/08,F01D5/02;;F04D29/26;;F16D1/08,,0,0,,,,PENDING
547,IN,A,IN 1595KON2014 A,048-716-948-882-93X,2015-10-23,2015,IN 1595KON2014 A,2014-07-29,GB 201200403 A;;GB 2012053082 W,2012-01-10,TURBOCHARGER HAVING A CONNECTOR FOR CONNECTING AN IMPELLER TO A SHAFT,A turbocharger is provided having a connector (3) for connecting an impeller (1) to a shaft (2). The impeller has a shaft side hub extension (H) with a central recess. The impeller is formed of a material having a greater coefficient of thermal expansion than the material of the shaft. The connector is inserted into the recess to frictionally connect an outwardly facing surface (14) of the connector with a radially inner surface of the hub extension. The connector has a threaded portion (11) carrying a thread which screws onto a corresponding threaded portion (7) of the shaft such that the connector provides a rotationally fixed connection between the impeller and the shaft. The connector is formed of a material having a coefficient of thermal expansion which is greater than the coefficient of thermal expansion of the material of the shaft.,NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/048-716-948-882-93X,Patent Application,no,0,0,10,10,0,F01D5/025;;F16D1/0835;;F04D29/266;;F05D2220/40;;F05D2300/50212;;F04D25/024;;F04D29/023;;F04D29/284;;F05D2300/171;;F05D2300/173;;F05D2300/50212;;F16D1/0835;;F04D29/266;;F01D5/025;;F05D2220/40;;F04D29/284;;F04D25/024;;F04D29/023;;F05D2300/171;;F05D2300/173;;F04D29/5853;;F04D29/601,F01D5/02;;F04D29/26;;F16D1/08,,0,0,,,,PENDING
548,GB,B,GB 2514693 B,048-701-155-975-624,2018-11-28,2018,GB 201410999 A,2013-01-11,GB 201201163 A;;GB 2013050044 W,2012-01-24,"Connection system, corresponding impeller and turbocharger",,NAPIER TURBOCHARGERS LTD,IAN PINKNEY;;OSAROBO FAMOUS OKHUAHESOGIE;;PAUL EIFION ROACH;;NEIL RYAN THOMAS;;IAN PATRICK CLARE BROWN;;PETER KAY;;STEPHEN WILSON;;DAVID LESLIE SMITH;;ROBERT NEIL GEORGE;;PAUL LESLIE JACKLIN;;GEOFF KINPOY NGAO;;KEVIN JOHN MUSSON;;MATTHEW ELIJAH MOORE;;JAMIE CLARE;;THOMAS JARLATH MURRAY;;STUART MICHAEL POTTER;;ALAN MARTIN TAYLOR;;FRANCIS JOSEPH GEOFFREY HEYES;;TREVOR KNIGHTON;;CHRISTOPHER JOHN MONAGHAN,,https://lens.org/048-701-155-975-624,Granted Patent,no,12,0,5,5,0,F01D5/025;;F01D5/025;;F04D29/266;;F04D29/266;;F05D2220/40;;F05D2220/40,F01D5/02;;F04D29/26,,0,0,,,,ACTIVE
549,US,A1,US 2013/0095193 A1,099-143-349-823-887,2013-04-18,2013,US 201213440981 A,2012-09-04,US 201213440981 A;;US 201161471937 P;;US 201161541862 P;;US 201161554167 P,2011-04-05,COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE,"The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: wherein the variables are as defined herein.",CHARRIER JEAN-DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN;;VERTEX PHARMA,CHARRIER JEAN-DAMIEN;;KAY DAVID;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,VERTEX PHARMACEUTICALS (EUROPE) LIMITED (2012-08-29);;VERTEX PHARMACEUTICALS INCORPORATED (2013-01-03),https://lens.org/099-143-349-823-887,Patent Application,yes,1,53,13,13,1,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,C07D413/14;;A61K31/497;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;A61K33/243;;A61K45/06;;C07D453/00;;C07D495/04,424/649;;544/405;;514/255.05;;544/357;;514/252.11;;544/120;;514/235.8;;514/210.18;;514/210.2;;514/252.02;;514/212.06;;514/252.03;;514/27;;514/49,0,0,,,,INACTIVE
550,US,B2,US 8877759 B2,181-057-041-472-532,2014-11-04,2014,US 201213440981 A,2012-09-04,US 201213440981 A;;US 201161471937 P;;US 201161541862 P;;US 201161554167 P,2011-04-05,Aminopyrazines as ATR kinase inhibitors,"The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: wherein the variables are as defined herein.",CHARRIER JEAN-DAMIEN;;KAY DAVID;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN;;VERTEX PHARNACEUTICALS INC,CHARRIER JEAN-DAMIEN;;KAY DAVID;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,VERTEX PHARMACEUTICALS (EUROPE) LIMITED (2012-08-29);;VERTEX PHARMACEUTICALS INCORPORATED (2013-01-03),https://lens.org/181-057-041-472-532,Granted Patent,yes,100,17,13,13,1,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,A61K31/4965;;A61K31/497;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;A61K33/243;;A61K45/06;;C07D403/00;;C07D413/14;;C07D453/00;;C07D495/04,514/255.06;;544/120;;544/359;;544/405;;546/114;;546/148;;546/210;;546/268.1;;548/131;;548/247;;548/335.1;;548/516;;548/518;;548/950;;549/59;;549/356;;549/429;;549/510,36,27,085-198-151-848-245;;025-014-335-224-722;;025-014-335-224-722;;025-014-335-224-722;;004-270-798-174-670;;038-079-421-868-515;;028-868-294-263-626;;003-323-336-373-632;;150-546-857-860-67X;;049-602-535-856-435;;035-713-618-058-133;;016-949-664-418-509;;023-875-722-970-081;;098-624-928-997-516;;004-983-328-524-787;;182-268-850-538-737;;121-030-464-860-75X;;046-436-912-948-15X;;120-107-476-330-613;;047-497-164-539-670;;083-644-891-365-534;;134-918-463-205-44X;;134-918-463-205-44X;;134-918-463-205-44X;;160-567-501-955-091;;185-717-175-218-018;;002-330-272-723-160,10.1021/ml4002198;;pmc4027249;;24900732;;10.3410/f.10073956.10832054;;10.1021/jm101488z;;21413798;;10.3410/f.10073956.10832054;;10.1021/jm101488z;;21413798;;10.3410/f.10073956.10832054;;10.1021/jm101488z;;21413798;;23682925;;10.1111/bph.12244;;pmc3753833;;10.1002/jccs.200600050;;10.1016/j.bmcl.2012.06.053;;22835870;;23222511;;pmc3542617;;10.1038/cddis.2012.181;;10.1016/j.ctrv.2013.03.002;;23583268;;10.1021/jm800250z;;18578476;;10.1038/sj.onc.1203077;;10597277;;15604286;;10.1158/0008-5472.can-04-2727;;10.1016/j.bmc.2009.11.058;;20022510;;10.1016/s0968-0896(00)00337-0;;11377173;;10.1074/jbc.274.53.37538;;10608806;;10.1135/cccc19653092;;10.1248/cpb.32.4140;;10.1007/s00044-013-0665-6;;10.1158/1538-7445.am2011-5501;;10.1016/s0040-4039(97)10547-0;;10.1039/p19920001607;;21490603;;10.1038/nchembio.573;;21490603;;10.1038/nchembio.573;;21490603;;10.1038/nchembio.573;;10485486;;10.1246/bcsj.50.2744;;11673449;;10.1074/jbc.c100569200,"Abdel-Magid, A., ""Inhibitors of ATR Kinase for Treatment on Cancer"", ACS Medicinal Chemistry Letters, 4(8), (2013), pp. 688-689.;;Ammar, Y.A., et al., ""3-Ethoxycarbonylmethylenequinoxalin-2-one in Heterocyclic Synthesis. Part 1: Synthesis of New Substituted and Condensed Quinoxalines"", Afinidad (2005), 62, pp. 151-160.;;Charrier, J.D., et al, ""Discovery of Potent and Selective Inhibitors of Ataxia Telangiesctasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents"" J. Med. Chem. (Mar. 17, 2011), 54(7), pp. 2320-2330 (DOI: 10.1021/jm101488z).;;Charrier, J.D., et al., ""Discovery of Potent and Selective Inhibitors of ATR (Ataxia Telangiectasia Mutated and Rad3 Related) as Potential Anticancer Agents"", Supplementary Information, Apr. 14, 2011.;;Charrier, J.D., ""Discovery of potent and selective inhibitors of Ataxia Telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents"", Presentation, ACS Denver 2011, Aug. 28, 2011.;;Clark, B.A.J., et al., ""Mass Spectrometry of Pyrroloä2, 3-Büpyrazines and Pyrazinoä2,3-Bündole"", Organic Mass Spectrometry, 12(7), (1997), pp. 421-423.;;Curtin, N.J., ""Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer"", British Journal of Pharmacology, (2013), pp. 1-52.;;El-Emary, T.I., ""Synthesis and Biological Activity of Some New Pyrazolo[3,4-b]pyrazines"", J. Chin. Chem. Soc. (2006), 53, pp. 391-401.;;Fernandes, P.S., et al., ""Synthesis and Biological Activity of Heterocyclic Derivatives derived from Ethy1-2-hydroxy-quinoxaline-3-carboxylate"", J. Indian Chem. Soc. (1986), 63, pp. 427-429.;;Finlay, M.R., et al., ""Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family"", Bioorg. Med. Chem. Letters, 22(17) (2012), pp. 5352-5359.;;Fokas, E., et al., ""Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation"", Cell Death and Disease, 3 (2012), pp. 1-5 (DOI: 10.1038/cddis.2012.181).;;Fokas, E., et al., ""Targeting ATR in DNA damage response and cancer therapeutics"", Cancer Treatment Reviews (2013), (DOI: 10.1016/j.ctrv.2013.03.002).;;Gentili, F., et al., ""Alpha2-Adrenoreceptors Profile Modulation. 4. From Antagonist to Agonist Behavior"", J. Med. Chem., 51(14), Jun. 25, 2008), pp. 4289-4299.;;Hall-Jackson, C.A., et al., ""ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK"", Oncogene, 18(48) (1999), pp. 6707-6713.;;Hickson, I., et al., ""Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM"", Cancer Research (2004), 64, pp. 9152-9159.;;Hilton, S., et al., ""Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2"", Bioorg. Med. Chem., (2010) 18, pp. 707-718.;;Jiang, B., et al., ""Synthesis and cytotoxicity evaluation of novel indolylpyrimidiens and indolylpyrazines as potential antitummor agents"", Bioorganic & Medicinal Chemistry, 9 (2001), pp. 1149-1154.;;Kim, S.T., et al., ""Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members"", J. Biol. Chem. (1999) 274, pp. 37538-37543.;;Klicnar, J., et al., ""Studien in der Chinoxalinreihe III. Syntheses, Reaktionen und ir-spektren einiger 3-hydroxy-2-carboxymethylch inoxalin-derivative"", Collection Czechoslay. Chem. Commun. (1965), 30, pp. 3092-3101.;;Kurasawa, Y., et al., ""Revised Structure for the Product from the Reaction of 3-Hydrazinocarbonylmethylene-2-oxo-1,2,3,4-tetrahydroquinoxaline with Nitrous Acid"", Chem. Pharm. Bull. (1984), 32(10), pp. 4140-4143.;;Luo, H., et al., ""Molecular dynamics-based self-organizing molecular field analysis on 3-amino-6-arypyrazines as the ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibitors"", Medicinal Chemistry Research, (2013), pp. 1-12.;;McKenna, G., et al., ""Evaluation of the first potent and highly selective inhibitor of ATR kinase: an approach to selectively sensitize cancer cells to ionizing radiation and hypoxia"", Abstract, Mar. 31, 2012.;;McKenna, G., et al., ""Evaluation of the first potent and highly selective inhibitor of ATR inhibitor, VE-821: an approach to selectively sensitize cancer cells to ionizing radiation and hypoxia"", Poster, Mar. 31, 2012.;;Middleton, F., et al., ""ATR as a Therapeutic Target"", Advances in DNA Repair in Cancer, Northern Institute for Cancer Research, Newcastle University (2013), pp. 211-228.;;Nakamura, H., et al., ""Bimodal chemiluminescence of 8-chlorostyryl-6-phenylethynylimidazopyrazinone: Large bathochromic shift caused by a styryl group at 8-position"", Tetrahedron Letters, 39, (1998), pp. 301-304.;;Pires, I.M., et al., ""Targeting radiation-resisitant hypoxic tumour cells thorugh ATR inhibition"", British Journal of Cancer, Jun. 19, 2012, pp. 1-9.;;Pollard, J., ""Inhibition of the DNA Damage Response Kinase, ATR, as a Promising Anti-Cancer Approach"", Presentation, Mar. 8, 2012.;;Qi, et al., ""Chemi- and bio-luminescence of coelenterazine analogs with phenyl homologs at the C-2 position"", Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry,13, (1992), pp. 1607-1611.;;Reaper, P.M., et al., ""Selective Killing of ATM- or p53-deficient cancer cells through inhibition of ATR"", Supplementary Information, Nature Chemical Biology, Apr. 13, 2011, DOI: 10.1038/NCHEMBIO.573.;;Reaper, P.M., et al., ""Selective Killing of ATM- or p53-deficient cancer cells through inhibition of ATR"", Presentation, Nov. 21, 2011.;;Reaper, P.M., et al., ""Selective Killing of ATM- or p53-deficient cancer cells through inhibition of ATR"", Presentation, Nov. 29, 2011.;;Reaper, P.M., et al., ""Evaluation of a potent and highly selective inhibitor of ATR kinase: an approach to selectively sensitize cancer cells to genotoxic drugs"", Abstract, Mar. 31, 2012.;;Reaper, P.M., et al., ""Evaluation of a Potent and Highly Selective Inhibitor of ATR Kinase: An Approach to Selectively Sensitize Cancer Cells to Genotoxic Drugs"", Poster, Mar. 31, 2012.;;Sarkaria, J.N., et al., ""Inhibition of ATM and ATR Kinase Activities by the Radiosensitizing Agent, Caffeine"", Cancer Research (1999) 59, pp. 4375-4382.;;Sugimoto, T., et al., ""Imidazopteridines. I. Synthesis of Imidazo[1,2-c]pteridine and Its Alkyl Derivatives"", Bull. Chem. Soc. Japan (1977) 50(10), pp. 2744-2747.;;Ward, I.M., et al., ""Histone H2AX Is Phosphorylated in an ATR-dependent Manner in Response to Replicational Stress"", J. Biol. Chem. (2001), 51, pp. 47759-47762.",INACTIVE
551,CN,A,CN 104040116 A,055-531-417-485-620,2014-09-10,2014,CN 201280065308 A,2012-12-11,GB 2012053082 W;;GB 201200403 A,2012-01-10,Turbocharger Having A Connector For Connecting An Impeller To A Shaft,"A turbocharger is provided having a connector (3) for connecting an impeller (1) to a shaft (2). The impeller has a shaft-side hub extension (H) with a central recess. The impeller is formed of a material having a greater coefficient of thermal expansion than the material of the shaft. The connector is inserted into the recess to frictionally connect an outwardly facing surface (14) of the connector with a radially inner surface of the hub extension. The connector has a threaded portion (11) carrying a thread which screws onto a corresponding threaded portion (7) of the shaft, such that the connector provides a rotationally fixed connection between the impeller and the shaft. The connector is formed of a material having a coefficient of thermal expansion which is greater than the coefficient of thermal expansion of the material of the shaft.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVO,,https://lens.org/055-531-417-485-620,Patent Application,no,5,3,10,10,0,F01D5/025;;F16D1/0835;;F04D29/266;;F05D2220/40;;F05D2300/50212;;F04D25/024;;F04D29/023;;F04D29/284;;F05D2300/171;;F05D2300/173;;F05D2300/50212;;F16D1/0835;;F04D29/266;;F01D5/025;;F05D2220/40;;F04D29/284;;F04D25/024;;F04D29/023;;F05D2300/171;;F05D2300/173;;F04D29/5853;;F04D29/601,F01D5/02;;F04D29/26;;F16D1/08,,0,0,,,,ACTIVE
552,US,A1,US 2015/0044047 A1,182-797-036-509-943,2015-02-12,2015,US 201214370894 A,2012-12-10,GB 201200403 A;;GB 2012053082 W,2012-01-10,TURBOCHARGER HAVING A CONNECTOR FOR CONNECTING AN IMPELLER TO A SHAFT,"A connector for connecting an impeller to a shaft is provided. The impeller has a shaft-side hub extension with a central recess. The impeller is formed of a material having a greater coefficient of thermal expansion than the material of the shaft. The connector is inserted into the recess to frictionally connect an outwardly facing surface of the connector with a radially inner surface of the hub extension. The connector has a threaded portion carrying a thread which screws onto a corresponding threaded portion of the shaft, such that the connector provides a rotationally fixed connection between the impeller and the shaft. The connector is formed of a material having a coefficient of thermal expansion which is greater than the coefficient of thermal expansion of the material of the shaft.",PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR;;NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/182-797-036-509-943,Patent Application,yes,3,3,10,10,0,F01D5/025;;F16D1/0835;;F04D29/266;;F05D2220/40;;F05D2300/50212;;F04D25/024;;F04D29/023;;F04D29/284;;F05D2300/171;;F05D2300/173;;F05D2300/50212;;F16D1/0835;;F04D29/266;;F01D5/025;;F05D2220/40;;F04D29/284;;F04D25/024;;F04D29/023;;F05D2300/171;;F05D2300/173;;F04D29/5853;;F04D29/601,F04D29/60;;F04D29/58,416/95,0,0,,,,DISCONTINUED
553,WO,A1,WO 2013/104880 A1,185-089-944-907-658,2013-07-18,2013,GB 2012053082 W,2012-12-11,GB 201200403 A,2012-01-10,TURBOCHARGER HAVING A CONNECTOR FOR CONNECTING AN IMPELLER TO A SHAFT,"A turbocharger is provided having a connector (3) for connecting an impeller (1) to a shaft (2). The impeller has a shaft-side hub extension (H) with a central recess. The impeller is formed of a material having a greater coefficient of thermal expansion than the material of the shaft. The connector is inserted into the recess to frictionally connect an outwardly facing surface (14) of the connector with a radially inner surface of the hub extension. The connector has a threaded portion (11) carrying a thread which screws onto a corresponding threaded portion (7) of the shaft, such that the connector provides a rotationally fixed connection between the impeller and the shaft. The connector is formed of a material having a coefficient of thermal expansion which is greater than the coefficient of thermal expansion of the material of the shaft.",NAPIER TURBOCHARGERS LTD,PINKNEY IAN;;OKHUAHESOGIE OSAROBO FAMOUS;;ROACH PAUL EIFION;;THOMAS NEIL RYAN;;BROWN IAN PATRICK CLARE;;KAY PETER;;WILSON STEPHEN;;SMITH DAVID LESLIE;;GEORGE ROBERT NEIL;;JACKLIN PAUL LESLIE;;NGAO GEOFF KINPOY;;MUSSON KEVIN JOHN;;MOORE MATTHEW ELIJAH;;CLARE JAMIE;;MURRAY THOMAS JARLATH;;POTTER STUART MICHAEL;;MONAGHAN CHRISTOPHER JOHN;;TAYLOR ALAN MARTIN;;HEYES FRANCIS JOSEPH GEOFFREY;;KNIGHTON TREVOR,,https://lens.org/185-089-944-907-658,Patent Application,yes,6,6,10,10,0,F01D5/025;;F16D1/0835;;F04D29/266;;F05D2220/40;;F05D2300/50212;;F04D25/024;;F04D29/023;;F04D29/284;;F05D2300/171;;F05D2300/173;;F05D2300/50212;;F16D1/0835;;F04D29/266;;F01D5/025;;F05D2220/40;;F04D29/284;;F04D25/024;;F04D29/023;;F05D2300/171;;F05D2300/173;;F04D29/5853;;F04D29/601,F04D29/26;;F01D5/02;;F16D1/08,,0,0,,,,PENDING
554,EP,A1,EP 2694498 A1,100-318-754-212-567,2014-02-12,2014,EP 12716870 A,2012-04-05,US 201161471937 P;;US 201161541862 P;;US 201161554167 P;;US 2012/0032438 W,2011-04-05,AMINOPYRAZINE COMPOUNDS USEFUL AS INHIBITORS OF TRA KINASE,,VERTEX PHARMA,CHARRIER JEAN-DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,VERTEX PHARMACEUTICALS INC. (2014-02-26);;VERTEX PHARMACEUTICALS INCORPORATED (2014-08-27),https://lens.org/100-318-754-212-567,Patent Application,yes,0,0,13,13,0,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,A61K45/06;;A61K31/497;;A61K31/5377;;A61K31/555;;A61K31/7048;;A61K31/7068;;A61K33/243;;C07D413/14;;C07D453/02;;C07D495/04,,0,0,,,,ACTIVE
555,KR,A,KR 20140027974 A,145-419-278-609-859,2014-03-07,2014,KR 20137029216 A,2012-04-05,US 201161471937 P;;US 201161541862 P;;US 201161554167 P;;US 2012/0032438 W,2011-04-05,AMINOPYRAZINE COMPOUNDS USEFUL AS INHIBITORS OF TRA KINASE,,VERTEX PHARMA,CHARRIER JEAN DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,,https://lens.org/145-419-278-609-859,Patent Application,no,0,0,13,13,0,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,C07D413/14;;A61K31/497;;A61K33/243;;A61P35/00,,0,0,,,,DISCONTINUED
556,ZA,B,ZA 201307332 B,013-573-104-278-796,2015-03-25,2015,ZA 201307332 A,2013-10-01,US 201161471937 P;;US 201161541862 P;;US 201161554167 P;;US 2012/0032438 W,2011-04-05,AMINOPYRAZINE COMPOUNDS USEFUL AS INHIBITORS OF TRA KINASE,,VERTEX PHARMACEUTICAL INCORPORATED,CHARRIER JEAN-DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,,https://lens.org/013-573-104-278-796,Granted Patent,no,0,0,13,13,0,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,A61K33/243,,0,0,,,,ACTIVE
557,AU,A1,AU 2012/240030 A1,074-939-419-423-624,2013-10-24,2013,AU 2012/240030 A,2012-04-05,US 201161554167 P;;US 201161471937 P;;US 201161541862 P;;US 2012/0032438 W,2011-04-05,Aminopyrazine compounds useful as inhibitors of TRA kinase,"The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in",VERTEX PHARMA,CHARRIER JEAN-DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,,https://lens.org/074-939-419-423-624,Patent Application,no,0,0,13,13,0,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,C07D413/14;;A61K31/497;;A61K33/243;;A61P35/00,,0,0,,,,DISCONTINUED
558,CA,A1,CA 2832100 A1,029-038-828-864-594,2012-10-11,2012,CA 2832100 A,2012-04-05,US 201161471937 P;;US 201161541862 P;;US 201161554167 P;;US 2012/0032438 W,2011-04-05,AMINOPYRAZINE COMPOUNDS USEFUL AS INHIBITORS OF TRA KINASE,"The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (I): wherein the variables are as defined herein.",VERTEX PHARMA,CHARRIER JEAN-DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,,https://lens.org/029-038-828-864-594,Patent Application,no,0,0,13,13,0,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,C07D413/14;;A61K31/497;;A61K33/243;;A61P35/00,,0,0,,,,DISCONTINUED
559,EP,B1,EP 2694498 B1,080-092-114-493-118,2016-03-30,2016,EP 12716870 A,2012-04-05,US 201161471937 P;;US 201161541862 P;;US 201161554167 P;;US 2012/0032438 W,2011-04-05,AMINOPYRAZINE COMPOUNDS USEFUL AS INHIBITORS OF TRA KINASE,,VERTEX PHARMA,CHARRIER JEAN-DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,VERTEX PHARMACEUTICALS INC. (2014-02-26);;VERTEX PHARMACEUTICALS INCORPORATED (2014-08-27),https://lens.org/080-092-114-493-118,Granted Patent,yes,2,0,13,13,0,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,A61K45/06;;A61K31/497;;A61K31/5377;;A61K31/555;;A61K31/7048;;A61K31/7068;;A61K33/243;;C07D413/14;;C07D453/02;;C07D495/04,,0,0,,,,ACTIVE
560,CN,A,CN 103562204 A,190-427-985-087-908,2014-02-05,2014,CN 201280026835 A,2012-04-05,US 2012/0032438 W;;US 201161471937 P;;US 201161541862 P;;US 201161554167 P,2011-04-05,Aminopyrazine compounds useful as inhibitors of TRA kinase,"The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (I): wherein the variables are as defined herein.",VERTEX PHARMA,CHARRIER JEAN-DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,,https://lens.org/190-427-985-087-908,Patent Application,no,2,1,13,13,0,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,C07D413/14;;A61K31/497;;A61K33/243;;A61P35/00,,0,0,,,,DISCONTINUED
561,WO,A1,WO 2012/138938 A1,077-010-258-737-644,2012-10-11,2012,US 2012/0032438 W,2012-04-05,US 201161471937 P;;US 201161541862 P;;US 201161554167 P,2011-04-05,AMINOPYRAZINE COMPOUNDS USEFUL AS INHIBITORS OF TRA KINASE,"The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (I): wherein the variables are as defined herein.",VERTEX PHARMA;;CHARRIER JEAN-DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,CHARRIER JEAN-DAMIEN;;MACCORMICK SOMHAIRLE;;STORCK PIERRE-HENRI;;PINDER JOANNE;;O'DONNELL MICHAEL EDWARD;;KNEGTEL RONALD MARCELLUS ALPHONSUS;;YOUNG STEPHEN CLINTON YOUNG;;KAY DAVID;;REAPER PHILIP MICHAEL;;DURRANT STEVEN JOHN;;TWIN HEATHER CLARE;;DAVIS CHRISTOPHER JOHN,,https://lens.org/077-010-258-737-644,Patent Application,yes,2,67,13,13,0,C07D413/14;;C07D453/02;;C07D495/04;;A61K33/243;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;C07D413/14;;A61K31/5377;;A61K31/7048;;A61K31/7068;;C07D495/04;;A61P17/02;;A61P17/06;;A61P35/00;;A61P35/04;;A61K33/243;;C07D413/14;;A61K31/497;;A61K31/497;;A61K45/06;;A61K31/555;;C07D453/02;;A61K33/243;;C07D413/14;;A61K31/501;;A61K31/5377;;A61K31/55;;A61K31/7048;;A61K31/7068;;C07D453/00;;C07D495/04,C07D413/14;;A61K31/497;;A61K33/243;;A61P35/00,,17,14,091-902-753-263-66X;;101-267-974-827-175;;058-421-916-536-842;;035-713-618-058-133;;077-295-491-167-117;;007-364-858-655-289;;054-653-029-565-687;;094-565-411-706-533;;160-567-501-955-091;;016-949-664-418-509;;004-983-328-524-787;;007-191-293-294-603;;056-032-425-357-506;;067-857-006-504-490,12011431;;10.1073/pnas.102167799;;pmc124461;;16530042;;10.1016/j.cell.2005.12.041;;14729973;;pmc321456;;10.1128/mcb.24.3.1292-1300.2003;;10.1038/sj.onc.1203077;;10597277;;10.1002/0471220574;;10.1002/jps.2600660104;;833720;;10.1093/carcin/bgh267;;15319300;;21826668;;10.1002/path.2953;;10485486;;15604286;;10.1158/0008-5472.can-04-2727;;10.1074/jbc.274.53.37538;;10608806;;10.1385/1-59259-811-0:125;;15220525;;10.1038/sj.onc.1205485;;12032824;;10.1074/jbc.m603747200;;16905549,"UNSAL-KACMAZ ET AL., PNAS 99, vol. 10, 14 May 2002 (2002-05-14), pages 6673 - 6678;;KUMAGAI ET AL., CELL, vol. 124, 10 March 2006 (2006-03-10), pages 943 - 955;;UNSAL-KACMAZ ET AL., MOLECULAR AND CELLULAR BIOLOGY, February 2004 (2004-02-01), pages 1292 - 1300;;HALL-JACKSON ET AL., ONCO ENE, vol. 18, 1999, pages 6707 - 6713;;THOMAS SORRELL: ""Organic Chemistry"", 1999, UNIVERSITY SCIENCE BOOKS;;""March's Advanced Organic Chemistry"", 2001, JOHN WILEY & SONS;;GREENE, T.W.; WUTS, P. G: ""Protective Groups in Organic Synthesis"", 1999, JOHN WILEY & SONS;;J. PHARMACEUTICAL SCIENCES, vol. 66, 1977, pages 1 - 19;;E. W. MARTIN: ""Remington's Pharmaceutical Sciences"", 1980, MACK PUBLISHING CO.;;SHINMURA ET AL., CARCINOGENESIS, vol. 25, 2004, pages 2311;;SHINMURA ET AL., JOURNAL OF PATHOLOGY, vol. 225, 2011, pages 414;;SARKARIA ET AL.: ""Inhibition of ATM and ATR Kinase Activities by the Radiosensitizing Agent"", CAFFEINE: CANCER RESEARCH, vol. 59, 1999, pages 4375 - 5382;;HICKSON ET AL.: ""Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM"", CANCER RESEARCH, vol. 64, 2004, pages 9152 - 9159, XP002498073, DOI: doi:10.1158/0008-5472.CAN-04-2727;;KIM ET AL.: ""Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Mcmbcrs"", THE JOURNAL OFBIOLOGICAL CHEMISTRY, vol. 274, no. 53, 1999, pages 37538 - 37543, XP000934014, DOI: doi:10.1074/jbc.274.53.37538;;CHIANG: ""Determination of the catalytic activities ofmTOR and other members of the phosphoinositide-3-kinase-related kinase family"", METHODS MOL. BIOL., vol. 281, 2004, pages 125 - 41;;KIM ET AL., ONCOGENE, vol. 21, 2002, pages 3864;;TAKEMURA ET AL., JBC, vol. 281, 2006, pages 30814",PENDING
562,CN,A,CN 113197512 A,170-274-079-001-404,2021-08-03,2021,CN 202110392284 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;CN 201610921399 A,2015-10-21,Surface cleaning head with dual rotating agitators,"The invention discloses a surface cleaning head with dual rotating agitators. A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roller) may be used to facilitate trapping debris in an airflow into a suction conduit on an underside of the surface cleaning head. The leading roller is positioned substantially adjacent to and forward of the opening of the suction duct. A rotating brush roller may be located in the suction duct in a manner such that the leading roller is located in front of and spaced apart from the brush roller to form an inter-roller air passage between the brush roller and the leading roller. The leading roller may provide a softer cleaning element than the brush roller and may also have an outer diameter that is smaller than an outer diameter of the brush roller. The surface cleaning head may also include a cleaning projection contacting the leading roller and/or a leading bumper extending forward of the leading roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA;;PINCHES CHRISTOPHER;;CLARE DAVID;;BROWN ANDRE DAVID;;FREESE JOHN;;FREESE JOHN;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/170-274-079-001-404,Patent Application,no,11,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04,,0,0,,,,ACTIVE
563,CN,A,CN 112450800 A,009-657-288-576-758,2021-03-09,2021,CN 202011084724 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;CN 201610921399 A,2015-10-21,Surface cleaning head with dual rotary agitators,"The invention discloses a surface cleaning head with dual rotary agitators. The surface cleaning head with dual rotary agitators (e.g., a leading roller and a brush roller) may be used to facilitate capture of debris in an air flow into a suction duct on an underside of the surface cleaning head. The front guide roller is generally positioned adjacent to and forward of the opening of the suction duct. A rotating brush roller may be located in the suction duct in a manner such that the front guide roller is located forward of and spaced apart from the brush roller to form an inter-roll air passage between the brush roller and the front guide roller. The front guide roller may provide a cleaning element that is softer than the brush roller and may also have an outer diameter that is smallerthan an outer diameter of the brush roller. The surface cleaning head may also include a cleaning projection in contact with the front guide roller and/or a leading bumper extending forward of the front guide roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA;;PINCHES CHRISTOPHER;;CLARE DAVID;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/009-657-288-576-758,Patent Application,no,5,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04,,0,0,,,,ACTIVE
564,US,A1,US 2022/0001556 A1,009-391-322-378-988,2022-01-06,2022,US 202016920288 A,2020-07-02,US 202016920288 A,2020-07-02,SENSOR-BASED SHAVING SYSTEMS AND METHODS OF ANALYZING A USER'S SHAVE EVENT FOR DETERMINING A UNIQUE THRESHOLD VALUE OF THE USER,"Sensor-based shaving systems and methods of analyzing a user's shave event are described for determining a unique threshold value of the user. A grooming device comprises a handle having a connecting structure connected to a hair cutting implement. A shave event sensor associated with the grooming device measures a user behavior, which includes collecting a first dataset comprising shave data defining a shave event. The first dataset is transmitted via a communication device and is analyzed to determine baseline behavior data of the user, and a unique threshold value of the user is determined from the baseline behavior data. One or more subsequent datasets, each comprising shave data of one or more corresponding shave events, is compared to the unique threshold value to determine comparison data. An indication is provided, based on the comparison data, to indicate a deviation from the threshold value and to influence the user behavior.",GILLETTE CO LLC,GOOD IAN ANTHONY;;AMAVASAI BALASUNDRAM PERIASAMY;;RAWLINGS CHRISTOPHER FRANCIS;;WASHINGTON AMANDA;;ROBINSON SUSAN CLARE;;HITTMEYER CLAUS;;BONIFER WERNER FRIEDRICH JOHANN;;YANG WEIYAN;;RICHARDSON ANGELA LOUISE;;FRIEND ALEXANDER JAMES HINCHLIFFE;;DIXON NICOLA DAWN;;NAMUBIRU SHIRLEY;;KISSEL JOSHUA THOMAS;;ROLLER MICHAEL THOMAS;;VASUDEVAN VENUGOPAL;;HINKLE ROBERT THOMAS,THE GILLETTE COMPANY LLC (2020-12-18),https://lens.org/009-391-322-378-988,Patent Application,yes,24,1,4,4,0,B26B19/388;;B26B21/4056;;B26B21/4081;;B26B19/388,B26B19/38,,0,0,,,,ACTIVE
565,US,B2,US 11278171 B2,124-936-319-429-912,2022-03-22,2022,US 201615331045 A,2016-10-21,US 201615331045 A;;US 201562244331 P;;US 201562248813 P;;US 201662313394 P,2015-10-21,Surface cleaning head with dual rotating agitators,"A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roll) may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The leading roller is generally positioned adjacent to and in advance of the opening of the suction conduit. The rotating brush roll may be located in the suction conduit with the leading roller located in front of and spaced from the brush roll, forming an inter-roller air passageway therebetween. The leading roller may provide a softer cleaning element than the brush roll and may also have an outside diameter that is less than the outside diameter of the brush roll. The surface cleaning head may also include debriding protrusions contacting the leading roller and/or a leading bumper that extends in front of the leading roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON;;HUTCHINSON PETER;;HOWES GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRIER DAVID W,SHARKNINJA OPERATING LLC (2018-06-19),https://lens.org/124-936-319-429-912,Granted Patent,yes,201,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04;;A47L5/26;;A47L5/30;;A47L9/06;;A47L9/30,,57,0,,,"EPO Machine Translation of Specification for JP2006-312066 (Year: 2006).;;PCT Search Report and Written Opinion dated Dec. 26, 2018, received in PCT Application No. PCT/US18/47525, 14 pgs.;;Australian Examination Report dated Oct. 23, 2018, received in AU Application No. 2016341998, 5 pgs.;;Australian Examination Report dated Oct. 16, 2018, received in AU Application No. 2016342001, 5 pgs.;;International Search Report and Written Opinion dated Mar. 17, 2017 in corresponding PCT Patent Application No. PCT/US 16/58155, 12 pgs.;;International Search Report and Written Opinion dated Mar. 24, 2017 in corresponding PCT Patent Application No. PCT/US 16/58148, 14 pgs.;;PCT Search Report and Written Opinion dated Aug. 23, 2018, received in PCT Application No. PCT/US18/34320, 11 pgs.;;PCT Search Report and Written Opinion dated Jul. 18, 2018, received in PCT Application No. PCT/US18/28635, 16 pgs.;;Extended European Search Report dated Mar. 28, 2019, received in EP Application No. 16858305.2, 7 pgs.;;English translation of Japanese Office Action dated May 21, 2019, received in Japanese Application No. 2018-520541, 11 pgs.;;English translation of Korean Office Action dated Apr. 30, 2019, received in Korean Application No. 10-2018-7014180, 11 pgs.;;U.S. Office Action dated May 15, 2019, received in U.S. Appl. No. 15/492,320, 13 pgs.;;Extended European Search Report dated Apr. 3, 2019, received in EP Application No. 16858308.6, 7 pgs.;;English translation of Japanese Office Action dated Apr. 1, 2019, received in Japanese Application No. 2017-557189, 6 pgs.;;English translation of Japanese Office Action dated Dec. 2, 2019, received in JP Application No. 2018-520541, 6 pgs.;;English translation of Korean Office Action dated Nov. 27, 2019, received in Korean Application No. 10-2018-7014180, 5 pgs.;;U.S. Office Action dated Sep. 17, 2019, received in U.S. Appl. No. 15/685,456, 11 pgs.;;U.S. Office Action dated Oct. 23, 2019, received in U.S. Appl. No. 15/492,320, 14 pgs.;;English translation of Korean Office Action dated May 31, 2019, received in Korean Application No. 10-2018-7014186, 8 pgs.;;English translation of Japanese Decision of Rejection dated Jan. 6, 2020, received in Japanese Application No. 2017-557189, 5 pgs.;;Chinese Office Action with English translation dated Feb. 25, 2020, received in Chinese Patent Application No. 201610921399.6, 18 pgs.;;Chinese Office Action with English translation dated Mar. 2, 2020, received in Chinese Patent Application No. 201711481216.4, 16 pgs.;;Chinese Office Action with English translation dated Mar. 25, 2020, received in Chinese Patent Application No. 201711405708.5, 11 pgs.;;U.S. Office Action dated Mar. 17, 2020, received in U.S. Appl. No. 15/768,879, 25 pgs.;;Chinese Office Action with English translation dated Jan. 2, 2020, received in Chinese Patent Application No. 201680061488.6, 11 pgs.;;Chinese Office Action with English translation, dated Jul. 31, 2020, received in China Application No. 201610921399.6, 21 pgs.;;PCT International Search Report and Written Opinion dated Mar. 31, 2016, received in corresponding PCT Application No. PCT/US16/15370, 15 pgs.;;3rd Party Observation filed Jul. 13, 2020 in EP Application No. 20160744107, 7 pgs.;;U.S. Office Action dated Feb. 22, 2016, received in related U.S. Appl. No. 14/744,438, 29 pgs.;;Australian Examination Report dated Jun. 24, 2021, received in Australian Patent Application No. 2021201452, 6 pages.;;Chinese Decision of Rejection with English translation dated Jun. 8, 2021 received in Chinese Patent Application No. 201711405708.5, 6 pages.;;Office Action dated May 3, 2021, received in Canadian Patent Application No. 3,073,677, 6 pages.;;Chinese Office Action with English translation, dated May 22, 2020, received in China Applicatin No. 201810965394.2, 20 pgs.;;Chinese Office Action with English translation, dated May 26, 2020, received in China Application No. 201810516731.X, 13 pgs.;;Korean Office Action with English translation, dated Aug. 31, 2020, received in Korean Application No. 10-2020-7018384, 7 pgs.;;Chinese Office Action with English translation, dated Oct. 15, 2020, received in China Application No. 201610921399.6, 21 pgs.;;Australian Examination Report dated Jun. 11, 2020, received in Australian Application No. 2019246800, 7 pgs.;;European Search Report dated Nov. 27, 2020, received in EP Application No. 18806820.9, 7 pgs.;;U.S. Office Action dated Sep. 1, 2020, received in U.S. Appl. No. 15/492,320, 14 pgs.;;U.S. Office Action dated Nov. 2, 2020, received in U.S. Appl. No. 15/987,589, 15 pgs.;;Japanese Office Action with English translation, dated Jan. 21, 2021, received in JP Application No. 2017-557189, 27 pgs.;;Canadian Examiner Report dated Feb. 8, 2021, received in Canada Patent Application No. 3,064,747, 4 pages.;;Korean Office Action with English translation dated Mar. 19, 2021, received in Korean Patent Application No. 10-2020-7006909, 15 pages.;;Japanese Office Action with English translation dated Mar. 22, 2021, received in Japanese Patent Application No. 2020-510098, 15 pages.;;Chinese Office Action with English translation dated Jan. 6, 2021, received in Chinese Patent Application No. 201711481216.4, 11 pages.;;Japanese Office Action with English translation dated Jan. 26, received in Japanese Patent Application No. 2019-564874, 9 pages.;;Chinese Office Action with English translation dated Apr. 13, 2021, received in Chinese Patent Application No. 201810516731.X, 13 pages.;;Japanese Office Action with English translation dated Jan. 26, 2021, received in Japanese Patent Application No. 2019-556824, 11 pages.;;Chinese Decision of Rejection dated May 7, 2021, received in China Application No. 201680061488.6, 9 pgs.;;Japanese Office Action with English translation dated Jul. 9, 2021, received in Japanese Patent Application No. 2020-08880, 8 pages.;;Australian Examination Report dated May 5, 2021, received in Australian Patent Application No. 2021201726, 3 pages.;;Chinese Office Action with English translation dated Aug. 31, 2021, received in Chinese Patent Application No. 202011084724.0, 8 pages.;;European Extended Search Report dated Jul. 13, 2021, received in European Patent Application No. 18848114.7, 5 pages.;;Korean Office Action with English translation dated Aug. 2, 2021, received in Korean Patent Application No. 10-2020-7006909, 14 pages.;;Chinese Office Action with English translation dated Dec. 9, 2020, received in Chinese Patent Application No. 201711405708.5, 7 pages.;;U.S. Office Action dated Dec. 16, 2021, received in U.S. Appl. No. 15/492,320, 17 pages.;;Korean Office Action with machine translation dated Jan. 18, 2022, received in Korean Patent Application No. 10-2019-7034239, 10 pages.",ACTIVE
566,CN,U,CN 208693165 U,016-372-381-699-28X,2019-04-05,2019,CN 201721448864 U,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;CN 201621147740 U,2015-10-21,Surface cleaning head with double -rotary agitator,"Surface cleaning head with double -rotary agitator can be used to catch the piece in the air current in order being favorable to among the suction ducts on the downside of surface cleaning head. The surface cleaning head includes: the shell that has front side and rear side, the shell is in the front side with inject suction ducts between the rear side, suction ducts has and is located opening onthe downside of shell, the roller, the roller is close suction ducts's opening ground installation extremely the shell, wherein, the roller is including material mild relatively, and a series of spaced apart protruding portions of cleaing away, it is located to clear away the protruding portion and contact mild roller in the shell, wherein, clear away the protruding portion at least partly angularity downwards and the position department contact of the bottom contact surface top of roller mild roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;WU DAVID POIRIER,,https://lens.org/016-372-381-699-28X,Limited Patent,no,0,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04,,0,0,,,,ACTIVE
567,CN,A,CN 108175334 A,050-330-325-482-649,2018-06-19,2018,CN 201711405708 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;CN 201610921399 A,2015-10-21,Surface cleaning head with dual rotating agitators,"A surface cleaning head with dual rotating agitators may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The surface cleaning head comprises a shell having a front side and a back side, wherein the shell limits the suction conduit between the front side and the back side, and the suction conduit has an opening locatedat the lower side of the shell; a roller getting close to the opening of the suction conduit to be installed in the shell, wherein the roller comprises a relatively flexible material; and a series ofspaced cleaning protruding parts, wherein the cleaning protruding parts are located in the shell and are contacted with the flexible roller, at least a part of the cleaning protruding parts are contacted with the flexible roller downwards and at the positions above the bottom contact surface of the roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRIER DAVID W,,https://lens.org/050-330-325-482-649,Patent Application,no,5,2,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04,,0,0,,,,PENDING
568,US,A1,US 2023/0090575 A1,154-006-517-035-962,2023-03-23,2023,US 202217699894 A,2022-03-21,US 202217699894 A;;US 201615331045 A;;US 201562244331 P;;US 201562248813 P;;US 201662313394 P,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,"A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roll) may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The leading roller is generally positioned adjacent to and in advance of the opening of the suction conduit. The rotating brush roll may be located in the suction conduit with the leading roller located in front of and spaced from the brush roll, forming an inter-roller air passageway therebetween. The leading roller may provide a softer cleaning element than the brush roll and may also have an outside diameter that is less than the outside diameter of the brush roll. The surface cleaning head may also include debriding protrusions contacting the leading roller and/or a leading bumper that extends in front of the leading roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON;;HUTCHINSON PETER;;HOWES GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,SHARKNINJA OPERATING LLC (2018-06-19),https://lens.org/154-006-517-035-962,Patent Application,yes,0,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04;;A47L5/26;;A47L5/30;;A47L9/06;;A47L9/30,,0,0,,,,PENDING
569,US,B2,US 11673282 B2,061-656-071-370-143,2023-06-13,2023,US 202016920288 A,2020-07-02,US 202016920288 A,2020-07-02,Sensor-based shaving systems and methods of analyzing a user's shave event for determining a unique threshold value of the user,"Sensor-based shaving systems and methods of analyzing a user's shave event are described for determining a unique threshold value of the user. A grooming device comprises a handle having a connecting structure connected to a hair cutting implement. A shave event sensor associated with the grooming device measures a user behavior, which includes collecting a first dataset comprising shave data defining a shave event. The first dataset is transmitted via a communication device and is analyzed to determine baseline behavior data of the user, and a unique threshold value of the user is determined from the baseline behavior data. One or more subsequent datasets, each comprising shave data of one or more corresponding shave events, is compared to the unique threshold value to determine comparison data. An indication is provided, based on the comparison data, to indicate a deviation from the threshold value and to influence the user behavior.",GILLETTE CO LLC,GOOD IAN ANTHONY;;AMAVASAI BALASUNDRAM PERIASAMY;;RAWLINGS CHRISTOPHER FRANCIS;;WASHINGTON AMANDA;;ROBINSON SUSAN CLARE;;HITTMEYER CLAUS;;BONIFER WERNER FRIEDRICH JOHANN;;YANG WEIYAN;;RICHARDSON ANGELA LOUISE;;FRIEND ALEXANDER JAMES HINCHLIFFE;;DIXON NICOLA DAWN;;NAMUBIRU SHIRLEY;;KISSEL JOSHUA THOMAS;;ROLLER MICHAEL THOMAS;;VASUDEVAN VENUGOPAL;;HINKLE ROBERT THOMAS,THE GILLETTE COMPANY LLC (2020-12-18),https://lens.org/061-656-071-370-143,Granted Patent,yes,28,1,4,4,0,B26B19/388;;B26B21/4056;;B26B21/4081;;B26B19/388,B26B19/38,,1,0,,,"Extended European Search Report and Search Opinion; Application No. 21182030.3 ; dated Nov. 30, 2021; 06 pages.",ACTIVE
570,US,A1,US 2017/0127896 A1,196-104-861-981-141,2017-05-11,2017,US 201615331045 A,2016-10-21,US 201615331045 A;;US 201562244331 P;;US 201562248813 P;;US 201662313394 P,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,"A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roll) may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The leading roller is generally positioned adjacent to and in advance of the opening of the suction conduit. The rotating brush roll may be located in the suction conduit with the leading roller located in front of and spaced from the brush roll, forming an inter-roller air passageway therebetween. The leading roller may provide a softer cleaning element than the brush roll and may also have an outside diameter that is less than the outside diameter of the brush roll. The surface cleaning head may also include debriding protrusions contacting the leading roller and/or a leading bumper that extends in front of the leading roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRIER DAVID W,SHARKNINJA OPERATING LLC (2018-06-19),https://lens.org/196-104-861-981-141,Patent Application,yes,6,28,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04;;A47L5/26;;A47L5/30;;A47L9/30,,0,0,,,,ACTIVE
571,EP,B1,EP 3364844 B1,057-579-312-579-802,2021-12-01,2021,EP 16858308 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;US 2016/0058155 W,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,,SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/057-579-312-579-802,Granted Patent,yes,8,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L5/30;;A47L9/04,,0,0,,,,ACTIVE
572,EP,A1,EP 3932632 A1,021-203-486-177-465,2022-01-05,2022,EP 21182030 A,2021-06-28,US 202016920288 A,2020-07-02,SENSOR-BASED SHAVING SYSTEMS AND METHODS OF ANALYZING A USER'S SHAVE EVENT FOR DETERMINING A UNIQUE THRESHOLD VALUE OF THE USER,"Sensor-based shaving systems and methods of analyzing a user's shave event are described for determining a unique threshold value of the user. A grooming device comprises a handle having a connecting structure connected to a hair cutting implement. A shave event sensor associated with the grooming device measures a user behavior, which includes collecting a first dataset comprising shave data defining a shave event. The first dataset is transmitted via a communication device and is analyzed to determine baseline behavior data of the user, and a unique threshold value of the user is determined from the baseline behavior data. One or more subsequent datasets, each comprising shave data of one or more corresponding shave events, is compared to the unique threshold value to determine comparison data. An indication is provided, based on the comparison data, to indicate a deviation from the threshold value and to influence the user behavior.
",GILLETTE CO LLC,AMAVASAI BALASUNDRAM PERIASAMY;;RAWLINGS CHRISTOPHER FRANCIS;;WASHINGTON AMANDA MICHELLE;;ROBINSON SUSAN CLARE;;HITTMEYER CLAUS;;BONIFER WERNER FRIEDRICH JOHANN;;YANG WEIYAN;;RICHARDSON ANGELA LOUISE;;FRIEND ALEXANDER JAMES HINCHLIFFE;;DIXON NICOLA DAWN;;NAMUBIRU SHIRLEY;;KISSEL JOSHUA THOMAS;;ROLLER MICHAEL THOMAS;;VASUDEVAN VENUGOPAL;;HINKLE ROBERT THOMAS;;GOOD IAN ANTHONY,,https://lens.org/021-203-486-177-465,Patent Application,yes,4,0,4,4,0,B26B19/388;;B26B21/4056;;B26B21/4081;;B26B19/388,B26B19/38;;B26B21/40,,0,0,,,,ACTIVE
573,JP,A,JP 2020114540 A,117-893-343-584-76X,2020-07-30,2020,JP 2020080880 A,2020-05-01,US 201562244331 P;;US 201562248813 P;;US 201662313394 P,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,"To provide a vacuum cleaner surface cleaning head with dual rotating agitators such as a leading roller and a brush roll.SOLUTION: A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roll) may be used to facilitate capturing debris in an air flow into a suction conduit on an underside of the surface cleaning head. The leading roller is generally positioned adjacently to and in advance of an opening of the suction conduit. The rotating brush roll may be located in the suction conduit with the leading roller located in front of and at a distance from the brush roll, forming an inter-roller air passageway therebetween. The leading roller may provide a softer cleaning element than the brush roll and may also have an outside diameter that is less than the outside diameter of the brush roll. The surface cleaning head may also include debriding protrusions contacting the leading roller and/or a leading bumper that extends in front of the leading roller.SELECTED DRAWING: Figure 5",SHARKNINJA OPERATING LLC,STEVEN PAUL CARTER;;ADAM UDY;;CATRIONA A SUTTER;;CHRISTOPHER PINCHES;;DAVID S CLARE;;ANDRE DAVID BROWN;;JOHN FREESE;;PATRICK CLEARY;;ALEXANDER CALVINO;;LEE COTTRELL;;MAYER DANIEL;;DANIEL JOHN INNES;;DAVID JALBERT;;JASON B THORNE;;PETER HUTCHINSON;;GORDON HOWE;;WENXIU NANCY GAO;;DAVID WU;;DAVID W POIRER,,https://lens.org/117-893-343-584-76X,Patent Application,no,7,1,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04,,0,0,,,,ACTIVE
574,AU,B2,AU 2019/246800 B2,128-413-794-531-679,2021-06-24,2021,AU 2019/246800 A,2019-10-09,AU 2019/246800 A;;AU 2016/342001 A;;US 201662313394 P;;US 201562248813 P;;US 201562244331 P;;US 2016/0058155 W,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,"Abstract A surface cleaning head including a housing having a front side and back side, the housing defining a suction conduit with an opening on an underside of the housing between the front side and the back side and a brush roll rotatably mounted to the housing within the suction conduit and at least a portion of the brush roll being proximate the opening of the suction conduit and a leading roller mounted to the housing in front of the brush roll and spaced from the brush roll to define an inter-roller air passageway between a lower portion of the brush roll and a lower portion of the leading roller, wherein at least an inside of the lower portion of the leading roller is exposed to a flow path to the suction conduit and wherein at least an inside of an upper portion of the leading roller is substantially outside of the flow path to the suction conduit, wherein the leading roller has a diameter ranging between 0.3 and 0.8 times the diameter of the brush roll, and wherein the leading roller includes a cleaning element that is softer than a cleaning element of the brush roll.",SHARKNINJA OPERATING LLC,HOWE GORDON;;WU DAVID;;JALBERT DAVID;;CALVINO ALEXANDER;;THORNE JASON B;;BROWN ANDRE DAVID;;HUTCHINSON PETER;;MEYER DANIEL;;CLEARY PATRICK;;GAO WENXIU NANCY;;PINCHES CHRISTOPHER;;CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;FREESE JOHN;;COTTRELL LEE;;INNES DANIEL JOHN;;POIRER DAVID W;;CLARE DAVID S,,https://lens.org/128-413-794-531-679,Granted Patent,no,3,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L5/30;;A47L9/04,,0,0,,,,ACTIVE
575,EP,A4,EP 3364844 A4,109-749-602-924-401,2019-05-01,2019,EP 16858308 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;US 2016/0058155 W,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,,SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/109-749-602-924-401,Search Report,no,3,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L5/30;;A47L9/04,,1,0,,,See also references of WO 2017070492A1,ACTIVE
576,KR,A,KR 20180084055 A,173-602-726-790-606,2018-07-24,2018,KR 20187014186 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;US 2016/0058155 W,2015-10-21,이중 회전 애지테이터를 구비한 표면 청소 헤드,"이중 회전 애지테이터(예를 들어, 리딩 롤러 및 브러시 롤)를 구비한 표면 청소 헤드는 표면 청소 헤드의 아래면 상에 있는 흡입 도관 내로의 공기 유동 내의 쓰레기의 포집을 용이하게 하는데 사용될 수 있다. 리딩 롤러는 일반적으로 흡입 도관의 개구 앞에서 인접하여 위치된다. 회전 브러시 롤은 리딩 롤러가 브러시 롤의 전방에 위치되고 그 사이에 롤러 사이 공기 통로를 형성하게 흡입 도관 내에 위치 될 수 있다. 리딩 롤러는 브러시 롤보다 부드러운 청소 요소를 제공 할 수 있고 브러시 롤의 외경보다 작은 외경을 가질 수도 있다. 표면 청소 헤드는 또한 리딩 롤러와 접촉하는 세정 돌기부 및/또는 리딩 롤러의 전방으로 연장되는 리딩 범퍼를 포함할 수 있다.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/173-602-726-790-606,Patent Application,no,10,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/30,,0,0,,,,ACTIVE
577,AU,A1,AU 2016/342001 A1,020-288-091-672-807,2018-05-10,2018,AU 2016/342001 A,2016-10-21,US 201662313394 P;;US 201562248813 P;;US 201562244331 P;;US 2016/0058155 W,2015-10-21,Surface cleaning head with dual rotating agitators,"A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roll) may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The leading roller is generally positioned adjacent to and in advance of the opening of the suction conduit. The rotating brush roll may be located in the suction conduit with the leading roller located in front of and spaced from the brush roll, forming an inter-roller air passageway therebetween. The leading roller may provide a softer cleaning element than the brush roll and may also have an outside diameter that is less than the outside diameter of the brush roll. The surface cleaning head may also include debriding protrusions contacting the leading roller and/or a leading bumper that extends in front of the leading roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/020-288-091-672-807,Patent Application,no,0,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L5/30;;A47L9/04,,0,0,,,,DISCONTINUED
578,CA,C,CA 3002867 C,138-039-310-461-324,2024-01-09,2024,CA 3002867 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;US 2016/0058155 W,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,"A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roll) may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The leading roller is generally positioned adjacent to and in advance of the opening of the suction conduit. The rotating brush roll may be located in the suction conduit with the leading roller located in front of and spaced from the brush roll, forming an inter-roller air passageway therebetween. The leading roller may provide a softer cleaning element than the brush roll and may also have an outside diameter that is less than the outside diameter of the brush roll. The surface cleaning head may also include debriding protrusions contacting the leading roller and/or a leading bumper that extends in front of the leading roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/138-039-310-461-324,Granted Patent,no,0,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L5/30;;A47L5/34;;A47L9/04,,0,0,,,,PENDING
579,KR,A,KR 20200080330 A,005-879-194-338-036,2020-07-06,2020,KR 20207018384 A,2016-10-21,US 201562244331 P;;US 201662313394 P;;US 201562248813 P;;KR 20187014186 A;;US 2016/0058155 W,2015-10-21,surface cleaning head,"이중 회전 애지테이터(예를 들어, 리딩 롤러 및 브러시 롤)를 구비한 표면 청소 헤드는 표면 청소 헤드의 아래면 상에 있는 흡입 도관 내로의 공기 유동 내의 쓰레기의 포집을 용이하게 하는데 사용될 수 있다. 리딩 롤러는 일반적으로 흡입 도관의 개구 앞에서 인접하여 위치된다. 회전 브러시 롤은 리딩 롤러가 브러시 롤의 전방에 위치되고 그 사이에 롤러 사이 공기 통로를 형성하게 흡입 도관 내에 위치 될 수 있다. 리딩 롤러는 브러시 롤보다 부드러운 청소 요소를 제공 할 수 있고 브러시 롤의 외경보다 작은 외경을 가질 수도 있다. 표면 청소 헤드는 또한 리딩 롤러와 접촉하는 세정 돌기부 및/또는 리딩 롤러의 전방으로 연장되는 리딩 범퍼를 포함할 수 있다.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/005-879-194-338-036,Patent Application,no,16,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L9/04;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/30,,0,0,,,,ACTIVE
580,WO,A1,WO 2017/070492 A1,020-630-410-710-649,2017-04-27,2017,US 2016/0058155 W,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,"A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roll) may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The leading roller is generally positioned adjacent to and in advance of the opening of the suction conduit. The rotating brush roll may be located in the suction conduit with the leading roller located in front of and spaced from the brush roll, forming an inter-roller air passageway therebetween. The leading roller may provide a softer cleaning element than the brush roll and may also have an outside diameter that is less than the outside diameter of the brush roll. The surface cleaning head may also include debriding protrusions contacting the leading roller and/or a leading bumper that extends in front of the leading roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/020-630-410-710-649,Patent Application,yes,12,17,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L5/30;;A47L9/04,,1,0,,,See also references of EP 3364844A4,PENDING
581,CA,A1,CA 3002867 A1,126-552-635-118-200,2017-04-27,2017,CA 3002867 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;US 2016/0058155 W,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,"A surface cleaning head with dual rotating agitators (e.g., a leading roller and a brush roll) may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The leading roller is generally positioned adjacent to and in advance of the opening of the suction conduit. The rotating brush roll may be located in the suction conduit with the leading roller located in front of and spaced from the brush roll, forming an inter-roller air passageway therebetween. The leading roller may provide a softer cleaning element than the brush roll and may also have an outside diameter that is less than the outside diameter of the brush roll. The surface cleaning head may also include debriding protrusions contacting the leading roller and/or a leading bumper that extends in front of the leading roller.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/126-552-635-118-200,Patent Application,no,0,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L5/30;;A47L5/34;;A47L9/04,,0,0,,,,PENDING
582,EP,B1,EP 3932632 B1,017-836-897-143-986,2023-12-13,2023,EP 21182030 A,2021-06-28,US 202016920288 A,2020-07-02,SENSOR-BASED SHAVING SYSTEMS AND METHODS OF ANALYZING A USER'S SHAVE EVENT FOR DETERMINING A UNIQUE THRESHOLD VALUE OF THE USER,,GILLETTE CO LLC,AMAVASAI BALASUNDRAM PERIASAMY;;RAWLINGS CHRISTOPHER FRANCIS;;WASHINGTON AMANDA MICHELLE;;ROBINSON SUSAN CLARE;;HITTMEYER CLAUS;;BONIFER WERNER FRIEDRICH JOHANN;;YANG WEIYAN;;RICHARDSON ANGELA LOUISE;;FRIEND ALEXANDER JAMES HINCHLIFFE;;DIXON NICOLA DAWN;;NAMUBIRU SHIRLEY;;KISSEL JOSHUA THOMAS;;ROLLER MICHAEL THOMAS;;VASUDEVAN VENUGOPAL;;HINKLE ROBERT THOMAS;;GOOD IAN ANTHONY,,https://lens.org/017-836-897-143-986,Granted Patent,yes,4,0,4,4,0,B26B19/388;;B26B21/4056;;B26B21/4081;;B26B19/388,B26B19/38;;B26B21/40,,0,0,,,,ACTIVE
583,EP,A1,EP 3364844 A1,153-879-253-787-082,2018-08-29,2018,EP 16858308 A,2016-10-21,US 201562244331 P;;US 201562248813 P;;US 201662313394 P;;US 2016/0058155 W,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,,SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRER DAVID W,,https://lens.org/153-879-253-787-082,Patent Application,yes,0,1,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L5/30;;A47L9/04,,0,0,,,,ACTIVE
584,AU,A1,AU 2019/246800 A1,109-780-612-637-209,2019-10-31,2019,AU 2019/246800 A,2019-10-09,AU 2019/246800 A;;AU 2016/342001 A;;US 201662313394 P;;US 201562248813 P;;US 201562244331 P;;US 2016/0058155 W,2015-10-21,SURFACE CLEANING HEAD WITH DUAL ROTATING AGITATORS,"Abstract A surface cleaning head including a housing having a front side and back side, the housing defining a suction conduit with an opening on an underside of the housing between the front side and the back side and a brush roll rotatably mounted to the housing within the suction conduit and at least a portion of the brush roll being proximate the opening of the suction conduit and a leading roller mounted to the housing in front of the brush roll and spaced from the brush roll to define an inter-roller air passageway between a lower portion of the brush roll and a lower portion of the leading roller, wherein at least an inside of the lower portion of the leading roller is exposed to a flow path to the suction conduit and wherein at least an inside of an upper portion of the leading roller is substantially outside of the flow path to the suction conduit, wherein the leading roller has a diameter ranging between 0.3 and 0.8 times the diameter of the brush roll, and wherein the leading roller includes a cleaning element that is softer than a cleaning element of the brush roll.",SHARKNINJA OPERATING LLC,JALBERT DAVID;;CALVINO ALEXANDER;;THORNE JASON B;;BROWN ANDRE DAVID;;HUTCHINSON PETER;;MEYER DANIEL;;CLEARY PATRICK;;HOWE GORDON;;WU DAVID;;GAO WENXIU NANCY;;PINCHES CHRISTOPHER;;CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;FREESE JOHN;;COTTRELL LEE;;INNES DANIEL JOHN;;POIRER DAVID W;;CLARE DAVID S,,https://lens.org/109-780-612-637-209,Patent Application,no,0,0,53,162,0,A47L9/0477;;A47L9/0494;;A47L5/34;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L5/26;;A47L5/30;;A47L5/34;;A47L9/0477;;A47L9/0483;;A47L9/0488;;A47L9/30;;A47L5/26;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/30;;A47L9/0405;;A47L9/0494;;A47L9/0606;;A47L9/0673,A47L5/30;;A47L9/04,,0,0,,,,ACTIVE
585,US,A1,US 2017/0347848 A1,122-818-292-742-553,2017-12-07,2017,US 201715685456 A,2017-08-24,US 201715685456 A;;US 201615331045 A;;US 2016/0058148 W;;US 201514867599 A;;US 201562244331 P;;US 201562248813 P;;US 201662313394 P,2015-09-28,SURFACE CLEANING HEAD FOR VACUUM CLEANER,"A surface cleaning head includes dual rotating agitators (e.g., a leading roller and a brush roll) and a removable cover for covering a top of the agitators and allowing access to the agitators from a top of the surface cleaning head. The dual agitators may be used to facilitate capturing of debris in the air flow into a suction conduit on the underside of the surface cleaning head. The brush roll may be located in a brush roll chamber and at least partially in an opening to the suction conduit. The leading roller may be positioned adjacent to and in advance of the suction conduit opening such that the leading roller engages debris and moves the debris toward the brush roll and the opening. The leading roller may be removable from the housing and held in place by the removable cover. The cover may be coupled using isolated latching mechanisms.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON;;HUTCHINSON PETER;;HOWE GORDON;;GAO WENXIU NANCY;;WU DAVID;;POIRIER DAVID W;;DER MARDEROSIAN DANIEL R,SHARKNINJA OPERATING LLC (2018-10-23),https://lens.org/122-818-292-742-553,Patent Application,yes,5,19,3,162,0,A47L5/30;;A47L5/30;;A47L5/34;;A47L5/34;;A47L9/0411;;A47L9/0411;;A47L9/0444;;A47L9/0444;;A47L9/0461;;A47L9/0477;;A47L9/0477;;A47L9/0488;;A47L9/0488,A47L5/30;;A47L9/04,,0,0,,,,ACTIVE
586,CN,A,CN 113951764 A,101-379-456-322-034,2022-01-21,2022,CN 202111186082 A,2018-05-25,CN 202111186082 A;;CN 201810516731 A;;US 201762511099 P,2017-05-25,Robotic cleaner,"The application relates to a robotic cleaner. The robotic cleaner includes a housing, a suction conduit with an opening, and a leading roller mounted in front of a brush roll. An inter-roller air passageway may be defined between the leading roller and the brush roll, wherein the lower portion of the leading roller is exposed to a flow path to the suction conduit and an upper portion of the leading roller is outside of the flow path. Optionally, a combing unit includes a plurality of combing protrusions extending into the leading roller and having leading edges not aligned with a center of the leading roller. Optionally, a sealing strip is located along a rear side of the opening and along a portion of left and right sides of the opening. The underside may define side edge vacuum passageways extending from the sides of the housing partially between the leading roller and the sealing strip towards the opening.",SHARKNINJA OPERATING LLC,STEVEN P CARTER;;UDY ADAM;;CATRIONA CA SUTTER;;PINCHES CHRISTOPHER;;CLARE DAVID S;;THORNE JASON B;;BROWN ANDRE D;;FREESE JOHN;;FREESE JOHN;;DER MARDEROSIAN DANIEL R;;MEYER DANIEL;;CALVINO ALEXANDER J;;COTTRELL LEE;;HOWES GORDON;;WU DAVID;;GAO WENXIU;;INNES DANIEL J;;JALBERT DAVID;;HUTCHINSON PETER;;POIRER DAVID W,,https://lens.org/101-379-456-322-034,Patent Application,no,9,0,18,18,0,A47L11/4011;;A47L11/4041;;A47L11/24;;A47L11/4002;;A47L11/4036;;A47L11/4061;;A47L11/4094;;A47L2201/00;;A47L9/0477;;A47L9/0488;;A47L9/0613;;A47L2201/00;;A47L7/0066;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/0613,A47L11/24;;A47L11/40,,0,0,,,,ACTIVE
587,US,A1,US 2018/0338656 A1,128-638-085-726-550,2018-11-29,2018,US 201815987589 A,2018-05-23,US 201815987589 A;;US 201762511099 P,2017-05-25,ROBOTIC CLEANER WITH DUAL CLEANING ROLLERS,"A robotic cleaner includes a housing, a suction conduit with an opening, and a leading roller mounted in front of a brush roll. An inter-roller air passageway may be defined between the leading roller and the brush roll wherein the lower portion of the leading roller is exposed to a flow path to the suction conduit and an upper portion of the leading roller is outside of the flow path. Optionally, a combing unit includes a plurality of combing protrusions extending into the leading roller and having leading edges not aligned with a center of the leading roller. Optionally, a sealing strip is located along a rear side of the opening and along a portion of left and right sides of the opening. The underside may define side edge vacuum passageways extending from the sides of the housing partially between the leading roller and the sealing strip towards the opening.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER J;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWES GORDON;;GAO WENXIU;;WU DAVID;;POIRIER DAVID W;;DER MARDEROSIAN DANIEL R,SHARKNINJA OPERATING LLC (2018-02-07),https://lens.org/128-638-085-726-550,Patent Application,yes,0,14,18,18,0,A47L11/4011;;A47L11/4041;;A47L11/24;;A47L11/4002;;A47L11/4036;;A47L11/4061;;A47L11/4094;;A47L2201/00;;A47L9/0477;;A47L9/0488;;A47L9/0613;;A47L2201/00;;A47L7/0066;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/0613,A47L9/06;;A47L5/30;;A47L9/04,,0,0,,,,ACTIVE
588,US,A1,US 2022/0110495 A1,128-391-187-400-832,2022-04-14,2022,US 202117556992 A,2021-12-20,US 202117556992 A;;US 201815987589 A;;US 201762511099 P,2017-05-25,ROBOTIC CLEANER WITH DUAL CLEANING ROLLERS,"A robotic cleaner includes a housing, a suction conduit with an opening, and a leading roller mounted in front of a brush roll. An inter-roller air passageway may be defined between the leading roller and the brush roll wherein the lower portion of the leading roller is exposed to a flow path to the suction conduit and an upper portion of the leading roller is outside of the flow path. Optionally, a combing unit includes a plurality of combing protrusions extending into the leading roller and having leading edges not aligned with a center of the leading roller. Optionally, a sealing strip is located along a rear side of the opening and along a portion of left and right sides of the opening. The underside may define side edge vacuum passageways extending from the sides of the housing partially between the leading roller and the sealing strip towards the opening.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER J;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWES GORDON;;GAO WENXIU;;WU DAVID;;POIRIER DAVID W;;DER MARDEROSIAN DANIEL R,SHARKNINJA OPERATING LLC (2018-02-07),https://lens.org/128-391-187-400-832,Patent Application,yes,1,0,18,18,0,A47L11/4011;;A47L11/4041;;A47L11/24;;A47L11/4002;;A47L11/4036;;A47L11/4061;;A47L11/4094;;A47L2201/00;;A47L9/0477;;A47L9/0488;;A47L9/0613;;A47L2201/00;;A47L7/0066;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/0613,A47L9/06;;A47L5/30;;A47L9/04,,0,0,,,,ACTIVE
589,CN,U,CN 213850515 U,054-564-910-477-24X,2021-08-03,2021,CN 201921681932 U,2018-05-25,US 201762511099 P;;CN 201820798373 U,2017-05-25,ROBOT CLEANER WITH DUAL CLEANING ROLLS,"The utility model relates to a robot cleaner with dual cleaning rollers. The robot cleaner includes a housing, a suction conduit having an opening, and a front guide roller mounted in front of a brush roller. An inter-roller air passage may be defined between the leading roller and the brush roller, where a lower portion of the leading roller is exposed to the flow path leading to the suction conduit, and an upper portion of the leading roller is external to the flow path. Optionally, the carding unit includes a plurality of carding protrusions extending into the leading roller and having a leading edge that is not aligned with a center of the leading roller. Optionally, a sealing strip is disposed along a rear side of the opening and a portion of the left and right side portions of the opening. The lower side may define a side edge vacuum passage extending partially between the leading roller and the sealing strip from a side of the housing toward the opening.",SHARKNINJA OPERATING LLC,STEVEN P CARTER;;UDY ADAM;;CATRIONA CA SUTTER;;PINCHES CHRISTOPHER;;CLARE DAVID S;;THORNE JASON B;;BROWN ANDRE D;;FREESE JOHN;;FREESE JOHN;;DER MARDEROSIAN DANIEL R;;MEYER DANIEL;;CALVINO ALEXANDER J;;COTTRELL LEE;;HOWES GORDON;;WU DAVID;;GAO WENXIU;;INNES DANIEL J;;JALBERT DAVID;;HUTCHINSON PETER;;POIRER DAVID W,,https://lens.org/054-564-910-477-24X,Limited Patent,no,0,0,18,18,0,A47L11/4011;;A47L11/4041;;A47L11/24;;A47L11/4002;;A47L11/4036;;A47L11/4061;;A47L11/4094;;A47L2201/00;;A47L9/0477;;A47L9/0488;;A47L9/0613;;A47L2201/00;;A47L7/0066;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/0613,A47L11/32;;A47L11/40,,0,0,,,,ACTIVE
590,US,B2,US 11202542 B2,159-750-216-920-973,2021-12-21,2021,US 201815987589 A,2018-05-23,US 201815987589 A;;US 201762511099 P,2017-05-25,Robotic cleaner with dual cleaning rollers,"A robotic cleaner includes a housing, a suction conduit with an opening, and a leading roller mounted in front of a brush roll. An inter-roller air passageway may be defined between the leading roller and the brush roll wherein the lower portion of the leading roller is exposed to a flow path to the suction conduit and an upper portion of the leading roller is outside of the flow path. Optionally, a combing unit includes a plurality of combing protrusions extending into the leading roller and having leading edges not aligned with a center of the leading roller. Optionally, a sealing strip is located along a rear side of the opening and along a portion of left and right sides of the opening. The underside may define side edge vacuum passageways extending from the sides of the housing partially between the leading roller and the sealing strip towards the opening.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER J;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWES GORDON;;GAO WENXIU;;WU DAVID;;POIRIER DAVID W;;DER MARDEROSIAN DANIEL R,SHARKNINJA OPERATING LLC (2018-02-07),https://lens.org/159-750-216-920-973,Granted Patent,yes,356,0,18,18,0,A47L11/4011;;A47L11/4041;;A47L11/24;;A47L11/4002;;A47L11/4036;;A47L11/4061;;A47L11/4094;;A47L2201/00;;A47L9/0477;;A47L9/0488;;A47L9/0613;;A47L2201/00;;A47L7/0066;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/0613,A47L9/06;;A47L5/30;;A47L9/04,,59,0,,,"US 8,359,703 B2, 01/2013, Svendsen et al. (withdrawn);;Chinese Office Action with English translation dated Jan. 2, 2020, received in Chinese Patent Application No. 201680061488.6, 11 pgs.;;Extended European Search Report dated Mar. 28, 2019, received in EP Application No. 16858305.2, 7 pgs.;;English translation of Japanese Office Action dated May 21, 2019, received in Japanese Application No. 2018-520541, 11 pgs.;;English translation of Korean Office Action dated Apr. 30, 2019, received in Korean Application No. 10-2018-7014180, 11 pgs.;;U.S. Office Action dated May 3, 2019, received in U.S. Appl. No. 15/331,045, 9 pgs.;;International Search Report and Written Opinion dated Mar. 17, 2017 in corresponding PCT Patent Application No. PCT/US 16/58155, 12 pgs.;;International Search Report and Written Opinion dated Mar. 24, 2017 in corresponding PCT Patent Application No. PCT/US 16/58148, 14 pgs.;;English translation of Japanese Office Action dated Dec. 2, 2019, received in JP Application No. 2018-520541, 6 pgs.;;English translation of Korean Office Action dated Nov. 27, 2019, received in Korean Application No. 10-2018-7014180, 5 pgs.;;U.S. Office Action dated Sep. 17, 2019, received in U.S. Appl. No. 15/685,456, 11 pgs.;;U.S. Office Action dated Oct. 23, 2019, received in U.S. Appl. No. 15/492,320, 14 pgs.;;PCT Search Report and Written Opinion dated Aug. 23, 2018, received in PCT Application No. PCT/US18/34320, 11 pgs.;;PCT Search Report and Written Opinion dated Jul. 18, 2018, received in PCT Application No. PCT/US18/28635, 16 pgs.;;English translation of Korean Office Action dated May 31, 2019, received in Korean Application No. 10-2018-7014186, 8 pgs.;;PCT Search Report and Written Opinion dated Dec. 26, 2018, received in PCT Application No. PCT/US18/47525, 14 pgs.;;Australian Examination Report dated Oct. 23, 2018, received in AU Application No. 2016341998, 5 pgs.;;Australian Examination Report dated Oct. 16, 2018, received in AU Application No. 2016342001, 5 pgs.;;Extended European Search Report dated Apr. 3, 2019, received in EP Application No. 16858308.6, 7 pgs.;;English translation of Japanese Office Action dated Apr. 1, 2019, received in Japanese Application No. 2017-557189, 6 pgs.;;U.S. Office Action dated May 15, 2019, received in U.S. Appl. No. 15/492,320, 13 pgs.;;English translation of Japanese Decision of Rejection dated Jan. 6, 2020, received in Japanese Application No. 2017-557189, 5 pgs.;;Chinese Office Action with English translation dated Feb. 25, 2020, received in Chinese Patent Application No. 201610921399.6, 18 pgs.;;Chinese Office Action with English translation dated Mar. 2, 2020, received in Chinese Patent Application No. 201711481216.4, 16 pgs.;;Chinese Office Action with English translation dated Mar. 25, 2020, received in Chinese Patent Application No. 201711405708.5, 11 pgs.;;U.S. Office Action dated Mar. 17, 2020, received in U.S. Appl. No. 15/768,879, 25 pgs.;;U.S. Appl. No. 60/747,791, filed May 19, 2006.;;CPU-Zilla, Electrolux Trilobite—Final Words, Hardware Zone.com, Jimmy Tang, Mar. 25, 2003, 2 pages.;;CPU-Zilla, Electrolux Trilobite—Lifes Better With Auto-Vacumming, Hardware Zone.com, Jimmy Tang, Mar. 25, 2003, 3 pages.;;The Electrolux Group, Trilobite Manual, Sep. 28, 2001, 10 pages.;;CPU-Zilla, Electrolux Trilobite—Things to Consider, Hardware Zone.com, Jimmy Tang, Mar. 25, 2003, 3 pages.;;CPU-Zilla, Electrolux Trilobite—Welcome to Paleozoic Park . . . Not Quite, Hardware Zone.com, Jimmy Tang, Mar. 25, 2003, 2 pages.;;Beforemario, Nintendo Chiritori, Mar. 13, 2011, 6 pages.;;Chinese Office Action with English translation, dated May 22, 2020, received in China Applicatin No. 201810965394.2, 20 pgs.;;Chinese Office Action with English translation, dated May 26, 2020, received in China Application No. 201810516731.X, 13 pgs.;;Korean Office Action with English translation, dated Aug. 31, 2020, received in Korean Application No. 10-2020-7018384, 7 pgs.;;Chinese Office Action with English translation, dated Oct. 15, 2020, received in China Application No. 201610921399.6, 21 pgs.;;Australian Examination Report dated Jun. 11, 2020, received in Australian Application No. 2019246800, 7 pgs.;;European Search Report dated Nov. 27, 2020, received in EP Application No. 18806820.9, 7 pgs.;;U.S. Office Action dated Sep. 1, 2020, received in U.S. Appl. No. 15/492,320, 14 pgs.;;U.S. Office Action dated May 21, 2020, received in U.S. Appl. No. 15/331,045, 14 pgs.;;Japanese Office Action with English translation, dated Jan. 21, 2021, received in JP Application No. 2017-557189, 27 pgs.;;Chinese Office Action with English translation, dated Jul. 31, 2020, received in China Application No. 201610921399.6, 21 pgs.;;3rd Party Observation filed Jul. 13, 2020 in EP Application No. 20160744107, 7 pgs.;;PCT International Search Report and Written Opinion dated Mar. 31, 2016, received in corresponding PCT Application No. PCT/US16/15370, 15 pgs.;;U.S. Office Action dated Feb. 22, 2016, received in related U.S. Appl. No. 14/744,438, 29 pgs.;;Canadian Examiner Report dated Feb. 8, 2021, received in Canada Patent Application No. 3,064,747, 4 pages.;;Korean Office Action with English translation dated Mar. 19, 2021, received in Korean Patent Application No. 10-2020-7006909, 15 pages.;;Japanese Office Action with English translation dated Mar. 22, 2021, received in Japanese Patent Application No. 2020-510098, 15 pages.;;Chinese Office Action with English translation dated Jan. 6, 2021, received in Chinese Patent Application No. 201711481216.4, 11 pages.;;Japanese Office Action with English translation dated Jan. 26, received in Japanese Patent Application No. 2019-564874, 9 pages.;;Chinese Office Action with English translation dated Apr. 13, 2021, received in Chinese Patent Application No. 201810516731.X, 13 pages.;;Japanese Office Action with English translation dated Jan. 26, 2021, received in Japanese Patent Application No. 2019-556824, 11 pages.;;Chinese Decision of Rejection dated May 7, 2021, received in China Application No. 201680061488.6, 9 pgs.;;Australian Examination Report dated Jun. 24, 2021, received in Australian Patent Application No. 2021201452, 6 pages.;;Japanese Office Action with English translation dated Jul. 9, 2021, received in Japanese Patent Application No. 2020-080880, 8 pages.;;Korean Office Action with English translation dated Aug. 2, 2021, received in Korean Patent Application No. 10-2020-7006909, 14 pages.;;Chinese Office Action with English translation dated Aug. 31, 2021, received in Chinese Patent Application No. 202011084724.0, 8 pages.;;European Extended Search Report dated Jul. 13, 2021, received in European Patent Application No. 18848114.7, 5 pages.",ACTIVE
591,CN,U,CN 209574580 U,072-115-074-089-637,2019-11-05,2019,CN 201820798373 U,2018-05-25,US 201762511099 P,2017-05-25,A robotic cleaner having dual cleaning rollers,"The utility model relates to a robotic cleaner with dual cleaning rollers. The robot cleaner includes a housing, a suction duct having an opening, and a front guide roller mounted in front of a brushroller. An inter-roller air passage may be defined between the leading roller and the brush roller, where a lower portion of the leading roller is exposed to a flow path leading to the suction duct and an upper portion of the leading roller is outside the flow path. Optionally, the carding unit includes a plurality of carding protrusions extending into the leading roller and having leading edges that are not aligned with the center of the leading roller. Optionally, the seal strip is disposed along the rear side of the opening and a portion of the left and right side portions of the opening. The underside may define a side edge vacuum passage extending partially between the leading roller and the weather strip from a side of the housing toward the opening.",SHARKNINJA OPERATING LLC,DAVID WU;;CATRIONA CA SUTTER;;DANIEL J INNES;;PATRICK CLEARY;;DANIEL R DER MARDEROSIAN;;LEE COTTRELL;;JASON B THORNE;;ANDRE D BROWN;;DAVID JALBERT;;DAVID S CLARE;;DANIEL MEYER;;CHRISTOPHER PINCHES;;JOHN FREESE;;GORDON HOWES;;STEVEN P CARTER;;WENXIU GAO;;DAVID W POIRIER;;ADAM UDY;;ALEXANDER J CALVINO;;PETER HUTCHINSON,,https://lens.org/072-115-074-089-637,Limited Patent,no,0,1,18,18,0,A47L11/4011;;A47L11/4041;;A47L11/24;;A47L11/4002;;A47L11/4036;;A47L11/4061;;A47L11/4094;;A47L2201/00;;A47L9/0477;;A47L9/0488;;A47L9/0613;;A47L2201/00;;A47L7/0066;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/0613,A47L11/32;;A47L11/40,,0,0,,,,ACTIVE
592,US,B2,US 11839346 B2,003-349-190-931-982,2023-12-12,2023,US 202117556992 A,2021-12-20,US 202117556992 A;;US 201815987589 A;;US 201762511099 P,2017-05-25,Robotic cleaner with dual cleaning rollers,"A robotic cleaner includes a housing, a suction conduit with an opening, and a leading roller mounted in front of a brush roll. An inter-roller air passageway may be defined between the leading roller and the brush roll wherein the lower portion of the leading roller is exposed to a flow path to the suction conduit and an upper portion of the leading roller is outside of the flow path. Optionally, a combing unit includes a plurality of combing protrusions extending into the leading roller and having leading edges not aligned with a center of the leading roller. Optionally, a sealing strip is located along a rear side of the opening and along a portion of left and right sides of the opening. The underside may define side edge vacuum passageways extending from the sides of the housing partially between the leading roller and the sealing strip towards the opening.",SHARKNINJA OPERATING LLC,CARTER STEVEN PAUL;;UDY ADAM;;SUTTER CATRIONA A;;PINCHES CHRISTOPHER;;CLARE DAVID S;;BROWN ANDRE DAVID;;FREESE JOHN;;CLEARY PATRICK;;CALVINO ALEXANDER J;;COTTRELL LEE;;MEYER DANIEL;;INNES DANIEL JOHN;;JALBERT DAVID;;THORNE JASON B;;HUTCHINSON PETER;;HOWES GORDON;;GAO WENXIU;;WU DAVID;;POIRIER DAVID W;;DER MARDEROSIAN DANIEL R,SHARKNINJA OPERATING LLC (2018-02-07),https://lens.org/003-349-190-931-982,Granted Patent,yes,378,0,18,18,0,A47L11/4011;;A47L11/4041;;A47L11/24;;A47L11/4002;;A47L11/4036;;A47L11/4061;;A47L11/4094;;A47L2201/00;;A47L9/0477;;A47L9/0488;;A47L9/0613;;A47L2201/00;;A47L7/0066;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/0613,A47L9/06;;A47L5/30;;A47L7/00;;A47L9/04,,88,0,,,"US 8,359,703 B2, 01/2013, Svendsen et al. (withdrawn);;Chinese Office Action with English translation, dated May 22, 2020, received in China Applicatin No. 201810965394.2, 20 pgs.;;Chinese Office Action with English translation, dated May 26, 2020, received in China Application No. 201810516731.X, 13 pgs.;;Korean Office Action with English translation, dated Aug. 31, 2020, received in Korean Application No. 10-2020-7018384, 7 pgs.;;Chinese Office Action with English translation, dated Oct. 15, 2020, received in China Application No. 201610921399.6, 21 pgs.;;Australian Examination Report dated Jun. 11, 2020, received in Australian Application No. 2019246800, 7 pgs.;;European Search Report dated Nov. 27, 2020, received in EP Application No. 18806820.9, 7 pgs.;;U.S. Office Action dated Sep. 1, 2020, received in U.S. Appl. No. 15/492,320, 14 pgs.;;U.S. Office Action dated May 21, 2020, received in U.S. Appl. No. 15/331,045, 14 pgs.;;Japanese Office Action with English translation, dated Jan. 21, 2021, received in JP Application No. 2017-557189, 27 pgs.;;PCT Search Report and Written Opinion dated Aug. 23, 2018, received in PCT Application No. PCT/US18/34320, 11 pgs.;;PCT Search Report and Written Opinion dated Jul. 18, 2018, received in PCT Application No. PCT/US18/28635, 16 pgs.;;PCT Search Report and Written Opinion dated Dec. 26, 2018, received in PCT Application No. PCT/US18/47525, 14 pgs.;;Australian Examination Report dated Oct. 23, 2018, received in AU Application No. 2016341998, 5 pgs.;;Australian Examination Report dated Oct. 16, 2018, received in AU Application No. 2016342001, 5 pgs.;;Extended European Search Report dated Mar. 28, 2019, received in EP Application No. 16858305.2, 7 pgs.;;English translation of Japanese Office Action dated May 21, 2019, received in Japanese Application No. 2018-520541, 11 pgs.;;English translation of Korean Office Action dated Apr. 30, 2019, received in Korean Application No. 10-2018-7014180, 11 pgs.;;U.S. Office Action dated May 3, 2019, received in U.S. Appl. No. 15/331,045, 9 pgs.;;Extended European Search Report dated Apr. 3, 2019, received in EP Application No. 16858308.6, 7 pgs.;;English translation of Japanese Office Action dated Apr. 1, 2019, received in Japanese Application No. 2017-557189, 6 pgs.;;U.S. Office Action dated May 15, 2019, received in U.S. Appl. No. 15/492,320, 13 pgs.;;Chinese Office Action with English translation, dated Jul. 31, 2020, received in China Application No. 201610921399.6, 21 pgs.;;3rd Party Observation filed Jul. 13, 2020 in EP Application No. 20160744107, 7 pgs.;;PCT International Search Report and Written Opinion dated Mar. 31, 2016, received in corresponding PCT Application No. PCT/US16/15370, 15 pgs.;;U.S. Office Action dated Feb. 22, 2016, received in related U.S. Appl. No. 14/744,438, 29 pgs.;;Canadian Examiner Report dated Feb. 8, 2021, received in Canada Patent Application No. 3,064,747, 4 pages.;;Korean Office Action with English translation dated Mar. 19, 2021, received in Korean Patent Application No. 10-2020-7006909, 15 pages.;;Japanese Office Action with English translation dated Mar. 22, 2021, received in Japanese Patent Application No. 2020-510098, 15 pages.;;Chinese Office Action with English translation dated Jan. 6, 2021, received in Chinese Patent Application No. 201711481216.4, 11 pages.;;Japanese Office Action with English translation dated Jan. 26, received in Japanese Patent Application No. 2019-564874, 9 pages.;;Chinese Office Action with English translation dated Apr. 13, 2021, received in Chinese Patent Application No. 201810516731.X, 13 pages.;;Japanese Office Action with English translation dated Jan. 26, 2021, received in Japanese Patent Application No. 2019-556824, 11 pages.;;Chinese Decision of Rejection dated May 7, 2021, received in China Application No. 201680061488.6, 9 pgs.;;English translation of Korean Office Action dated May 31, 2019, received in Korean Application No. 10-2018-7014186, 8 pgs.;;English translation of Japanese Office Action dated Dec. 2, 2019, received in JP Application No. 2018-520541, 6 pgs.;;English translation of Korean Office Action dated Nov. 27, 2019, received in Korean Application No. 10-2018-7014180, 5 pgs.;;U.S. Office Action dated Sep. 17, 2019, received in U.S. Appl. No. 15/685,456, 11 pgs.;;U.S. Office Action dated Oct. 23, 2019, received in U.S. Appl. No. 15/492,320, 14 pgs.;;Chinese Office Action with English translation dated Jan. 2, 2020, received in Chinese Patent Application No. 201680061488.6, 11 pgs.;;English translation of Japanese Decision of Rejection dated Jan. 6, 2020, received in Japanese Application No. 2017-557189, 5 pgs.;;Chinese Office Action with English translation dated Feb. 25, 2020, received in Chinese Patent Application No. 201610921399.6, 18 pgs.;;Chinese Office Action with English translation dated Mar. 2, 2020, received in Chinese Patent Application No. 201711481216.4, 16 pgs.;;Chinese Office Action with English translation dated Mar. 25, 2020, received in Chinese Patent Application No. 201711405708.5, 11 pgs.;;U.S. Office Action dated Mar. 17, 2020, received in U.S. Appl. No. 15/768,879, 25 pgs.;;Australian Examination Report dated Jun. 24, 2021, received in Australian Patent Application No. 2021201452, 6 pages.;;Chinese Decision of Rejection with English translation dated Jun. 8, 2021 received in Chinese Patent Application No. 201711405708.5, 6 pages.;;Japanese Office Action with English translation dated Jul. 9, 2021, received in Japanese Patent Application No. 2020-080880, 8 pages.;;Korean Office Action with English translation dated Aug. 2, 2021, received in Korean Patent Application No. 10-2020-7006909, 14 pages.;;Chinese Office Action with English translation dated Aug. 31, 2021, received in Chinese Patent Application No. 202011084724.0, 8 pages.;;European Extended Search Report dated Jul. 13, 2021, received in European Patent Application No. 18848114.7, 5 pages.;;Canadian Office Action dated May 3, 2021, received in Canadian Patent Application No. 3,073,677, 6 pages.;;Australian Office Action dated May 5, 2021, received in Australian Patent Application No. 2021201726, 3 pages.;;Chinese Office Action with English translation dated Dec. 9, 2020, received in Chinese Patent Application No. 201711405708.5, 7 pages.;;Chinese Office Action with English translation dated Feb. 18, 2022, received in Chinese Application No. 202110712842.X, 13 pages.;;UK Examination Report dated Mar. 30, 2022, received in UK Application No. GB191515.4, 5 pages.;;Australian Examination Report dated Mar. 17, 2022, received in Australian Application No. 2019362030, 3 pages.;;Japanese Office Action with English translation dated Apr. 22, 2022, received in Japanese Application No. 2021-521415, 13 pages.;;U.S. Appl. No. 60/747,791, filed May 19, 2006.;;Cpu-Zilla, Electrolux Trilobite—Final Words, Hardware Zone.com, Jimmy Tang, Mar. 25, 2003, 2 pages.;;Cpu-Zilla, Electrolux Trilobite—Lifes Better With Auto-Vacumming, Hardware Zone.com, Jimmy Tang, Mar. 25, 2003, 3 pages.;;The Electrolux Group, Trilobite Manual, Sep. 28, 2001, 10 pages.;;Cpu-Zilla, Electrolux Trilobite—Things to Consider, Hardware Zone.com, Jimmy Tang, Mar. 25, 2003, 3 pages.;;Cpu-Zilla, Electrolux Trilobite—Welcome to Paleozoic Park . . . Not Quite, Hardware Zone.com, Jimmy Tang, Mar. 25, 2003, 2 pages.;;Beforemario, Nintendo Chiritori, Mar. 13, 2011, 6 pages.;;UK Examination Report dated Sep. 20, 2022, received in UK Patent Application No. 1915155.4, 4 pages.;;UK Examination Report dated Oct. 24, 2022, received in UK Patent Application No. 2212062.0, 4 pages.;;U.S. Office Action dated Oct. 20, 2022, received in U.S. Appl. No. 16/656,930, 11 pages.;;Chinese Office Action with English translation dated Oct. 18, 2022, received in Chinese Patent Application No. 202210128813.3, 14 pages.;;Australian Examination Report dated Nov. 15, 2022, received in Australian Patent Application No. 2021232679, 5 pages.;;U.S. Office Action dated Dec. 16, 2021, received in U.S. Appl. No. 15/492,320, 17 pages.;;Korean Office Action with machine translation dated Jan. 18, 2022, received in Korean Patent Application No. Oct. 10-2019-7034239, 10 pages.;;Extended European Search Report dated Jun. 17, 2022, received in European Patent Application No. 19872356.1, 6 pages.;;Chinese Office Action with English Machine Translation dated Jun. 28, 2022, received in Chinese Patent Application No. 202111186082.X, 14 pages.;;Chinese Office Action with English Translation dated Jun. 24, 2022, received in Chinese Patent Application No. 2019800688188, 16 pages.;;Korean Office Action with English Machine Translation dated Aug. 1, 2022, received in Korean Patent Application No. 10-2021-7014906, 12 pages.;;U.S. Office Action dated Aug. 10, 2022, received in U.S. Appl. No. 15/492,320, 15 pages.;;Chinese Office Action with English Machine Translation dated Aug. 10, 2022, received in Chinese Patent Application No. 202110712842.X, 20 pages.;;Canadian Office Action dated Jul. 25, 2022, received in Canadian Patent Application No. 3,117,040, 3 pages.;;Chinese Office Action with English summary dated Nov. 23, 2022, received in Chinese Patent Application No. 201980068818.8, 7 pages.;;Chinese Office Action with English summary dated Dec. 26, 2022, received in Chinese Patent Application No. 202210063972X, 10 pages.;;Chinese Second Office Action with English Summary dated May 10, 2023, received in Chinese Patent Application No. 202111186082.X, 17 pages.;;Chinese Office Action with machine generated English translation dated May 27, 2023, received in Chinese Patent Application No. 202210128813.3, 19 pages.;;International Search Report and Written Opinion dated Mar. 17, 2017 in corresponding PCT Patent Application No. PCT/US 16/58155, 12 pgs.;;International Search Report and Written Opinion dated Mar. 24, 2017 in corresponding PCT Patent Application No. PCT/US 16/58148, 14 pgs.;;Chinese Office Action with English Summary dated Jun. 19, 2023, received in Chinese Patent Application No. 201711405708.5, 10 pages.;;Chinese Office Action with English Summary dated Jul. 15, 2023, received in Chinese Patent Application No. 202210063972X, 16 pages.;;Australian Examination Report dated Aug. 31, 2023, received in Australian Patent Application No. 2022202981, 4 pages.",ACTIVE
593,CN,A,CN 108926295 A,064-062-272-548-930,2018-12-04,2018,CN 201810516731 A,2018-05-25,US 201762511099 P,2017-05-25,ROBOTIC CLEANER WITH DUAL CLEANING ROLLERS,"The invention relates to a robotic cleaner with dual cleaning rollers. The robotic cleaner includes a housing, a suction conduit with an opening, and a leading roller mounted in front of a brush roll.An inter-roller air passageway may be defined between the leading roller and the brush roll wherein the lower portion of the leading roller is exposed to a flow path to the suction conduit and an upper portion of the leading roller is outside of the flow path. Optionally, a combing unit includes a plurality of combing protrusions extending into the leading roller and having leading edges not aligned with a center of the leading roller. Optionally, a sealing strip is located along a rear side of the opening and along a portion of left and right sides of the opening. The underside may define side edge vacuum passageways extending from the sides of the housing partially between the leading roller and the sealing strip towards the opening.",SHARKNINJA OPERATING LLC,ADAM UDY;;DAVID WU;;PETER HUTCHINSON;;STEVEN P CARTER;;DAVID S CLARE;;JOHN FREESE;;CHRISTOPHER PINCHES;;ANDRE D BROWN;;WENXIU GAO;;DANIEL R DER MARDEROSIAN;;DAVID W POIRIER;;CATRIONA CA SUTTER;;PATRICK CLEARY;;DANIEL MEYER;;ALEXANDER J CALVINO;;LEE COTTRELL;;DANIEL J INNES;;GORDON HOWES;;DAVID JALBERT;;JASON B THORNE,,https://lens.org/064-062-272-548-930,Patent Application,no,7,3,18,18,0,A47L11/4011;;A47L11/4041;;A47L11/24;;A47L11/4002;;A47L11/4036;;A47L11/4061;;A47L11/4094;;A47L2201/00;;A47L9/0477;;A47L9/0488;;A47L9/0613;;A47L2201/00;;A47L7/0066;;A47L5/30;;A47L9/0477;;A47L9/0488;;A47L9/0613,A47L11/32;;A47L11/40,,0,0,,,,ACTIVE
594,AU,A1,AU 2022/283934 A1,076-158-843-564-646,2023-11-30,2023,AU 2022/283934 A,2022-06-03,US 202163197253 P;;US 2022/0032238 W,2021-06-04,SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS,"Compounds of formula I and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,BECK ELIZABETH MARY;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;SKERRATT SARAH;;HADIDA RUAH SARA S;;MILLER MARK THOMAS;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JINGLAN;;KINTZER ALEXANDER;;DURRANT STEVEN JOHN;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;JACQUES REECE;;GEDDIS STEPHEN MICHAEL;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE;;SOUSA BRUNO ARTUR;;STEVENS REBECCA E;;WRIGHT MIRANDA ADELE;;TWIN HEATHER CLARE;;MUI JAMES JUN BON,,https://lens.org/076-158-843-564-646,Patent Application,no,0,0,3,3,0,C07D405/12;;C07D471/04;;C07D405/14;;C07D413/14;;C07D407/14;;C07D498/04;;C07D417/12;;C07D409/12;;C07D491/052;;C07D471/08;;C07D487/08;;C07D491/10;;C07D521/00;;C07D491/08;;A61P29/00,A61P29/00;;A61K31/443;;C07D405/12;;C07D405/14;;C07D407/14;;C07D409/12;;C07D413/14;;C07D417/12;;C07D471/04;;C07D471/08;;C07D487/08;;C07D491/052;;C07D491/08;;C07D491/10;;C07D498/04;;C07D521/00,,0,0,,,,PENDING
595,CA,A1,CA 3221788 A1,182-344-664-702-769,2022-12-08,2022,CA 3221788 A,2022-06-03,US 202163197253 P;;US 2022/0032238 W,2021-06-04,SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS,"Compounds of formula I and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.",VERTEX PHARMA,BECK ELIZABETH MARY;;PULLIN ROBERT;;ETXEBARRIA JARDI GORKA;;STAMOS DEAN;;SCHMIDT YVONNE;;PONTILLO JOSEPH;;THOMSON STEPHEN ANDREW;;SHAW DAVID MATTHEW;;AHMAD NADIA M;;CARVALHO MEIRELES LIDIO MARX;;SKERRATT SARAH;;HADIDA RUAH SARA;;MILLER MARK THOMAS;;NEUBERT TIMOTHY DONALD;;HURLEY DENNIS JAMES;;ZHOU JUNGLAN;;KINTZER ALEXANDER;;DURRANT STEVEN JOHN;;WRAY CHRISTOPHER;;VIRANI ANISA NIZARALI;;NORTH KIRI;;DODD JAMES;;JACQUES REECE;;GEDDIS STEPHEN MICHAEL;;GALAN BHAIRAVI;;KNEGTEL RONALD MARCELLUS;;CHUDYK EWA IWONA;;PINDER JOANNE LOUISE;;SOUSA BRUNO ARTUR;;STEVENS REBECCA E;;WRIGHT MIRANDA ADELE;;TWIN HEATHER CLARE;;MUI JAMES JUN BON,,https://lens.org/182-344-664-702-769,Patent Application,no,0,0,3,3,0,C07D405/12;;C07D471/04;;C07D405/14;;C07D413/14;;C07D407/14;;C07D498/04;;C07D417/12;;C07D409/12;;C07D491/052;;C07D471/08;;C07D487/08;;C07D491/10;;C07D521/00;;C07D491/08;;A61P29/00,A61K31/443;;A61P29/00;;C07D405/12;;C07D405/14;;C07D407/14;;C07D409/12;;C07D413/14;;C07D417/12;;C07D471/04;;C07D471/08;;C07D487/08;;C07D491/052;;C07D491/08;;C07D491/10;;C07D498/04;;C07D521/00,,0,0,,,,PENDING
